<SEC-DOCUMENT>0001193125-12-191261.txt : 20120427
<SEC-HEADER>0001193125-12-191261.hdr.sgml : 20120427
<ACCEPTANCE-DATETIME>20120427163243
ACCESSION NUMBER:		0001193125-12-191261
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20120613
FILED AS OF DATE:		20120427
DATE AS OF CHANGE:		20120427
EFFECTIVENESS DATE:		20120427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STEMCELLS INC
		CENTRAL INDEX KEY:			0000883975
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943078125
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19871
		FILM NUMBER:		12790063

	BUSINESS ADDRESS:	
		STREET 1:		3155 PORTER DRIVE
		STREET 2:		.
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		6504753100

	MAIL ADDRESS:	
		STREET 1:		3155 PORTER DRIVE
		STREET 2:		.
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CYTOTHERAPEUTICS INC/DE
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d339540ddef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Definitive Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>(RULE 14a-101) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>INFORMATION REQUIRED IN PROXY STATEMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>SCHEDULE 14A INFORMATION
</B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section 14(a) of the </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>(Amendment No. &nbsp;&nbsp; ) </B></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed by the
Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a
Party other than the Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the
appropriate box: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, for Use of the Commission Only&nbsp;(as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant to &#167;240.14a-12</FONT></TD></TR>
<TR>
<TD HEIGHT="32" COLSPAN="5"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B><BR>STEMCELLS, INC.</B></FONT></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified In Its Charter)</B></FONT></TD></TR>
<TR>
<TD HEIGHT="16" COLSPAN="5"></TD></TR>
<TR>
<TD COLSPAN="5" VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</B></FONT></TD></TR>
<TR>
<TD HEIGHT="32" COLSPAN="5"></TD></TR>
<TR>
<TD VALIGN="bottom" COLSPAN="5"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate box):</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid:</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials.</FONT></TD></TR>
<TR>
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify
the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
<TR>
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="85%"></TD></TR>

<TR>
<TD VALIGN="top"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">SEC&nbsp;1913&nbsp;(02-02)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Persons who are to respond to the
collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.</B></FONT></P>
<P STYLE="font-size:8px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD></TR>
</TABLE> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="4"><B>STEMCELLS, INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7707 Gateway Blvd. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Newark, California 94560 </B></FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>To be Held on June&nbsp;13, 2012 </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To the Stockholders of STEMCELLS, INC. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notice is hereby given that the Annual
Meeting of Stockholders of StemCells, Inc. (&#147;StemCells&#148; or the &#147;company&#148;) will be held on Wednesday, June&nbsp;13, 2012, at 2&nbsp;p.m., local time, at 7707 Gateway Boulevard, Newark, California 94560 for the following purposes:
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.&nbsp;to elect the two Class&nbsp;III directors named in the accompanying proxy materials to serve until the 2015 Annual
Meeting of Stockholders; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.&nbsp;to consider and vote upon a proposal to ratify the selection of Grant Thornton LLP as
independent public accountants for the company for the fiscal year ending December&nbsp;31, 2012;&nbsp;and </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.&nbsp;to
transact any and all other business that may properly come before the meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has fixed the close of
business on Friday, April&nbsp;20, 2012, as the record date for determining those stockholders who are entitled to notice of, and to vote at, the annual meeting of stockholders and any postponements or adjournments thereof. The stock transfer books
will not be closed between the record date and the date of the meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Representation of at least a majority of all
outstanding shares of common stock of StemCells is required to constitute a quorum. Accordingly, it is important that your shares be represented at the meeting. This year we are again taking advantage of Securities and Exchange Commission rules that
allow issuers to furnish proxy materials to their stockholders on the Internet. We believe these rules allow us to provide our stockholders with the information they need, while lowering the costs of delivery and reducing the environmental impact of
our Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Please read the proxy materials carefully. All stockholders are invited to attend the Annual Meeting.
Your vote is important, and we appreciate your cooperation in considering and acting on the matters presented. </FONT></P> <P STYLE="font-size:32px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors,</FONT></P></TD></TR>
<TR>
<TD HEIGHT="8"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g339540g32t36.jpg" ALT="LOGO">
</P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth B. Stratton,&nbsp;J.D.</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary</FONT></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;27, 2012 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Newark, California </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>OF </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>STEMCELLS, INC. </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The accompanying proxy is solicited on behalf of the Board of Directors of StemCells, Inc. (the &#147;company&#148;) for use at its
annual meeting of stockholders (the &#147;Annual Meeting&#148;) to be held on Wednesday, June&nbsp;13, 2012, at 2&nbsp;p.m., local time, at the company&#146;s headquarters at 7707 Gateway Boulevard, Newark, California 94560. The company will bear
the cost of solicitation of proxies. Directors, officers and employees of the company may solicit proxies by telephone, facsimile or in person for no additional compensation. The company will reimburse banks, brokerage firms, proxy solicitors, and
other custodians, nominees and fiduciaries for reasonable expenses incurred by them in sending proxy materials to the beneficial owners of shares. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors has fixed the close of business on Friday, April&nbsp;20, 2012, as the record date for determining stockholders entitled to notice of, and to vote at, the Annual Meeting or at any
postponement or adjournment thereof. There were 23,527,746&nbsp;shares of our common stock, $.01&nbsp;par value, outstanding on April&nbsp;1, 2012, each of which is entitled to one vote for each share on the matters to be voted upon. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders are being asked to vote on two proposals at the company&#146;s 2012 Annual Meeting. The proposals to be voted on and related
recommendations from the Board of Directors are as follows: </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal&nbsp;Number 1&nbsp;&#151; To elect the two director
nominees named in this Proxy Statement to serve as Class&nbsp;III directors on the Board until our 2015 annual meeting of stockholders or until that person&#146;s successor is duly elected and qualified. The Board of Directors recommends that you
vote &#147;FOR&#148; each of the nominees. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal&nbsp;Number 2&nbsp;&#151; To ratify the appointment of Grant Thornton LLP
as the company&#146;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2012. The Board of Directors recommends that you vote &#147;FOR&#148; this proposal. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the election of directors, which is Proposal&nbsp;Number 1, you may vote &#147;FOR&#148; both of the nominees or your vote may be
&#147;WITHHELD&#148; with respect to one or both of the nominees. For Proposal&nbsp;Number 2, you may vote &#147;FOR,&#148; vote &#147;AGAINST&#148; or &#147;ABSTAIN.&#148; If you &#147;ABSTAIN&#148; as to Proposal&nbsp;Number 2, the abstention will
have no effect. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Shares of our common stock represented by proxies in the form enclosed that are properly executed and
returned to us and not revoked will be voted as specified in the proxy by the stockholder. In the absence of contrary instructions, or in instances where no specifications are made, the shares will be voted: </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(i)&nbsp;FOR the election as directors of the nominees as described herein under &#147;Proposal&nbsp;Number 1&nbsp;&#151;
Election of Directors;&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">(ii)&nbsp;FOR ratification of the selection of accountants as described herein
under &#147;Proposal Number 2&nbsp;&#151; Ratification of Selection of Independent Public Accountants;&#148; and </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">(iii)&nbsp;in the discretion of the named proxies as to any other matter that may properly come before the Annual Meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any stockholder signing and delivering a proxy may revoke it at any time before it is voted
by delivering to the company&#146;s corporate secretary a written revocation or a duly executed proxy bearing a date later than the date of the proxy being revoked. Any stockholder attending the Annual Meeting in person may revoke his, her or its
proxy and vote his, her or its shares at the Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Our 2012 Proxy Materials are Available on the
Internet.</I>&nbsp;&nbsp;&nbsp;&nbsp;This year we have again elected to provide access to our proxy materials over the Internet in accordance with rules adopted by the Securities and Exchange Commission. Accordingly, we are sending a Notice of
Internet Availability of Proxy Materials (the &#147;Notice&#148;) to our stockholders of record and beneficial owners, which will instruct them as to how they may access and review all of the proxy materials on the Internet and how they may submit
their proxy on the Internet. We expect to begin delivering the Notice to our stockholders on April&nbsp;27, 2012, our initial mailing date. Any stockholder wishing to receive a paper copy of our proxy materials can request them from us by following
the instructions found in the Notice for requesting such materials, or by calling 1&nbsp;(800)&nbsp;579-1639. Requests for a paper copy of our proxy materials should be made on or before May&nbsp;30, 2012 to facilitate timely delivery. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>How to vote shares at our 2012 Annual Meeting. </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">This year company stockholders may cast their vote in any of the following ways: </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vote by Internet.</I>&nbsp;&nbsp;&nbsp;&nbsp;Any stockholder can vote over the Internet at www.proxyvote.com by following the
instructions on the Notice or proxy card. Internet voting facilities for stockholders of record will be available 24&nbsp;hours a day and will close at 11:59&nbsp;p.m. (EDT) on June&nbsp;12, 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vote by Phone.</I>&nbsp;&nbsp;&nbsp;&nbsp;Any stockholder can vote by phone by following the instructions on the proxy card and
calling 1 (800)&nbsp;690-6903 up until 11:59&nbsp;p.m. (EDT) on June&nbsp;12, 2012. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Vote by
Mail.</I>&nbsp;&nbsp;&nbsp;&nbsp;Any stockholder that receives proxy materials by mail can vote by mail by signing, dating and mailing the enclosed proxy card in the postage-paid envelope provided. If the envelope is missing, such a stockholder can
mail the completed proxy card or voting instruction card to Vote Processing, c/o&nbsp;Broadridge, 51&nbsp;Mercedes Way, Edgewood, New York 11717. The completed card must be received no later than June&nbsp;12, 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Voting at the Annual Meeting.</I>&nbsp;&nbsp;&nbsp;&nbsp;All company stockholders are invited to attend the Annual Meeting in person.
Any stockholder that attends the meeting in person may deliver a completed proxy card in person or vote by completing a ballot, which will be available at the meeting. However, each stockholder intending to vote in person at the Annual Meeting
should note that if his, her or its shares are held in the name of a bank, broker or other nominee, such stockholder must obtain a legal proxy, executed in his, her or its favor, from the holder of record to be able to vote at the Annual Meeting.
Stockholders should allow enough time prior to the Annual Meeting to obtain this proxy from the holder of record, if needed. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The shares voted electronically or represented by the proxy cards received, properly marked, dated, signed and not revoked, will be voted
at the Annual Meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>QUORUM, REQUIRED VOTES AND METHOD OF TABULATION </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with Delaware law and the company&#146;s amended and restated by-laws, a majority of the votes entitled to be cast on a
particular matter, present in person or represented by proxy, constitutes a quorum as to such matter. The company will appoint one or more election inspectors for the meeting to count votes cast by proxy or in person at the Annual Meeting.
</FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>What vote is required to approve each item? </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Election of directors by stockholders, which is Proposal&nbsp;Number 1, will be determined by a plurality of the votes cast by the
stockholders entitled to vote at the election that are either present in person or represented by proxy. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For
Proposal&nbsp;Number 2, the affirmative &#147;FOR&#148; vote is required by the holders of a majority of the shares present at the Annual Meeting in person or by proxy and voting. Abstentions will have no effect on the outcome of this proposal.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you hold shares beneficially in street name and do not provide your broker or nominee with voting instructions, your
shares may constitute &#147;broker non-votes.&#148; Generally, broker non-votes occur on a matter when a broker is not permitted to vote on that matter without instructions from the beneficial owner and instructions have not been given. This year if
you hold shares beneficially in street name and do not vote your shares, your broker or nominee can vote your shares at its discretion only on Proposal&nbsp;Number 2. In tabulating the voting result for any proposal for which the required vote is
based on the number of shares present, shares that constitute broker non-votes are not considered entitled to vote on that proposal. However, for proposals for which the required vote is based on the number of shares of common stock issued and
outstanding, broker non-votes have the same effect as a vote &#147;AGAINST&#148; the proposal. Thus, broker non-votes will not affect the outcome of Proposal&nbsp;Number 1. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Management does not know of any matters to be presented at this year&#146;s Annual Meeting other than those set forth in this proxy statement and in the notice accompanying this proxy statement.
Stockholders will have no appraisal rights under Delaware law with respect to any of the matters expected to be voted on at the Annual Meeting. If other matters should properly come before the meeting, the proxy holders will vote such matters in
their discretion. Any stockholder has the right to revoke his, her or its proxy at any time until it is voted. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER
MATTERS </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows the number of shares of our common stock beneficially owned, as of April&nbsp;1, 2012,
by (i)&nbsp;each of our directors, (ii)&nbsp;each of our named executive officers, (iii)&nbsp;all of our directors and executive officers as a group, and (iv)&nbsp;all those known by us be to a beneficial owner of more than 5% of the company&#146;s
outstanding common stock. In general, &#147;beneficial ownership&#148; refers to shares that an individual or entity has the power to vote or dispose of, and any rights to acquire common stock that are currently exercisable or will become
exercisable within 60&nbsp;days of April&nbsp;1, 2012. Unless otherwise indicated, we believe that each person named below, based on information furnished by such owners, holds sole investment and voting power with respect to such shares, subject to
community property laws where applicable. We calculated percentage ownership in accordance with the rules of the SEC. The percentage of common stock beneficially owned is based on 23,527,746&nbsp;shares outstanding as of April&nbsp;1, 2012. In
addition, shares issuable pursuant to options, restricted stock units or other convertible securities that may be acquired within 60&nbsp;days of April&nbsp;1, 2012 are deemed to be issued and outstanding and have been treated as outstanding in
calculating and determining the beneficial ownership and percentage ownership of those persons possessing those securities, but not for any other individuals. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="69%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:138pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Address of Beneficial Owner*</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Amount&nbsp;and<BR>Nature of<BR>of&nbsp;Beneficial<BR>Ownership</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percentage&nbsp;of<BR>Class&nbsp;Beneficially<BR>Owned</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Directors and Named Executive Officers</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric Bjerkholt(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig(2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38,926</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricardo Levy(3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,636</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn(4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">228,033</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger Perlmutter(5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Schwartz(6)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,770</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton(7)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,877</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto(8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">106,372</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Irving Weissman(9)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">106,147</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young(10)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">109,972</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All directors and executive officers as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>698,754</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.92</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>%&nbsp;</B></FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5% Stockholders</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alpha Capital Anstalt(11)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,352,645</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.99</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">ICS Opportunities, Ltd.(12)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,350,421</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.99</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The address of all directors and executive officers listed in the table is c/o&nbsp;StemCells, Inc., 7707 Gateway Blvd., Newark, California 94560.
</FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">**</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Less than one percent. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 7,000&nbsp;shares issuable upon exercise of stock options exercisable within 60&nbsp;days. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 25,457&nbsp;shares issuable upon exercise of stock options exercisable within 60&nbsp;days. Includes 7,347&nbsp;shares included in Dr.&nbsp;Craig&#146;s 401(k)
plan. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 9,636&nbsp;shares issuable upon exercise of stock options exercisable within 60&nbsp;days. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 174,109&nbsp;shares issuable upon exercise of 168,242 stock options and 5,867 restricted stock units, either exercisable or vesting within 60&nbsp;days.
Includes 12,345&nbsp;shares included in Mr.&nbsp;McGlynn&#146;s 401(k) plan. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 12,021&nbsp;shares issuable upon exercise of 11,021 stock options and 1,000 restricted stock units, either exercisable or vesting within 60&nbsp;days.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 8,000&nbsp;shares issuable upon exercise of 6,500 stock options and 1,500 restricted stock units, either exercisable or vesting within 60&nbsp;days.
</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 22,353&nbsp;shares issuable upon exercise of 20,020 stock options and 2,333 restricted stock units, either exercisable or vesting within 60&nbsp;days. Includes
5,662 shares included in Mr.&nbsp;Stratton&#146;s 401(k) plan. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 76,539&nbsp;shares issuable upon exercise of 74,206 stock options and 2,333 restricted stock units, either exercisable or vesting within 60&nbsp;days. Includes
10,332&nbsp;shares included in Dr.&nbsp;Tsukamoto&#146;s 401(k) plan. Includes a total of 3,643&nbsp;shares held in trusts for the benefit of Dr.&nbsp;Tsukamoto and her family members, as to which she disclaims beneficial ownership.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 1,390&nbsp;shares issuable upon exercise of 390 stock options and 1,000 restricted stock units, either exercisable or vesting within 60&nbsp;days. Includes
14,578 shares held in trust for Dr.&nbsp;Weissman&#146;s grandchildren as to which he disclaims beneficial ownership. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes 84,936&nbsp;shares issuable upon exercise of 79,270 stock options and 5,666 restricted stock units, either exercisable or vesting within 60&nbsp;days. Includes
10,616&nbsp;shares included in Mr.&nbsp;Young&#146;s 401(k) plan. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">According to a Schedule&nbsp;13G filed by Alpha Capital Anstalt on February&nbsp;28, 2012, Alpha Capital may be deemed to beneficially own all shares listed in the
table, and has sole dispositive and voting power with respect to all shares listed in the table. The address of the principal place of business of Alpha Capital is Pradafant 7, Furstentums 9490, Vaduz, Liechtenstein. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on a Schedule 13G filed on December&nbsp;23, 2011, ICS Opportunities, Ltd., an exempted limited company organized under the laws of the Cayman Islands (&#147;ICS
Opportunities&#148;), held as of that date: (i)&nbsp;674,841 shares of our common stock; (ii)&nbsp;800,000 of our Series A warrants; and (iii)&nbsp;800,000 of our Series B warrants. The Series A warrants are exercisable immediately and will expire
on December&nbsp;21, 2016. Each Series B warrant entitles the holder to purchase one unit, each of which consists of one share of our common stock and one Series A warrant to purchase one share of our common stock. The Series B warrants will expire
on May&nbsp;2, 2012. Due to the limits on the exercise of the Series A warrants and Series B warrants included in the terms thereof, the holder will not have the right to exercise any portion of either warrant if the holder, together with its
affiliates, would beneficially own in excess of 9.999% of the number of shares of our common stock outstanding immediately after the exercise. Millennium International Management LP, a Delaware limited partnership (&#147;Millennium International
Management&#148;), is the investment manager to ICS Opportunities and may be deemed to have shared voting control and investment discretion over securities owned by ICS Opportunities. Millennium International Management GP LLC, a Delaware limited
liability company (&#147;Millennium International Management GP&#148;), is the general partner of Millennium International Management and may also be deemed to have shared voting control and investment discretion over securities owned by ICS
Opportunities. Millennium Management LLC, a Delaware limited liability company (&#147;Millennium Management&#148;), is the general partner of the 100% shareholder of ICS Opportunities and may be deemed to have shared voting control and investment
discretion over securities owned by ICS Opportunities. Israel A. Englander (&#147;Mr. Englander,&#148; and together with ICS Opportunities, Millennium International Management, Millennium International Management GP and Millennium Management, the
&#147;Millennium Entities&#148;), a U.S. citizen, is the managing member of Millennium International Management GP and of Millennium Management. Consequently, Mr.&nbsp;Englander may also be deemed to have shared voting control and investment
discretion over securities owned by ICS Opportunities. The address of the principal place of business of the Millennium Entities is 666 Fifth Avenue, New York, NY 10103. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INFORMATION CONCERNING DIRECTORS OF THE COMPANY </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board of Directors </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We
currently have seven directors serving on our Board of Directors. Since June 2010, our Board has been composed of Drs.&nbsp;Ricardo Levy, Roger Perlmutter, John Schwartz, and Irving Weissman and Messrs.&nbsp;Eric Bjerkholt, Scott Greer and Martin
McGlynn. The following table shows the names, ages, principal occupations, and public company board memberships for the last five years of our directors, as of April&nbsp;1, 2012: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric Bjerkholt</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">52</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric Bjerkholt was elected to the Board of Directors in March 2004. He is Executive Vice President and Chief Financial Officer of Sunesis Pharmaceuticals, Inc. Mr. Bjerkholt is a
member of the board of directors of Round Table Pizza, Inc.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">53</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Scott Greer was appointed to the Board of Directors in June 2010. He is currently a principal and managing director of Numenor Ventures LLC, which he founded in 2002 to provide
funding and strategic advisory services to early stage enterprises. Mr.&nbsp;Greer currently serves as Chairman of Ablexis, a development stage biotechnology company, and is also on the board of Nektar Therapeutics and BAROnova.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricardo Levy,&nbsp;Ph.D.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">67</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricardo Levy,&nbsp;Ph.D. was elected to the Board of Directors in September 2001. He currently serves as a director on the board of Accelrys, Inc., a public company focused on
molecular modeling and simulation software for both life and materials science research.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">65</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn was elected to the Board of Directors in February 2001. He is President and Chief Executive Officer of the company, a position he has held since January
2001.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger Perlmutter,&nbsp;M.D.,&nbsp;Ph.D.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">59</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger Perlmutter,&nbsp;M.D.,&nbsp;Ph.D., was elected to the Board of Directors in December 2000. Until recently, he was Executive Vice President, Research and Development, of
Amgen, Inc. He is Chairman of the Board of Trustees of Reed College.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Schwartz,&nbsp;Ph.D.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">77</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Schwartz,&nbsp;Ph.D., was elected to the Board of Directors in December 1998 and was elected Chairman of the Board at the same time. He is currently President of Quantum
Strategies Management Company.</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="44%"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Irving Weissman,&nbsp;M.D.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">72</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Irving Weissman,&nbsp;M.D., was elected to the Board of Directors in September 1997. He is the Virginia and Daniel K. Ludwig Professor of Cancer Research, Professor of Pathology
and Professor of Developmental Biology at Stanford University.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because we have a classified board, with each of our directors serving a staggered three-year term, only
two of our directors are standing for reelection at our 2012 Annual Meeting. The following table shows the composition of the three classes of our Board: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Class&nbsp;I Directors (terms scheduled to expire in 2013): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric Bjerkholt</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Schwartz,&nbsp;Ph.D.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Class&nbsp;II Directors (terms scheduled to expire in 2014): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricardo Levy,&nbsp;Ph.D.</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Irving Weissman,&nbsp;M.D.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Class&nbsp;III Directors (terms scheduled to expire in 2012, but nominated to stand for reelection at our 2012 Annual
Meeting): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger Perlmutter,&nbsp;M.D.,&nbsp;Ph.D.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The independent members of our Board, as determined by the Board of Directors in accordance with the
existing Nasdaq Listing rules, are Messrs.&nbsp;Bjerkholt and Greer and Drs.&nbsp;Levy, Perlmutter and Schwartz. The Board of Directors held four regular meetings and two special meetings during the fiscal year ended December&nbsp;31, 2011. Each of
our directors attended more than 75% of the meetings of the Board of Directors and of the committees on which he served. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For
many years the roles of chairman and chief executive officer at the company have been separated. We believe that this is appropriate under current circumstances, because it allows management to make the operating decisions necessary to manage the
business, while helping to maintain Board independence so that it can provide an effective oversight function. We feel that this has provided an appropriate balance of operational focus, flexibility and oversight. Our independent directors meet at
regularly scheduled executive sessions without members of management. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Committees </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Presently, the Board has four standing committees&nbsp;&#151; the Audit Committee, the Compensation and Stock Option Committee (the
&#147;Compensation Committee&#148;), the Corporate Governance and Nominating Committee (the &#147;Corporate Governance Committee&#148;), and the Strategic Transactions Committee &#151; as well as a single-member committee established under the
company&#146;s 2001, 2004 and 2006 equity incentive plans. The Board created the Strategic Transactions Committee in March 2009 as an <I>ad hoc</I> committee with direction to consult with management and advise the full Board on various corporate
initiatives, such as the acquisition of substantially all of the operating assets of Stem Cell Sciences plc, which the company completed in April 2009. In June 2010, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
however, the Board reconstituted the Strategic Transactions Committee, which Mr.&nbsp;Greer currently chairs, as a standing committee of the Board. All members of the Audit Committee, the
Compensation Committee, and the Corporate Governance Committee are, and are required by the charters of the respective committees to be, independent as determined under Nasdaq Listing rules. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><U>Audit Committee</U>.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee is composed of Mr.&nbsp;Bjerkholt and Drs.&nbsp;Schwartz and
Levy. The Audit Committee held four meetings during the fiscal year ended December&nbsp;31, 2011. The primary function of the Audit Committee is to assist our Board in fulfilling its oversight responsibilities. The committee does this primarily by
reviewing our financial reports and other financial information as well as the company&#146;s systems of internal controls regarding finance, accounting, legal compliance, and ethics that management and the Board have established. The committee also
assesses our auditing, accounting and financial processes more generally. The Audit Committee meets quarterly, and at such other times as it finds necessary. It recommends to our Board the appointment of a firm of independent auditors to audit the
financial statements of the company and meets with such personnel of the company to review the scope and the results of the annual audit, the amount of audit fees, the company&#146;s internal accounting controls, the company&#146;s financial
statements contained in this proxy statement and other related matters. Each of the members of the Audit Committee is independent, and the Board has determined that Mr.&nbsp;Bjerkholt is an &#147;audit committee financial expert,&#148; as defined in
SEC rules. The Audit Committee acts pursuant to a written charter which is available through our website at www.stemcellsinc.com. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I><U>Compensation Committee</U>.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Compensation Committee is composed of Drs.&nbsp;Schwartz and Levy and Mr.&nbsp;Bjerkholt. The Compensation Committee held three meetings
during the fiscal year ended December&nbsp;31, 2011. The Compensation Committee makes recommendations to our Board and management concerning salaries in general, determines executive compensation and, except to the extent that such decisions have
been delegated to, and made by, the single-member committee, approves incentive compensation for our employees and consultants. The Compensation Committee acts pursuant to a written charter which is available through our website at
www.stemcellsinc.com. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><U>Corporate Governance Committee</U>.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Corporate Governance Committee
is composed of Drs.&nbsp;Levy, Perlmutter and Schwartz. The Corporate Governance Committee held two meetings in 2011 to discuss a slate of actual and potential nominees to the Board of Directors. The committee oversees nominations to the Board and
considers the experience, ability and character of potential nominees to serve as directors, as well as particular skills or knowledge that may be desirable in light of the company&#146;s position at any time. From time to time, the committee has
engaged the services of a paid search firm to help the committee identify potential nominees to the Board. The Company&#146;s Governance Committee and Board seek to nominate and appoint candidates to the Board who have significant business
experience, technical expertise or personal attributes, or a combination of these, sufficient to suggest, in the Board&#146;s judgment, that the candidate would have the ability to help direct the affairs of the company and enhance the Board as a
whole. The Committee may identify potential candidates through any reliable means available, including recommendations of past or current members of the Board from their knowledge of the industry and of the company. The Committee also considers past
service on the Board or on the board of directors of other publicly traded or technology focused companies. The committee has not adopted a formulaic approach to evaluating potential nominees to the Board; it does not have a formal policy concerning
diversity, for example. Rather, the committee weighs and considers the experience, expertise, intellect, and judgment of potential nominees irrespective of their race, gender, age, religion, or other personal characteristics. The committee often
looks for nominees that can bring new skill sets or diverse business perspectives. Potential candidates recommended by security holders will be considered as provided in the company&#146;s &#147;Policy Regarding Shareholder Candidates for Nomination
as a Director,&#148; which sets forth the procedures and conditions for such recommendations. This policy is available through our website at www.stemcellsinc.com. The Corporate Governance Committee operates pursuant to a written charter, a copy of
which is also available through our website at www.stemcellsinc.com. The members of the Corporate Governance Committee approved the nomination of the Class&nbsp;III directors standing for reelection at the Annual Meeting. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><U>Strategic Transactions Committee</U>.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Strategic
Transactions Committee is composed of Messrs.&nbsp;Bjerkholt, Greer and McGlynn and Dr.&nbsp;Levy. The Strategic Transactions Committee held three meetings during the fiscal year ended December&nbsp;31, 2011. The Committee was created at the
suggestion of our Chief Executive Officer in March 2009 to provide advice and direction, on an <I>ad hoc</I> basis, on a range of strategic initiatives being considered at the time, such as the acquisition of substantially all of the operating
assets of Stem Cell Sciences plc. The Committee does not have a formal charter. However, the Board of Directors has authorized the Committee to be available to advise, consult and participate with management, as requested by the company&#146;s Chief
Executive Officer, with respect to the identification, implementation, evaluation, and negotiation of potential strategic corporate transactions, with the exception of financings. Since June 2010, the Strategic Transactions Committee has been the
Board&#146;s fourth standing committee, and as such it routinely provides recommendations both to management and to the full Board with regard to such matters as the Committee may deem advisable. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows the members of our four standing Board committees: </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:28pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Director</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Independent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Audit<BR>Committee</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation<BR>Committee</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Corporate<BR>Governance<BR>Committee</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Strategic<BR>Transactions<BR>Committee</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric Bjerkholt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chair</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#252;</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#252;</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chair</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricardo Levy,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#252;</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#252;</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chair</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#252;</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">No</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#252;</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger&nbsp;Perlmutter,&nbsp;M.D.,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#252;</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Schwartz,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#252;</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chair</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#252;</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS"></FONT>&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Irving Weissman,&nbsp;M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">No</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Director Oversight and Qualifications </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">While management is responsible for the day-to-day management of the risks the company faces, the Board, as a whole and through its committees, has responsibility for the oversight of risk management. An
important part of risk management is not only understanding the risks facing the company and what steps management is taking to manage those risks, but also understanding what level of risk is appropriate for the company. In support of this
oversight function, the Board receives regular reports from our Chief Executive Officer and members of senior management on operational, financial, legal, and regulatory issues and risks. The Audit Committee additionally is charged under its charter
with oversight of financial risk, including the company&#146;s internal controls, and it receives regular reports from management, the company&#146;s internal auditors and the company&#146;s independent auditors. The Chairman of the Board and
independent members of the Board work together to provide strong, independent oversight of the company&#146;s management and affairs through its standing committees and, when necessary, special meetings of directors. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe each of our directors brings valuable skills, experience, judgment, and
perspectives to our company. The Board took the following qualifications into consideration, among other things, when nominating or appointing our current directors: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="67%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric&nbsp;Bjerkholt</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Bjerkholt is a financial expert and currently serves as the Executive Vice President and Chief Financial Officer of Sunesis Pharmaceuticals, Inc., a biopharmaceutical
company. His business experience spans approximately 20&nbsp;years, during which time he founded a nutraceutical company and worked as an investment banker. Mr.&nbsp;Bjerkholt currently serves on the board of directors of Round Table Pizza. We
believe Mr.&nbsp;Bjerkholt&#146;s qualifications to serve on our Board of Directors include his considerable financial and business experience, especially in the life sciences industry. Mr.&nbsp;Bjerkholt has served on our Board for over eight
years.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Greer was appointed to our Board in June 2010. He is a financial expert with over 25&nbsp;years of experience in the life sciences industry. He was founder, CEO and
Chairman of Abgenix, Inc., a biotechnology company he took public in 1998 and then sold to Amgen in 2006. Mr.&nbsp;Greer currently serves as Chairman of Ablexis, a development stage biotechnology company, and is also on the boards of Nektar
Therapeutics and BAROnova. We believe Mr.&nbsp;Greer&#146;s qualifications to serve on our Board include his more than 25&nbsp;years of experience in the life sciences industry.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricardo&nbsp;Levy,&nbsp;Ph.D.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Levy has over 30&nbsp;years of experience leading technology companies in both North and South America. In 1974, he cofounded Catalytica, Inc., a manufacturing
technology and energy systems company, and served as CEO from 1991 until the company was sold in 2000. Dr.&nbsp;Levy currently serves as director of Accerlys Inc. (formerly Pharmacopeia, Inc.) and NovoDynamics, Inc. We believe his qualifications to
serve on our Board of Directors include his more than 30&nbsp;years of business experience. Dr.&nbsp;Levy has served on our Board for over ten years.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;McGlynn has been our President and Chief Executive Officer since January 2001. He has held management positions of increasing responsibility in several countries for
more than 30&nbsp;years. Prior to joining our company, Mr.&nbsp;McGlynn was President and Chief Executive Officer of Pharmadigm, Inc., a privately held company in the fields of inflammation and genetic immunization. Prior to this, he was President
and General Manager of Abbott Canada Ltd. and President of Anaquest, Inc., a company focused on anesthesia and acute care pharmaceuticals. We believe Mr.&nbsp;McGlynn&#146;s qualifications to serve on our Board of Directors include his significant
managerial experience in our industry and his intimate knowledge of our operations as a result of his day to day leadership as our President and Chief Executive Officer. Mr.&nbsp;McGlynn has served on our Board for over eleven
years.</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="67%"></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger&nbsp;Perlmutter,&nbsp;M.D.,&nbsp;Ph.D.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Until recently, Dr.&nbsp;Perlmutter has been the Executive Vice President of Research and Development of Amgen, Inc., a world leading biotechnology company, a position he held
for approximately eleven years. Prior to joining Amgen, he held scientific leadership positions of increasing responsibility at Merck. He also worked as a researcher and administrator at the University of Washington. We believe
Dr.&nbsp;Perlmutter&#146;s pharmaceutical industry experience brings an important industry perspective to the Board. Dr.&nbsp;Perlmutter has served on our Board for over eleven years.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Schwartz, Ph.D.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Schwartz has over 40&nbsp;years of business and legal experience, including several years spent in the 1990s as President and Chief Executive Officer of Systemix, Inc.,
a cell-based therapeutics company which was acquired by Novartis in 1997. Before joining Systemix as its Senior Vice President and General Counsel in 1993, Dr.&nbsp;Schwartz served as the Vice President and General Counsel of Stanford University. He
currently runs a registered investment advisor firm called Quantum Strategies Management Company. We believe Dr.&nbsp;Schwartz&#146;s qualifications to serve on our Board of Directors include his over 40&nbsp;years of business and legal experience
in our industry as well as his significant experience working at Stanford University. Dr.&nbsp;Schwartz has served on our Board for over 14&nbsp;years.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Irving Weissman, M.D.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Weissman has been a leader in the stem cell field for over 20&nbsp;years. He is a professor at Stanford University and serves as the director of the Stanford Institute
for Stem Cell Biology and Regenerative Medicine. He co-founded Systemix in 1988 and Cellerant Therapeutics, Inc., a hematopoietic stem cell development company, in 2001. He is a member of several scientific advisory boards and national science
institutes, including the National Academy of Science, the American Academy of Arts and Science, and the Institute of Medicine of the National Academy of Sciences. We believe Dr.&nbsp;Weissman&#146;s qualifications to serve on our Board of Directors
include the fact that he has been a leader in stem cell research for over 20&nbsp;years as well as his substantial business experience in our industry. Dr.&nbsp;Weissman has served on our Board for over 14&nbsp;years and serves as the chairman of
our Scientific Advisory Board.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders who wish to communicate with our Board of Directors or with a particular director may send a
letter to our corporate secretary at the following address: StemCells, Inc., 7707 Gateway Blvd., Newark, California 94560 (c/o&nbsp;Legal Department). Any communication should clearly specify that it is intended to be made to the entire Board or to
one or more particular director(s). Our corporate secretary will review all such correspondence and forward to our Board a summary of all such correspondence and copies of all correspondence that, in the opinion of the secretary, deals with the
functions of the Board or committees thereof or that he otherwise determines requires their attention. The secretary maintains a log of all correspondence received by us that is addressed to members of the Board, and any director may at any time
review and request copies of any such correspondence. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Concerns relating to accounting, internal controls or auditing matters will immediately be
brought to the attention of the chairman of the Audit Committee and handled in accordance with established procedures, which are set out in the Audit Committee&#146;s Policy on Receipt, Retention and Treatment of Complaints Regarding Accounting,
Internal Controls and Auditing Matters. A copy of this policy is available through our website at www.stemcellsinc.com. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Code of Business
Conduct and Ethics </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have adopted a Code of Ethics and Conduct that applies to all of our directors, officers,
employees, and consultants. A copy of our code of ethics is posted on our website at www.stemcellsinc.com. We intend to disclose any substantive amendment or waivers to this code on our website. There were no substantive amendments or waivers to
this code in 2011. </FONT></P> <P STYLE="margin-top:30px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>INFORMATION CONCERNING EXECUTIVE OFFICERS OF THE COMPANY </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Officers, Positions Held </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Following are the name, age and other information for our named executive officers, as of April&nbsp;1, 2012. All company officers have been elected to serve until their successors are elected and
qualified or until their earlier resignation or removal. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="44%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn,</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; text-indent:1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">65</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn joined the company in January 2001, when he was appointed President and Chief Executive Officer of the company and of its wholly-owned subsidiaries. Mr.&nbsp;McGlynn
was elected to the Board of Directors in February 2001.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto,&nbsp;Ph.D.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President, Research and</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; text-indent:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">59</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto,&nbsp;Ph.D., joined the company in November 1997 as Senior Director of Scientific Operations; was appointed Vice President, Scientific Operations in June 1998; Vice
President, Research and Development in February 2002; and Chief Operating Officer, with responsibility for the company&#146;s research and development efforts, in November 2006. In October 2008, Dr.&nbsp;Tsukamoto was appointed Executive Vice
President, Research and Development, with responsibility for the company&#146;s scientific and clinical development programs. Dr.&nbsp;Tsukamoto is married to one of our outside
directors.</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="48%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="44%"></TD></TR>

<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young,</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Chief Financial Officer and Vice President,</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; text-indent:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Finance and
Administration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">49</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young joined the company in September 2005 as Chief Financial Officer and Vice President, Finance. In November 2006 he became CFO and Vice President, Finance and
Administration. He is responsible for functions that include Finance, Information Technology and Investor Relations. From 2003 to 2005, Mr.&nbsp;Young was Chief Financial Officer and a director of Extropy Pharmaceuticals, Inc., a private
biopharmaceutical company focused on developing drugs for pediatric indications.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Development and</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; text-indent:1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D., joined the company in September 2008 with responsibilities for Development, Manufacturing, Regulatory, Quality Systems, and Facilities. From 2005 to 2008,
Dr.&nbsp;Craig was Chief Technology Officer and Vice President of Progenitor Cell Therapy, a contract services provider for research, development, manufacture, and commercialization of cell-based therapies, prior to which he has held executive
positions at Xcyte Therapies, Osiris Therapeutics and SyStemix.</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D.</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px; text-indent:1.00em"><FONT
STYLE="font-family:Times New Roman" SIZE="2">General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">43</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D., joined the company in February 2007 as General Counsel, with responsibility for corporate compliance and legal affairs. In March 2008, he assumed
responsibility for the Human Resources function. Prior to joining StemCells, Mr.&nbsp;Stratton served as Deputy General Counsel for Threshold Pharmaceuticals and as Senior Legal Counsel for Medtronic, Inc.&#146;s Vascular business
unit.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:30px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXECUTIVE COMPENSATION </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Discussion and Analysis </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We structure our compensation
programs to attract and retain talented employees and reward them for helping us achieve our short-term and long-term goals. We intend for our compensation programs to be equitable and competitive when measured against those offered by companies
against whom we compete for high-level scientific and executive personnel. We also intend for them to link pay to both company and individual performance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In seeking to accomplish these objectives, we follow a compensation strategy designed, ultimately, to reward increasing stockholder value. However, because achievement of our principle mission&nbsp;&#151;
the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry&nbsp;&#151; is a long, expensive and challenging process, we often set individual compensation by using surrogate
endpoints to gauge employee contributions towards building sustained stockholder value, such as: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the achievement of stated corporate goals adopted from time to time by the Board; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the leadership an executive officer has shown in inspiring and marshalling excellent performances in his or her direct reports;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the anticipation, identification and successful disposition of issues and problems that, if not addressed timely and effectively, might have a
deleterious effect on the company;&nbsp;and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the speed and effectiveness with which an executive officer discovers, assesses and, where appropriate, pursues promising opportunities for the
company. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation elements.</I>&nbsp;&nbsp;&nbsp;&nbsp;We, like most biotechnology companies, use a
combination of base salary, bonuses and equity awards to compensate our employees, including our executive officers. As a small company&nbsp;&#151; we have approximately 50&nbsp;employees in total and only five executive officers&nbsp;&#151; we feel
that having so few people in each job classification and level makes it inefficient to establish a formulaic allocation of total compensation among its various elements; we rely, instead, on our experience and judgment. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2">In exercising this judgment, we periodically collect and review information (i)&nbsp;from third party market reports
such as the <I>Radford Biotechnology Survey&nbsp;&#151; Executive Report</I>; and (ii)&nbsp;from the proxy statements of other similar biotechnology companies, especially those operating in the San&nbsp;Francisco Bay Area, as well as those pursuing
cell-based therapeutics.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> In the case of the executive officers who report directly to the chief executive officer, we also carefully consider the
recommendations of the chief executive officer when setting compensation. We integrate all of this information with our evaluation of the individual performance of each of our executive officers. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">While we believe our officers and other employees are outstanding, we realize that the company is not yet profitable and that it is still
in a relatively early stage of development. We therefore generally prefer to target our compensation practices so that our employees&#146; base salaries, bonuses, equity compensation, and benefits all fall close to the 50th&nbsp;percentile paid by
comparable companies for similar positions. Actual compensation may fall slightly above or below these targets, however, because of any number of factors such as general economic conditions, market competition for specific jobs, personal
performance, and the need for internal equities within the company. For example, we have recently paid many of our employees, including some of our executive officers, at below the 50th&nbsp;percentile because of the global recession and the crisis
in the financial markets. At the same time, however, we have paid many of our employees, including some of our executive officers, at above the 50th&nbsp;percentile because of highly competitive demand for workers with their unique skill sets.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Interaction of compensation elements.</I>&nbsp;&nbsp;&nbsp;&nbsp;The basic compensation elements&nbsp;&#151; base salary,
bonuses and equity awards&nbsp;&#151; are, as noted, standard in our industry. Though not set independently of one other, we use each element as a portion of total compensation because we believe we would not otherwise be competitive and because we
feel that together they are the proper components of a balanced compensation package: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">base salary is compensation for current efforts; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">bonuses, whether in cash or equity, are paid at the Board&#146;s discretion typically for achievements in meeting or exceeding corporate
goals;&nbsp;and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">equity awards are inducements to remain with the company and to build future value. </FONT></P></TD></TR></TABLE>
<P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">1</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> In 2012, for example, we collected executive compensation information
from the recent SEC filings of Aastrom Biosciences, Inc.; Affymax, Inc.; Alexza Pharmaceutics, Inc.; Anacor Pharmaceuticals, Inc.; Athersys, Inc.; Cerus Corporation; Cytokinetics, Incorporated; Cytori Therapeutics, Inc.; Dynavax Technologies
Corporation; Geron Corporation; InterMune, Inc.; MAP Pharmaceuticals, Inc.; Maxygen, Inc.; Medivation, Inc.; Neuralstem, Inc.; Osiris Therapeutics, Inc.; Rigel Pharmaceuticals, Inc.; Sangamo Biosciences, Inc.; and Sunesis Pharmaceuticals, Inc.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On occasion, we have considered our employee compensation programs, including our executive
compensation programs, and the effect they may have on company risk. We have concluded that our employee compensation programs are simple and straight-forward and consistent with those of similarly situated research and development companies. In
determining that our compensation policies and practices do not present risks that are likely to have a material adverse effect on our business, our directors have, from time to time, discussed with management the various pay practices used to
compensate our employees at both the executive and non-executive levels. These inquiries have included discussions about our three primary components of compensation, namely base compensation, cash bonuses and equity incentive compensation.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board of Directors has also periodically considered how bonus awards are determined and calculated by the company, noting
that all bonuses are awarded entirely at the discretion of our Board after taking into consideration the progress of our company&#146;s programs. Based on its review, our Board has concluded that our bonus program properly aligns compensation with
our overall goals, all of which are designed to have a positive impact on our business. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, our Board has
periodically examined our equity compensation practices, noting that we typically grant customary equity awards that vest over many years after the date of grant. We believe discretionary equity compensation that vests over multiple years does not
encourage short-term or high-risk opportunistic behavior and instead aligns our employees&#146; interests with the long-term interests of our stockholders by encouraging activities intended to build long-term value for the Company. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For these reasons, we have concluded that our employee compensation programs are designed with the appropriate balance of risk and reward
in relation to our company&#146;s overall business strategy and do not incentivize executives or other employees to take unnecessary or excessive risks. As a result, we believe that risks arising from our employee compensation policies and practices
are not reasonably likely to have a material adverse effect on the company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Other compensation elements and
benefits.</I>&nbsp;&nbsp;&nbsp;&nbsp;We offer all employees various health and welfare benefit plans. Our executive officers may participate in these on the same terms as other employees. We do not have a pension plan nor do we use non-qualified
deferred compensation.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">2</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> We offer our U.S.&nbsp;employees
(again, including executive officers on the same terms as others) a 401(k) defined contribution plan, and match employee contributions on a 1:2 basis (i.e., $1 contribution by the company for every $2 contribution made by the employee) up to a
maximum of 3% of the employee&#146;s salary, subject to legal limitations. At this time, our 401(k) match is made in the form of shares of common stock in the company. We offer our U.K. employees a tax preferred pension scheme, and match employee
contributions on a 1:1 basis up to a maximum of 12% of the employee&#146;s salary. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation of Named Executive Officers
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Base salary compensation; target bonuses.</I>&nbsp;&nbsp;&nbsp;&nbsp;We consider base salary to be a critical
component of our executive officers&#146; overall compensation packages. We intend the salaries of our executive officers to reflect their actual responsibilities and job scope. We also endeavor to set base compensation levels so that their salaries
are competitive with salaries paid by comparable companies to employees with similar experience, taking into account the cost of living in the San&nbsp;Francisco Bay Area. Accordingly, we have made occasional adjustments to the salaries of certain
employees to address perceived below market anomalies, address specific retention concerns or reward special contributions made to the company. As described below, we changed the base compensation paid to certain of our executive officers in 2009,
2010 and 2012. </FONT></P> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">2</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> </FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">Accordingly, we omit tables showing pension benefits and non-qualified
deferred compensation. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to base salary, each full-time employee of the company, including each of our
named executive officers, is given a personal target bonus (calculated as a percentage of base salary), based upon factors such as seniority, job title and the existing targets of co-workers with comparable job responsibilities within the company.
Bonuses at the company are discretionary and awarded by the Board in its sole discretion. But when bonuses are awarded, we use the personal target of each employee to calculate his or her bonus amount. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With these various principles in mind, we recently took the following actions with respect to the base compensation and bonus targets of
our executive officers. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">From March 2007 through 2008, we maintained the annual base salary of Mr.&nbsp;McGlynn at $385,000,
plus a housing and transportation allowance. Effective January 2009, however, we eliminated Mr.&nbsp;McGlynn&#146;s housing and transportation allowance of approximately $200,000 per year and increased Mr.&nbsp;McGlynn&#146;s annual base salary by
$140,000, from $385,000 to $525,000, and began providing him a car allowance in the amount of $10,000 per year. The net effect of these changes was a decrease in Mr.&nbsp;McGlynn&#146;s base compensation of approximately 11% for 2009. Concurrent
with these changes, we increased Mr.&nbsp;McGlynn&#146;s target bonus from 40&nbsp;percent to 55&nbsp;percent of his base salary, beginning with the 2009 fiscal year, to reflect the Board&#146;s view that Mr.&nbsp;McGlynn&#146;s leadership is a
major factor in the achievement of the company&#146;s corporate goals and to further align his compensation to corporate success. More recently, effective February&nbsp;1, 2012, we increased Mr.&nbsp;McGlynn&#146;s base salary to $550,000 in
recognition of contributions made on behalf of the company and market factors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">From March 2007 through 2009, we maintained
the annual base salary of Mr.&nbsp;Young at $275,000. In January 2010, however, we increased Mr.&nbsp;Young&#146;s annual base salary to $325,000 in recognition of contributions made on behalf of the company and job scope. In January 2010, we also
increased Mr.&nbsp;Young&#146;s target bonus rate from 25% to 30% of his base salary, beginning with the 2010 fiscal year, to further align his compensation to corporate success. In February 2011, we increased Mr.&nbsp;Young&#146;s target bonus rate
from 30% to 40% of his base salary for the same reason. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">From March 2007 through 2011, we maintained the annual base salary of
Dr.&nbsp;Tsukamoto at $300,000. In January 2010, however, we increased Dr.&nbsp;Tsukamoto&#146;s target bonus from 25% to 30% of her base salary, beginning with the 2010 fiscal year, to further align her compensation to corporate success. In
February 2011, we increased Dr.&nbsp;Tsukamoto&#146;s target bonus rate from 30% to 40% of her base salary for the same reason. More recently, effective February&nbsp;1, 2012, we increased Dr.&nbsp;Tsukamoto&#146;s base salary to $335,000 in
recognition of contributions made on behalf of the company and market factors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Craig joined the company in September
2008, with an annual base salary of $275,000 and a target bonus rate of 25% of his base salary. In January 2010, however, we increased Dr.&nbsp;Craig&#146;s target bonus from 25% to 30% of his base salary, beginning with the 2010 fiscal year, to
further align his compensation to corporate success. In February 2011, we increased Dr.&nbsp;Craig&#146;s target bonus rate from 30% to 40% of his base salary for the same reason. More recently, effective February&nbsp;1, 2012, we increased
Dr.&nbsp;Craig&#146;s base salary to $300,000 in recognition of contributions made on behalf of the company and market factors. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Stratton joined the company in February 2007, with an annual base salary of $220,000 and a target bonus rate of 20% of his base
salary. In February 2008, however, we increased Mr.&nbsp;Stratton&#146;s annual base salary to $250,000 in recognition of contributions made on behalf of the company and because he had assumed additional responsibilities in early 2008. In January
2010, we increased Mr.&nbsp;Stratton&#146;s annual base salary to $275,000 in recognition of contributions made on behalf of the company and job scope. In January 2010, we also increased Mr.&nbsp;Stratton&#146;s target bonus rate from 20% to 30% of
his base salary, beginning with the 2010 fiscal year, to further align his compensation to corporate success. In February 2011, we increased Mr.&nbsp;Stratton&#146;s target bonus rate from 30% to 40% of his base salary for the same reason. More
recently, effective February&nbsp;1, 2012, we increased Mr.&nbsp;Stratton&#146;s base salary to $300,000 in recognition of contributions made on behalf of the company and market factors. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The base compensation and target bonus information presented above can be summarized as
follows: </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year&nbsp;Ended&nbsp;12/31/09<BR>Base Compensation/<BR>Target Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year&nbsp;Ended&nbsp;12/31/10<BR>Base Compensation/<BR>Target Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year&nbsp;Ended&nbsp;12/31/11<BR>Base Compensation/<BR>Target Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>As of 02/01/12<BR>Base&nbsp;Compensation/<BR>Target Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,000/55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,000/55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,000/55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">550,000/55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CFO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000/25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">325,000/30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">325,000/40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">325,000/40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">EVP, R&amp;D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000/25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000/30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000/40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">335,000/40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">SVP, D&amp;O</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000/25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000/30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000/40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000/40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">GC</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250,000/20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000/30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000/40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000/40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Bonus compensation.</I>&nbsp;&nbsp;&nbsp;&nbsp;We view periodic bonuses, whether paid in cash or
equity, as an important element of compensation for several reasons. Bonuses help align individual employee efforts with overall corporate strategies and objectives. Bonuses also help us manage salary expense, while still allowing us to reward
successes. By using discretionary bonuses as part of the compensation mix, we have greater flexibility in managing the timing and amounts of compensation. Accordingly, each year we estimate for planning purposes an aggregate &#147;bonus pool,&#148;
which is calculated by using the base salaries of all our full-time employees and their respective target bonuses, and which assumes the Board will elect to award each full-time employee 100% of his or her personal target bonus amount for the year.
However, as explained below, the actual bonus award for any particular year is entirely within the Board&#146;s discretion. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In practice, over the past few years, we have awarded bonuses on an annual basis after considering, among other things, the
company&#146;s accomplishments against stated corporate goals adopted by the Board, the company&#146;s financial position, the status of its development programs, clinical progress and corporate development activities, and general economic factors.
This has necessarily involved a subjective assessment by the Compensation Committee of corporate performance and market conditions each year. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The process of establishing our corporate goals over the past few years has been a lengthy one. For each fiscal year, our executive officers have presented the Compensation Committee of the Board with
approximately five to ten proposed corporate goals, each often consisting of multiple sub-parts. Management has usually presented its recommended corporate goals to the Compensation Committee concurrent with our proposed corporate budgets for the
following fiscal year. Goals have been designed to be challenging, so that one would not expect consistent achievement of all of them. Typically these goals have included some preclinical and clinical goals for our HuCNS-SC cell product candidate,
financing and corporate development goals, goals related to advancement in cell manufacturing practices, and goals related to advancement of our Liver Program. While all these goals have been considered important, and we have used a cross-functional
and balanced approach to setting them, we have typically prioritized our goals by assigning relative weightings to each of them, with all of them together adding up to 100%. However, by design, no one goal has ever accounted for a majority of the
relative weightings. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">After receiving management&#146;s recommended goals, members of the Compensation Committee typically
review them with our executive officers and oftentimes provide suggestions for additional goals or changes to the recommended goals. After our executive officers and directors have completed this iterative process, which has often taken several
weeks, the Compensation Committee adopts revised corporate goals consistent with the foregoing principles and recommends the updated corporate goals to the full Board for consideration and approval. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Thereafter, during each fiscal year, our executive officers have used the Board-approved corporate goals as a management tool, for
example to coordinate activities, motivate personnel and help prioritize the use of company resources. The executive officers have sometimes referred back to the corporate goals when providing business updates to the Board, similar to
management&#146;s reference back to an approved annual budget. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Recently, at the end of each fiscal year, our Chief Executive Officer has presented the
Compensation Committee with his assessments of corporate performance against the Board-approved corporate goals, together with a summary of any important factors that weighed in his assessments, which he has provided as context.</FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because our corporate goals have not been formulaic or quantitative in nature (we have not had a corporate goal tied to specific stock
price, revenues or expenses, for example), our CEO&#146;s assessments have been largely qualitative in nature. Along with these assessments, our CEO has provided a percentage score for each goal reflecting the degree to which each goal was or was
not, in his judgment, achieved during the year. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has usually considered these percentage scores as
well as our CEO&#146;s commentary about corporate performance and more general assessments of the state of our business when determining whether to award employees a company-wide corporate bonus in any given year, and if so how much of the available
bonus pool to award. However, the Compensation Committee members have used their own judgment to determine the size of any bonus award, if any. In any given year, the Board may decide in its judgment to award more than 100% of the bonus pool for the
year. The Board may also decide to award less than 100% of the bonus pool, even if all of the corporate goals have been achieved, if it decides doing so would be in the best interests of the company. While the Compensation Committee and the Board as
a whole use the corporate goals as a measure of success, the amount of any bonus grant, as well as how and when it will be paid, is completely within the Board&#146;s sole discretion. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With these various principles in mind, we recently took the following actions with respect to corporate bonuses for 2011. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February 2012, as part of its annual year-end review of performance, the Compensation Committee (with input from the Chief Executive
Officer and other Board members) considered, among other things, significant company performance accomplishments in 2011, the company&#146;s successes measured against its 2011 corporate goals, the degree of difficulty in achieving these goals, as
well as other events and circumstances that affected performance. The 2011 goals, as approved by our Board, consisted generally of the following: (i)&nbsp;progress in our CNS Program, including activities aimed at dosing patients in our on-going
clinical trials and activities in support of initiating a study of HuCNS-SC cells in age related macular degeneration; (ii)&nbsp;partnering and corporate development activities; and (iii)&nbsp;successful fundraising efforts. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Highlights of the 2011 accomplishments taken into account by the Compensation Committee in determining the overall company performance
included: </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><U>Therapeutic Product Development </U></I></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In February 2011, the fourth and final patient in our Phase I clinical trial in Pelizaeus-Merzbacher Disease, was enrolled and transplanted with our
proprietary HuCNS-SC<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> cells (purified human neural stem cells). This trial is the first to evaluate neural stem
cells as a potential treatment for a myelination disorder. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In March 2011, we initiated a Phase I/II clinical trial of our HuCNS-SC human neural stem cells in chronic spinal cord injury. This trial is expected
to enroll a total of 12 patients who are three to 12 months post-injury, and will include patients with both complete and incomplete injuries as classified by the American Spinal Injury Association Impairment Scale (AIS). In December 2011, we
successfully completed the enrollment and dosing of the first cohort of patients in this trial. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In April 2011, we entered into a collaboration with Frank LaFerla, Ph.D., a world renowned leader in Alzheimer&#146;s disease research, to study the
therapeutic potential of our HuCNS-SC cells in Alzheimer&#146;s disease. Dr.&nbsp;LaFerla&#146;s published research has shown that mouse neural stem cells enhance memory in a mouse model of Alzheimer&#146;s disease, and the goal of our collaboration
is to replicate these results using our human neural stem cells. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2011, at the International Society for Stem Cell Research (ISSCR) 9th Annual Meeting, we presented evidence of engraftment, migration and the
long-term survival of our HuCNS-SC cells following transplantation into patients with a severe neurological disorder. Importantly, the results show that the cells can persist following the cessation of immunosuppression.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In November 2011, we reported that an interim review of one patient&#146;s MRIs from our Phase I PMD trial showed changes consistent with the
development of new myelin in the regions in which the HuCNS-SC cells were transplanted, and that the safety data suggests the procedure and cells have been well tolerated. More recently, in March 2012, we reported that the data from the study
provided evidence of progressive and durable donar-cell derived myelination in all four patients who underwent transplantation with the company&#146;s proprietary HuCNS-SC cells. In addition, clinical assessment revealed measureable gains in motor
and/or cognitive function in three of the four patients; the fourth patient remained clinically stable. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2012, we published preclinical data demonstrating that our HuCNS-SC cells protect host photoreceptors and preserve vision in a
well-established animal model of retinal disease. The data was featured as the cover article in the February 2012 issue of the international peer-reviewed <I>European Journal of Neuroscience</I>. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2012, the U.S. Food and Drug Administration (FDA) authorized the initiation of a Phase I/II clinical trial of our HuCNS-SC cells in
age-related macular degeneration (AMD). AMD is the leading cause of vision loss and blindness in people over 55 years of age, and approximately 30&nbsp;million people worldwide are afflicted with the disease. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:24px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I><U>Tools and Technologies Programs </U></I></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2011, we launched STEM24</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">TM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> and STEM133<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, two new antibody reagents that have utility for the detection of a range of different human cell types. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In March 2011, we launched nine new products and three related kits to facilitate stem cell research. This new line of purified nucleic acid and
protein stem cell lysate products enable stem cell researchers to more accurately test and validate stem cell lines and associated genes and gene products. We also launched three new cell culture supplements for the derivation, culture and
differentiation of human and mouse embryonic stem cells, induced pluripotent stem cells, and tissue-derived neural stem cells. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I><U>Financing and Other Business-related Activities </U></I></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2011, we sold 1,000,000&nbsp;shares of our common stock to selected institutional investors at a price of $10.00 per share. We received net
proceeds, after deducting offering expenses and fees, of approximately $9.4 million. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2011, as part of our cost reduction program, we relocated our corporate headquarters and U.S.-based research and development operations to
Newark, California. Our new facilities comprise newly constructed, custom designed laboratory and office space, and house the majority of our U.S. workforce. We estimate annual savings in excess of $1 million from this move.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2011, following the affirmative vote of our stockholders at our Annual Meeting, we effected a one-for-ten reverse stock split which reduced the
number of shares outstanding from approximately 139&nbsp;million to approximately 13.9 million. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In July 2011, we received notification from The NASDAQ Stock Market that we had regained compliance with the minimum bid price requirement needed to
continue listing on the NASDAQ Global Market. The NASDAQ Listing Rules require the Company&#146;s stock to evidence a closing bid price of $1.00 per share or more for ten consecutive days. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In September 2011, the California Institute of Regenerative Medicine (CIRM) awarded us a &#147;Disease Team Therapy Development Planning Award&#148;
totaling approximately $100,000. We were one of only four companies to be awarded a disease team planning grant. The funds helped us and our collaborators prepare and submit an application for a &#147;Disease Team Therapy Development Research
Award&#148; to develop our HuCNS-SC cells as a potential treatment for Alzheimer&#146;s disease. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">In December 2011, we raised total proceeds, net of underwriting discounts and expenses, of approximately $9.2 million through a public offering of
8,000,000 units and 8,000,000 Series B Warrants. The combination of units and Series B Warrants were sold at a public offering price of $1.25 per unit. Each Series B Warrant gives the holder the right to purchase one unit at an exercise price of
$1.25 per Unit and is exercisable until May&nbsp;2, 2012. Each unit consists of one share of our common stock and one Series A Warrant. Each Series A Warrant has a five-year term and gives the holder the right to purchase one share of our common
stock at an initial exercise price of $1.40 per share. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Following this review, the Compensation Committee
awarded a discretionary bonus equal to 65% of the available bonus pool, based upon the committee members&#146; assessments of market conditions, corporate risks, our market comparables, and the company&#146;s performance in 2011 measured against its
2011 corporate goals, including the successes highlighted above, among other things. The bonuses were calculated using each employee&#146;s annual base salary as of January&nbsp;1, 2011, and paid in February 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Accordingly, in February 2012, the company paid Mr.&nbsp;McGlynn a 2011 bonus in the amount of $187,688, because on January&nbsp;1, 2011
his base salary and target bonus were, respectively, $525,000 and 55%. The company paid Mr.&nbsp;Young a 2011 bonus in the amount of $84,500, because on January&nbsp;1, 2011 his base salary and target bonus were, respectively, $325,000 and 40%, and
the company paid Dr.&nbsp;Tsukamoto a 2011 bonus in the amount of $78,000, because on January&nbsp;1, 2011 her base salary and target bonus were, respectively, $300,000 and 40%. The company also paid Dr.&nbsp;Craig and Mr.&nbsp;Stratton each a 2011
bonus in the amount of $71,500, because on January&nbsp;1, 2011 their base salary and target bonus were, respectively, $275,000 and 40%. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Equity Compensation&nbsp;&#151; general practices.</I>&nbsp;&nbsp;&nbsp;&nbsp;We believe that equity compensation awards are an important component of our overall compensation policy because equity
compensation can provide strong inducement to remain with the company and to build future stockholder value. In order to achieve these objectives, we believe that equity compensation awards need to be structured to provide both meaningful value and
a meaningful opportunity to realize that value. Accordingly, from time to time, we have considered several forms of equity compensation awards, including stock options, stock appreciation rights, restricted stock, and restricted stock units, because
each of these have certain advantages and disadvantages relative to the others with respect to how they might reward effort and success and how they might help us retain high contributors. Generally speaking, over the years, we have used stock
options and restricted stock units as the most common equity compensation instruments. We feel each of these forms of equity has unique and important features for employee retention and for incentivizing the executive officers to build a profitable
and sustainable business. Unless otherwise specifically noted in the tables herein, all option awards: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">to our employees, including our executive officers, are intended to be qualified incentive stock options (ISOs) to the fullest extent permitted by law;
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">have an exercise price set at the closing market price of our common stock on the grant date, or on an adjacent market trading date if the market on
which we are listed (currently the Nasdaq Global Market) is not open on the grant date;&nbsp;and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">vest over four years, with one-fourth of the shares included in any grant vesting on the first anniversary of the grant and the remainder vesting
1/48th&nbsp;per month thereafter, always provided that the grantee remains in the company&#146;s employ on the vesting dates. These awards are time-vesting and do not depend on performance factors. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have typically granted company-wide equity awards to full-time employees once every year or two, however we have not done so since
June 2010. In addition, we have typically granted stock option awards to newly hired employees, effective as of their date of hire, and occasionally to existing employees upon their promotion. Both on-hire awards to non-executive officers and awards
upon the promotion of current employees are usually made by either Mr.&nbsp;McGlynn, acting as the Board&#146;s single-member committee, or by the Compensation Committee. Awards to executive officers are made by either the Compensation Committee or
by the full Board. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">With these various principles in mind, we recently took the following actions with respect to equity
compensation. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In early 2009, consistent with our practice of reviewing equity incentives on a periodic basis, we evaluated
the equity awards held by the company&#146;s employees in order to evaluate the retention value these past awards likely provided. We noted that a number of key employees continued to hold predominantly unexercisable options with a strike price more
than 200% the company&#146;s then current trading price. Furthermore, our review of market trends indicated that biotechnology companies with volatile trading prices were using restricted stock units with increasing regularity. We also continued to
believe the retention benefit of equity compensation would be enhanced by awarding a mixture of both options and restricted stock units. The Compensation Committee therefore determined to award equity grants to the company&#146;s employees,
including those working for its U.K. subsidiaries and the company&#146;s named executive officers. Specifically, in May 2009, after a review of the market and company-specific information described above, the Compensation Committee approved a
company-wide award to employees of 104,640 restricted stock units and options to purchase up to 105,580&nbsp;shares of common stock, in the aggregate. All of the restricted stock units awarded at this time have four-year vesting, with one-fourth
vesting on each of the first four anniversaries following the grant date. All of the options awarded at this time will vest one-fourth on the first anniversary following the grant and then 1/48th&nbsp;each month thereafter, in keeping with the
company&#146;s standard practices. In this award, our named executive officers received, in the aggregate, 74,133 restricted stock units and options to purchase up to 27,800&nbsp;shares of common stock. The Compensation Committee decided to defer
the equity grant award to Dr.&nbsp;Craig, consisting of 9,333 restricted stock units and 3,500 options, until his one-year anniversary of hire in September 2009. The Compensation Committee also approved the grant of up to 75,000 stock options to
employees working for our Stem Cell Sciences (UK) Ltd. and Stem Cell Sciences Holdings Limited subsidiaries, which we awarded in 2010 because of foreign tax considerations. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In June 2010, after a review of the market and company-specific information described above, the Compensation Committee approved a company-wide award to employees of 190,000 restricted stock units and
options to purchase up to 184,500&nbsp;shares of common stock, in the aggregate. Of particular importance, the Compensation Committee noted that a majority of the stock options issued to employees had strike prices significantly below the current
market price of the company&#146;s stock and were therefore of limited retention value. All of the restricted stock units awarded at this time have four-year vesting, with one-fourth vesting on each of the first four anniversaries following the
grant date, except for the restricted stock units granted to Mr.&nbsp;McGlynn and Dr.&nbsp;Tsukamoto, each of which has three-year vesting, with one-third vesting on each of the first three </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
anniversaries following the grant date. All of the options awarded at this time will vest one-fourth on the first anniversary following the grant and then 1/48th&nbsp;each month thereafter, in
keeping with the company&#146;s standard practices. In this June 2010 grant, our named executive officers received, in the aggregate, 250,000 restricted stock units and options to purchase up to 265,000&nbsp;shares of common stock. In September
2010, Mr.&nbsp;McGlynn voluntarily surrendered his rights and interests in 20,000 restricted stock units from this June 2010 grant in order to bring his grant into accordance with the provisions of the company&#146;s equity incentive plan under
which the grant was made. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2011, we awarded Mr.&nbsp;McGlynn 20,000 additional restricted stock units in
recognition of his service and importance to the company&#146;s long-term goals. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In January 2012, after a review of the
market and company-specific information described above, the Compensation Committee approved a targeted award of 1,231,000 restricted stock units, in aggregate, to certain employees considered to be key contributors with leadership roles within the
company and therefore most likely to have a direct role in building stockholder value. Of particular importance, the Compensation Committee noted that a majority of the stock options issued to employees had strike prices significantly below the
current market price of the company&#146;s stock and were therefore of limited retention value. All of the restricted stock units awarded at this time have four-year vesting, with one-fourth vesting on each of the first four anniversaries following
the grant date, except for the restricted stock units granted to Mr.&nbsp;McGlynn and Dr.&nbsp;Tsukamoto, each of which has three-year vesting, with one-third vesting on each of the first three anniversaries following the grant date. In this January
2012 grant, our named executive officers received, in the aggregate, 796,000 restricted stock units. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table
summarizes the restricted stock units awarded to our named executive officers in May 2009,&nbsp;June 2010,&nbsp;January 2011, and January 2012: </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of Restricted Stock Units Granted(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1px solid #000000;width:91pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name&nbsp;&amp; Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>May&nbsp;2009</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>June&nbsp;2010</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>January&nbsp;2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>January&nbsp;2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn&nbsp;&#151; President and CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,467</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">406,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto,&nbsp;Ph.D.&nbsp;&#151; Executive VP, Research&nbsp;&amp; Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">70,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">130,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young&nbsp;&#151; CFO and VP, Finance&nbsp;&amp; Administration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D.&nbsp;&#151; SVP, Development&nbsp;&amp; Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">130,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D.&nbsp;&#151; General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">130,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">All share numbers reported on a post-split adjusted basis. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;McGlynn was granted 120,000 restricted stock units in June 2010, however, he voluntarily surrendered 20,000 of these in September 2010 in order to bring his
grant into accordance with the provisions of the company&#146;s equity incentive plan under which the grant was made. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Granted on Dr.&nbsp;Craig&#146;s one-year anniversary of employment, September&nbsp;15, 2009. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We may grant additional options, restricted stock units or other equity compensation to current employees, including our executive
officers, in 2012. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Employment, Severance and Change-in-Control Agreements </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Employment agreements.</I>&nbsp;&nbsp;&nbsp;&nbsp;Mr.&nbsp;McGlynn joined the company as our president and chief executive officer on
January&nbsp;15, 2001. Under the terms of an employment agreement between Mr.&nbsp;McGlynn and the company, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
dated January&nbsp;2, 2001, as amended, Mr.&nbsp;McGlynn received an initial annual base salary of $275,000 per year, reviewable annually by the Board of Directors, and a bonus, in the
Board&#146;s sole discretion, of up to 25% of his base salary. Over time, however, we have increased Mr.&nbsp;McGlynn&#146;s base salary and target bonus so that they are, respectively, $550,000 and 55% of his base salary. Pursuant to his January
2001 employment agreement, we granted Mr.&nbsp;McGlynn an option to purchase 40,000&nbsp;shares of our common stock with an exercise price equal to the fair market value of the common stock on the initial date of his employment, one-fourth to vest
on the first anniversary of his employment and the remaining three-fourths to vest in equal monthly installments during his second through fourth years of employment. These options remained unexercised and expired in 2011. Mr.&nbsp;McGlynn&#146;s
employment agreement also provided that the Board could, in its sole discretion, grant him a bonus option to purchase up to an additional 2,500&nbsp;shares, which it did. These options also remained unexercised and expired in 2011. We also agreed to
pay Mr.&nbsp;McGlynn a $50,000 relocation bonus and to reimburse him for relocation expenses, which we did. Since January 2009, we have been paying Mr.&nbsp;McGlynn an annual car allowance of $10,000. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Tsukamoto joined the company in November 1997 and has served as our executive vice president of research and development since
September 2008. Under the terms of an employment agreement between Dr.&nbsp;Tsukamoto and the company, dated February&nbsp;2, 1998, Dr.&nbsp;Tsukamoto received an annual base salary of $130,000 per year and a discretionary target bonus of up to 10%
of her base salary. Over time, however, we have increased her base salary and target bonus so that they are, respectively, $335,000 and 40% of her base salary. Also pursuant to her employment agreement, we provide Dr.&nbsp;Tsukamoto with $750,000 of
term life insurance on an annual basis during her employment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Young joined the company in September 2005 as our
chief financial officer and vice president of finance. Under the terms of his agreement with the company, dated August&nbsp;16, 2005, Mr.&nbsp;Young received an initial annual base salary of $250,000 per year, with a target bonus of up to 25% of his
base salary. Over time, however, we have increased Mr.&nbsp;Young&#146;s base salary and target bonus so that they are, respectively, $325,000 and 40% of his base salary. Pursuant to his August 2005 employment agreement, we granted Mr.&nbsp;Young an
option to purchase 45,000&nbsp;shares of our common stock. This option vested over 48&nbsp;months; with one-fourth of the shares having vested on the first anniversary of the date on which Mr.&nbsp;Young&#146;s employment began and with the
remaining shares having vested at the rate of 1/48th&nbsp;per month on the last day of each month during the ensuing 36&nbsp;months. In addition, the employment agreement provided for an option grant on the first anniversary of his employment to
acquire an additional 2,500&nbsp;shares of our common stock. The grant of 2,500&nbsp;shares was duly made, and vested in the same manner as his earlier option grant over 48&nbsp;months. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Craig joined the company in September 2008 as our senior vice president of development and operations. Under the terms of his
agreement with the company, dated July&nbsp;24, 2008, Dr.&nbsp;Craig has received an annual base salary of $275,000 per year, with a target bonus of up to 25% of his base salary. Over time, however, we have increased Dr.&nbsp;Craig&#146;s base
salary and target bonus so that they are, respectively, $300,000 and 40% of his base salary. Pursuant to Dr.&nbsp;Craig&#146;s July 2008 employment agreement, we granted him an option to purchase 20,000&nbsp;shares of our common stock. This option
will vest over 48&nbsp;months, with one-fourth of the shares having vested on the first anniversary of the date on which Dr.&nbsp;Craig&#146;s employment began and with the remaining shares vesting, subject to his continued employment by the
company, at the rate of 1/48th&nbsp;per month on the last day of each month during the ensuing 36&nbsp;months. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Stratton joined the company in February 2007 as our general counsel. Under the terms of his agreement with the company, dated
February&nbsp;2, 2007, Mr.&nbsp;Stratton received an initial annual base salary of $220,000 per year, with a target bonus of up to 20% of his base salary. Over time, however, we have increased Mr.&nbsp;Stratton&#146;s base salary and target bonus so
that they are, respectively, $300,000 and 40% of his base salary. Pursuant to Mr.&nbsp;Stratton&#146;s February 2007 employment agreement, we granted him an option to purchase 15,000&nbsp;shares of our common stock. This option vested over
48&nbsp;months, with one-fourth of the shares having vested on the first </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
anniversary of the date on which Mr.&nbsp;Stratton&#146;s employment began and with the remaining shares having vested at the rate of 1/48th&nbsp;per month on the last day of each month during
the ensuing 36&nbsp;months. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Severance arrangements.</I>&nbsp;&nbsp;&nbsp;&nbsp;Each of our executive officers has entered
into a severance agreement with the company under which he or she would receive payments upon termination of his or her employment by us without cause</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">3</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> or consequent to a change of control or, in the case of Mr.&nbsp;McGlynn, by virtue of disability. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the case of Mr.&nbsp;McGlynn, upon termination without cause, we would continue to pay his salary and provide benefits for one year,
at the base wage rate then in effect. If the termination of Mr.&nbsp;McGlynn&#146;s employment were associated with a change of control, the company would pay (in a lump sum) (i)&nbsp;two years of his salary and the reasonably projected cost of
healthcare benefits, (ii)&nbsp;a bonus with respect to the termination year at 25% of the base salary, pro-rated for the portion of the year served, and (iii)&nbsp;a tax gross up for his continued healthcare benefits. In addition, all unvested stock
options would vest and all stock options would be exercisable for two years after termination. If Mr.&nbsp;McGlynn&#146;s employment were terminated on account of disability, we would continue to pay his salary for up to six months (or until he
obtained other employment or became eligible for disability income under a company plan, if sooner). </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the case of
Dr.&nbsp;Tsukamoto, upon involuntary termination without cause whether or not associated with a change of control, we would continue to pay Dr.&nbsp;Tsukamoto&#146;s salary and provide benefits for twelve months, at the rate then in effect.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the case of Mr.&nbsp;Young, upon involuntary termination without cause, we would continue to pay his salary and provide
benefits for six months, at the rate then in effect. If the termination were associated with a change of control, we would continue to pay Mr.&nbsp;Young&#146;s salary and provide benefits (including his share of COBRA, grossing up for the tax
effects, if any) for twelve months; in this event, any unvested options and any other stock awards held by him would vest upon termination. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In the case of Dr.&nbsp;Craig, upon involuntary termination without cause, whether or not associated with a change of control, we would continue to pay his salary and provide benefits for six months, at
the rate then in effect. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the case of Mr.&nbsp;Stratton, upon involuntary termination without cause, we would continue to
pay his salary and provide benefits for six months, at the rate then in effect. If the termination were associated with a change of control, we would continue to pay Mr.&nbsp;Stratton&#146;s salary and provide benefits for twelve months; in this
event, any unvested options and any other stock awards held by him would vest upon termination. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we terminate the
employment of any executive officer for cause, or if the officer resigns without good cause, he or she would not be entitled to any severance or other benefits. </FONT></P>
<P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">3</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> Or termination by the executive officer for good reason, as defined
in their respective agreements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Potential Payments Upon Termination or Change-in-Control </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table displays the value of what the executive officers would have received from us had their employment been terminated on
December&nbsp;31, 2011: </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:24pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Officer</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Health</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Accelerated&nbsp;Vesting&nbsp;of<BR>Options&nbsp;and&nbsp;Restricted<BR>Stock Units*</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated without cause</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,908</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">556,908</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated, change of control</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,050,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">131,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">120,332</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">112,832</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,414,414</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Disability(2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">262,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">262,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated without cause</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">315,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated, change of control</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,527</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42,094</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">357,621</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated without cause</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">162,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,320</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,820</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated, change of control</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">325,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,640</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">367,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated without cause</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">146,926</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated, change of control</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,127</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163,053</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated without cause</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">137,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,320</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">147,820</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Terminated, change of control</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,640</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,127</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">311,767</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Value shown represents the difference between the closing market price of our stock on December&nbsp;31, 2011 of $0.82 per share and the applicable exercise price of
each grant. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes tax gross-up on two&nbsp;years of healthcare costs. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payments stop before six&nbsp;months if individual obtains other full-time employment or qualifies for payments under any disability income plan provided by the
company. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">All unvested options and restricted stock units issued under the applicable equity incentive plans vest upon a change of control under the terms of those plans.
</FONT></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee and Stock Option Report </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Compensation and Stock Option Committee has reviewed and discussed the Compensation Discussion and Analysis required by Item&nbsp;402(b) of SEC Regulation&nbsp;S-K with management. Based on this
review and these discussions, the Compensation Committee has recommended to the Board of Directors that the Compensation Discussion and Analysis be included in the company&#146;s proxy statement for 2012. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="98%"></TD></TR>


<TR>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">COMPENSATION&nbsp;AND&nbsp;STOCK&nbsp;OPTION&nbsp;COMMITTEE</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Schwartz,&nbsp;Ph.D., Chairman</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric Bjerkholt</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricardo Levy,&nbsp;Ph.D.</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Notwithstanding anything to the contrary set forth in any of our previous filings under the Securities Act of
1933, as amended, or the Exchange Act that incorporate future filings, in whole or in part, the foregoing Compensation and Stock Option Committee Report shall not be incorporated by reference into any such filings. </I></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Executive Officer Compensation Tables </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following tables set forth information with respect to the compensation of our executive officers for the fiscal years ended
December&nbsp;31, 2011, 2010 and 2009. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Because the &#147;Stock awards&#148; and &#147;Option awards&#148; column reflects the
dollar amounts recognized as compensation expense for financial statement reporting purposes in accordance with U.S.&nbsp;GAAP, these imputed values include amounts from awards granted from 2004 through 2011. </FONT></P>
<P STYLE="margin-top:30px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary Compensation Table </B></FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary<BR>($)(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Bonus<BR>($)(2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards<BR>($)(3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards<BR>($)(3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Compensation<BR>($)(4)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total ($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">187,688</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">194,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,819</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">955,507</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">259,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,050,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">260,970</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43,467</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,139,312</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">540,885</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">202,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">410,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">132,079</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38,626</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,324,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">78,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,444</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">402,444</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">EVP, Research</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">81,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">714,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">169,020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,627</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,288,647</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">311,538</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">52,532</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,591</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">601,494</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">325,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,842</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">436,342</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CFO and VP,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">325,192</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">87,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">204,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42,255</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">683,530</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Finance and Administration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">285,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">396,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">127,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,435</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">882,381</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,888</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">374,388</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior VP, Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">204,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84,510</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,736</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">664,496</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">and Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">285,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">159,599</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,712</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,629</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">567,642</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">375,945</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">275,096</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">204,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">42,255</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,713</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">621,314</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">259,615</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">163,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,166</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">483,114</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">We pay salaries on a bi-weekly basis. There were 27 pay periods in 2010. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each employee&#146;s target bonus is based on his or her salary as of January&nbsp;1 of the year to which it applies. For 2011, the Board awarded 65% of the target
bonus for all company employees. For further description of the non-equity incentive plan see the discussion in our &#147;Compensation Discussion and Analysis&#148; and &#147;Compensation of Named Executive Officers,&#148; above.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amounts shown represent the full grant date value of the option awards granted in each year as computed in accordance with FASB ASC Topic 718. Assumptions used in the
calculation of these amounts are included in Note&nbsp;10, &#147;Stock-Based Compensation&#148; in our Form&nbsp;10-K for the period ended December&nbsp;31, 2011, filed with the SEC on March&nbsp;15, 2012. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts shown in the &#147;All Other Compensation&#148; column for 2010 include the following: </FONT></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:97pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Employer<BR>Match on<BR>Defined<BR>Contribution<BR>Plans</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($)(a)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Transportation<BR>Allowance ($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Employee<BR>Health&nbsp;and<BR>Welfare<BR>Benefit<BR>Plans&nbsp;($)(b)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other<BR>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,350</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,469</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">48,819</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto, Ph.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,350</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,094</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,444</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">EVP, Research and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,350</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,492</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,842</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CFO and VP, Finance and Administration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,350</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,538</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,888</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior VP, Development and Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,350</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,095</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,445</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(a)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under a 401(k) plan, which is open to substantially all of our employees, we make matching contributions in the form of company common stock based on each
participant&#146;s voluntary salary deferrals, subject to plan and legal limits. We match participant contributions on a 1:2 basis up to a maximum of 3% of the employee&#146;s salary. Registered stock is valued and transferred to the employee&#146;s
401(k) account at the end of calendar each quarter. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(b)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">We offer all employees various health and welfare benefit plans. Our executive officers may participate in these on the same terms as other employees.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(c)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes life insurance benefit of $1,180. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Grants of Plan-Based Awards </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table shows grants of plan-based equity awards made to our named executive officers during the fiscal year ended December&nbsp;31, 2011: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:91pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name &amp; Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All&nbsp;Other<BR>Stock<BR>Awards:<BR>Number&nbsp;of<BR>Shares of<BR>Stock or<BR>Units #(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Option<BR>Awards:<BR>Number of<BR>Securities<BR>Underlying<BR>Options #</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise<BR>or Base<BR>Price of<BR>Option<BR>Awards</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($/share)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant&nbsp;Date<BR>Fair Value<BR>of Option<BR>Awards&nbsp;($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/25/11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">194,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">EVP, Research and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CFO and VP, Finance and Administration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior VP, Development and Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Restricted stock units granted in 2011 to our named executive officers were made pursuant to our 2006 equity incentive plan. The restricted stock units granted to
Mr.&nbsp;McGlynn vest over a three-year period from the date of grant: one-third of the award will vest on each grant date anniversary over the following three years. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Outstanding Equity Awards at Fiscal 2011&nbsp;Year-End </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following tables show equity awards held by our named executive officers as of December&nbsp;31, 2011: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Grant</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(#)<BR>Exercisable(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(#)<BR>Unexercisable(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($/sh)(1)</B>
</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/12/2002</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29.60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/12/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/2/2002</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20.11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/2/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/2/2004</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/2/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7/21/2006</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">67,267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7/21/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/23/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/23/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,683</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,117</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17.50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/25/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,249</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,751</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/25/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10/7/2002</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10/7/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">EVP, Research and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/3/2004</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/3/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7/21/2006</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,498</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7/21/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/23/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/23/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,260</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,240</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17.50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,499</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,501</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/6/2005</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54.30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/6/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CFO and VP, Finance and Administration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7/21/2006</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7/21/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/6/2006</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22.80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/6/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/23/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/23/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,489</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17.50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,874</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,126</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">09/15/2008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16,249</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,751</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/15/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior VP, Development and Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,968</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,532</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/15/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,749</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,251</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">02/28/2007</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">02/28/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,260</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,240</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17.50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,874</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,126</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date&nbsp;of&nbsp;Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Restricted<BR>Stock&nbsp;Units<BR>That&nbsp;Have&nbsp;Not<BR>Vested
(2)<BR>#</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market&nbsp;Value&nbsp;of<BR>Securities of<BR>Restricted<BR>Stock&nbsp;Units<BR>That Have Not<BR>Vested
(3)<BR>$</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,734</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/25/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">54,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/25/2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,934</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">EVP, Research and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">756,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,601</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CFO and VP, Finance and Administration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">216,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior VP, Development and Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">216,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/15/2009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6/1/2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">216,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Unless otherwise noted, options are granted at the close of market price on the grant date (or on an adjacent market trading day if the Nasdaq Global Market is closed
on the grant date). They vest over a period of four years as follows: one-fourth of the option vests on the first anniversary of the grant date and 1/48th of the original grant vests each additional month of service. </FONT></TD></TR></TABLE>
<P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Restricted stock units granted under our 2006 Equity Incentive Plan. These restricted stock units vest ratably over a three to four-year period on each grant date
anniversary. </FONT></TD></TR></TABLE> <P STYLE="font-size:4px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on the per share closing market price of $0.82 for our common stock on December&nbsp;31, 2011. </FONT></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Shares<BR>Acquired on<BR>Vesting&nbsp;(#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;Realized<BR>on&nbsp;Vesting&nbsp;($)(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">111,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and CEO</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ann Tsukamoto, Ph.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,541</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">227,183</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">EVP, Research and Development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rodney Young</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,542</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">131,190</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">CFO and VP, Finance and Administration</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stewart Craig,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,333</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">38,739</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior VP, Development and Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ken Stratton,&nbsp;J.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,083</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,773</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Calculated as the aggregate market value on the date of vesting of the shares with respect to which restrictions lapsed during 2011 (calculated before payment of any
applicable withholding or other income taxes). </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;McGlynn was granted 41,250 restricted stock units on March&nbsp;10, 2008, 13,750 of which vested on March&nbsp;10, 2011, when the market price of our common
stock per share was $8.10. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Tsukamoto was granted: (i)&nbsp;20,625 restricted stock units on March&nbsp;10, 2008, 6,875 of which vested on March&nbsp;10, 2011, when the market price per
share of our common stock was $8.10; (ii)&nbsp;9,333 restricted stock units on May&nbsp;15, 2009, 2,333 of which vested on May&nbsp;15, 2011, when the market price per share of our common stock was $7.50; and (iii)&nbsp;70,000 restricted stock units
on June&nbsp;1, 2010, 5,000 of which vested on June&nbsp;1, 2011, when the market price was $6.60. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Young was granted: (i)&nbsp;20,625 restricted stock units on March&nbsp;10, 2008, 6,875 of which vested on March&nbsp;10, 2011, when the market price per share
of our common stock was $8.10; and (ii)&nbsp;22,667 restricted stock units on May&nbsp;15, 2009, 5,667 of which vested on May&nbsp;15, 2011, when the market price per share of our common stock was $7.50; and (iii)&nbsp;20,000 restricted stock units
on June&nbsp;1, 2010, 5,000 of which vested on June&nbsp;1, 2011, when the market price per share of our common stock was $6.60. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Craig was granted: (i)&nbsp;9,333 restricted stock units on September&nbsp;15, 2009, 2,333 of which vested on September&nbsp;15, 2011, when the market price
per share of our common stock was $2.46; and (ii)&nbsp;20,000 restricted stock units on June&nbsp;1, 2010, 5,000 of which vested on June&nbsp;1, 2011, when the market price per share of our common stock was $6.60. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Stratton was granted: (i)&nbsp;8,250 restricted stock units on March&nbsp;10, 2008, 2,750 of which vested on March&nbsp;10, 2011, when the market price per
share of our common stock was $8.10; (ii)&nbsp;9,333 restricted stock units on May&nbsp;15, 2009, 2,333 of which vested on May&nbsp;15, 2011, when the market price per share of our common stock was $7.50; and (iii)&nbsp;20,000 restricted stock units
on June&nbsp;1, 2010, 5,000 of which vested on June&nbsp;1, 2011, when the market price per share of our common stock was $6.60. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Director Compensation </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Cash Compensation.</I>&nbsp;&nbsp;&nbsp;&nbsp;Prior to December 2009, non-employee directors received quarterly retainers for Board service in the amount of $4,500 ($8,750 for the Chairman of the
Board). Each of the chairs of the standing committees also received quarterly stipends of either $1,000 (Audit Committee) or $500 (Compensation and Corporate Governance Committees). Non-employee directors also received $1,500 for each board meeting
attended in person or by videoconference and $1,000 for each standing committee meeting attended in person or by videoconference, plus $500 for each board or committee meeting attended by phone. The non-employee directors serving on the Strategic
Transactions Committee received $1,200 per meeting attended in person or by videoconference, plus $500 for each meeting attended by phone, but the chair of the Strategic Transactions Committee did not receive a quarterly stipend. All dollar amounts
were paid in cash. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In early 2009, however, management began a review of our director compensation practices. We wanted to
assess whether we were being responsive to market dynamics, as we had not adjusted director compensation for almost five years. We obtained and reviewed, among other things, the <I>2009 Radford Board of Directors Compensation Analysis&nbsp;&#151;
Level&nbsp;2, Life Sciences Edition</I>, which provided us with a broad survey of director compensation paid by publicly traded life science companies in the United States. We also benchmarked our compensation practices against compensation
information from other publicly traded companies in the stem cell field.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">4</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"> From this information, we determined that the median (i.e., 50th&nbsp;percentile) cash compensation paid by comparable companies tended to be approximately 40% higher than that paid by the company and
that the average initial equity grants awarded by comparable companies tended to be approximately 25% higher. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Therefore, in
both June and December 2009, management presented to the Board a series of recommendations to change both the cash and equity compensation paid to our non-employee directors. The Board considered in particular the market comparables collected by
management. In recognition of the fact that the company&#146;s director compensation fell significantly below the average compensation paid by market comparables, the Board approved the recommended changes to the cash-based and equity compensation
paid to the company&#146;s non-employee directors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Since December 2009, non-employee directors have received quarterly
retainers for Board service in the amount of $6,250 ($12,500 for the Chairman of the Board). The chairs of the standing committees have received quarterly stipends of either $2,500 (Audit Committee) or $1,250 (Compensation Committee, Corporate
Governance Committee and, since it became a standing committee in June 2010, the Strategic Transactions Committee). Non-employee directors have also received $2,000 for each board meeting attended in person or by videoconference and $1,000 for each
board meeting attended by phone, as well as $1,000 for each standing committee meeting attended in person or by videoconference and $500 for each committee meeting attended by phone. All these dollar amounts have been paid in cash, and we expect
that this will remain largely the case for the foreseeable future. However, in March 2011, the Board approved a sub-plan under our 2006 Amended and Restated Equity Incentive Plan, called the Directors&#146; Fee Plan, which permits directors to elect
to receive all or a portion of their board fees in the form of company common stock. We issued 10,824 shares of stock under our Directors&#146; Fee Plan as consideration for Board service in 2011. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Directors are reimbursed for their expenses in attending meetings of the Board and meetings of committees of the Board. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Equity Compensation.</I>&nbsp;&nbsp;&nbsp;&nbsp;Prior to June 2009, non-employee directors received an initial option to purchase
2,000&nbsp;shares upon appointment to the Board, with one-third of these option shares vesting on each of the first three anniversaries following the grant. Following appointment, each non-employee director received an option </FONT></P>
<P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%;padding-bottom:0px;"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">4</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> </FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2009 we collected director compensation information from the recent SEC filings of Aastrom Biosciences, Inc.;
Athersys, Inc.; Cytori Therapeutics, Inc.; Geron Corporation; Neuralstem, Inc.; and Osiris Therapeutics, Inc. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
to purchase 1,000&nbsp;shares upon each anniversary of his or her appointment, vesting one year after issuance, with each exercisable at the fair market value of the stock on the date of the
respective grant. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In June 2009, however, the Board adopted management&#146;s recommendation to award non-employee directors
with annual equity grants paid in restricted stock units rather than common stock options. The Board&#146;s decision to change the annual grants followed several months of deliberation by the company&#146;s management and Compensation Committee,
which considered among other things equity compensation practices at various comparable companies, as described above, outside reports, the company&#146;s trading history, and market trends, such as the growing use of restricted stock units as
director compensation by comparable companies. Each of the annual grants from June 2009 until June 2010 was for 1,000 restricted stock units, vesting on the first anniversary of the grant. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Then, in December 2009 and June 2010, the Board approved further changes proposed by management to the equity compensation practices for
non-employee directors. Among other changes, the Board approved management&#146;s recommendation to award newly appointed directors an initial grant of restricted stock units rather than options. Presently, newly appointed non-employee directors
will receive an initial grant upon their first appointment to the Board of 15,000 restricted stock units, with one third of this grant vesting on each of the three anniversaries following the grant. Thereafter, each non-employee director, other than
the Chairman of the Board, is to receive an annual grant on each anniversary of his or her appointment to the Board in the form of 1,000 restricted stock units, vesting on the first anniversary of the grant. In addition, the Board determined that
the Chairman of the Board is to receive an annual grant of 1,500 restricted stock units, vesting on the first anniversary of the grant. Each of the annual grants from June 2010 to December 2011 was for 1,000 restricted stock units (1,500 for the
Chairman), vesting on the first anniversary of the grant. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">More recently, in March 2012, the Board approved a further change
proposed by management to the equity compensation practices for non-employee directors given the Company&#146;s stock trading price and our desire to fairly compensate our outside directors for continued Board service and incentivize them to build
stockholder value. Effective January&nbsp;1, 2012, each non-employee director, other than the Chairman of the Board, is to receive an annual grant on each anniversary of his or her appointment to the Board in the form of 10,000 restricted stock
units, vesting on the first anniversary of the grant. In addition, the Board determined that the Chairman of the Board is to receive an annual grant of 15,000 restricted stock units, vesting on the first anniversary of the grant. </FONT></P>
<P STYLE="margin-top:30px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Director Compensation Table </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table summarizes cash-based and equity compensation information for our non-employee directors, including annual Board and committee retainer fees and meeting attendance fees, for the year
ended December&nbsp;31, 2011: </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned<BR>or Paid<BR>in Cash<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards<BR>($)(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All Other<BR>Compensation<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric Bjerkholt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">62,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">R. Scott Greer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">41,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">32,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">74,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricardo Levy,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">49,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,880</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61,380</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger Perlmutter,&nbsp;M.D.,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">34,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,810</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,810</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Schwartz,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Irving Weissman,&nbsp;M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">35,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">94,725</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amounts shown in this column represent the full grant date fair value of restricted stock unit grants in 2010 as computed in accordance with FASB
ASC Topic&nbsp;718. Assumptions used in the calculation of these </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">
amounts are included in Note&nbsp;10, &#147;Stock-Based Compensation&#148; in our Form&nbsp;10-K for the period ended December&nbsp;31, 2011, filed with the SEC on March&nbsp;15, 2012.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes an annual retainer of $25,000, a fee for Mr.&nbsp;Bjerkholt&#146;s role on the Audit Committee of $10,000, and additional fees of $18,500 for Board and
committee meetings attended. Also includes $13,750 earned in 2011 but paid in 2012. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Bjerkholt was granted 1,000 restricted stock units on March&nbsp;1, 2011, vesting on the one year anniversary of the grant. As of December&nbsp;31, 2011, he
had stock options and restricted stock units outstanding for the purchase of 8,000 shares of common stock, in the aggregate. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes an annual retainer of $25,000, a fee for Mr.&nbsp;Greer&#146;s role on the Strategic Transactions Committee of $5,000, and additional fees of $11,500 for Board
and committee meetings attended. Also includes $11,500 earned in 2011 but paid in 2012. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Greer was granted 1,000 restricted stock units on June&nbsp;3, 2011, vesting on the one year anniversary of the grant. As of December&nbsp;31, 2011, he had
restricted stock units outstanding for the purchase of 11,000 shares of common stock, in the aggregate. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes an annual retainer of $25,000, a fee for Dr.&nbsp;Levy&#146;s role on the Corporate Governance Committee of $5,000, and additional fees of $19,500 for Board
and committee meetings attended. Also includes $12,000 earned in 2011 but paid in 2012. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Levy was granted 1,000 restricted stock units on September&nbsp;26, 2011, vesting on the one year anniversary of the grant. As of December&nbsp;31, 2011,
Dr.&nbsp;Levy had stock options and restricted stock units outstanding for the purchase of 11,078 shares of common stock, in the aggregate. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes an annual retainer of $25,000, and additional fees of $9,000 for Board and committee meetings attended. Also includes $9,250 earned in 2011 but paid in 2012.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Perlmutter was granted an 1,000 restricted stock units on December&nbsp;14, 2011, vesting on the one year anniversary of the grant. As of December&nbsp;31,
2011, Dr.&nbsp;Perlmutter had stock options and restricted stock units outstanding for the purchase of 12,421 shares of common stock, in the aggregate. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes an annual retainer of $50,000, a fee for Dr.&nbsp;Schwartz&#146;s role on the Compensation Committee of $5,000, and additional fees of $10,125 for Board and
committee meetings attended. Also includes $8,875 earned in 2011 but paid in 2012. As of October&nbsp;2011, Dr.&nbsp;Schwartz received 50% of his board service fees in the form of company common stock under our Directors&#146; Fee Plan. In March
2012, Dr.&nbsp;Schwartz elected to receive 100% of his future board service fees in the form of company common stock, until such time as he may deliver an updated election in accordance with the provisions of the Directors&#146; Fee Plan.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(11)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Schwartz was granted 1,500 restricted stock units on April&nbsp;18, 2011, vesting on the one year anniversary of the grant. As of December&nbsp;31, 2011,
Dr.&nbsp;Schwartz had stock options and restricted stock units outstanding for the purchase of 8,000 shares of common stock, in the aggregate. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(12)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes an annual retainer of $25,000 and additional fees of $10,000 for Board and committee meetings attended. Also includes $9,250 earned in 2011 but paid in 2012.
</FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(13)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Weissman was granted 1,000 restricted stock units on October&nbsp;1, 2011, vesting on the one year anniversary of the grant. As of December&nbsp;31, 2011,
Dr.&nbsp;Weissman had stock options and restricted stock units outstanding for the purchase of 19,769 shares of common stock, in the aggregate. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(14)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Weissman receives $50,000 per year for his services as a consultant and as the chairman of our Scientific Advisory Board. As of May 2011, Dr.&nbsp;Weissman has
received his consultancy fees under this agreement in the form of company common stock. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Section&nbsp;16(a) Beneficial Ownership Reporting Compliance </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;16(a) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), requires our executive officers,
directors, and persons who own more than 10% of a registered class of our equity securities, to file with the SEC reports of ownership of our securities and changes in reported ownership. Executive officers, directors and greater than 10% beneficial
owners are required by SEC rules to furnish us with copies of all Section&nbsp;16(a) reports they file. Based solely on a review of the copies of such forms furnished to us, or written representations from the reporting persons that no Form&nbsp;5
was required, we believe that, during the fiscal year ended December&nbsp;31, 2011, all Section&nbsp;16(a) filing requirements applicable to our officers, directors and greater than 10% beneficial owners have been met, with the following exceptions:
(i)&nbsp;the Form&nbsp;4 filed by Dr.&nbsp;Levy on September&nbsp;29, 2011, reporting his annual equity grant for Board service, was filed one day late; (ii)&nbsp;the Form&nbsp;4 filed by Mr.&nbsp;McGlynn on February&nbsp;1, 2011, reporting a grant
of 20,000 restricted stock units, was filed three days late; (iii)&nbsp;the Form 4 filed by Dr.&nbsp;Perlmutter on December&nbsp;23, 2011, reporting his annual equity grant for Board service, was filed one week late; and (iv)&nbsp;the Form 4 filed
by Dr.&nbsp;Weissman on July&nbsp;5, 2011, reporting the issuance of shares of our common stock as consideration for his service on our Scientific Advisory Board, was filed two weeks late. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Related parties can
include any of our directors or executive officers, certain of our stockholders and their immediate family members. Each year, we prepare and require our directors and executive officers to complete Director and Officer Questionnaires identifying
any transactions with us in which the officer or director or their family members have an interest. This helps us identify potential conflicts of interest. A conflict of interest occurs when an individual&#146;s private interest interferes, or
appears to interfere, in any way with the interests of the company as a whole. Our code of ethics requires all directors, officers and employees who may have a potential or apparent conflict of interest to immediately notify our general counsel, who
serves as our compliance officer. In addition, the Corporate Governance Committee of the Board of Directors is responsible for considering and reporting to the Board any questions of possible conflicts of interest of Board members. Our code of
ethics further requires pre-clearance before any employee, officer or director engages in any personal or business activity that may raise concerns about conflict, potential conflict or apparent conflict of interest. Copies of our code of ethics and
the Corporate Governance Committee charter are posted on the corporate governance section of our website at www.stemcellsinc.com. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In evaluating related party transactions and potential conflicts of interest, our compliance officer and independent directors apply the same standards of good faith and fiduciary duty they apply to their
general responsibilities. They will approve a related party transaction only when, in their good faith judgment, the transaction is in the best interest of the company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Weissman, a member of the Board of Directors, was retained in September 1997 to serve as a consultant to us. Pursuant to his consulting agreement, Dr.&nbsp;Weissman provides consulting services
to us and serves on our Scientific Advisory Board. In return, we pay Dr.&nbsp;Weissman $50,000 per year for his services. We also agreed to nominate Dr.&nbsp;Weissman for a position on the Board of Directors, and he agreed to serve if elected. Since
October&nbsp;1, 2000, he has been compensated for this service in the same manner and amount as other non-employee members of the Board. The consulting agreement with Dr.&nbsp;Weissman contains confidentiality, non-competition, and assignment of
invention provisions and is for a term of fifteen years, subject to earlier termination by either party. In May 2011, Dr.&nbsp;Weissman&#146;s consulting agreement was amended by the parties so that the company could choose to pay fees owed to
Dr.&nbsp;Weissman under the agreement in the form of company common stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PRINCIPAL ACCOUNTING FEES AND SERVICES </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Audit and Tax Fees </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Board of Directors, upon the recommendation of the Audit Committee, has selected the independent accounting firm of Grant Thornton LLP to audit the accounts of the company for the year ending December&nbsp;31, 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee considered the tax compliance services provided by Grant Thornton LLP, concluded that provision of such services is
compatible with maintaining the independence of the independent accountants, and approved the provision by Grant Thornton LLP of tax compliance services with respect to the year ending December&nbsp;31, 2011. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee received the following information concerning the fees of the independent accountants for the years ended
December&nbsp;31, 2010 and 2011, has considered whether the provision of these services is compatible with independence of the independent accountants, and concluded that it is: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year Ended</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/31/11</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>12/31/10</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit fees(1)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">432,693</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">422,867</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">46,866</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61,097</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit fees represents fees for the integrated audit of our annual consolidated financial statements and reviews of the interim consolidated financial statements, and
review of audit-related SEC filings; also includes fees related to issuing comfort letter(s) in 2010 and 2011. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit and tax fees include administrative overhead charges and reimbursement for out-of-pocket expenses. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Pre-Approval Policies and Procedures </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has adopted policies and procedures for pre-approving all services (audit and non-audit) performed by our independent auditors. In
accordance with such policies and procedures, the Audit Committee is required to pre-approve all audit and non-audit services to be performed by the independent auditors in order to assure that the provision of such services is in accordance with
the rules and regulations of the SEC and does not impair the auditors&#146; independence. Under the policy, pre-approval is generally provided up to one year and any pre-approval is detailed as to the particular service or category of services and
is subject to a specific budget. In addition, the Audit Committee may pre-approve additional services on a case-by-case basis. During 2011 and 2010, all services performed by our independent auditors were pre-approved. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>REPORT OF THE AUDIT COMMITTEE </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee oversees our accounting and financial reporting processes and the audits of our financial statements on behalf of the
Board, and selects an independent public accounting firm to perform these audits. Management has the primary responsibility for establishing and maintaining adequate internal control over financial reporting, preparing the financial statements, and
establishing and maintaining adequate controls over public reporting. Our independent registered public accounting firm for fiscal 2011, Grant Thornton LLP, had responsibility for conducting an audit of our annual financial statements in accordance
with the standards of the Public Company Accounting Oversight Board (United States) and expressing an opinion on the conformity of those audited financial statements with generally accepted accounting principles. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee oversaw the independent public accounting firm&#146;s qualifications and independence, as well as its performance.
The Audit Committee assisted the Board in overseeing the preparation of the company&#146;s financial statements, the company&#146;s compliance with legal and regulatory requirements, and the performance of the company&#146;s internal audit function.
The Audit Committee met with personnel of the company and Grant Thornton LLP to review the scope and the results of the annual audit, the amount of audit fees, the company&#146;s internal accounting controls, the company&#146;s financial statements
contained in the company&#146;s Annual Report to Stockholders and other related matters. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has reviewed and
discussed with management the financial statements for fiscal year 2011 audited by Grant Thornton LLP, as well as management&#146;s report on internal control over financial reporting, using the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) in Internal Control&nbsp;&#151; Integrated Framework. The Audit Committee has discussed with Grant Thornton LLP various matters related to the financial statements, including those matters required to
be discussed by SAS 114 (The Auditor&#146;s Communication with Those Charged with Governance). The Audit Committee has also discussed with Grant Thornton LLP its report on internal control over financial reporting, has received the written
disclosures and the letter from Grant Thornton LLP required by Public Company Accounting Oversight Board (PCAOB) Ethics and Independence Rule&nbsp;3526, <I>Communication with Audit Committees Concerning Independence</I> (Rule&nbsp;3526), and has
discussed with Grant Thornton LLP its independence. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based upon such review and discussions, the Audit Committee recommended
to the Board of Directors, and the Board approved the recommendation, that the audited financial statements be included in the company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ending December&nbsp;31, 2011 for filing with the SEC.
</FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:14px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">AUDIT COMMITTEE</FONT></TD></TR>
<TR>
<TD HEIGHT="24"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Eric Bjerkholt, Chairman</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ricardo Levy,&nbsp;Ph.D.</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">John Schwartz,&nbsp;Ph.D.</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL&nbsp;NUMBER 1 </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Election of Directors </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The number of directors is currently fixed at seven. Both our restated certificate of incorporation, as amended to date, and our amended and restated by-laws provide for the classification of the Board of
Directors into three classes (Class&nbsp;I, Class&nbsp;II and Class&nbsp;III), as nearly equal in number as possible, with the term of office of one class expiring each year. Unless otherwise instructed, the enclosed proxy will be voted to elect the
nominees named below, who are now Class&nbsp;III directors, as Class&nbsp;III directors for a term of three years expiring at the 2015 Annual Meeting of Stockholders and until their successors are duly elected and qualified. Both Class&nbsp;III
director nominees have been recommended by the company because of their past experience serving on the company&#146;s Board of Directors, the breadth of their business expertise, sound judgment, and demonstrated leadership, among other things. In
prior years, the Class&nbsp;I and Class&nbsp;II directors were nominated for appointment to the Board for similar reasons. Proxies cannot be voted for a greater number of persons than the number of nominees named below. It is expected that the
nominees will be able to serve, but if any are unable to serve, the proxy will be voted for a substitute nominee or nominees designated by the Board of Directors. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The nominees for election as Class&nbsp;III directors are as follows: </FONT></P> <P STYLE="margin-top:30px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOMINEES
FOR ELECTION AS CLASS&nbsp;III DIRECTORS&nbsp;&#151; TERMS TO EXPIRE 2015 </B></FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:73pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Principal Occupation</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age*</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:27pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Executive Officer, StemCells, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">65</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director,&nbsp;Executive&nbsp;Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Roger&nbsp;Perlmutter,&nbsp;M.D.,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Executive Vice President, Research and Development, Amgen, Inc.</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ages are as of April&nbsp;1, 2012. </FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Martin McGlynn joined the company on January&nbsp;15, 2001, when he was appointed president and chief executive officer of the company and of its wholly-owned subsidiary, StemCells California, Inc. He was
elected to the Board of Directors in February 2001. Mr.&nbsp;McGlynn began his career with Becton Dickinson, Ireland Ltd., and spent eight&nbsp;years in manufacturing operations. He joined Abbott Labs in 1977 where he held positions as the general
manager of Abbott Ireland Ltd., the president and general manager of Abbott Canada Ltd. and the vice president of Abbott International Ltd. In 1990, he joined the BOC Group as the president of Anaquest, Inc., a company focused on anesthesia and
acute care pharmaceuticals. From 1994 until he joined StemCells, Mr.&nbsp;McGlynn was the president and chief executive officer of Pharmadigm, Inc., a privately held company in Salt Lake City, Utah, engaged in research and development in the fields
of inflammation and genetic immunization. Mr.&nbsp;McGlynn is a native of Dublin, Ireland. He received a Bachelor of Commerce degree from University College, Dublin, Ireland in 1968, a diploma in industrial engineering from the Irish Institute of
Industrial Engineering in 1970, and a diploma in production planning from the University of Birmingham, England in 1971. He is a former member of the board of directors of the Confederation of Irish Industries and the Pharmaceutical Manufacturers
Association of Canada, and currently serves as a member of the Board of the Alliance for Regenerative Medicine. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Roger
Perlmutter,&nbsp;M.D.,&nbsp;Ph.D.</I>, was elected to the company&#146;s Board of Directors in December 2000. Until recently, Dr.&nbsp;Perlmutter was the executive vice president of research and development of Amgen, Inc., a position
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
he held for approximately eleven years. Prior to joining Amgen, he was the executive vice president of worldwide basic research and preclinical development of Merck Research Laboratories, a
division of Merck&nbsp;&amp; Co., Inc., a position he held from February 1998 to January 2001. Dr.&nbsp;Perlmutter joined Merck in February 1997 as the senior vice president of Merck Research Laboratories, a position he held from February 1997 to
December 1998. Prior to joining Merck, Dr. Perlmutter was a professor in the Departments of Immunology, Biochemistry and Medicine at the University of Washington from January 1991 to January 1997 and served as chairman of the Department of
Immunology at the University of Washington from May 1989 to January 1997. He also was an investigator at the Howard Hughes Medical Institute from October 1991 to January 1997. Dr.&nbsp;Perlmutter is a trustee of the Institute for Systems Biology,
and is Chairman of the Board of Trustees of Reed College. Dr.&nbsp;Perlmutter is licensed to practice medicine in the State of Washington. He graduated from Reed College in 1973 and received his M.D. and Ph.D. degrees from Washington University,
St.&nbsp;Louis, Missouri in 1979. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE <U>FOR</U> THE ELECTION OF THE NOMINEES
DESCRIBED ABOVE. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL&nbsp;NUMBER 2 </B></FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Ratification of Selection of Independent Public Accountants </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The company is asking the stockholders to ratify the selection of Grant Thornton LLP as the company&#146;s independent public accountants
for the fiscal year ending December&nbsp;31, 2012. The affirmative vote of the holders of a majority of the shares represented and voting at the Annual Meeting will be required to ratify the selection of Grant Thornton LLP. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the event the stockholders fail to ratify the appointment, the Audit Committee of the Board of Directors will consider it as a
direction to select other auditors for the subsequent year. Even if the selection is ratified, the Audit Committee of the Board at its discretion could decide to terminate the engagement of Grant Thornton LLP and engage another firm at any time if
the Audit Committee determines that such a change would be necessary or desirable in the best interests of the company and its stockholders. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A representative of Grant Thornton LLP is expected to attend the Annual Meeting and is not expected to make a statement, but will be available to respond to appropriate questions and may make a statement
if such representative desires to do so. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>THE BOARD OF DIRECTORS RECOMMENDS THAT STOCKHOLDERS VOTE <U>FOR</U> THE PROPOSAL&nbsp;TO RATIFY
THE SELECTION OF GRANT THORNTON LLP AS THE COMPANY&#146;S INDEPENDENT PUBLIC ACCOUNTANTS FOR THE FISCAL YEAR ENDING DECEMBER 31, 2012. </B></FONT></P> <P STYLE="margin-top:30px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>OTHER MATTERS </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stockholder Proposals </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders who wish to present proposals for inclusion in the company&#146;s proxy materials for the 2013 Annual Meeting of
Stockholders may do so by following the procedures prescribed in Rule&nbsp;14a-8 under the Exchange Act. To be eligible, the stockholder proposals must be received by our corporate secretary on or before December&nbsp;28, 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders who wish to make a proposal at the 2013 Annual Meeting of Stockholders, other than one that will be included in our proxy
materials, must notify us no later than March&nbsp;13, 2013 (see Rule&nbsp;14a-4 under the Exchange Act). If a stockholder who wishes to present a proposal fails to notify us by March&nbsp;13, 2013, the proxies that management solicits for the
meeting will confer discretionary authority to vote on the stockholder&#146;s proposal if it is properly brought before the meeting. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stockholder Nominations of Directors </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Stockholders or groups of stockholders that, individually or as a group, have beneficially owned at least 5% of the company&#146;s common stock for at least one year prior to the date of such submission
(the &#147;Nominating Stockholder&#148;) may submit a candidate for nomination for election as a director at any annual meeting of stockholders in accordance with Board policy. The submission must be in writing and delivered to StemCells, Inc.,
Attn: Secretary, Board of Directors, 7707 Gateway Blvd., Newark, California 94560, no later than on or about December&nbsp;28, 2012 for nominees to be considered for nomination at the 2013 annual meeting. Submissions must include the name, address
and number of shares of common stock beneficially owned by each participant in the Nominating Stockholder group, a representation that the Nominating Stockholder meets the requirements described in the Board policy and will continue to meet them
through the date of the annual meeting, a </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
description of all arrangements or understandings between or among the Nominating Stockholder group (or any participant in the Nominating Stockholder group) and the candidate or any other person
or entity regarding the candidate, all information regarding the candidate that the company would be required to disclose in a proxy statement under SEC rules, including whether the candidate is independent or, if not, a description of the reasons
why not, the consent of the candidate to serve as a director, and representations by the candidate regarding his or her performance of the duties of a director. Full details may be obtained from the secretary of the Board of Directors at the address
above or on our website at www.stemcellsinc.com. The Corporate Governance Committee will consider and evaluate up to two candidates recommended in accordance with this policy in connection with any annual meeting. The Corporate Governance Committee
will consider and evaluate candidates recommended by stockholders on the same basis as candidates recommended by other sources. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, the company&#146;s by-laws provide that a stockholder entitled to vote for the election of directors at a meeting may
nominate persons for election as directors by giving timely notice thereof in proper written form to the Secretary accompanied by a petition signed by at least 100 record holders of capital stock of the company representing in the aggregate 1% or
more of the outstanding shares entitled to vote in the election of directors, which petition must show the class and number of shares held by each person. To be timely, such notice and petition must be received at the principal executive offices of
the company not less than 60&nbsp;days nor more than 90&nbsp;days prior to the meeting, except if less than 70&nbsp;days notice of the date of the meeting is given to stockholders, in which case the notice and petition must be received not later
than the close of business on the tenth day following the day on which notice of the date of the meeting was mailed or public disclosure of such date was made. The requesting stockholder is required to provide information with respect to the
nominee(s) for director similar to that described above, as more fully set forth in the company&#146;s by-laws. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Form&nbsp;10-K
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The company&#146;s Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2011, as filed with the
SEC, is available without charge upon request by writing to StemCells, Inc. at 7707 Gateway Blvd., Newark, California 94560, Attention: Investor Relations. A copy of this report is also available through our website at www.stemcellsinc.com or,
alternatively, at www.sec.gov. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&#147;Householding&#148; of Proxy Materials </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The SEC has adopted rules that permit companies and intermediaries such as brokers to satisfy delivery requirements for proxy statements
with respect to two or more stockholders sharing the same address by delivering a single proxy statement addressed to those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially provides extra convenience
for stockholders and cost savings for companies. The company and some brokers household proxy materials, delivering a single proxy statement to multiple stockholders sharing an address unless contrary instructions have been received from the
affected stockholders. Once you have received notice from your broker or us that they or we will be householding materials to your address, householding will continue until you are notified otherwise or until you revoke your consent. If, at any
time, you no longer wish to participate in householding and would prefer to receive a separate proxy statement, or if you are receiving multiple copies of the proxy statement and wish to receive only one, please notify your broker if your shares are
held in a brokerage account or us if you hold registered shares. You can notify us by sending a written request to StemCells, Inc., 7707 Gateway Blvd., Newark, California 94560, Attention: Investor Relations. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Other Business </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors knows of no business that will come before the meeting for action except as described in the accompanying Notice of Meeting. However, as to any such business, the persons designated
as proxies will have authority to act in their discretion. </FONT></P> <P STYLE="font-size:24px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors</FONT></P></TD></TR>
<TR>
<TD HEIGHT="32"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em">


<IMG SRC="g339540g32t36.jpg" ALT="LOGO">
</P></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Kenneth B. Stratton,&nbsp;J.D.</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary</FONT></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;27, 2012 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g339540g31h25.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">STEMCELLS,
INC. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">C/O EQUISERVE TRUST COMPANY N.A. P.O. BOX 8694 EDISON, NJ 08818-8694 </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE BY INTERNET - www.proxyvote.com </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your
proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">If
you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic
delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE BY PHONE - 1-800-690-6903 </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you
call and then follow the instructions. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE BY MAIL </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote
Processing, c/o Broadridge, </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">51 Mercedes Way, Edgewood, NY 11717. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">M46660-P26533 KEEP THIS PORTION FOR YOUR RECORDS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">DETACH AND RETURN THIS PORTION ONLY </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">THIS PROXY
CARD IS VALID ONLY WHEN SIGNED AND DATED. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">STEMCELLS, INC. For Withhold For All To withhold authority to vote
for any individual All All Except nominee(s), mark &#147;For All Except&#148; and write the The Board of Directors recommends you vote number(s) of the nominee(s) on the line below. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">FOR the following: </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1. Election of Directors </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Nominees: </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">01) Roger Perlmutter, M.D., Ph.D. 02) Martin McGlynn </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The Board of Directors recommends you vote FOR the following proposal: </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">2. To ratify the selection of Grant Thornton LLP as independent public accountants of the Company for the fiscal year
ending December 31, 2012. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">NOTE: Such other business as may properly come before the meeting or any adjournment
thereof. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For Against Abstain </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For address changes and/or comments, please check this box and write them on the back where indicated. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign
personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Signature [PLEASE SIGN WITHIN BOX] Date </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Signature
(Joint Owners) Date </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g339540g49z29.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Important
Notice Regarding the Availability of Proxy Materials for the Annual Meeting: </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The Notice and Proxy Statement
and Form 10-K are available at www.proxyvote.com. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">M46661-P26533 </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">STEMCELLS, INC. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">ANNUAL MEETING OF STOCKHOLDERS, JUNE 13, 2012 THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The undersigned stockholder, by completing this card, hereby appoints Martin McGlynn and Kenneth Stratton, or either of them with power of substitution to each, proxies of the undersigned
to vote at the Annual Meeting of Stockholders of StemCells, Inc. to be held on June 13, 2012 at 7707 Gateway Boulevard, Newark, California at 2:00 p.m., local time, or at any postponements or adjournments thereof, all of the shares of Common Stock,
par value $.01 per share, of StemCells, Inc. that the undersigned would be entitled to vote if personally present. The undersigned instructs such proxies or their substitutes to act on the matters listed on the reverse side as specified by the
undersigned, and to vote in such manner as they may determine on any other matter that may properly come before the meeting. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">WHEN PROPERLY EXECUTED, THIS PROXY WILL BE VOTED AS DESIGNATED BY THE UNDERSIGNED. IF NO CHOICE IS SPECIFIED, THE PROXY WILL BE VOTED FOR EACH OF THE NOMINEES FOR DIRECTOR LISTED ON THE
REVERSE SIDE AND IN FAVOR OF PROPOSAL 2. IN THEIR DISCRETION, THE PROXIES ARE ALSO AUTHORIZED TO VOTE UPON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE MEETING AND ADJOURNMENT THEREOF. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Address Changes/Comments: </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">(If you noted any Address Changes/Comments above, please mark corresponding box on the reverse side.) </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Continued and to be signed on reverse side </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g339540g31h25.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g339540g31h25.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@##`(P`P$1``(1`0,1`?_$`+4``0`"`@,!`0$`````
M```````&!P0%`P@)`@$*`0$!`0$``````````````````0(#$``!!`,``0(#
M`@00#`0#`@\%`@,$!@`!!P@1$Q(4"146(1=8F#$BM+4VMM8W5W?7>!DY61I!
MDB/3))345=66>0I181C8<8$R)70XD:%2,[,T-78H4W,F)[<1`0`"`00!!`,`
M`@$%```````!$2$Q40(206%Q@1/PD2*A4K'!T>'Q,O_:``P#`0`"$0,1`#\`
M_OXP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P,0@U+?@36!\M(^>]$DM0
MIZXR9B(4MQE:(TM41:VT2DQGMI7MO:DZ7I/P[WKU]<#^>ASZAOEX6HH6Q7(Y
M6/&>NC+9;>$]%ZI;.#6FWC!7D7XY<A^TNF@1E>V5@:>JO=NZ$)0:LR/=7[\"
MJR(@YQTB6A/-].L6W4-;T_S6\^:.+,6^S7,!S:,5MWA2*(4JQ\EJU>8XNWY'
M<LL'2.G!2'0;F7;#37^:V`&D`B67;:;1MW:9&MREM8B((B'9WR(\I/+`9Y_<
M_P#%3B]KI86K=&X`(,!#%AYJNZ)C]"LM0\I"4.\ST"3(\TY4*[:N3U5DDXSK
M[+@PRKC,EQ$LB,4F1$=;E(B*M'NB^:GF$%\!N4^4$>NU:K=5[C8.HV6'SV/2
MS-VA<IH<?QF\@^D\XJ1/;3HHG:+`/M7,P;Y2>XS"3*?FOP&66TJ87B(BZ(B+
MKPK^B^8'G?TJU`&2Q8?R6=4/(:^>/_6.>M\*</C29;CO@V!\@;38ZQ;3)5@A
MNIW_`*V,GQ@<YEMUIP`9C-I5N<SZ[3'&(^%J*=;JW]2WSUET[QZN\0M4K97K
M9X\R+[U^PQ.:5NR5JL=1M`OM^ZY2IK]$L;98*89LG/10D9`;CREPBD],6PJ8
MW(:<U>O&Z*BUE<U^H=YMWGL?#N-=(EU7BQ0GT\%Q_K!IZ@#`X@I=&.!^/UR?
M(<^)=%(('G:UT>R]/EF`D*&ITLY"D-CFU*DP)6]IXQJ5%6]2/$+J?>2/!`MQ
M[8Y9^VW6T=_ZES=+M)YM4><*I=.IO8;QRD/:["`*6\<VNM-#J,@P1EQWID[>
MR?PQ(CS26]:S-7AF:MUTZ']3+K58\A+IXV53Q&-VN[A;T9Y?5#DBZ%!%,M%[
M6`3V&E09)U'/B,4.%L?C;"(V"00^-]B`>A:"*TX\\A_5CC<7:QQQ=JJ$?62N
MUIK!Z\5?PWO4JKAMT$C&V5L!T2<,5CR+G3*?XGF(PASG3BV)71^F#GAEEBJ4
MI=.A?!.D*?;7I&.OJ=<MA<_K'OUWBU%Z=%XB"'6FY=`O=1WS:^](/U4Y"A<[
MYEU&Q3-L:A\M.DIUEZ%UCAUII=1AZ@ML%Y;,*7N0VW*2UIUR=6_8^JOT-%HK
M8FQ^.]9HHNWG>@QJ^JU=.MS=EF5>I=5Z]R21:]A8/')`[3'-)''GK1T-C4]6
MZW4#@V5$63?=W'VZP=6AK'U=.H6L#4Y<7PXL`>X7;E/5NV#N='KN8A66N5'Q
MX)7@7WJGW1&^;:V(ZQ6)<>DMBA*&G&3"K_"4A]#49UQQ/&-SKZM+T7ZM_7_N
MI<IG+/'0!&L3_`K=W#EP_H%COCEC(T]'*KCVV@=6L_/@?.HTF-R0G3*_`"%7
M&S#1<=?"K87<7:$*F*=(.L+-`_5@F3:KY4GBW#XS$WA/SL'FL`7T6,4_'(6$
M_?MPA*2/BUU^W5:GR*E0W+O#*[%3$S*3-1+CM/OLK9<=<P=48)_5CZ+]ZB](
MI_`*+?C2"5+KH0M7NM6QVLHD6(]Q\$QT:USV..3=AN-](:ZM()T(I#V2E6$;
M6YZWH\)>EICNIUW=\?"'R@M/E?RLW?;ERYGDAT/9P(A59BV4C;(KPNV\@Y9V
M8%,07*5*E2E3H(7JK`LBUJ%[318=*2VXXWI.\S,5*3%.Y.1#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`PR+[\8?/DQ6O?DQX4I^.Q\*U^\^TPMQEKX&]Z<7[CB=:]$_AWZ_@P//=
MSSPB``L2SV`"%/5QWFM'L,TC3BCSZX703]!,7`GS],9A)YYPO)E1&&H[3VHK
M8^.I2YDCW7(C,C75KJL*[^2/0H59Y66K'.Q`\CT>,86\*MMIV/G0287H5!J<
M(:)1]B[;+#;5`LDJ4U+=U$E1(*6I*X:EZ<BIE)3AK_EY*N<'KV@7-RHJ5RWF
M5EM4@R8E[F5[=PKM7"GWJV_[,88_,$RG3Z$PIL9W:IK<*7MQJ)\+'OJ*14IY
MMEPX@98R'+8K(-P<;.3=ZN>I!B:#C#^E1Z](##(E?D(V3+67F,W4J(MYSY`2
MM,KW'G$O1VK121PO,(Q)8^?E<8+C!T2<XR8W-MXY):*.$"N;$;,3@!D!U2"/
MLJZA`2+CN+C2"33;KCJ86_;;<E%-ARGRIL76I^UC>8MUP'+Y=:K[7W+'9WHY
MD_/#/U98J%$&(KVE($/0K0ADC)_3.0"3#C+;<EGVI+RB8I\\Y\L9]^@$(J*0
M&8M$/DI:^L11UV:,#9%BKE3H)XR&G:8"-E`M:G$.B1&0Y5QEU1./'D/_`"[6
MDLI?3'Z*0V?YU,URO!"]EYW&5,+KFLQQU;NJ#+A%L72P!J<;%R55N,';`KMY
MU(=E4V;$DN-I^:2TI/JUJ];*1JS]JYPR<+C#OBSSDC>GG+6[(B39=-E?>0M4
M#=K;OTF*>D4EU4N&':KK4A;\Y$6;+DDXZ4QMM>[);5ZGSAM:A<N=6_I-.IN_
M&_D`5!@S(!6S[3'U"0]7Y;E<ZB=@N5F3$J>DVR49;HC*)#+NH&HS:W-H4_\`
M!O>,T*Z/=<\8YQF.=G^)O.R$_E!4ZS\Z1!\]CV0-=F=O<QN(2@"U`GI-J*5P
MT2E"SBV7&&X8Y*Y/^43MMI3.ZPNFOVWB=K?["]5O'7F9VN\CK$@Y*-BQO/IO
MWK)Q"5J@Z!U^)!!R6'=HB4N0O<ER0E"7EM,)2O?N*:93+K^CH?C.:OL&^TGQ
M.XC,LMK=HG/A5\LD6E"2\WF)&Y\^+Q#\@<S4B<L'3BU6Z[#+AI*E:;(D5)B2
M/9^",XXSNM3HD$OO/'A5318)?B]S%34L.2-`2!I/.ZR,,(JM>,V"UR[#,=K,
M^#2Y3SH-4<4TMR;J?-D--K<C)]7-*G=*6A;+=R&KVUD+"\<.?'8FZQ4;<2=5
M7:"#6"!'2@`2XY$W($2?MHJB=9HGPQE[AL:0RXK<A/Z76V=Q6\+M?+Y3LN1O
MQ;XR^$A5I9V>Q"D5+9VO.UX)VDMT2`9'D*`/8=D5R7R=0QG<1;T:7.EK5I_4
M5&I"WR+1'>1]3!OV81Q;FO-1P@#T2I5>RS=6P!3(Q1-AZ\YRR7:J\)KM;)-V
M,;#AP77=37GHS/S^M0OB4II]3<J?)3'B><29,09\ASEPS)(`[`=9TJY!QQ!@
M50JV?/7:9;`K`\G)IY"6FN/*KT-2I6C<=Q+^G8S*'%(O4I/S_ET`K?*;1THE
M74L3JST$Y0GJ6HU*?,/3`8F1;7&]SQM<(BD%YG/XJC333;CPWY=2$K()WM2D
M2LT4KRW>:16&,4P*H8X"9(N1"H&=9;F*2,D4Q_H<3G[4[3?R<=,R\D2"W78]
M>:=4IR(A3B9>W4;8RT4DMT\I3G,>C]("VNM0B=:"'QT6MH''X<$BY6AE4Y*0
ML;\*+.$MNV._$+!UZ.F$#9?]'X$%Q:'FW=);D*N"GWT;RO.U*E<WF1N:3TW'
MJG+;1T2'"C%&SPJDQ!4"O+BO$R#$"#!L"QS]NA29[*'8;:(,>6MEYY:&&Y"(
M(C](S!\W9]@%67[M<M<9+B`/3S@*3>K1]S@-H9Y>VJ"3@0%_8!0H[;'3JF=N
MB68[R&!KVI'SBG-*83**9Q7S977X9.<9YG'W&%-$'4Z%]$"2Y]D9C%SE3B2Z
M8.D"X>[!#<MM8F_/*TZWL4%W'(O^NGMQVK12;U+R=E6/ID+F,NI00ED>F%8)
MA@I;H,<&+55K,:K1]%;.[%:F74[->CQGX(WY*`X[&T^XMQO3"OBE%*RL?F[-
MK_6B%)C\\?L<!1*96`8@"<AS;7),5ZW],KUA('8341?W7<),\W?4!@RO\D50
M^TXN7%3[^F+UPO5K8'G;L)61*;'2"=CMY*'69,7[&4V,"SXY5RMUXX:WIAHZ
M1&5^M7:X@XDM>V9,EMLY'6EISX=IVZI2WJ)Y6JM]OI]0)\Q.5*?T,L?'4Q@H
M>$R24EBBBV"'1Y1X?#:4V!=J;LV,TAC3\E4WYE&T[;WO:=28*=O,B&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P,(D0BB1
MT\K.6IJ$,A2B$QQ+;CJFXL)AR3(6EII*W75(:;WO24ZVI7Z&M;W@=):[Y`U^
MU6B6T"Y3%KE=K7+NE=6LLX^'J,LTP4E@^=60']GLU^T/LJW<J3T%$T@XG;SC
MJMZBON,+2K;FJ6FM*>5]:@,TS07E<^%5PATJLC+GBJ<C46H!0'7X4<K0@T6X
ML*'S#ETY7+%QM2-M*C1'4OO-)9<VMM17[;Z1Y8T6%(LD]GBU\DE:Z[/I]P=@
MPN:)F1"57B6\Q;*MJ;)NT39F-5XM8DN;4TM<.4],91&4XM;VFE%/DWY7T5PB
M-JHWF!*P69<P9`(@Y#U,3'JT[?10/+;H.*$-%I@O1JI?C!9FZB,NJ43'3?B8
M7IN1I:Y4E."%Y?\`.1X,"N#S*UR89((<*US0(72!PXL`H(LY(Z*7'#YEMCO`
MA]0>I4B,F+-TS)FK1'U$1(;WMUM4V4LRT]PYKSPO]DCJ41)6-RVCJJ'@5P75
MASY:R]`9I)-'RDTJ7"QXS)=^X#MS9#RVO5QM2G/BVA'Q*LU:ESR0X_5JG&O4
M>JEQT8E0ZU9EQ1@&OQC"A,PD>##*ZO312/&E3Q)`1+;TTA]<1.E?$RZM"]JQ
M$3)2N;'Y+"QTC8R#QID"_67PH6"]9DU&:P.L9JP]1J]BJD>%63,Q8K4&%RER
M0F?'=?B3&GVV?A2I*MIM"R.E]2+T0IW2:/YU1B4KG%!Y3<!I*8;D02-G#W.Q
M7P988IUUBJ2W1BP":K*=@,-N3&YKCWHXY&TXI2)$61_AK.O=?O//[K%'0.11
M2028!(2*62D#)9@A:^H#VKW);`#5U1)I\.N!3:^X81I<5V=/B/OQ8Z$S-)8=
M1!$0KBC]F?6SXYQ*+R(:67TFS=M)V*2H?>Y1$5NN=AKU#Z#?1!.Q@GC%='6%
M5SFV%3EB<A..0&&QFM[E2&$:M%-CPCRI3T$YQNC0>:UNJS+=7+W,Z+`#%]+A
M\^E!$ME.;"QS#02`DO'Z-5G))EG;B8ORL+X-_"YMW\"8)ALCGD;6*B=[1+OM
M$%-U:A76N<O#K%5J4\?LP^%585Y+2FIYB/!!62!5(<B3+6-&.2'1K$1;KWP>
MN]IE%(K?_)3E=O@2Z-=>/]!G54UL*+V'K\J/JT$[`Z4ZH]8:%8*C53<6P#I@
M2O\`)9D^7`D.*^<4^U&2TIW:-JM3J4NRC>0E4O-AK-:A<VM@1BU0FV0ADY#I
MR1:69,/H)2KPY<099B)>,V<`<J)SFV_E]_*M:C-OZ:?=VVW**5**\BE443)=
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M=S-_`E$8*<.O*6@WJDS++0*%.LI>LD>+SE5VQBZZ+E07^MW0(!J,=IT@:9AC
M+$7K5F<)0''7FF6H\EM;JTZ=4C<HI#S/FI2[$VQ+J?-K#/15[N!;M]CM-9&O
M!Z=L;%@R>AKA2V#;;4^YU>ND-1XB8DA:IJU.NP_G(\9Q+EHI([%Y@<Z@24C;
M!QSH,LU6)P6$H-'!TFSS0UDLE?L-D!`PJ0UG*ZGFB7/*Z0(IV/\`=:2TE,-3
MJ9;R6,44V-T[N,J?390"3Q9,JKBRL>Q6"X-HJBB6]R:,..2KGH/.G#2D*96H
M9/<*6EUMXG)0K28R%Z^).2OV?\I%4>_\\O-5I]EJW+K-)4:N?XO^<"B5;K]=
M>*M&:/)O3QNN$3D^`&C5J301LAZ3MN0EW;T5R#MI<A.FMJW*?$?R/YT?M%;A
M:I$^16WZHQTB=<I@\7/=JY.4,Y<8JD=%:%?;5EFER,'L<?XY<5G:8"TN?$K;
M2]NZ5^RE.7CR@<)N0%<WXI!*.V`.-OA*7=(E(6HB**DZ`'Y-;=-1[O`6_P#.
MIN"IVF9#J2<)`SY9QJ*J0V^BQ!2PNG^3]+HUSL%1+4%9.J5\!>(!Z>]'K6UV
MBS!(G(2LFCU$+*,:(EWW@'28[[[;\-#4O<;:&E*]KU4B+]R(M\\^[]SR^=:J
MHG7+;>+M[,6YA:N6AMM&ZT`I$^P6*"*LA-`6:L96]7[?)Y"=J<CJDP%,,1'G
M4ZD)TM,&7=?,H8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`Q)\V(.@S"!!]N-`@1)$V=)>WZ,QXD5E;\E]W?IOT;:90I2O
M_+6!U;Y/TO@-@)/T;G_.':V[]USEF."U<TB5H:)K!Z/7"B'CFVHS<)EKH`HG
M`EQ8FO<>E,,;2^TTN*MMJU*U*!R_*#Q?8`ND#U#(A14J&U`&1;+S`<)39HQX
M-&L4L2&9(Z:C2].4_J*2<J.ZIK2XAI]OX5RE2XR;4E2Q0/DMXR3=0J]SZAPB
M=5C)*1WSH^EAH=,"C1Y$-4T/2VF6G2R&K`JQR(<1I,%3^]LN:EHCQWFW7)4F
M6^%]7\9;:<';:Y)(>.7>;5AIN7/Y%"1-%1KF6K1OGY2\25Q5OP!=S,D!LR"X
MO;KB9+2%R4L.QM^TR9:\]VOQVH=SNC9#EH@0!A09,>Q7Y5+KXV-9R@,Y/Y::
M%A_G&(;]LC5..LK!G(:4N2AAM]J/'D-.^JK4F7,,O'C+Y#71JC67FK$;HQ4<
MEV=`M-4KJK"D1SZ\NE!0`P7&2"SJ1)5RHMDVXJG=PI`Y:&W5)=7[&,Q[&8]G
MW=.Q>/X;H'XOK1RP%+*<Q.%J.&DSJ>-T(KU;C<)'=;>>KIXV$A4P1'F0)+09
M(O1.,Y[GPKWK3.]ZU*FK,ZL.7Y1>'\Q=7L,H:*FD;4MO0^1)Y_&4788*//G'
M)DU4R&A_X7FYCQ)*&E/293;RWH[;RG=_%:DJ5I7[O'%JW9;#33X:?8[@ZVH*
M?K0RE[/%BHBOU^/>4_.-NLI8(`!]=L4R?%TZYMMW<<@W&2Y);<:5(B3+3,7W
MQLO]OID*!21MSL/0Q%HA`S3//&9K?W2,3[U$M4\D;FP6M#*X=G5,DF0IQ>MS
M%26_5"]R=>K,&6IG>1OCR!>357:8:BM5C5EJP4=$Y@O[/9K-7,'11V37&8\7
M3$>FHMO+MP&TH2SJ5/CP/:9<2]#<6J2I8*/(;Q:'D2$*756@!P)!C$K%#E\R
M;BS*XH(BT5D%$*RXD!Z'H@X9Y@7KPE##[_S!`,N+&VI'L;<5)4MQTZT>-%1(
M](L-WY;7B3U=36#_`$JUR*)4GF5GW!S":^,(E#CD%^PW*#4R&I*(['S4AL:O
M2$[VMQIAQ%^#*,"^A>.]HM]$I%5XG")-'KL4`[.$>;0`P,(F"KJMBAV!J7*'
M;?>38K3RXJL>K:&O?]52-K1\Q'U*9,K7Y]U7E5KN3=3!U;4$Z,=,QX)IBH;A
M5Y)*I,K9DA1!V0/@O;,"Z]=-N[0AI++;!&0VVZOXGD[5(J2!Y1>/DBH5.SWF
MD?=8A9()-Z4#*4\5-)P9%DHZ.CFEQ1VD_;IH1<1UM>VF3&AN;FR)JTS&V''E
MIW:GP5*4@.S\D+=4IHVI\OFQKU8SIND6VP3:7#!$:,M0SJ-LD`[*8CLR%NE#
M)CG<YY$9+KD=S4CYA3VEOM(?E30@]A[CXQ-"&*56>6CKI)19J+6=\\@<WBQW
M&DW*P@!<Y<&',%,C=2:Q*#Q&IC>ULMQ2,*''><94EI2+4ZE/@SY&^'ES,S9\
MZE0KZ='!6Q[Y%/,(%@*QZQ%KI*XGFG)4F,N>+%4X2.DN36)&X[B7D;;BMR'=
MZ3M4E2FEB->-_+S%RYT3IZ[$<Z42I[LSG<:D0C;5FBQ*\%KM#%`@RH,.OIJP
M*!6V(<'W5-Q84F,OXG$*3M6IF3*7<\M?CA:6$GJ)6ZHS&DU!TVDHBEP:_'75
MZ!*;KK.G9$X>/:BM5Y2DQV&WMM_+,H^'7P(1Z)9\IE6-9ZWXM66KLA:=R5DU
M75EQ89%=`<UK+PS5\9/&WA-.81'>0$E6:$XV2,(=CO.P(L#;LM4IM+Z-NLPN
M7+ORL\7#9"PV)D)L^1C"#<<J?32Q<APF`JGL[TRV9G.M-3X3NBZW$1E.^[!B
M)?ESFHD-M<C5J="I;/IO0>4<]E@>=ZX,]::U8'P'1I**[4ZN1KK<TS,L,A!4
M>/C2%ZF7$=(K7SJW4M-,ZC;VZB5M:=-JD#8\]ZYXKS$72Q<^"U@;#YH>;F'+
M*$I4`9'BR;N6>IA:SQYL"&W):BKGUY^,5>?TP^U%&Z>=1\HF,ZM4^3*L2GE3
MXD4X"2DU"HAWS)8';+S'KT3GK()\D:B^U)=:-,K$I(-EC=B##6'=MQI4EI:X
MC[R$LMZ=1:E:E9=JN/CB8#(Z+;^6!IIBTV6=S(PJY<\";L,&P5EB82=!W2?.
MC2TQ8<9%6:4SK3\G<W:(C<1$EU3#>YG1,M7SSMGCP<Z16`T3GD>F]1.DK=!`
MO2*B`BDUQX<FP`E'8Y$6Z\0C@KJW0B.H;BT-KVB!M,QN,M;*753\%3\.ZF1#
M`8#`8#`8#`8#`8'\XG0;`DQY6_5`L#K7<O(^D`?$[J-Z!GZR6\ON33O'N[<K
MK]3I[OAV$KX$M3Z!>5=7LM3E7"K&JDQ]XU/+*ID//Q)<"0[TC2/#7B%$<YYQ
M9^+^4GB3R6_6+MQP#Q#P;Y)V/K0J_P#2//.RD^Q^4IZ%8;]URP4NS4VT3J`9
MM]7&\(@-.UZV3_N^TU8/EHPY;LMU#B[B:K7T6:J9]76W@H+ZDEKD^.7C_<CG
ME5`'UOSKX!Y`]"OEB/\`4H">D6#OG`:?Y6%>-$[2E]LE&X!P^#5[@$L(QV0V
M%0<L049MOWHRV=W^8S&R_P`ZIY;K:B?X>>/A9FY>48[S3ZAW;DU6^HU9^RRO
M/<3!I!BO!^@=NZGSNR5KD&VG*%SB?T+FD.I`5\^AQ6&P,^$RU*U#FK<D*S.E
M>"-?1?73>VGZ3RKZFG*J]<?(:JV]=R\1/&WDPD.`\J[5^+GA`RM^.W-NL=OY
MS=2P>R'Y41-GZ[=B;I..3FV62R'0]*4XY'TM,B(Q/_9(C25^]9\G.3B?J*\M
M\@B'0>E]$\;Z_P"/*RUN%30'EIS,/X=N5>JVJ[5WMR0D077N;]C%>2F[V'I<
MBOEQA.SKL;(AH8AU3,Z*S*GK7DJ:KRGWU9SG?+3?^0\QX;+[;769W`>[.%SW
M,V[V(8C7KR(O/!/#SE,DF2K;;##9OGXONMKM\=$E?N"55[[3]&OE/>0XUK*<
M:\O.JF6CR1>>K6O,@WY:U;Q.YEY(5WP7\F++7GNZ13-SK_AOX]]%C4CK!8ES
MI+O18O'/)ONUYBOV2U`_:;/21PZ'/F;A*<3FL>*O7]M8\:OZ=?'8GRI_F<"M
M\85<-T/GD^;0!Z;Q&ZGHVT^"TP](8T8[&U]]K3"8U/2AHDZ_,9>]-MMOK]I2
M4\YN\L3?E>>1#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'&ZTT^TXR\VAYEYM;3
MK3J$N-NM.)VAQMQM6MI6A:-[UO6];UO6_3`Z8TKJ'AYSY)5NH.P:[IF(6%V*
M8BIWEW8YD6@TC5</EI8>7L?(7"H\MD.,?>2Z[%'HCP&=MI8;WJ;7+1G+7X^N
MTBA6<ERR0,K1KIMZHS!22+MM8G\_C<A'62*<MQ*4,$MV6H.QZ_X^QX[+#B84
MA?M,15N)3MSXID:UOH/BV[:GJVJB$%BFYQBRL*6*NLF<B^FCXX8<I4'EWRCE
MI@V&>?\`AE21+0]#.Y$;YY;'Q)U(TJ2I;AAGQ,ZA?^5S:C:Q*35;GUVU5\)6
M!,B*NRNC%RJK3/M*<\%W.=&5]SE3OMQ=/-H::'MON:0RXVX]<P9A%2UI\,SU
MVOA"]\^EUV3$V<DF[?;*K>!`^=/$V?LU-M8YEV/&^1%1+`[SHZ_IC2F6[4S*
M=W[,EU3J5*F%RM5BR>,U3;KO1P;"H\/I:BC8^97&K]**6$Q!Z#`>4&12`D>7
M/(G(W0#JHWL.1$R(+BG(NDH8VXVF9T3+36WK/BA:6UZ-")]J"GSY2US+0&H=
MW)#&;C6ZK10#!318(+^TV;:L%8PL`8N$E4M3_MML[2\C7I:DBWU,F>(U58AD
MPU7]XN,$A[]`B<_J=WD7)(CGE:(5P46>378;1AH8(`PG!3OSCC<1?NMQ9/Q*
M?;0N9,HH9MOB39SUUO/279#Y2[B*4R68+5FT-/UP/2!=^<I]7FS*W7HA`1:C
M46Q6G?V3*DNDR;,F7"0A^+I+*F3*RZ:6\9PKG2.DT"KN?;//@)"S7-0FH6MH
M^%9^7LIB?6AX4I"C+'&4O+)*<!Q6F5LS93WQLH>><WMDSHCE!%>)DV'?G(XU
M$AX@,Z!?KR1OP2PP)&@-D+V(YT*/'(&H,(7L74RUTG1"T06M21,]]:96D3%K
M6NS9E45JM/ALQHS!73[`-BT6'3>E&I([FUPFVRTDZI93?5H//;&BR5I\_&M,
MHYQ.)8&8I)Z.0,_%[T=:OFI#CS*Y6YTBQ>)UCNAR->A&BUL94)`V0:R&Z"FR
M3"+NX8>J1&JG7A^IMDGE6+=(%M2FF7'=Q'I,)2U1EOM:F4BTG*DO$ZCSJ#T8
M@BMA9L*N0K+SPM&&V'>WPMI58V1Q`(+'Q76RA"1]^BC;"?EW9L5!E]"4MIEJ
MTXR990SI?C'5XJ;8)W#%RH]I(BML0:9;EVF->;"L*",`7:W'!O6!JU3)*84*
M3#W&U(0\C32TI4A6M,R>41Z(YX7U*V,!.A":R(/@1M9`[^=K]I:$Q1)`'\G7
MQQ,I$@_=N7!"UVL:>4F2\X@/&91(=^7TZVXXB_!E]3.C>((6T#>HSHFA5B'Q
M"5N&6E=$Z&PEU)Z+>W(9QII@#N&4,7(7+L>P"U-.SBL1^8D;[C;^TN,Z&='S
M4+;XL&>P.5NNT>''ND]]XR(L"Z)91KUB/'^A6J\71Z!(G`XGNL".@<KT0GD/
MCW$43;2C2_<:7K+4T9990IXAT*QV.C3Q<$8:8W"AG*I&K5W)#XT,Q1#P1\\V
M'@#YH0<%>H48FP5,,MM1_EF7?G'_`(M)WN9DRBI^R^/=\/\`8^KGJU<;E`HM
M*YA25S!=7/(G2@)&WS;0$G<Z8'#`UN*LNV;<::T6B27XJFX[;T)U"4OJ7<P9
M3VN_^DZ&(Z@<`@@D((W6(=2O+/W7L\>`5I1IV;6!8ZMU^4.2T>J]N(BI,**H
M%&>C&I[+J6]R)'Q;W,F4#8(^$K9=-7T/<$6*;-?%N098?JH$Y*L0`DNX[F2I
M\J/"F3+F/L))]I@JIYPG]H.28#4C;OS$?3)E@0;[X4F-PQ>T$A095B4W59,U
MOI02KOG>DATPC$RF*;E,P@J8#)Q0LA)8;A,AI)%R+M3&YCFG;DRMF^6KQDHU
MH#UZWCXT*S4FH1!U:!#:C;2CS%/=B/QFH8$16Q,U@M`"CX[FE^RT]]F,+7Z[
M:2XOXIDRT5\M_C'R6NGJ`_`"RHG7*NN>_P`W9>*.5ZW5^UQR8MR.RQ)W(JU>
M8M\)LDO36OD_M5QB4YK3KVG%8S)E!)]Z\(YX>TG@-:^^;<*';B%O%\YH]X*3
M)HB["`04\Y:!H.#&B3J]?`;`_<1)+>X)5EA#\73FV%+;9@RD\R]^'>ZBU0""
M'W:4'L)`BL/.JG4GA1.V03]A]8Q5^4(4NYGC)^ODI,")+7.=++@;E1FWTM,N
MY?ZU,I;SDQXZDN@Q)5`%O,7:1]J>S]B#KVP]%&/B!I$FN\"]0XPRKQ&"15UA
MF,90VELLY)VPE,QV7K4R9=K<B&`P&`P&`P&`P&`P/-MSSOMA*]^1!RM<AJC'
MB7XAW*V4#O\`Y"WGK,NM69VS\]HL.Z]*;Y%R(/S>UN749S]PI$%2'R9L"LB5
M5(8A-NZC>X_JL>JU^Y41SGZI_3[>[S6XV7Q*^Y?#[;Y04CPNM=TF]DB2>@5S
MR(N16/3RD*N\RW0(\:X<[YIU:3]SSQ59L<0V5B3Y,0<_`A>_(L\?7*]4Z[7]
M4JI\9\I>Y\&*UWG+=+\8.$"^_P#<+?8.P$`G45U612+_`-#/0>/<5'\NL3/2
MB=4JU1@/3-2K("3M9V,A'Q;UOXI'&XO<CC<(7,^J/U>A&$4;M_B,QSWJUXI?
MC1T?B_/0O<(=SEV"O>2/DG3?&N/4ND$V^<!F:!U'GQVZ1B9&#!;/B9<1N0W$
M).*C/+U>L5<3@ZQ5Q)V?ZN.N7W7NU3JWC7;NL)XBYY4/NN5"V^Z:M`7Q1YAX
MXV2[G(-<B4XM.CPG.H^1D6KO::5,=ALA)Y!*)"TI@XCCN=<6Y1_U,Y%P['XO
M^/$NC>*=E.=]XR(\C#%H'^51([RUWG4SJ!L+3I_"RCWCPY,[7:9E6I!&SMQ)
M<2KM0UCML;E:4G4C4ZXF3KBU5>,GUN8/D(CGUCE\!"USE70>I<<Y^CKE:[K"
MO-+I".RTON=R@@^BDI'-:C"KO9*%`Y.'D6>JM/S&0X^XCI#I+2_]'<L\*]UG
MC2T>$?5<,>0OD9RGA%4XOSVGIZAS.N=X'/=0[_-JW2"/#^@W7KD3F=BI7+QW
M&K#JSW.Q\?Y8S>)P268#I$#S\*,Y+=>TZM*>-1:3QJ+;+RM^ICUGQ=ZKY.5F
M=XT\^M?*_&#QG$^4=KZ.CR/(`["0J%LEWJJT.I:HB^$DX`J^W#H?/"$)F*X<
M<B-#-(G*D;<5J'B.-Q'J1QOW<GCS]5?79RM7'V'BX>L!R-;\MN@G.ETKKR.E
M<DF\F\5(W'8TSK?*KF]SRDR.F4"\W#KB@4:<J"*:8(U\EIM4MII#BY/&CJQ^
M#_4UZGY#W6=1:KXZ\XH-E%^)G*/)M=4[1Y#F*);+)'['RT5T4%*H4"#PJRP;
M;QVF&C+-7M%M9D)D!SR'FE"5:0S\S9XQ$?)/&(2JB?4=Z&2\%:)YF]%\9XE<
M-=Y+\:`^,G"J+V-%XLW53/D*:K%6X\,L5KL?-N;@N>/V$]:6GIKJFR<8:%;7
M-4XXXG<74ZYHJ+IJ>D>?_E#S8C>>=O>)'+[9V?B?"#GE+WL36_)\E&Y;2.)M
MS+'#H(L)T:P\$$ES_9NGNT&S:@A9((<'@L`UR9A=IN3'2IUC6\%1NHFV_79Y
MW737DBW!X-:"U6Y!XW\<[1R<R]=Q8DUWCH?8:?RZXQ>(PJV^`D:IABH0.T5Y
M9DFN63:@Q')LIQA+4)S:KTDZRRZ!];^I&>NAJ!TCCP'GE7@\GK?1NOV"%VV#
M;[WQ1<WPS#>9=P+7#D[//@Q3?'Z:$L4"H?>O9!A<^XSHT!@=MQWT0Z;+U2Y?
MUC8H;D?CYT&\^--IH]QZQYDG_%GJ?+"E^%23OCS5ZH8F-6[LET)QJW\J5@TZ
MK$`!,J)9:CJB[-;8^;5\O[KKIGX3KGX;D5]68S8CG+Z=6?%^Q'+MY-B[21\1
MA$.\NK%==8H/D-=>1]&*VVQ-4)Z#S"J\\Y4&"='*$74D=;!GDPHK<B<TRB6Z
M^IUQ:7^7OU5JQXD=^N/#CG)"EM8J7A_=_([=Y@W"*)$D.IB(UY+<Y\;OL]ZO
MSWXEIZM7>9'IT$E[KB6$0?AW$=VO6]2.-Q?J1QM;_FGY\#/#4!Q]TKS2=T*\
M=%-A9UNI8.TQ!:>7<:&6"F5[LG;CQN4'FM3*KRR??1,1#&F&'C!(G%C-*9TX
MXZRB+2(MZ$9E#`8#`8#`8#`8#`8&M,J&)#E5&ELMADC9RBSDAQ33#8S45W<]
M;[J%)4VRF+\>U*UO6])]=^N!T9GA_!7G%4L58G%*\L+'$QCQT='L]MM!1<,$
M`/0A3K*19`D5V1@URP3EPF(WI*W';7(:1O43;K.LKF4SV8\34TV1SD[8P\H1
M6Y=R/%`UAN!FPGE%;],/5^U32!5LP4+%[!99/4G_`$BZDNS65F(^VV65[CZ1
M,ZF6C)5;P]"PZX6('8<'[X"Q%RJW2-=*L&[%87;%,E6>!<A=HCV9RRR2DQD6
M_.<*IUII(UIU*WM1$.MI9,OVORO"3GUX%&@$FLUZSB6G20(TW)M:0^_M:)7N
M$[;$D'W'*X4?G1Z#%'M,-*>4M;,B8VG:Y$J2ZS)EE]&B^'0P5;6K]/&%Q]DD
M2++8AS)6WVE]&BSITEJ:R-`2"4T/`D3>S3ID;VD,M:D%MNL_IFV]M,F6_D6W
MQ9C1JA&L%K`-SN4L09]>9*6A^<8%ORSM=3#UMP21EM'S<PTT*6J(E4J5ZRHW
MQM)U)1IQDRA9*#XGT2YA(,SYF'\S0JOT>#:=VNRR:Y]SPDRO4WG8.%(:+O:.
MP9+[#+\&#';D)_T#4AS\&F][N3+@>?\`".O&II/\8@F(5?G'Q<N1%Z5;YC,D
M7(VXL[1&TQC4J`]1ER9>][#LZV/U+;U[;>GF->VR971'\8>&2MCR2*Y*)M?+
MP9.GG;?:IT$[*B-3_L6QEF_MQ<,Z<%QS4O4*>]IQ]E$M?P+_`/HVB7*6F<'B
MG.!YFT'6`;ZYUP`F*P;3),F9,1P#83IBSGQT.&]/7''LESY^7*>VSI"O=>W\
M&TZ_!BQKP'`>75U)UN*$G$&+)6RE2*1#]BL-@AJ`V';;MJA0X9@G,C#/OC.:
M3++N1DM.$IFM/OJ6YK2L7*W*+Z\4.**DS)LL'8B<PK`?@')1:_WPF]85.#+"
M$B%#ZIMC>T8/A@UJGQ!\]_2Y<&.\E#+B-,L>TN2Y;*O^,G%ZT=W9AM6DJ/[-
M)L.B<^R68C(262?=M6Y.M32[S6_<LLEZ:M.T[2X^^O:M;2KX=+DN7%:_&_G=
MR)<U^V8'N5?E=)M5+JM:8>)1W(L>SB@`#4S1YDH@DAT.#!:;BJ3Z26I2D24O
MI=:1O%EN89XT<@%&!QU@$7?)#)S!IIV=<+?.9EV=LRP??N)6')-N0R]O(DXS
M:Y1*2V[*D(1IM:MM_I,7):2VKB?-KF=A68_7_FCP\Z.L48FV0(QWDD!HMT&A
M"VVI28[H^8'>5&E1E(VQ);]-N)4M"%)6EH>UXM<71L6EX`9G1@L.&/&0"-TN
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MK?R[/P+DMMYGCWR6?>#'1IM87(MIW<I1&>LV>3'6Y/KX^K$'FAK9-`Z.]/`B
M(D=U2&M;VF.C>O17Q*5+DN7,=X'RJQE1)DM6=/S0]2BT5C:"15AF55!SDA\6
M&)LLS4((L"9,Q]R,IWXG6EON[TK_`"BM;MR6CH_Q<XX(@J&"`AH2.<!$:N["
M&6^U0(S]:F^ZJ$"DMQ2[6I4"LO/*=#>Y\3@EU2E1EM[6OXER6V<CQPY!+)C2
MLJM2WWQ6H;L>.Y8[+L:\2&RRTP8>G"]%]0)]B&+/SVV)SS:Y+;$M;6E^WI"4
M+E+;<%P[F]7M;=UK0><"L/OE79TH;8;`Q'-H,):W*B'Q^R:QYJ"S(92_&:D-
M+1#D?&XQ[>W7?C6MRMO(A@,!@,!@,!@,!@,#S$)>%?BC9O(WI,$3W^^"S=WZ
M52O)+M_AK6NRTQ[FUTZ%6MTZ>*Z)>N/$`9F^"H%FD4\'+*,0IXT,;>B-.R6'
M5//[>U<TU<T_.=>'/A@7\E[-;J=VH]T>Q\I[I<O(N7XN,=S!6[E7#_)'I:3K
M%MZV_P`C$I79*[=C)*PF9L9@Y,DC1A4K-ECH<64YMQ*9Y5\$S--C?O$3Q0:[
M'WV/U7N]K;D?4$!F:MT/QJNO8::%I7552>8U+C+TZB4QX2*Z$X=!T:JP8D58
MLHO4-Y:GM(T\M*]+FL>"YKV=?*SX&>,/WB\C*%U'S:M?8>V-&N$=/%]*LO8:
M.QY;^,7/O&5V!<N3"IY)AU^M0Z31+[-*6!N;.J$",3V?D?;:2COPRUWM.*C!
M<[8712_`/QH#SD.\@\BNRU;K(_E!-N?U.D=FIIWK4VN]O[:]Y"7?KI^38*K:
MQ!`KW?H0'XIY60,V+G#1J(<%EB/$0AN=I\Z':?*H.?\`A]]/3D=5>Z1S+S*.
MT3B]BY..\.["^'\H.8.<BNR`\#K0\>*,VHN.).2>N1;5VJR'O2(7COJL$W;R
MHVT(2QJWRG$QDN=$O-?3=^GGUCF_<?'UFZS"='@6OQK+]II-/[0'9D\X/>+W
M-*ESRBPK(@+M1/GZ[5ROG\(=96I>X[Q<:T[OU:TI2\G;E&2YU=IN6^+/)A7?
MK/YB\DZUT-^'VNL4-HO2*A=JB4\=K>!I5`CT7G94*%&UB3(^1!US6WX&X!A$
M+<A];WP*TOTR3,U4I?B7/T7P6X?U.Q]PM%O7=9A#R$+^,A'HK+%D0S!D#_$V
MY,WWEU4$1MCG/LVJ2[+\P\:B:4O9),Z2C:VTN?I7:2Y4A=?I/^-UQ@1Q46W]
MXH@QUCR3K5F@\]Z4S6V;MR7RRZ\ON'9^%V1S==FR6>5E[VZM<)H8X.,#(3KD
M:.10TXM*KVE>TK'E_3VY*6Z#;NB6+H';;).+<?ZSPGF]>)W0+&JGCOS3ML.M
M0>A`^$B@=2#O5M9"+3!#<5\H^:='M#F6HNVFOC;6[2EK$Z%X9\6Z-XQ4_P`3
MB;%K!<VYP%Y*-YH:I]FEUOH?.2W"95;(\DNE-N$)OYD3<J06J,"7&E>VXTXZ
MSM#S3K+CC2Y<W9<W:@^B?2]X]UAQ,CH'9?*$[-LW*1G#N]3X_5AU;E>4_)@M
MJM-L#TGOGW3IX%@D,'2;R:@I<KB*W*<#E9(]UUR&YMG+VGT7M+0="^CYX9]-
M.'K)90M\2;.B_*42F<)N"1GV''\N*K4*!T5VOQ6!/R0V36.=TN*`JJO:7H`+
M=>0SI3BTNH=I.TPM4Y]-_P`8[-S[H/*CX2R%>>]<\@!GD-UBK3#4=P9TPP$D
M5M\-S2Z(^R].&>*C4TL,PFN*4F.[$%L1WEN,;>;=G:4N5=?T1?A=&']'KP.G
MV*JTGI`'R*!2.?54^P#I-/UY14#D?.NJE^?A88M/W7.2!'&1LH?(;<<^0)3)
M\AM/Q2MZ1>TKVEV&Y1X7\6XT5\="M-:M7Q^+7CJ;\9.2PR]@V2@0*%99/,9-
MA,F&51&EE[V95R02F044M*EHW(U[?J\K>I,S/RDS,JP[O]-'QC\C[=8KMU.#
M=RQNS=M\=N\$-P[8N!$;L_C&$)U[G=<B1D0%Z:H1`78"B#0M6UI)?:TOXEH]
MS6DV.4Q@N80_IWTFO$CNNKM/\@!]][W<;;S"#R41TGK=JC6OH'+JN/*VJPLR
M>1GUA8J:+87;+;72+TYAE;STF%`TOU9@QFFW:8T7M/AWZY_2?N""D@]VZ[W9
M4JQVFQK-]`/:L1UI5IL)&P?8D::B'`:C5RNZ(_(BHB&DIACX[+/JK:-K5EE-
M\!@,!@,!@,!@,!@?*T(<0IMQ*5H6E2%H6G2D+0K6TJ2I*M;TI*M;]-ZW^#>L
M#J;!\,.0"QL<,-EWB$)CC9D7Y!%ET^A\R]`N0D;;Y<F:/E3Y-GKXB]D(L-Q3
MVXGL>QIZ.]N-'VW;E;ELK)XO51X`\BJ2R4&WPK-/O-;L!8O+<2+NQ.53WY-@
M6W!9;0MUO[F1MML^TJ/K:G$J;4VXI&++;&!XPT/[LT0'8)IT[/I/)8W(=&DD
M7QSI8+JFG*62(R8[;DC;9,C`LDUWW/=6IMUQ._B5M&M[66R!?C)ST6647U.M
M4MQXV>/RX#Q(?$#29QY]Q]Q*!(<0,@C(T+YJ3[:(*(NGW9LB1*W(E/+?VN2V
MI$>*5)"QS+,*Y=-]VRA8P*SS7[")?DV&$&AQ85-5/TNN[BQY%$;BZ4,7$:C>
MJG'-2]2DN*3M9;*#^*?+PMD%62,]:W7`=A3<1`J2<0X'@W)Q0%).TMQVX+4I
MPH;AUJ''DH<>7$TRA?LLLN//+<66D)7Q]I9`;4(4(G;:[-H-<K=9IQ\$9:9-
M`8=69>ACI<9PA`(CY!%T;+D17W)$9Y+K$AS7PZ5\*DK1ABO&?E@,0)`B81J"
M)!P-C!<-HW+4F)!^T[860PEQWW'G--2KI-^%2U*5\.T:WO>T>NURMYORN6N`
MH]9"P`4.3.E0AC*8D%1!UI^0Q":_21(6G6F(^EL08^DM-[5K;GMHU\:E*]5;
MB-W@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#P,JGT_>\2?*S
MMGES:6[`*ZYT7OOEY(X&\(1QF)7>$`SGCDCQTXYVWI]TBN2>N]`#V:F<T#-C
M*A!DOQ`<\^J;+'I?86_'Z=HJO#5XKPT'A5XO]^Y/T;P\O#OA+)X8+\4?%I7B
M_P!"1"OW$)_0/(7K7=;]Q;\<O9"]BJ]S)IM/&^7ZYH4N2YYV4U;+,8/NJC"4
M2=/>])F)O.LK,QG.LMKYI^&WDKY'_4KY?T8=R8F3X;06O#<<Q<C%@X@GE<RK
M<P\@+AW_`+@Y9H!6;+\C!%W@F!5/^["*BT+B%"(_;1J2\*TZPM$Q''U(F(XT
MH3DWB'YC\_&>.1%CP?K\WL'B&+\K[9U?HEJZ'QAYWSV\B_)499N;(VFV#K+/
MM7XB[<_T.3?+K,MT<>2A1@T`7`%3I45MMNS,;XG_``7&^'8SQK\%/(_Q;^G3
MYM^-M?H=*Z5Y)G1W0:%SGJ5E/)@"/)'GT_E`&N<F'/.OW*2?YY6./5$M)H%<
MKL\D.B#HU<8?T\VW.?FN2>43RB?!,Q/*)\///F/TR_/2A=&X#T*K\_M;+@KH
M=EU69'19OB=*E5.LN7OQEY\U<_,'G8!!?F.R1+PMX^4JX_7)HSAI$EJ*F5*8
MESI\I>IY<9C\_P`+VBDAD_3`\]-U?S$L/$`$2J4CH%:.4*J\&\C9O.JYV7N-
M!E7WR$\AK=5KG?\`Q^N-NJTS=P[AU@6)C%K*8U/.5<?-B$TCHA%U;SMQQ>IV
MXX?TL>*/*2O"?&#QXXD=CUJ*9Y#Q/F',RC%.^;W5D3Z-3`U:D[!*GL19JQJW
M1NU-J=;0XK6_52=;WZ9SF;FV)FYM?^1#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`_%*2A*E*WI*4ZVI2M[]-:3K7KO>]_X-:UK`ZHU#SF\2KY4BM[JO=*82IX
M7G5]Z]/L#BB@P>GE?+VJ\]?>BQ7"PV"HC2JVS;!JGB4;3L1>IC>VUK]=^@:`
M]]0SPTK`ZN$SO=:\/:M5.(]"$PUA;@\;11!90P%D7`W7(U<>L%7K;Y:O3X\6
M83C0V)SL)_493OM+^$-?6_J2^"5L6Z@/Y0\KUIGG9#K+CY@R_6HFN="@DRSD
M+7J;9(8F&L=&JP]XKO6E[=V*;W-TC<7T=P)`(\_/#(Z-'E1WD;S)<8G5^AW*
M,S+-*&%$5WDIVM5KIDR<$)QX9D7)HQFXBVB425'9F14SV7%M::7I>!+ZKY>>
M--YOM2YA2^Q5&V7V[@"-IKM:KC\PS-?KHR=9QCY@DX/AR(E>@22-*+L0UD7(
MNI[PR4B-[JF'-)"M8OU'?!V>#*V$;Y)\[+#PET#<](,!Y)0N;1;K%JU[KPN-
M61HR59"#9_5$-_(RH\1V'+^QYOM.K^5?^`+1F>6GC8/=HS,[LU&BN]+N5GYY
M1$/%?@W9[M3.I`.)6JM#?5KT64!=<M(VNR$*^'X"LYECU^-Q.MA7A;ZA7A@$
MG6\?/\@:9\Q0H29UQ7!:/%H8!IZ_O\LAQYQ$2&FCTDBO1(S@B%#2ZJ7.FHVB
M.V[Z>N!.Z!Y@>+_5)]9%<X[GSJZD[D4%!ZJ.KE@C$YQ^<;YD[V07H9%C_&_)
MAR^91W"VI*4_+)8:6A3FGD*;T$')?4'\+!3G1V)?D;SE<GDQP16[W#@$)A:<
M,.G+TGEPX:,@BH,V7:I"NF+U77OLE$Y,4[ZP']MR];:P)M</+_QKY_<8-`NG
M6ZY6K?/I]0OS88HT7CN1:AT"S/TRC&BTK[-W!!LVZUQ71PYN:['>ERV7&VT*
M4A>M!`;1]1#PJI5S)\^M/D+2`UM"QNAS"XV2@ZI@9#Y(9)5WI\N<78#O!8L:
M@'Q+T(NXN1I$&5[;3NTK>92X$IL7F]XE5+HT/DEF[[SL'T6;8RM09JY(QN-,
M1:`J`*IP"9(6QH>/*[<M(UEAF0\TN7)G,L,:<><2C8:V5YY>(<#B]:\B2?=:
MB(XE<K''J=5Z09:.!JZ>-2@Q"QQVQCQ01$D21[E;$RB6IR6_D?LZ,[*V][#:
MG-!IOZ1;P>4&O)]GR9Y?+&\YM`JEVO8\P^1G,V8Z;M5<""PHB!$D%K<LR<HA
MR-$<$,3F9+H0AIM:ODI.V@WQ'SP\-Q<%TG,\D.4?9[`L78'9L6T0R$9%7,T(
M+U`;<=O0/F4;H\CG]BA%?MO6_LE$60G:Y"5:4G03$EY7>.`9NE/%>R4:`QT?
MNA'QFH4F462U$M_?1$RR#2?*:_+4CY8G;H12GE(CD=I2M:EP'V?B]UM2-!H*
M]YK^)MM1SMRL]_YH=UURV=:HO+T"[`Q,>O\`<.$1#T[L%=J3#*5/G"?/XE8G
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MX=:W@<N`P&`P&`P&`P&`P&`P&`P&`P&!_/IV7Z@7EN+MWU&KMS=WY+D_C!8'
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ME;U>D?FR]8>OWU0?)[N'C7XV`[+XLBZE;.]=`ZG6*1SD1:A\D\`+Q0H:U]9Z
M9&5`%D1TB1.>Y'RRPM0UH>TEB<MEQ6E:1M&\\8B9SHQ$7.='7CQT^HEU'R3Z
M?XR)HLFES^/^3GDCYDEZ28BUZ0X1F^&_B]S:'4!QMB5]MK:^\%E\C38U3A3V
MU,I'2OE4LZ7Z.Y9XQ$3O"S$0ZL]=^JKY45NZ=$D4=WG)01U)WR/Y[XO\A@\S
M+V;I(>U<)\S.3^'%(L3LIBYBV.B7GO\`8"7020:N3M5X/&56(34@DRP@G*RQ
MQA>L(GP7ZK7EOU[LOA_1!EBH9NJ=`N-'H]]M+G&'`H`J<OMT[_9FN=]OLC71
MI;/"/(Z'XL\J%'1U9J\:VC'[?,F0YTV+!U#]U/&(B2>,0Q.S_51\YJ%X\(M6
MI_'GNIDN]>=$^1-Y+R6Q7^JTSQF\2+<[Q4)?S,*YWBJ:C\:=\@OL\3;KI,EL
MEF!)74@6%<=2M,1'&)G]'6+IVE^HC]3?I?(.74Z-XVSD/=9#O]D*=\>:X)T.
MSM4*L\"Y_!DWB_B@G3G.2"I_CT)[)<ZJ'L%T9(3M10AA3PIDA+2OY><>-SG1
M(XW.5&USZF_FCU*=Y`2*P%?KIZO;<@<OY]3_`![_`!NU]_B=!\K:GXI^1'E[
M4"H7J"^I=8.\ML0RVEX=&E`:VF>-;@:CJ([CSGEWK"U#C\<?K.=%\ANI_3DX
M8(LG(@%L[%9)CGD<3ME<(UNT7JHS:!V>\\OWRGGTRQ./5*7>:51ZV>,S%O%8
M(Z;;AXF&I]W4Q49/"KDGC5OZ6\YL&`P&`P&`P&`P&`P&`P&`P&`P&!P2?;^7
MD>\XEEKV'?=>6I*$--^VKXW%*7Z(2EM/KO>]_@UK7X<#P<YC]*%#''(7'.;^
M8%>G5BN^,OD!X7W8P&X>HJNR\R\C*MR@DX48GS^REH(OHX9BIP"&R,%;H>6W
M.VV@;$VG2L#M7RGZ>5MY(7,3JUY`#HHGIG"@'#>ZUB+R%[8JW0:##ZP/YI:N
M<$3G4K%:>7F0D'JKC92/,(V:`4^10MAD>Z\\M04#9OHD<TM!%!R7W.^1CNN%
M<[X(X18KPB5'17^8\.K',ZM8H5?+D2=7A6^%?Z(%M'VAJ$N2Y$:G`'G'A9)]
M.@T/;/HTU'JTBW=1['Y1G(O:NA6)TE8NM5WG5;IHN-=KQ<O'RI1X%0J#MA+L
M@ZS9^2\;A<]F")!`B\6:/2IKTM4SY?38=D_%[P_$^&?1RYND>34"=2[M/&U3
MLO/+?00DDI9^F5VOW"Q5"14+G"L\`C09T:AV:`X0%/Q#<:;%$HDQDP')4MQT
M.KXKZ-`VR5WG%D:\K%74E09W-97&3<[D<+=&@<EIEB[A?!%7,A*CTFKV.YE+
M`<[S)E/'=6&$E#0R&B+#8;<FZEA;Y;Z5TZ[!KN!/^3LJ8`>B^:;?'9=7Y4%#
M67C]S\L^^U/R+7=7+&Y=#46Y6?AO:>?CYP+XH8Y*OE-,RM*VG:L"..?1DI+T
MDL+?[,4?HUIX]XF\FMXY-0*BKT53XN]"I?19-@&WZL])`1P,WKQFJOO&G6Q#
MA6)-(+E02#"T?`L.Q'BAX!\OXC=>']QKUXA](-<R\-!'B-4[;]T``F59.:#K
M\F]U>TS"HB4ZW).Z%):A2GT-^I%Q3TM:TKD+;P.O!7Z/?/IL>I!NE][.V#C_
M`!ZR:=XI1GJD(JDBGT"P>5G/?*WH%%N5Z"GX9WH)*SV/EX8$/+HT)D"Q,=3B
MF9A%YZ8X'83N?T\^8^2EGZ3U^#T$M7[)TOQ_\?>5\RM`6+]MP>>,<-ZG=.WT
M^XQ1TTPD-?8-DLMJ&_/0B+/JN"*TAB4RJ4ZXD(I)^F",L/.['2[QW2TFS-]X
M]YY\ZZ!:0=1"UMLG:O/CLE"[7>;W6:\\2.PJS$H-CH;,8,(>=)(=A+UJ9)D.
M(4XZ%2O_`$?A%MZ>/[G??)(W:NZ"K^7Z%8+"%Y^+KE(EVVSVVC&#<1?+46\R
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MP^9=6\/O&/Q$IG9S-$;\+8X\54NF4FO!'+3![#4.#6[G%:Z<_`>G*BB;Y7KU
M>8M[<]77E2BT;3;RU(DNNX%9UOZ)]&IY7EQ6J>1_5:SKQ\OL?H/C\#!A:Y$K
M%**$?(1ONM^8MHIQ4B3?FN@PQ`FN35ZDBW-#8#B][<7*<2D++O7TK(-J-T8N
M-[;('?=,'Y[UF:DUSYP_+E"//'M1#L]BD@I(^_UB*(L'/)D[[,@OD(QJ%/B:
M4M^&EY25-A3XGZ&_.1@J/0V_(?J,/DBW1,8U4@X@0U;CU<#W49UZ+62?3;#.
MM)PI!1V<-$*I=(L3Y#8>'&":7\G&94@-RGZ0]RB\DZ#Q>/Y8,F*W>:EP@3!M
MERX4@OUFAWKQUYO3>1<T[+1NCUOKM+*5[J=>I-&@R(A6,TU(8L*%3]J<9<>@
MNA[.5L0[7Z\!`R#!:Q/A`HL0]8#SS,DZ==&P6(;A@U(C,18\@L36SM^2MMIM
M"WEJVE*=;UK0;&-,BS=/[BOMOZC27X;^VU?%IJ5&7\$AA?\`X.-+_`K7^#>!
MDX$=A6ZL$C<ZMP#HV6>&->\0$L24.3H;/S,F)IR3'3OXVD*DPW4:WO\`!M3:
MM:_0W@2+`8#`8#`8#`8#`8#`8#`8'3XO]/[PH/2>LRS/C%QXE([L5:.]C<ET
M\>[^,<VQ<(/06C%K0I/P%"C=X&1BNI"]>[\^PV]\7QH3O5[3NMRW+W@[X?.T
M@/S=/C7QR'1:_6[I4@58%T8((%AP'1BU9/7Z&,9%Q8:H3MR.TP3-)R&U)DS9
M8]AYUQ3C>E8N=RY:NQ^`7A/;Z-S7F=G\6N(G:!QY1??-:D2H`*2$JC=CE(GV
MF)!AKB_`^/N!%M,DU&D>]',2DI>FH?=UI>G;EK9<IO:O%#QRN3:OMSCM#=GH
MZ8)[6.-QZZ-BG@/9:[18?,ZOUBO%VH^I@3H=4H8Z,+%E8ZD2H$.,RVRI"6TZ
MTN2Y;>F^.'$*'3.(T"O<YKC=9\<1<85Q:*1B?;$FAMQZ.5YNY/$D2BI<[9LC
M23T\?,G..+ES&9\GWG%J?<VI<EHSQ[PX\5O'VQL6[B/`.6<MLL.A1.6CS%*J
M(L',%<XA&Y-E9I(=4-E"0]:<L,M<YZ)%TTU(E_"Z[I:T(4E,S.I,S.K3F?!C
MP[L$?K\8SXU\>G-]]L(FV]C6[20Z9-_M($H\="6(Y,:CMS%&A-ADO$H\EI;3
MS).0],2K4EYUU;M)<MC6/"[Q*I70*1U2G^.7'*OT/FM1'42@VP!0J^*+5"J!
MQ<T$(%`7(4)EL?H4!)28$9Y"=2&($IZ,AQ++KB%+DN=&-8_"/Q"N`GFH&T^-
MW'3X3CQPU8^9"BM&!S(%.+V6PZMUDD"8KT53*6+%:TH)SX[FEQYI!IN0\VMY
MIM:5R7*9=D\9?'OR&ETF=W/C7.NKR^<EW3E(D7JKB["Y7"$ER"],^0408>_T
M$@^*B.2HB_CB2G(C"G6UJ9:VA$S&B7,*TL/@'X66K?45'_&7D!!7;+,+N/6W
M-U&!'<Z'8@TTD3@S[4Y$3'<*HT4-3I3S#F]QY,J=)>>;<=D/*6[3NMROU/*.
M9-FN>V-F@5&.;Y,",U?F!&*`&Q7^?5RPCPPDT#I^H\=INO"B(JNP8SC$5+;>
MX\5MO6M(3I.+E%@9`P&`P&`P&`P&`P&`P&`P&`P&`P,`K#V1%DAZ7--*GP)D
M-+JD[7IO<J.XQIS:-;3M6D;7Z^GKKU],#H0[XF6.C\.!<LYX;<AV&?V&BGSM
MGJD9FMQVZN0"`.>=C(%V'SD=Z1+,<K9-M0G6E29#!B5`>2RK<?W$APU;Q&ZM
M5"<&0-ZB`C#UD:S`L,-B-=-Z.":Y<^>W`KT.0A^S.I7UOHZ:)\D:<4KY#VY6
MG$^[[;K<D.+I/B=;+?;[K;!GD/)KU5MQ@X+%5Q4DWL?#8+,MSQE4=GQ+;!;D
M/*[U-)S9.HZ&)+PN8D2W[:F4.X'&QX=]47%;`KZV(!5=VQ:N[4$`/LSLBDE_
MMN/,%TVAMSCZ!T6DT@=#9V(6\SI]$MI*M,L-(0VD-W6?#ZSA^8ZI:;;5:T7U
MV%CJ")-.%6=L5&;C<AA<L>C,*+6208^UCLB&LM-D:?0C;\MUK2%?A>6&!R[P
MQN7/+CQXP4ZZ3MX3EC)IE#2WR`,K.>(>LJ,2F+1]JL$G5LR?L*3%:6.AN@18
MY'P?$RXVL-_S_P`2#M#ZN"N8VR5@95PEPO-F8%`AAF`59@6NV=DL\JMPT:):
M!M#+=-ZO&EGMK8<4_.KT9Q/Q[7'4/"O'_!"S13#!(;T=!"'$KU8;4`,3+"U7
MK`:&75=MNH&X067II2P4KJ3TAV01;=G_`.CD=I=W'E-I0T@,FK>&G5*R!H%6
ME=#H]KJ?.(8;V*@9&79FO7IU0?GHTR$MD==H*;BUFO3Z4L@";UJ<O4M3&Y>G
M4H>T^$JK7AP9%<AET"PVZ#>K(CLM-ZI&L-PW/,#2,ZGE0;^CKPG4>(JOVLW#
M'/2)3C"Y?QDW/>6\[\:_0'/?"\ESKI?,+,*OTI5%YT('01M''R282&')0:.%
MKQ@L,2K9A9!N_'(LJ8:B./Q6W]J9<6M]U"_C".SO#"^3Y.M2KM6I"=D3JYEB
M8>O(:Z$FI]H599EF2;&'$J$WOHP->JI9)C?O(;",M+@Z:3K4%(2+EGB1<^=W
MVD795CH"R(TO#,W@L'JZQ;]F;UQRJ\NGAT5N.RS6F)J%TH>]#.1TP9L5CYEA
M#.H\M^.H(\]X>&'&XAN)U$!9#)BP;F3XUD^\$JM]0KT*/S*6+YS9%L625(E5
MF#KGA:<AMA#[:)$];JF'6MS6Y0;4GX:6RX/S(]\OXHH!&@S=9IXF"W<V?EH!
M6RV8M]M&'/O4PA9[==M\L+_HZ4I9AH2II>MJ^%L(`8\*3,$LUHKUVO2OMKJ\
MFS0(%WFE78BXSG4:A=`%@J]=@3:[&B=1K@L7JJ,/;<FM21LYO2UI:;0/<#*Z
MAXLW@OU/H)JA]"$";+>+S7STV'4I<L9;X?/;](H-'O9/HS$VW1F)8JN\SI-L
MA5>1!C>XDN=VXVREV*^X^%[7?QWOI?JDWI%4NP87[!6L6`/%GMV1,R8S7&*-
M';YB=?@%4P_Q:JF5"071IEA4E!8HZKX-HT[J5;BEMBA_%^P`^1RZ7NV"+/;"
MEVJ5SM,^PQK#]W+^S61U?&.5*SQU&R9=JN3(P3_)M-O.LM+TWMUF0GWT/KS9
M:'PO"XI-GNNVZZ#BHQF0PZT-BLV=ML\39NHVQS+_`&7W+"E"[X?K:)`&8MG7
ML?(I:TCT;WMA%[1!:!+\,>O3H_1!+'00(&&41JKBBK\4H7*6NGN5CED&`P3T
M0)FH=>C48M2I#P3Y>/\`-LNOO_!N,J0Y+=61*?K\6;P`LO/I(*Z$YZ25Y'$.
MN%6Y$^(P>JT.Q=+N]D^VM3+.N=**6F02JX9AQAN0['B"E-[^"+O6F5EK,`>-
MI,3VJ5V&;=G"<M5QD&!T)ULOMT;4YHOKD:?3HRWC3T)J#.*=`%RWO@82VXX"
M8^)&]MQU,912Q+P;.Q!9=51OPF#8K#$0-L\XN)*%6+0&(IB[MHR=HR2L$.(_
M9)+'S'S:H4M4>2AIW32UM-[0'/7_``@L[+M?;NO6G+J-CHJ,:XP2$$_I-V@5
MFWPK*]`,J=LTA4N$08CNQMLR-OM?!(<2I*VUK0H(<%\8NU5]WOPB)(4:D&_&
M6[<SKO1B)2>)L70.@VH"$8KFICS?0"+V@U"T'7"'S76Q$R+'E?`EU:_=?P-W
M)\&;6^',.HNU88.F2:5Q@B8MR52:97G&>M:AURHL)LK)&-#I)_I,6PB-ZTQ\
M1@.SM6F=)AN00D?,O%[J'/.S4\M/Z.:M]*;)])OMWF37R#$6>2G-!XG)N?Q(
MLNV$9FA//9Q^R2H?P14QMPU16WE>ZTW\8>@V`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!AD69,@?.8A/:C3'X<IF)(WM
M6M,27&%H8>WM*5*UIIU6E>NM;W^#]#`\Y37BSY(BZ09"43LDUZP6("R$*$[7
MUGK1-^%*9K/+TPK#6R139[8(P/Z&`L99;J(JTR8QIQE;:OC:3$#$D>*/?UGC
M<(-V$I6*J03T20N/5^IW8;,4:Z#?.AVTV8((<$2R<95F$W8?&1J%-B/@YE<9
M?@OZ0^MO0;VS>,_D,?O;#V^CBX_-@\HF^,&0[E<&#DJ%^-R+T.K:D)(A#<*/
M<*</C+C0#25J5'^)I"VI'P./*"Y1`GL`KQPN=+M34B'T.GT.:)K-GHEB,6<W
M92T:K-DP9N&AW35BV6BF7409"7U-[)2XC[S;+$1]EK04G4N(^8`LB$N);HL`
MK8$,U2TVD/.ZC>(P:SDGW.;&;+RQ`5NO&J]3ZS6;")L^QY>&U,DS81=B&^SI
MG3JDA=EBYKW)ZI<(C0+*%L%HH%.^S;TT6NMZKH.P=%15`4`-T.:0KT9!VZBZ
M]91LQYT,0W%:)L$E/..-R8S.MA!.&<#[M4CU1M70>L2K%]C%9>E!8W0KL>")
MI9)/:I4@"J!,A"@9N<@E<*MMN7)BJ?:8`);0_P#"RW[P8][X7Y"G+);IX2[-
MMLE;B=+`R_XVNCUU4,:5#NQ*!/74Q`B0%AKX>34MU(-IQ0JX:>]\@XU(3\.!
M%[%XT>3C`AF'1.URHA^8'.LSK'9.B]#+0QM@L=#D@SMD@AI,69(49>L;41T2
MIN2T.!LKENMP'7G4:0";XJ=<(59UBP='+GY+TD&ZNOV/L'1/LU(@"2YU:`51
M04$0A<-EP=;JS.;9+('_`&B]#DM(DN2?C?0L+;[GQ"_73HPZ_4F5'VVBDCJG
M8`SG4.@\W=L(H9<OO$[6FRM-ADE@F#&YOS#A6*RF>E0U$)?QQ9CNV0_.F<2[
M7;>>T$0#ZW/@7VF\B+UHI8F+):*W`MW29Z.;0WK.7A@O5J2P1"`K'$;?DM2'
M1+IQ,N,RJ0TE384U(\;/)ET>/%L]@/*=BVRFDR%KUUVRHM<BF0J!+".T-$75
M-<JL6?0K]*0?CD]0E*LJ&D-DF]+TK;@;;7C?Y'2OG1;_`'M3@R.D5H<R/N%R
M'E8.SM4L8KI&G9L&(U)A^[8$"WP*V%-N0&5STHVRI2-*#8T'G?:*?Y*UB&2+
MVZQT,6&O,R18Y5XZ._6QE0EQF!7/N:20A_7W3N)X7+862475(F'D*<<;D;]A
M#;SP8Z_&ONUC[!)OURN51DUR!U2O7"M@&3-I),C@P/H@ZP/+%0"@EQ-?(EJ;
M7Q,:3%;E/15E(3CR%-,N(0@)WU#A_69%[Z'T3D-@$B#W0@H"LS/M2ZW,"S&B
M"N>]-JD(TI@<,L`Y$JKV.X#RD6/%C1U2EQ%J6^TZEM2@K>1XY=Z@P27/ZC?8
M=2I)NPW0R_,'];Z4Q:8D`Y;.]%EQPVT"G"D"788/4`;S[[)-K8R2!VECW?@C
M/)"?!>3]SI7/O*KYN_62UVJZ#>C.\@1#N!.9L+IYB]RJ!]A,SAL,E3["/&FQ
M`A[34^8PM85B0VI#BG7'@K.+XW^0:Q)"9)O<U<Z4H.D5S)SR#[(V-KU:<UU!
MV:$<Z*Q`59I1"-:K#7S>BJH*YDI(+8;:VX&D[<#.K'&_*2K=9HNK#UT_<*Q8
MN@$3UVDPB]FV*!<WK=9$&(5<:9F:8%PRY[L%7ARM?!ZNOA;>;%)3]GB(2EA,
M.G<,[;8>J&KW43@!V`.,1++SZ'<>@=";9"V=[BG2N93G-!*Q$'BH5+CE;2,G
M_96_FI4B6W.E:F,J=88;"IAOB=Y(0)`*<WU:6/GR2E0<O!87U*XN6$G7ZN9[
M$FM!V)A2JS`TEZB!KH#=3M<%J.;>@.M2V]Z98<>#<&_%+R(CUYQNK=RL&CLY
M%>^\Z2?5^I2H]CAPX''G[4'%S"JC**>NR62LVJ2F;#C)=9:-(9UI+#CK;(;R
M9XJ]8=9"2"?3;-<"(VQHL<J62ZY?!!M15A?6*^+/A2,03)KH(X%I5\&ITS'$
M-BI,X9I3D7?PM+T%E$0G>FO%?H5"DPFHO8`W-R%6IARFW0S\S:RZJ;`W!/C3
MK^TVBN3&#LYV`Y*<7\WN1"<FLMM-NL-:"H"'C-Y'/!"+\+J,]LO/)*;#5M?;
M.LLB:36MM=9=JX^)968"R%@G\[/70#/7(?AMO6)L`W%EN(99CIP-S1>3>3%6
M[+2F+1TX[;:43M?3KQ=I#!RU.B1E,BL`I')N<PG"/M06YP.V$IB']-I]PP(1
MO<CX?92C8>@F`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&!@E&R#HPBT(D1XA9R#+;&2I;*I$6,07'<3"D26$*2I^.S)VE
M2T:WK:DZWKU_#@>=,/F_F09,\U%R#UDI=6A!:V-ZF97U*,?LMEENW*&3Z*1&
M36]R!XEV=&@+2$^1$PGHXF:MGWH3FD0V0S>-\I\HJIV0?<;A++$A)DLQ#Z,H
MOT0:5"&D#J$^/FW0,/$11109"=N6M?=ZOOLS846!-E+?3"D-1=Z#:E>=^8-@
MZ/T4LFX/5*EI,D#%`#!KCZQ914-JV0ZDY/U.2<G;JY@>H')+"]:&1%$$26OE
M7&4[DS`S^<\W\C:I3/(4B6;<+],N^JJS7I1J_IG_`&P3$U:$#MMAKTL*W77:
M<$FDG)DROB53(JXW^3;<?@(7OV`BU4XQYB2!-:9N_7+$F:37%'W[8:[1(3L4
M`$#\R0&U6G8P%[8HT1*0+&HI*8=5*D_.:^*0XG3&V0XK+5_/*:&:"BYPU!.&
M@>AVW)N@V,J::=*6&S1C`P,.C@T:"B%N#`Q)B>MUMZ*F0MH?-2EO3H3^V<A\
M@XG'N957F-OW4[/1.9VJ!/AC#;<82:N+D.NCJ]"FNKAM2I\)@2LSJ*O4F&W&
M).19#BMZ:UM(4:%HOFS**GF)=CZ62`@3(D;86YMVK%--7NI?=#D\^$"YLN-H
MM$J-FKEA6=23.K*24EV_=8^?=>=2J`$EG<6\O($`/:)%_MMQZ@L);HY=H=TI
M(3G>RJKWRLO61"JTWNIQA-3-5RJD8LXB.:4<@HE/K:2][WRJPL?O7+/)7H'4
M%KIMN@C>9IJ]"D!@TC41T"W<J[=I9X\NV1Y!-J<]I:V`L^`_%&S'5?93L13L
M1J2]J2%5@N.^7LZJM">F6R^V:=]ETTJ.76NE0J$L'9:UT$:?Z(%*RPMBE$K2
M.Z`*&(V`EOS%MP6'GX3\48QM.E!*8?(/+?16M"9G3;>X-E.4AV[6S70A6D:J
MDN4,E=0J88,S6F9<.].61V9+%FXZ668M?TV/96TZE.!CQN=^80:*:3/G/VZ9
M-K;8ZO/A[_$K;8PU]F5L!9[)=&AGW+)76PDZW$6L"YH@RF*8B+W(<BMRTRXP
M0.D\E\L^?6WGY`H=0[8^H6?G=;ZV2!2%$67:L$&VRU]"N$^:T`=&!S<64)B#
MH#CBV6Y*S\E*-J=TUK87WUBC^5$V_6PQ0S@8I1X+;!6BUZ><2+GND;/SVQ5:
MW#W9+$*`0&.4\P&'$`3L<G#<DR+#.:=E16&$KP,0M1/+>7S_`,;!,6_K&6:N
M3T([27@?990P0<85$U7RTI$TX`&GQ,**P^V8A[E252ERDN);EK:TK8?5AY9Y
M5KN,^Y0.IJ+38$^)+$5P>8D4?F1M(O?!D1H,VGN,W(H%%DXT7H*9:5$B,C;D
MZ,[M:U-PDPPU/`>3^20^_5:Y]L(CB#`,9;X41#IADD<&QCQ0Y*@C9,E,@W,)
M(AQ949EM4@J04VRWK6G/B^/U"1\=YWY+1.ECC?4KJ>W2PL.S/E`R;D-*0[CT
M.:ZW#U9X4&$#C21/,)(65ZB:\X\RH9-C+==;5M3:E!5=@\??)V"8ZO;.87LV
M`N),A:8=+F6;H,FPUX@#/VWM]LC?-B)L:<]&A@(MZ"Q!$1Q;38F5'?4PA+.O
MB>"TK!R7NMCYMP08W<3L:Z5.Y3"=WL,PS!"6R%4S<&T!I0R/.'3KG`(FQ%:/
M('MRU3)K[RF=2U2-RM^YH*AG<7\S1QYIVM=*L41@B3@$#1E^WQK3I<X73Z?6
MJTXT%/E0PT>&CM5DMH\TU%DHGS#D<@B'*E,+7'#9VSB_F,-!ML4CKEJ(O2'!
M0\_]KVV"9..`1('E<>+(JZI.J;`B6A^VLV<A->7.A(G1EZC.+VRN,PP':?BM
M)M5<IMEHG2F2EK;FVOI1&58+98(ULCVT/=+Q:"\6%H9*>EK$!DUPG'9V*4G4
M.'I2XK"=L-HVH.N_#^%=MY#8.-5L0@76^95>KBF+:)K1D5$I^Y/V1T)-TASJ
MHR*CSK!;[);B5<G0S.E)U'ACY#2E-?IVB`5WVRN^6%<B]2LP\Q;Y5:18+TBF
ML54[_P#[<L[%B@S9%$#@W0`"WQ:H'K=X='ZC,M_+,D!$#X2$74IY],P.Q//:
M%Y'"*1U1JR7J:3NEPYZ0=I\HN=BSF*MTV69ZLF$H:B.%1%!@X-:F5-OVFVGV
M=/Q'E[0MW;SL@*_Y_`\LBOD.T5N#=EKE!BO,'I8J7;@).G#ZD;G]W9^Y2QPP
M0VFPWI'Q4^0J5&E/LC&8:F]/ITM>B(>@.`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!QO-J=9=:0\Y'6XVMM+[.FMO,*6
MG:4O-:?;>9VXWO?Q)^-"T^NOPZWK\&!YG<WI7F=3V>:\WADK"&JH2'S(?;[%
M(8XX4:;J[8_E\VXSA4U<!XJ0ZH6MN[@P:>D0W1_V:XS(B)^;]AYX)=W05YF'
M^DW./SA`K=(!-5"P\N'2FPD8.8.B&01!+YT_HE`/P)\&Y,SD3H3VGX$\*IC3
M:$.Z<7L(^+C>9Q,;#U;C'3VYXL_S6Q`E5(5QNOPS%1BW^`NXUWH2).Y9&3=F
M!:U-3$0%0!$\$SIR,E,QQ]K`V`L9YTO&05:)6FR,0'(E39NMY^RN'(99&O`>
M=R"D^EQV14C:+NNVJM48FW+'/C(XU,14-M3FFG7PM;A&_(UFZRV>TBR8L-*K
MRR05%:;H;E.?/S#!1^SJN+\>1.MD:QZVY#V+;AK0-5#4YMS:W_C2@.ICM5\^
M2A.W,N)L$(9?@LD9;)1K7,WMO6Z'0*V*(!JHQ63,1^O<IFSWCS((JI<<VS,^
M4D3U/MH0E\)^1B?4`$1!X2LH$B*_!+1I;YB..HIXWJ!9W[5$:%M!Y,[7S\>A
MFZH,GDW-NM/DA5O<;8>U(@+5'"Q.:WKR+!=;@4CITHQ<@J:D)MELE@JQ4I$F
MO6_H70C5.K-$VU6(T9(ZCU^LBUGUD9#LB<W&C+3(D/*4E"P@_87_`"]N/2NJ
MB>212<T)0[D&?J3-E;I("AZFB^=<:N%5T'*,/PKR>GKO!H]HTB>M8M<#X&4:
MTMM'Q!K'C/GZA89#(ZQ3(`ZJNRR,EL9R2&4MY)5S@$P0)YJ4XIFE61RMN201
M,HVT0'H0UHFB"UM:&L"Q1E1\H>E^/_6*IV$C+&W>S6@;`$CZU$IXF0)K39\$
M]9A@8YO1(&?J942W);C+G1=3]PW7&7U..[2I(5/9:GYO6<O!.11Q%PO38)=\
M&DZ2H`(,U?7S(2=-B`8-7*1&3O*&8P&#L"X;2HNI>YB)V]-K3K`F429Y^++#
M61<9Q5-E'&O8)7B)R=B]0:E8["3H[:K;!KLAD(NR\^#2(UT=T/;TR18CZ'_"
MJ0MR/H)IUBB^11#MY*TT"S7J/7@P$;8*H/3-H#E(6:A4V]"I=4U`,PEF&T6>
MR."UE%.Z4KV-H5%E1E:6IL,RIM^6\_B%Y=NR!D[K^[[7I%4"J$UB#`$C!UCJ
M4D\T/(,$$"3];;2P0DBGY:6I^HWP-/[>>3I2@@A(7YFHE#`)$]T,T'8^YI4G
M8ZRCC=?.I:#VWE=IMC6WVAC<$Y*L41VQ@F1K$8:B*-B(6I^6Y)]Q(9DDCYMB
M!`(`_#LUDF_)UBQ7FYB8'%XI..&)"J1]^:M18DB3#$/WT`=78=!VY<!Z`J(U
M%V_*E.+2E8:"8,\S0$T^JL+OYN'+L%M>'F3V^.3K6Z^0.])-\P"O_-:@B8O)
M1S1<#'.Z98;,Q&]/-1%_"AUQ`692/_5X)OG.4WB23M-6+2UR;U&C1>9BAE?<
M+`"JYR4%AD-LL]7*85'Q&AX]##A`DLFMYXCM,3V'`JCH#/FR9["3/5ZNVL15
M*U8++#YNV/)<G(C'ILV)91`9VXZ*/CB$KE%A0*!$"6V(KI\5\Z^Q%?4ZV\M(
M<TN?]1+0<EJMP8\@G,"E6?BND?E,9P#>@M4:L$Y==2#DMQRO.;7<8S@"OJG?
M&3CQY&I)#>D-I?V%IV^!Y3/<AY"6K1JR3NL"25YE66%&@T6OL%XI3GO3H5%C
MWP.4=6%EK!G9@+WOD7XL=XNTB4MEJ+[C;(;22_Y8JY-37ZRTI5^F](-A";=W
M9HC)T?R8^9L8FJW:Y,`U-UA=NI`:0++3X(C?I-TPZQIE3R]M)#K]+UY^JB,'
MHR[PT3:"O!G1,W7%]I9E2S7"YM_,M"127Q,^0,;A7)BDO.*=<5"_2S&W''8R
MWP[)W\GY-C!]`%U2+(,E#5%KD&WVP'7:9\C7+Q%L-0>N%FF5JS6J%)U`E5+9
MA0\;$DS-.2THCJ=;5MM_84E$WYRIKIBTMZ:J):("'3HE>L4CEQ`8=-.5(<%,
MGKP8BP(TJ(D<^.V08CPE#FXZU)9?^90TK2PS!Y+N79/&5HM7;!U"89=[+;(P
MJ<K7+0-SMO)X-HLM:$1S[H"-%H9()*A/,.R)0E<=Z5"8T^R]MWU^,)5S(3Y?
MU[JE%JUL/.DN.``;4:8?)"*22,6MQJN$%E(MIE`/L>0"GCST@<V&E0X_MO1H
MLEN6V^XXF1H.]V`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&!K3/S?V.5^S_<^?^S9WR7L^GO?-_*N_+>U\7X/<][X?A]?
MP>N!YK1+AYT"*-3"C@PB5.CQT>?(K+M`BKG'"(:J=&`"Z;<C?VO/D(CWBUQ:
M_/)%XS,)0Y3RUZVU%VYM`2(%>O.`H#47D0*_'W&0\\/@M\JLS$\Y!#4SH=K9
MV5:M1"FEQ1NUV(:"`R&4BH[,-;KZX^W=R&7F`W/+NC>6).TKL74:O/'5^"`[
MDE'-*E1B2I4VT@54`A2PD^W688$&^XY&T88!$(4MX.8^->GI7O);2@(=7NL^
M<)"M2+&1HB8*(LUROMB5\U,/'I`67*Z9,D],U"F3ZT6GE:T$KH5,<&D7!V1E
M3MM?#\<ACV0G]:Z)WZ/X\Q7:B'.7#M(.]RJY9X5_I1X'.W$Z)8S35-L4D1.*
MQM0QM0%W*O6(O#8G/[@`8<J#_DI*=):"LE]`\YHL*S],8HTE,BP0*:%C<KEU
MB?*^Z$6,CHC%IO(]<0T:ERC0](.',;&1H4A1!)**QM#KWMIT$W5UGROJW-^J
MWV]"*TAX#QOHEEK4490;$T,'V^DU;G)"LR%,&S(&S6!-X)V4VI8V3%$/HV'3
M'1["M...!HI'4_-)D=/+-5AZ0+:,R@U22GC)G[Q6E@<Q?B%5-6<!NT-$*E$Z
M1-'A!A%3L>*U6VW7)#_L_,Z5`#AL/5_,6GAT6.UQ8$(6:/<_`R(P?CY`[/I*
M;Y<J:(GR!L,?<Y1&ZDJ\P8D#X3"6-*ERE:>4T[O2(Z@TD/J_GM$F1MLT*&:F
M&%SK!L;9J(?"`X+D?F'))`.@PB%<BFOL]NR&YUHFKEE)S#8TU&0.DSFFDH2\
M%H\ZOG9'^6=1COQKW;.J#^BC;*`CVR@VKG<N?SP_?8`85(BU]\JVL/%2-K1=
MS[/1-2XF.SI]^.AF4VAT*MNUU\V'8%>!RPIY<]N133B2%(YH8ALV^;-"52TV
M^KGRHRY[5ST%2)Q*4/:=7(6Z;]AR-I2GVG%K#:6KK7F-.&1`%9I5M$6\RGK,
M:PD-<O>77J`_#KUAATB!4RI'1,;>)8LK!'D&BDN:P.+ZF^TVAUS3T.&$Q`WO
MRPL58Z;+-Q)-277K_P`L9J+@OF=BE70A1F.IQ(MS)N`3E>B@3;5LY%&9)/,#
M'YL\1/FS(RFV'F&&$!7OWV\W:S4J'S^,`L9VS3@8=N;T5ZCMRFQC!CG549FP
M"NWY9]B7;Z+;S$R2F83DP(A'0Y;;RGWM[9="8VOMWD<,/5*A5L2\6TYQ_E?1
M[[=$\U(E[M5HI\O&I5P8<YF.)Q9[URT0VZ;C#_DTZ3%BS&4,/KC;;4$GJG;?
M)656[.NY<9L4"TU_FA\](@5^HSFXTBVS%4Q5-'5LE/(&(%@E-CBA.40A0TD7
MXSD3<;>G)"$LOA2]2[_YC6&_4CGQ8*&KEI."8I2R5]7-IT]L'4`QKCL:;>7#
M<FT!UC2]K:MAR,X-FP6EB_;C2%1TZ:VW."P^(]3\T[7>N>#>HT6K52I&0LHM
M9Y:*GT>+-C3WQIQ9VJ2),ZI1Q(8W1K'$@-#7Y$AD6=%2UK8E3I+:E(#XYMT?
MR_:CM";,`+6,N+YM9')$JP<KD5B.4L(:B1R0FSO'(!*`%D'"W5URJ]]W(C3:
MGA,5HHVXEEU#[X<(OIGFA$N;X"TUN']TH%CK0&=:P7,;5/-2HZJFX5@V$:)C
M,3*ZBO7NT,Z'E76"1:15-/(^89:;TN8V&DJW6/.^0($&2/)P4T]8F*X"?$_8
MMO%0ZL:-ZM)$A)/M6.368S8FB%`K@V3,'QY#,^$2&/IFR?A6K02F#U?R^5S#
MG)TC2F/OB;)6=XJ,$<XN$V4HE#;KJZ=SZV##C-3DT82?(33$>;:$LR!D",-B
MNZ><^9VXL-C>>I>7=3J'$4UGG#G0.C6*MF;'T9E%3?#4^(3EP6W8-+<1'(E)
M%=(UZ621\#LTI!9G-05_Y9QYS;*`CA[K7EFRVEJF!B9MU=HIXF"3N7#K[5Q[
MM)GT.8>D7TU%#B3QN(2)=4;362`9J&B6%$HU/6VA#B"&PY4=V\F0->[&9M-/
MF:^Y'$>T6JNF%<UL(FJR+Y0B!277IJV3^ZZ5+URUBWHK0<8B1&*[^SIVYF]L
M/0"4@,"5U7S29#ES$>L2)`R,54'J2_Q*&]6:S1(L?JI,%9+#5=VEHG7&KJ6!
MUD+-96Q%2#C3WIS^V=/I4/"5<U[;Y.%.Q5+G?1J('KL"X'.F$676@3L>6&Y?
MS1D0Z'M!!6[404LCTQZ\B8ND>TA(B;!F,N(4I37J'?[`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`PR,AZ(/G2X["I+\6
M'*D,1DZ4I4AYEA;C;"=(TI>U.K3I.M:UO?X?P8'F\<\G/*NF4HG8+%R,4=-2
MPC<BKC:CS/I"F(]B8J/,;BZ&L^I]I7*;B&Y%W)5^&^QK3[9<+K>H\A<E<*&'
MV/\`(GRS=MTJCQN<U8@]HV6AHM1RE7D)!C12O;KA3X#\45$,NN'X_-:1$"OD
MFVW6/M..1T03+B,HTW(#0$_)3R3EEXX0'SHN%131\HX6+6VH7(<'F&1]1L4A
M0JR%F%%'R5+.RR\%^$\TP+D)EC5L*<<:VJ0D+!ZKWKR`DS:2!Y]S0S$$W#DE
M(Z!,-SJ^7`W5!LU.+O'ZR'$KDV`<&L%0:%#FR8F9\X[I@]\>I;?R>]R0A(_R
M>\H;143#TVF5KE%D35=V6O[E<SZ/?GR\N//B*M]3>&P#(R'7++RJ!'E((M2I
M,IXVAYB3#CQ_A?CMA*9WD;Y0Q2@@+'YA79A:PN0=CHC7/NH_*P@%AL-Q@M78
MD8^U%0$#N?01`F.7&N?+3B,HKI]A<./["9`?6_)3M8B58(]RYU+%1X8FR28S
MS',K]:6+W80@2N#4B:B.^W`D&I"(TQU\Y+^TR,K4@:IQJ.ZIR/*DMA7E2\DO
M)F(:"6FT\^,-0NGG><T`?4S(&QC0=2N%Y@1(,$T+T]$9**JT(P/E22B7G7GH
ML1].].:]M2]AV>@]+[2OLA*LKHS"N90[^)`R"9$%:91B?#.#;O*8L`(UIV-7
MQH.L3JA`]]*XTS3JRFM:=CJTUMP*(/\`:O)"B@>C5.('FFNA%379K/2;7-YG
MT,\(%UL0=\D'A.OL2,2D#W(%=%<WJ,2'&3/B_:&[`RM#3CDEKW0D=G\H._)=
ML;-#Y"BPKI`*^%K!N72>C1T'9U<F]88K8"JO/['0G2%D$UNN%=*2],UJ(46V
MVEQU^-Z!D]$\G^\4>@<H+"^1!KU>^GUGHDR$!K6K`[#0;Y_#D7)A:F-+?FPX
MENYN'G/18>W'GF#BH\!,B3[J''`T(KR>\ES]KJ--%\I!M/%QPIVPVZ93+X]3
M!6GK0`7JPP)H\[)=E!K#03+BVX[VV5"3D.7&W))-1'%J#MYPCHY?IO.@9^SB
MGPEN4Q(19!OW=-5\6B;'+%1B9==T:D3GB=;(Z%[D#YGO[7,@N,R'&HVWM,-A
M<N!P(BQFY#\IN.PB5)0RW)DH:;3(D-QO=^7;?>2G3CJ(_OK^#2M[TCXU>GIZ
M[P.?`PVAP]B;*),P(;)&<W'9G3VHK#<V8S#TYJ(U*E(1I^0W%TZKVTK5O2/B
MWZ>GKO`S,!@,!@,!@,#Y6A#J%MN(2XVXE2%MK3I:%H5K>E)6E6MI4E6M^F];
M_!O6!]8'!\K&^9^=^78^<]CY7YOV6_F?EO<]WY?W_A]WV/=_3?!Z_#\7X?3U
MP.?`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`U\P0*(RA<T@,'SIH26[/"RYD./)DB)S\*4->FC'WFUNP
M);PZ:]'4XUM"U,/+1O?PK5K8;#`8#`U[H@4^4AFWA@]XR/AS1\`N["C.$X,`
MDY#>(PH<];>Y4:(0>'1UOMH6E#JF&]JUO:$^@;#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`Q)^IRH,W0M<1LGN))T.<GM//06YVV5ZB+FLQW8\AV(F1\.W$H<0M2/72
M5:WZ;T'@=#^K#VBVU4`5@#/'3BC6R]PY?>.A]V=ND;F]1\A_'?B?W^\EN1/*
MAVJMOKF.](*-5RMNKG(=9CUX]+<:).L,0][ZM]6+=/J<^6U?A2K-NK\$JX2P
M6CPQ#URJ6FF6.+=:#&\L>4G^LSAW0"MT\B.34@P?YW%`+$N?',K#,N2O;_HT
MI"8+R.,'6'8WR&\Z/(*B^<=)\0.2@N'$W>@\2#6:KE+_`/;;<B=U*V4SRDL-
M9CNKKW04G$TUPUP"!$?U$K\Z.S%*R9$DQ"<8A12*.,5<I$15RCMS^H!Y3SO#
M?QW\CN4<+J4OI/E9VW58Y%Q4G$(W$W#YR7YKU:]4D7:)@/H%3"KO]B<YHTHD
M28(MAZ_`)N/+CS-P%ZD.L74D1%TK(S]5KO<,C`JY/B%,Y?-(V[KM"E]2Z+/;
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M`C7*J2USJML6'E<AE^?'AK@0(<AE*I4B4\AO2M%K1YJ@_K6=[E5069)\^X>V
M;9;E5@_7G4GQYC1LN9\DH,?KZ(@CI=U`0^/<2A<+@.WML:9LL3_[=W\O8(NX
MZ4/ZGA"]8=E[C]5ZW57G'C6<DT&,@AT+K%CIW5>F1*!:9W'R-*HUELU?DVKQ
M^?L-ZH<+J$_J44'')`QX>Q6$F/@RU?##,OM(8?G7*=554WZNOD1,Z#"HM\Y%
MS"N3@W81M.M$`>@V9(W=LI?/&.AGN-\1?`7^RP+OV#E6O(648GDHVYD8Z+`Z
M4R%&_..+@NL5<'6$C[=]6_K-5O/D>`Y]S$(#$<B#54Y76.NT<J#M\2GQ0O%K
M#TSI'0JF<[%S6YA$0E]O%B@M9F!`DHDI,J?$*3UP)HIE''0ZHL;^KUWEKF_9
M+^S2.(5`QS^OURYQN9VM9.9;Z2B/T6[\XLW*^L;G]1H;[=ZM$:HZM89\/!DE
MF*WM[Y6MGWVVO?=87K#^AMM?N-H7^A\:$K_!\7I^F3K?X/B2A7^'_#K6_P#R
MUF&'W@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@81&4J"/GS4->\N'"E2D,^N]>ZJ.PMU+7J
ME*MZ]S:/3UUK>_P_H8'0\CY1<JBU]A_IG,Q#=)GT&B=H(3(HX+8`$6RVFG'^
MFNPYC!*/"BRKE+EA$_8ND)7.*RE+=3IM3?JJU*TLZ[]CY#^*`=TWH/-WI`6V
MF]#YU.MM3!OV:5,K$DVQ/GJ`F%+18F*Z,`S2,=Z/M_3@MOYIG?L*VO2LT>::
M\#Y&\E-W>I_-<X.A+M978=5H)<F`J#YDP&+2!<J/&%%A1PC.'CU!)DLT_`<6
MR\R,$S7ELZ4VE"U%.>Q^1E0HEFL-/L/+S$(;SBS;CCR@C50GCH5:@5KE#T^]
MQ!GVG!FB61I3MX\7J#&:>)N-+>>;:VWO:,4(M=?(^@OUZW1:;RI=T+#*%]YS
MP@F*J$<2BM7X)3KCL>5:FFV%E%7)^YQF7XK.G4+G-N.R]H9]IYZUN4V]A\AN
M7UH-7I6^72G80N<4#744D17(TCF</EE7ZM8("8OQ+57[3L.8YB0@#V`TUY$-
M4A,CXF6E>JY1320O*_D/-QA\=#Y19J**JQ24)M,$&"HT,6*Z5+?M;;5/U&KM
MB6T3,&=TF6YLC&;=')2N/[TE"UK2U:DI/KGY%UBD5"E]0(<ZLB*U?A-GGVZ7
M-@#0MIJXJETBS6II@U7B;C!*P/RWQ#D",RRM;2/FO?\`CTQOXE2O!2C(WE7Q
M2N2IX@IQ$F,B@*U96Q``%S46DO5^:,5RJ%+A#-CW51(0\(8MA?;6D15?9DF"
MVU/D+3&]'MVI*2:1Y2T.$5(5ZS\<*#ZES;54A"H:A=%GNT_J<![IS8JIPXL:
MS20S$E(SG[2PY$8K<*'N4E,B1&_3>THIRO>3O$ZRRK3W&C(5%+MI(1&3'K5"
M]D-VLH;G5PM50FA9Q]QJR$24Z4F2:CMI'/(><VN6K;BD[5(G'0.KT"#!Y[;#
M'%)%C%]>KC9<J^=`U<9:Q3E96#)4"NV2OVK<6;-*.VVSLQXB7'DQ@\M2I#CC
M3?J[DH<=TZESJ!4*QTR=Q1JQQS_0;3JXLR!M%79JE9^*5+IDPO89'S<IZ':;
M%5Y'+9@H<["F.+4EQ#D=_3&O7;.AZ.(KYDTL.8+UR32;Q(/@($,F;&C7*;.;
M%0VJO<+5;D3"[=L2#41H<:ADHI&*Q)??^>0VRUIS;FU(44_2/F'6X,N=!C\T
MZ22FB)Y6`=AL)I0^=7GH'WLE0VCH\]<1$\=*,!*5-),,[:4OY%R*[OT3+9VI
M127TCR$:N#/3"+%..2*_S^L)M<`P.4,=GW*,HUT46^'#UC9-TC"+0?N#M"-R
MG6FYKLE.T>WK6]:4-`"\P.;64H$9"B;5.K5FN(>@UN[LL`E5\[9[`^.?"-#F
M-'MG70Q6LE6#$<DJ&F$[!<TE+FY.TL;5)265CR,JMJI?0.B0:Y;8].YVF$X2
M+RV0/_VK'<K(>WF9H:)$/RI+D&M`SC#DIR0F-I:TNI8T]IOUVHI7?_K)K!28
M'AU"A7"P(L-K`5D&1E2JL$&E4$+-SP,=+0]R3ST_Y0"&ZB'*LZ>CL:)QW]HC
MK^-/X5%.!KS/JWV*R010KZ5DRQ,DD";@-4T<BX(KU8GVNZR`J3%V9:#QJZ)%
M/N:25?AJE+TEN.IY6_BQ12P;YY%A*.]6U)KMDLB;135W`:*"Q@C!-`V.',6>
M?,F33ED#BHS0ZN5^6ZMG2EN./)0VVI2EZUBBD1UY;#I%B0&&\RNA&.J7(#NK
M21J$`_$L#_0^9T&N09]6*GX,\:/LK'3X9MB9)<91]BI3(0ASWVD[44Y3/ES6
M$BS3]*I=INIL)RJ;U^2$1,K%=;8JC%$KMXAKF%#!M#+$F<BVCX?MM-R'&7G%
MN*3[*$K<5DIA3?,6IA'B<,M4+G+F"#DRJDM!HM<4S$NKTFWJ`T=O4VU,O3B9
M*!2IJ]D4)2)2I*/<>:VYM#:I*632_(&MW%VWQM@;#7IM+K:K&3'G=A$3YS$*
M28&GT@&8)B<V<A`#@.0.?GL+5!W.;4VEW?IK:E%-!&\I:3.MPJJ0J];I*)LF
ME0R)_35=0(`R>B-!=4]F>PJQ:.2EDYQ^/&<^4AR$Q5[VM[:&=>YBBF?<?).J
MU,D\!8K5MLMBU8;!68@8.BN1W9I&M1:7-*.HEG+$(@QX#42\15Z==<1Z^V[K
MX?B]O3BD16H>3+]UO-2K,.I.A!]HMM@$0GRLN'-DE*L*J=CL`^UPG1<]Q`U\
MI*%QVMCI3/OL-J<VM?K\.L3%+3MID0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P.D]:(<P?USN(CQGIX6-<NM=^J$^+$
M'TB5JN6GGD?H8V<86/A#4MGB/0`W/'VO\AK_`$9IU+#KJDI3I=RJO^F=^H5(
MK-LKEP\>*VS6N36+3M9JMN8GBH2:D.K-P-KZ)'B%>7R:Z-'E%`GPP?8F28;F
M&2+$"6_`5(WO+$;%,[I?9Z55NE3I8;B\NS3>%\7,]OK;8"7'`N.%BO.KG'!1
MB<!54T(!JE@(L^N#ISY93C$H\XU\@ME2Y#2B(6W0;GQ_N/4[7$A<M`D95+KG
M(^D1^A&0H"9)GV>YP+&VS`C)<B/$(=CH(BM#VI$E;OQMO2$1T_"N$KTF8@S"
MF:IVKQDATFF7&T<:I%,0>/=(=IH:M5&*>*1U!A+;YN4X-DTRHF/M*PP`K;#J
MA<,F)VJ+'1L@M"&U(M25*86+RJ\;&F70E^J,F"/@&[$6#CRM2K]CB%T(J`&S
M%KO7H-?G'D$X9_\`&C]FZ?C)=D394N5M:=Q5NO[E25*9UVR<=L@6W4:E<:$Q
MYE6K123'IESI,*EUDRH4@F(.!$D&@1]A'V+-LLJ`1<3#D:0X1?TWI]+KV]LZ
MR((-\@^5&:9S\/>N/IDS)E<J)H+SNHUM[IHRJ0[T"J@$!!60(5BL"8[I6/U8
M>&_R36FMZ(O(<5J*W)=0HK+!G]4\3+[0.GZK5`:ND+F7/I\B8-JE-#PK(NO6
M:O;J9B#4I<]8U<`FP.C_`&=*:D/0W$;BH^'3C;3:LN3+E"=W\9`8D52;-S,3
M0W2=G+T@939-#%+'D0T6VWFAZL<%GY)IHG6),]\I'D;0TN1[A*3Z,NL2%O.I
MB2I;&V=E\=*5,L-',\O$QN:U0&<8*FWJ:"A5:7.KAT'33@&M12+,./8EU[1B
M2W/2QOYI'RJVX[,G:OP2I^2IU2*V]EXL6J54EP></=/JT&WJYTZ'AT?[4F5=
M4SE-GL1J".`$8'PN/B*O!W!*P];9^79?<:7M2T>PM4WZB`+\HO'*PMU&D4FD
MC;MSD,5)H>=@5"%+K(&*&&%QU;W4P;;#GS):V6[2P@]C3,=Q2U/;=2AA]AQ]
M4^2MTA1Y`>*D>VO,2:2R+M5RLZ*@=GDN9P84Z;:GFHU>LX(Q.D1DR2\ZIO72
M..-(8W+2PHQM.O=:7)6A4E2^'^W\/I%TNE:.<<52ZK7Y]M>MM]ETD*H%LD'=
M%Q9)\DL4W/?6$/:NZXT64]_I3CKKS:F$,[6YEJ3*9#.S\,<J4&Z4\(4%KN("
M[CG)M-J`Z-9P%8YP0)2+B9(OQ6W1K(6F';$M]+B7);3DXFE4=M]<A6E2I*E$
MH5C\3:I+GT0O1*M7JOSOE-=I*[W=:[6HE?DUD9(E!A7+XI0LO[>-%8S%<U):
M@HC+1(2C2F=K=1M.KG4RP&_(>K1K`#Y3S[A<^+6CLBDUFUCB53'58;77;L4"
M5Z$./5EE&F?DH_-$(F[3MMQ"X<F`QZ)2E]#,HKR_++V'QLJMTM$(WRD'`!#!
M8>O$[U(I(&!$.2*7>FJ<P!`)EQHC]B&\Z/5/T<1&VN1$<$M;BQW4-,+U:DRU
MY#HGB]W`&4Y%9ZY+Y_MZIV&QV8!,JM6@SPU8K1"=(+CR+L&+9(PQ)4*$T32N
M.G2ODEM*:?:E_"A,J8R9U6L$[7Q&Q[,Q%TL['?YES>?9;*W9>>/[ETJFQPRG
M(0J>_)9F/:FV:HD%RH8]A;[TF`ZYIU*%[6WBI@J5:?\`J&\3:G,AD"_/5T0U
MNSS_`)#[>Y=!!F7#&R$Q-M-P%;:V]+W7YW/-*GN,K7(4L?&U'0^M,=.*DJ6A
M&=[\1)_LS:ORH+*J\)NVW"9<HG.`N@$1V6S5!AA4=(F'/+DCMVJ5KA/,M(BJ
M1)A)3&EK8>:^71:GR5*SZKT'QPL-[JE9&\H^0M[BB-);D$.6#XJJ20;3>CWW
M-L91,=Y(:46:H9B8PA*W8R]ZTI3B7)C.GY4U9E&AWDSPL#8+*<C\[D`_M]RJ
MA@%@CU@0)L'4(UJA%C@.4,@35C").LG)SS*(;Z5.I5)(Z<EHBI]QW5J2F?PH
MEXL="OZ)W.^<AZUT"DTP),2'>J(,8JEMG6FRY2'!;%:E#Q-I&RK"B$4<:6A;
MJM);:<?:9VI";B/0FT2'>4?C;).V&ZF>=#@YV..A.VRU2ZI`0><EMW:Q\^C0
M&B)D2&E6[4-FEN25+&/SE_*M)0VVYM"-;E3H5*R:9W7Q@*=+KU0IPP.S>;-\
MC.@RX5*BC7XLR1377A[4J9N)'FQ9VZZ)F#5[;2I,-X<_"DJ9<2AM:IJRIKT=
MO<B&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P,2?.C#(,TE-6IN&/B2)TMQ#+TA;<:(RM]]:(\9MZ0^I+3>]Z0VA2U;_`G
M6][UK`ZQ-=<\7'2`X/%-!G%PK*7-CY\$)9=B!]TZ5#LDHCMJR11GV3$M5R'V
M$N\AC4E,J0TN4M"/1"]IM2N6I(N^+!=KIYN>P1-L!B%+!=%FZB]4+,S);T[0
M6K4-C33<A%B@SB))")-=':DPY+LUMR9%7N0E:V3+ZG]B\5+?++19DK[7<LJA
M(>RJ32N@IARTMB((N(.LKS(!J&U'#Q^E0Q\MJ5M*!T\O'C2=-2U(0E4E2VO.
M+KXJ.RW[!S0C4X+SNK7:I10/!+A8DN)HA;KM;;'+>=B0H,T*D[?#4J1+<^.(
MDE+D-Z7\PWM#:;\E2KAW_P!&-<D5%,P.9`DBD)9NAQ9X;L\`Z[!LUJA5>+]V
M!\B.@S!89L)YAR#&8;:2)1-W,CHC-..O9<F6`$*^(NJW8[A!IL:O42F&&*"Z
M9EQKM7X!BN6#C-./2W8]<5%CD#M8+T-(_28[L5Z,4^4:EHVX[M#FV3*V9O5>
M(U2?3;(P"E,0^F$.D`)=C;JMDC30<P435+O,>WAG@^C8&-JQ#74DGYK$:/#=
MC[6^M"?3>Y4Z&91YKH/B$"-OP=)""2]37&KA1;M1M4=BI,\V?I\L*R?)+#?9
MU>'CI-=!*&.RW66I;C,9,=3JOTN*DRU=<N_BX%YWT2:0".\YYZ=*6ZDV(*?%
MW</#+1J.+CC3;R*?*AL3*S/?&RM[<;;AQ2,SV]O[]U2?<TS9EKE=2\1HAXU,
M*QD5Z;R2VI!5VUQAMX;V>G05"#9"-5SX2'I5I^&T=7=;G"VWYFY>W]RWVG(R
MVW4VI,MI]G^%_595PN[HH$=W[PY=@LT@=<QHN9&MADI0]D@<]QF`+G5RRFHD
M\:6EB]J@3=MR$D%K;^-6YF#,-97'O$(S69E!DE6+0.,W[HG6G"1`':`+%ANY
M1=EME^-UXR*#@H!&0!%&)46>@<ZYN+%>1&E>KC_PNLZF4T-,^+59&VD=-`,[
M`QJO(Z)8XPJO74O7*R`NOJWN?%0*ARP]+F63;3DMJ'"^3EN+97,2UI:=O8R9
M1RA'_'F>'M-M'4A5:K_$;#(.0[6)D&YT\G[CLD`]96GJ\\[8#D.QCZG%D36I
M?S22&M-.RTNN-[7IDRUUQZ[XA,A>CW-T9&NDDF.FGBP]BFW4HB_?8`B<9D+`
M-/`I(LP*B-<W<42F04.0(;D#;DU:5?A6R99USNOCU6SU(Y=:J3;I$:G?(N0C
M,P9?CHVMB[E3+K9Y+3EH9V5G66KNA:9,;.,//O#(L=#6YB?:;1I"I&7SV]^'
M4$PU5^>RADLD3^U*--8B"+N>B38=CL05A[[U$Y\(@-DAK+9K#"CP"9-Y4><]
M.]J(^M+KB=V8GR5/E'!_0_'#G.^@06N>/@9_,;26@"&YHFWS)UAGTR$+G"C,
MRR%1+\`(/*6LC]B5Z60(.1IKT=N/%<W\&HS2IDRUT4OX87DMNRW*IBP=PLYH
MI$FN%H=L7#^VVY11)*OMV,:UJIQR!T:;43*"&'VUS(Y;4B:PY[^UJ9,PEDSH
MOC)0ZE)Z_2P4VT"[K`/AWW*J-MD\*;;G<XL7?W8UJ&2TJ#CX$NKJ>VF5-B;T
M.W,3!W[*=.,-S.A4Z-YS6P^*&R/XK*5'&P+!?Z^2#E:D7#6V'8"`V&BSQIE8
MM"K3#;)QI\<>!*IC0)SB).A@]?RZ/E&6_A3>IEJ8=Z\3K<5K,E,-G=M781C]
M=DA*]?H\]^UF%E+'.B5>R"A`Y1]#+MAF++:ANN1M(F*;F)UIW3>V8,PUE//^
M'=PK8ER.$?&!Q56T:C!+I7N@"(]9K][@\^L#X%44XSL-"C0X-FKCZA4=Q;`=
MJ9'VVTPA?KC)EI"%K\:W.Q5/J&EV.N+J@W=ZAEGZ'8JU5[1)OPSL8T78HQ27
M6=%;T6(#VSWV;"C[5[Z""7XFW/>VV[<U1FJ<K$WP7'&EE&J_$BG8AB(Z_P"Y
M3NEH=CV1)ZO185&EQGQ>HC9H+8HP[;55<3\0M^,VZF&Q['QH?T9=LJAR3GM%
M<]^H@%A-+6+?5'CESZH:GQ`1RO093@V43>A*F_8SOLO/*:]Z3\"%O*<<;;4F
M6C3&_'[C-C8%QS'/04MH,S)BC-)3*BKB0YSQE\@/;>AR8[RAI)=AG:E1E*4Q
M)1*<0ZA:%?#BY&Z!\AYM63L:R5NICZ^9C/6B1\T$<FBFY;USL1JVV-96%!E,
M0#7S]GL<^>G4QI_4:5-><8TVIQ6]RQ9&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!\.Z<4TXEI:&W5(7IM;C>W6T.;3O
M2%K:TMK;B$J]-[3I2?77X/77Z.!U5J?AOQFMU6MUN2+)DG0`7Y!R='L%E"1Y
MIO;]AF(MR!`\WJ'#LPF5;2>A<WU<FC&).FFG_1EG:+<K<IQ.\>Z'OGACG`!9
MZLBCUAK%E*%1]C/R;+(+5H_73J2*+%.*/F8Y6>Y6VDKEMOI>2M6W=;]S\.UR
MEL3?C!QCY09":K9*,R,F2IWQP[;;HD@H_.U5G9^C\N.;;DGFB!.DB2#Z)2W4
MO$829*O5U;RG%RMRQ*EXP<MIMJ.'`X.''!D^8[Y+!IZ6YK@8;4"5FL%NM4!>
MII*:F6Q8S9]3BF]-LH8TE6D_%[JO1<EN85XM\9%V,;;=@C1:Q"&1S,(K8KG<
M+!)TD2Z-4.7*47-R]$'(L8+"C:5(]W>XT5"%>OQ.;6N2VP'^-O'QU3(4A%<(
M3*V3-Q#\J&5M5L+/_/#:M`I(EJ.0(FY)"(-#U(7&@18K3J([3+*=Z1[FU+4N
M=2TM(<CY\5A['SZ^E^(J5>)BF=D"C>MR.CSY1.YN;4U-0O\`^V9LUU>]>OHS
M\7HUI&M:UJ6EH`&\5.$`A1L)"HZ7!=B3#:,Q)YRQ$&IL4=L9H="7J86>VB'!
M8#16D(3\.MMLZTKXMJ7M5N5N6[3X\\H771E7)`2%@&"KQ)Z2RY9;3:CY.5=9
MD8C#E'"9<J9DDBJGHA5]K<>0ZY%TVK2=-:TA&DKE+::3XK\,DUL+5/N7[(FM
MH%_=[3!VPZFAI`4/2`(PA"(.%')FB<85SH0TJ0XM;KWRZU.[6J1)VZN5MM+3
MP*D&Z'T*D!XB*\GHU(L-!,%-*(%'&0EG*6HR55'C/%(Z43/M6[DY++B'&U,O
MR$[UZMM(;TLMII7BMQ>6R\PL&=CM*B.0H:!UVN(I(-B>/CBK$FLI&'(B*TJY
M#8J&32H.HZBB?7;^UJWM6UR6VUO\<.37=;JC@0IIJ2(K069"%VFS!QTZ-396
MY53DS1XTM&ARBU?]QUJ-,6C<E+#JFU+4E+>D+DM^K\;N.;J16CL51<.N&9P`
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M0I/R[+;;+;2&UI;,#<5YQ7K]/Z8$`J&W$LS-9,DF"))31?<V>1([?(0GI3L-
MZ3%DF)?L.:0E33<A3>OTFD)2N="T><\;..K%"0;=8D1A0:5$DQ8<6PV)EMW4
M,T!L3,6;M)3:YL+1NL#Y.VW-JU[D5'^#XM;7*W+C=\:./OBA@5T"66-%ST34
M1]VZV)^?8:A50<V$-.(-)=-5I,*AA6]CI.W8BTBV-*;5\*OB66XG?&/D$D?"
M%3@QTB.&"V`@N,0NMQEZ&#!NSVJ[&@//'%28ZZ>U9Y[8=[2_?&HD;]E:=H;V
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M`*DWB+`+F@B;I?2LX*6H`/2JWP3OEI'6$EU09(.\V:HQBN<T*".@,WBNPWR8
MQX(_/8E#&'):%[CH4YJ]9*E.^K^</C/Q&]KYKTV^%JY<FN>.]2?&M\YZ<<C1
MZ>T!Z):=/2#->IQ8*P>D5KDEGGL!UR-%Y$0%,<:C+TUO)UF<^"I99;S7\7PE
M7K-W(=9$ZI5S[Z#\8JC;X0FRE:Q9>U6,FH((JP0Z+"S!A$<^<:=A+--NJ!,2
MX[S3LQ"V7=)=9*EI:WY\^(MN(TL37^T!)T_HG>^D>,5*9V%ML1-A[=R1HF[?
MZ;"?FU^/'2T%4*6T@HXM`>=(=C,Q93[LN*AYUDJ5K<6\BN-^0P\R4X]<V+E`
MK_W=T8D,B#XG4/[UUV!;*_\`$@\*%NN_:%?)L2->VE7MZ<^%?PKUM.DQ,:DQ
M,:KKR(8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`^5J2A*EKWI*$)VI2M_@TE
M*=;VK>__`"UK6!XYT?P1\6Q=<J+/"/*:_P!'L]X.]U\AN7=&K%EYK83FN)]?
M!T3G]SH=4AVREG:T[QBDT]VJ"J^X[#<G`WH0YQ,I:_?0_NY\PU<IOT+Z:?CE
M:H$/D8B^6"JKC+\<;35*Q/!\[Z6&#!?$&C?BAHP^=6>G4JW5JQ#'P]XBZFME
MVI+[TW;#\?:%-[WJ1RD[2NN_>$W,+%Y;\_\`-&S7>T1+CSNB"*3%K,(71VQ5
MAC5@+V6&TU)+:J,KH?V83%=C,N$P`LG&&%WH0]R1&=W!;3M>*2\4B%D^G=X^
MV3Q+XOX=?>JS5WFO`G8+=3(5V7505HCFE<^O='`D9FV@"18VP0G>DK-0UQX<
M=W1B-%>]%)^-#CM-WYDN;ORJ6%]'[QS"+JK4;JO<QA&DEH-IY&H?T&(`W3>@
M#+3R2_%[T@2'%CAE_-G+%PJLS"#)^.4@[5`6M+"%.K7CM*]I7OXW>*]!\.++
M(FU+NEP)TKIP^ETZ-SBRP:!.$E;K5*^&IP2S"[`#J,*WI(_=^OIC/Q?GMBDK
M<6YMI"]IWJ3-I,V[N$K;6@YB``*&H$$P3'DBL*%)>]MQP:']C[1G.+WKV8T6
M-N2C6UNJ0E6][TGUWI7I$9D0^"(29L.`:$S98TIL(1BQ",21(@&DCF3"A$QE
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M)@E`?3Z0U?$S,CN:]".M;'[]4.*UZ3]*UMG_`/J^OZ7UP->,M->,Z/*&%X4Q
MNL$W`YY]IWTC#230L<:>C/R5Z3'WMD86CNK4E2D(]SX5;TI*DI#8[)C=:<5L
MA!TEJ&D@ZK<MC6FH"]*4F<YO;GHB&I*-[T[OT1O6M_A_!@8(2R@K&$$V,,3C
M30AUB-)$$-;6PS/9F;UJ*IA,E#+NU2-[UI"=ITI6]_H8')&L("80<$Q#@B45
M9&PC+PV.2AOSVA!%^=%'E7(;3RI"!TZ4,DMLO[3[;CD=Q*5;VA6M!F_/P=O)
MC_.Q/F%NJ80Q\RS[RWTQ]RU,I:^/XU.IBZV[M.M>NF_TWZ'X<#7.64`P:CUV
M07@Q3LW;NAXJ6^F)-*?+1-3I?V0Q)]I1;Y*&K3C_`,M[OL)WK;GP^NL#,9*C
MWWW(J)*$R6Y3\/V'DN1G7I$5EJ1(3%;D(:5,;:9>2I2VOC;UZ[_#ZZWZ!HI=
M\ID$_$JLFSA6[',GM"V@NIS+I!LC(%R#<2'-CM*6L=(G"HKC\=,CVMR$)_R?
MQ;]-;5(D[<F.]I[;+[+NH[JV)&VW4+TP\WK2G&7MI5OVG6TJUM25>F]:W^'`
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M?"M7QM_&$CP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P,>9'^;B2HOQ[;^9COQ_<3KU4W[S2F_CUKUUZ[3\7K^C@=`XW@
M?&%!MB@O5)\;Y:HHH`E$VH0)0\;1I;]!-V2J-1HAD=.:%V6Y5PT3=6Q*CRV-
MGDLLO(1`8VO5K:0PO%8#S2?S:Z#+Y`8MM')6-B$_9P[#0'HEMZ%"H=6%;N;3
M,]4R:<B:ID2,*G(6[.@JD;TS\2/C8>66N#K?%"77A='01LHVN6&MQS3)8Z+`
MRR"Y#5HJS]=LP\#%G'FH0V`5^8WZKEM3Y++*$^PXQ(UJ1J1-$2ZSCO"AT[=.
MFR+2Z(A5>:R3AU(F_7@I*UG2QQCN^Y%PLLMDG)22FU>3VE/V+(?^6F,(&I:V
MTWO6I+MLM?/D-PK\;#U:.%^DN4VK4(799I2*H.W(0I4P=[$L[LR@P)=@HCB$
M/LR6Y"9D5R,ZK>FVW=)=U(FB$5'>)%?AW:E76NV$#%!5NS"K:-")H@YY0N,-
M>LY"&+H!6.7AQZ1`.R;>^LPMF)(V20RQKT:VA:UKG0M^](\39-YZ';KZ.O@P
M`_:H$N(\A^AL&#>XQ2!RL,9K<RS_`'C&SW*-.#\OUI$"*W#E1YA:5*;EI<TU
MI*\%X:6O>%(P#9N<'EW-LBQ0"8(L]#W7R(B38B@>G\7KGW@*D0=N'NR[.HCQ
M6+(;E2DRVMPR4J'(9DMJ^-2RVQZ7XZ3.A]FL%HE&Q`<-)K]#>J=?L8EBWUBQ
MWZO'%D;B;L=124#NE!4^G@P0EQA<MA6_DTO-[3MO6W+$X+:ZE>+`!3-)*/=-
MBWWGE0?"'0$(C6HL]9(D#5SUV82-'7CLR"2:;+\RCR(*6H,?8];BM;4^IMM>
MI9?[9O4_&F/Y!7\C>'K)78]!LO*:B`%$H`%@Y8S#:QG;8$YF(>62BL0J27"]
M8CNS(>F9"2NF4I]QE.E;6NH+IAV'PK'G2Q2:Q=80*"[;X]N$1A%$',$%+A7>
M1T(>%N)/9GVK@!&%-M`V(WR\)"*2N8#WZM37'T7L6DU$\?)>N&="YF8L.X):
M[W"TD=O[^3LK58K\<]&8YG0R\5N3'C'PU7YH`"A2,/;S29\9M]&W->_MW<F<
MV-/OQ!9)WN=?+I>(!)IQD-\G7@5*CUT+7MU^K'005P%'6?+01ZZC-/.30LA,
M;YV"XTW[C\AQ"'4++;^A<&;J7&+_`,_`]"JT%Z_%1TMNR5:B"Z\`&;D4V@TR
M+`W5='R34J591599<FN_.,RI,DHXXQMA>V5)7DF<J^C^&-2JE=!PG[Z(2;9D
MUH6R9LE8AOP;8^'5QM-<IMBA3;&@G9*N])Y`A&A*R.W'FR+J4N:<1[CBRUBN
M^.U//</Y5RZ5=(DH3RH<1KX^V!8`J$E-@;YU=^-Z)@V&YTR#5S=;)6QYZ$AI
MQYR!.B(8UO2T[5I>2\VK`CXOUOE%,4;D=5H/.=#004.8O=CK#L<,T0^W^EL,
M/NR[%T=N3"$ED]CF-,BE$_E6BK<5R/\`"WMR([;LU6+6?$^C#WZI9!I@<0GA
MRNK5!LC%<#KFDYI#IU3Z1)+M%H[ZW?F2X:KL!%R6U[4Z,7I/KMI.F=RRUFS>
M+1)77Q77=%(;A$81D26X)"OQYST6%,I+M1FQ@I?<UF6(E2W$,/N/)2M"VD.,
MJ:5\:76UXH1)WQXK;O5W.@R+&AZT+L@RY"67@T)PB'@"YTK[6&BB2Y*ID0>;
M241'EJ:TW[C>DI6E:?P:7BDMC=`\7*YT&YVBVD9H9E5A1'FLI73ATTJ/LT3G
M%KYO`L&S+LUM4QX*/L34J!ZLHD0Y#"](?^%U.FEK:-#O'"+SWC_<^<#;?$+V
M?N8_H@4`4LD@A$E%3-EJUI6(A%&"5A,02YR''E27)DJ!&AJEQ(NW7(_^2WM*
M\V7<JK.>*-##FP8>X]5YJ*+W]P^V)ILRM,55@J5<5?5O5;DPV+T$=8*[19"^
MHI^W1(Z1(E$7&&%:E15OJ];9:;S?#4D00$CR>K[;CQ;?3;S99@BAC:X?M-FJ
M=5Y75OMMPL"-P&H!:1#YDXAA7L/1F&#4E+C$A;$5UM9:M>4>'NQ-M`F;Q81-
M3,0)-B)@Z%46I-6EHK(2J<VHT:[CWJ7<(\,+>%D`+,@Q+2HI&F)(,)6AE>M(
M2F5F6P)^([MQ(]'&[ZH$KSW2T628#U"`+/6RV\X)QN;0)A3H%C=L@PU;I0LC
M6H#PV2RN"^->EN)<?D-REM[6EKFJOBFS5NI5#H^KE%,*K!8T<<;+U"/)LSLL
MK!Z\.2-$6[9OW`-=<:ZX\_,B)B/;ES8#;WN-Z=<1DLMV\R(8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`P2<1Z>-(08\U\
M:_-@RXC!&+\/S4!Z0PXRW-C?'^E]^*M>EH]?P?$G6!Y[<[\26?NN$CS.O-6,
MC$C:K35B#6.>06W*;@W(?<Y%;>'RQ,,(3ML,O'FSXS;+KK<V,\X\_)4O;N:M
MJW)$\1;LZ7G&[#WF5/.SAE3B$;-#??A*&7_4NMEK1L97ENOZ8@S;?&?-`8[I
M/U$2R:FFV%:W[RUQ5);3/>'W6)IEV!$N0"ABEU)Q@19J;)MRI/-3,K9J!/%\
MP%DK(O;,:SL^W,.O3T^KKA)]$=6]IUM*X+6@?\9SB^.\]I#74)-%DU,C8EV4
MNR9)2A\P-994\U%K@F7'73]"X`^^Q@+\-.F&VXX^"Z/:;TB1\6I>2\OJC>+5
MOKDWJDVS=.GVN7T?ETFF?:<F5/9CP#!RK5\98Y+H%3:UO"X]H$S2HO:B:UCT
M&9<9IMOXW7WUEHF1\3[,HJ!C5#K(:L5.KC[0NH"Q<.2W/KQ&VUBPP@S34MLB
MHD3K[EMD##7RFYL>*MX2YKV7G)/OQK9;>5_QAZ!3!O=)Z.A%[G8[_P`E+U:M
M/NFIPM;5F)4L6.D:>C+VRIAEBWBWYPJ4LKM8ULO)9;2S\3K[TLM$Q_C#);"G
MU3+ISB180C%:<*4)TG9WN:U2O0CMKM!VDE&'+&Z:'5.PNDX19UUU*''"(M"G
M-.14I:1;6TDC^)5[CC7XSW99MN;8<!(&1+(D]L<<KP]FO6`_6+:N.>E.$!U\
MOJC[LYY*7'&PY1B'I+R8F_>7"6@83P<O`06]">Z&(L;:`%-%L5LJNS0Z!.@@
MA5?'3J,8`0I3AZ93AY(*LL)>=+OOQYLEU*F?\K(>?=BUF73Q=M18'0QD;HPX
M/%IG&J]SB99'$V.`5KS]7`G1QD[4%Q+"U''Q.C1RS40[\TZM]L>.8]MY3NDK
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M=A<SL-`L'3+%/(GNOTOH<RWPS1*(7E0Z?<ZW9W94%4!D2_5;598P-34R1'>D
MKW)<][;R][^%*\EM(1\.",.2+CT*ZL4L;&,'9<8A"U8G3]'C.V0)/KLZB+=-
MNPT&HE(KT:J2/FM;C_9&O\FG6MOL25EHY,\.+U.^8DJMX(:]KF0ZH!@0`@>&
MU$)9!16;,67>&3AAF;:`%GER6S),82D/1Y)5G;<I,YM?OH66EK7B;:2BRL2U
MWH9/K9"UVFP*K<2&<3&F_>%$*;MTS+T6BR2KB;.R[.CLROF=CHZF8+;[[$9I
M>I9;FXOR;KO/>S6LS-C0S5:(P!($W>;"5F1+!<=ND;I:)AW0R/8+,R4DUAR<
M+!#ER&1:_LOU^+:_ETLZ3,'@.>+=O.3;$[,LM4ELIM%KN(1Z5#/*G70E9[P&
M/Z%]-=3-WO8@5SN'.H[6H*G$;!%']Z90C6HFUEEC\5;B=;\=V]="CH=Y!$F1
MSLUURU[U,VJ_<SZ"*C"A#1Y`^P"@3W.T#84:P;GMQ6EQYR=*FQ&U;MEHP_X=
M78;$;&5:]UZ)`8I=>J[L@F/-$R9D;&K%.K-GI)+9J=8!7W2-30!&PLRGXLZ<
MQ8##DA2'-I<5(665;POLD&RUPK<+R'M30(?7V"9MV/;=6RZO!]4.9%@V60]9
M7!VP5;+4=*QK&D.[<;?_`-(^)25^\[+:&W?Q#Z0/'GST.>&Z:;^[#8)D9(:.
MH,='DSF!,:-!Z!/)WT`/8K=(FP6Y`K<5]+[>XD=QWXU-J2I$I<+[X%Q#I/'C
MA(B:LB+M]])(S5H)E+(1V^*%#`U@F0FH(;89310T-.DHHAJ7(G.+=!1&]J4A
M3+4?),V3-NW^1#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8'PXC3C;C:M?$EQ"D*3Z[3ZZ4G:=Z^)/X4^NM_HZ_#K`Z:\H
M\<SE/B\B:)0JL.@\@ZI9;!20Z26K46J/-R_%+'S5-8B73=.JDT\4G68J@@\[
M*C(=1`4F*N3)W&;6YJ964`N/B'T,[>;@:"V^JB*W;.V5SO[D)YLM)GQNF4:7
M0`M,/_*_):'/ZATD++7(84K>G"@@/O2O@^86VN"X9M:\=^_":M!W8.EG+>?B
MQ:?#*5Z?V&^C1!N%!LMC)W\?$L@8+`GB4VQ+HF9'FNPY1%O41T8IYJ`^O%P6
MT!'QD\C"XUX>?ZDNU;FWR89>;+]#MD`&/::NU0LE?N<`2+K>GB+PNMA9PQVJ
M3G70CKTI#J'6](6I:X+A9O%N-=XHUBHI*\]#F71B#!M\.^?;MY-G1LETB.$-
M0"=.`IKP7Y<@8L0Q9![[3DS&8$>9)C1V];VPMJ3,&%7!_$'JU6+2CP*S421,
M:'W(8.8G/V5E#@VC"RM&\4H#[\*#&DQE4GG]S.K,.LN)4V8<C.1O>0A2]6X+
M6)Q*H>0U$N^AMR+G;]5PM8IP-QXC:)^X#-FLSY-=U.,$CD*"[;15)J-*K+4+
M3,1M;A@\6_\`H_RJTIHPA%Y\8.PFHG>!5>)@8T#J/1+-9V&M=!,U%HX&M//+
M/5A\8Y/IO.8EK')IUG)P"CL&21.Q"FHFTIW%3\+*EQ@M'!W&/):QWNQQ(_0;
MS7:F`NH'[9-;O-V"+ONTFNJR91^FB[`"G"ZNU5`IZNQMC8$9VOE4P4>DA:HR
M4)7!A.(W`_*!K9!=BZ\FZB?G!DU%28Z+T"E?;[,*?]V'@TFWAQ4@W5X<F@4^
MNE7'(:7UNVF:=TK_`$>;[[DN"X:4SXX>2Y2NF0I;I#%J>G@R8JPNR.J]&JL;
MI\LH&*C@$^4T%"RM\I8YU)G1UJ8"IDIL^HOQ3M(4OTRW!<+HN_%+7U'GG(ZR
M2W`IQWDG0H5D%&$SM%7VYO/ZE=*Q1;H)1$C)9TY/L$X<4<&OJ3K8Q3T20OXU
M+;R71;'\?O'"=RTI7+-9W@,@X/XES.GSQM<F%'ZN/ZB-%NANK7&MP2D"&MI%
MR#@*U!3,<TB8_%#:]QII;KZI"9)FVP$>/"A,FEOQXU08U3_)7I?:H/RT-QM4
M$'T(;T>)-AB_A'H^6L$^1=TJG;U\#3VE/^KJ]J_3K+<=5\<F0L_FUBE"J*Q9
M`/9>F]3MCHD6AB(F'?N>WCG\4!6?A%QOT@P#/KP]];C<?4N,(VXOU<WI*EEK
M)XKSJ9R^K(`R!E6C3392S7:W3*OI0\;NXVDX\2?&B1.A41#@,.->:@1)+BVG
M]Q8+.EL_%M2M))RN7(A@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@16]5N'<*9:JM/'#B\4^`*BG!I9AF4-F*F0GF66IC$AMYE;
M'OJ3O?Q)5K7IZ^GX,#H]SGQPN='N'-41*-61*:O*YL2_&8'L4=IRLTVN<@@5
M&Z\@'U]$1@A)AVGH31`JMMM.A,G9AT@\I)&,TAS4S"V^;!X\=$^WI4\U5!'6
M>>4^]%(5.Y3-M3;,:U\RLHZY6G<DS&LJ-5[9FH=#NT.!%A375,Z%5B-,;<^;
MTPSB)+1%SQ'N8J?1[`]4ZO9#T*Q<&FWTH.;I9HU9&J3RGH=5MLN=(Z4(W"L"
M6;@>%R=29FM$I"8NIK>T3F6O19:^.N4?K_0[!QKJW-X.Z9::97.C#7@5M._(
M*C-],*<ZKTE!N&$67&$)(&K0")R,WM3NDE!D6-M2=/N+1(K22*\NL+7B#Y!L
M5>!7&#-22#8Y@*\?-"YQ8Q8#C7/`[XH_"N).6?ESJ;93'WL@25/0Y@IQV8/G
MJ8D2'&];:W;A;A=WCOP'K/+.A/&+I*'VBKKKHZI5^/\`>*3O[A3J[3*P!)W.
MOA41HXMR#U=\%\#T124RJZQ#B1HFU17Y26Y,VDS$J&Y9XS^2%&I1"I."FVMV
MKFURIZWV;M7PS=>-S*_R)AY\LS4X@V%%$70I1RK#9(/%DG&T$/GY_NSWY"\L
MS!:[Z#Q&U@.C#;@5XL!1SF2>F/4GD;5DK,V-X_$'=4M#]]&"5[13ER[#/`S)
MSR`[KDL2I:=1-.KGS_@3,"-<H\>>S4&-PUFR#1UUO%"L\)^P]%,'0YT$7JAP
M%4(%C=-`#<?1@'>J($`*!UB=7DI1I,1#CNVHQ4FPE,P7"'K\7NQ-]?/7*77X
MQBHS?(=/0)(OYCF!"06"I(]UDB3,40?#I$D&QD'H@AN1(-+?L41</VQCK3$.
M(G:X+2;?">PV$)1A%GYQ%D&`=%H_.0=N(]&@OS.3GJC;Y12W=7K_`,H[)FS&
M^@5Z;%;;3'V@J\L,W!G-MPY;KJ%P)IQ'Q][!3>EU^QW4K"E5]#1N?8$1[,1)
MNK.\U'SN+\07%@R8[;*H]JXN8=,'=ZVC3!^.VG:7E;T_I,Q6"X1;@GC=W3F5
MVI1(X3@3*O)GVT_?(KMR*$Y`NSL\BIW.*J0`-/1MZDCK"Q`?02C_`!M(C2!<
M:6TE;LN3O29B3"M.6^,_D91Z+,J4@$PI=AYT>KK#J+G6A;-9LT4;RR6S)+0:
MS$'!VQUKL%*((8F"HDDA\,S4PGIV9(EKVF8+AV"Y)R7IXSR',];N]2U`&6X"
M7<',+)4.S2Z#)E6NZSOL.<7DL/V8?)(!2,!2T5V2H8ZXM34E3VHS3JI,Q1XI
MU^LWA[V*WA!X6"#K5%GA(.F[G8%V2#9==QZ"+JO468_5)S$T9+>"%#!FPQ4-
M%GT-V,6Z6<?C[1L,/<=MPMK,[%P;M5B[J8ZE40R9([5.YXU'AJL];%R27W:+
M:*&ZHP65$;LNRKTV.RIEN7,16G$*<?<;^>TRXA$Q5)>*9!_B?D/8[A>K^7'5
M(E6^FRZQ*M/(5V(I")O5CF%L`3:=121I9<K2YOWAJVSNB2(D>'!ES2+<6:[(
MAZ6\E<%PM'FG([Y6^[&NC3`(X?S2P@:\)IW//MF+&WP^2+Y]61966$"`O=J9
M%-KE"]BIFF5K<'-CHZX3BHTV<E,O%$SAU(C^'7E!"!A``"]1ZNX:,Q[)9;(U
M;R!8E1[:#B\<KPNP5>++82@G`-5JJSOG87N1M,S!C#[.]/3Y#K=N/*W#LWT;
MD?;[14N'C:`-H?.WN0-Q;P[6Y]@M!X;-Z%5)(R)7*Z-/#)X0C.KQ,-LPS)G%
MVY6WD$VG9$-<AM7PS"7'EHF?'6]GN9S.;210NLUM/D2`O(U-@8I-JLY*C09H
M\S8)E]TD86J=Z,S3K<AN&^1:D$9`U,5<Y:I[2G=V\V6C`#A_9:C;J;:!W.XB
MYM-M+LGHY8/T`:@KY"S2!FP.0>@S6"2X4:-*K`PJZYMDHZW*1]IO0(VE1(<9
M;K"W#';X5V,Z!H`FS<WB/FZ_1*-SL%;"?11[\ODUBJ-O>+6KK`#Y)R3*F-WP
M!*BM-IC;;*/+#-P9K;<.6ZZA<%Q=M2UXH]?<:*QK<_,/5TN%.I-"ZO=(VS\X
MCR=M[E?CZR*9M["*D^BW\H+OF;+'):4.=+Q41);<MEU:\7"7#OSR0;;1%'"P
M+P/%B[-&%@(Y6#77VU5.--BU<%$FL5`>WI.@==C3X[K3,/TTEM;:UH_R:T;W
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M35/+KKQI^L()N#QIJ79HDDG5V1@`S$/E#5FYD'3P6K$A\V.^.O5.J]L*SS$.
M8MXO`FP$.OKU`;DM)5"5"67SR'[4)<[!8I!*+R>HQ#]6HO*6.BA*3$G/=1/4
M_F]BKM0)N[M4IA`.7+/&EVHA->CM#A\5E8U]:FY*D*@J&FD^4_6%%+;(GD10
M*+2>R*%V.LP)%*=+S:)%.]1J8&F46.6:D3B/6KB_38)E0.:M)">)FLO#E1]/
MI:2J%I)6_(OHV[.Z-'W:NGH;'E+7>:`FXRJ`15<.>G54Q%DDPM`R2I5C53U6
M"0E3`76RX7U;>,Z4RP_[BDIZ.YE#`8#`8#`8'7KR,[?*X77Z.8B@HAI=TZ'#
MY]N04(."`%9V5J=P-QK9:B[<>7]C4\'.KK2R\S;:]1!RGGM)4I"4[L18HUCR
M?Z@]:QP751$['D.M]?I29K51N+S6JQQZ<0$D#$<EHPF%*8.386MN%=(3`$*5
M[#K4A?\`E,M0M-O7>]]OM'#^:],14Z75C5WZ'SBMZCVD3<8@\K5.C3ZP,BV$
M0$?FC;&'DC2%C=90U/WM,Y$#<AOX&93.TRHNC""PO->^VE5>%4[CA%5B/\\K
M5N9B'8A:*Y(E&6.A2RLNIBE_)/WD*(&494J*W'D19!;:OEV5MNN-[R]2H2OI
M_EI:*A/J,NBU4)T6G%^-".KEK&RW9`(ED79'2$(79I-AEQ)(NH5.!(C,2)#1
M%#I%^'(=VPC:XCJ52((AJG/*7K$7LH7ASU;H$P]]LDJF>N@QJTO471V:`@V*
MLRVYSDM**ZN+&)(8D")LAV43GL.18<E#BF][M15E8MI@/EWU<H'C-20/)HEC
M@\7B]_.39I>QB*O+J2:=6[?.J`94A4N;'L6F[2RULB\MR+%887)7&<TXAE*B
MF^K/FF4L(SI?S%$@A+'1>6^0?6H(*86E//EZGS2Y;KO."2VT0V7FF[6U'FQ"
M[:=*6,,BI4=&W6_:=6HIK;5Y;=1I]2LMOGU2DR&J>A%4*UJ<U:*O>I]])<@>
MZT+*QJD0D$)(NJQ6'X\.1`>>>GN,1Y\U#[:(R6'5%+,C^1-_WR/G71$<_@E2
M=SN1CE\\,R^2!20MVF70GSZA$3(@LT\3K8.5:![35C@R%/%*]\VI.TR5Q'M+
ME9,6TE9\H[9.M?-!YH'1M@.PF22:QL*<)*/TX*$L$^L2XU\CS&?E4V`F3U%3
M'0S[+;,U$V`O3CL5+[]HI&>3>8]NZ%(ZB\0I`4:+IO)B'1P#K;YEALM($T^D
M65^%%,36MC[/"??N/P2G("$+"H;B_,Z<V1C[2F(@I'*CYI=*-BY94I00D!H%
M0FCIO4H3;041JQF.DVSG(5NTDB3\G?)Q,"37D3IS!*.0F+'^](:W[:6]K5!2
MW+MWWI?.R)&$9&\Y,HY\)YI/Z#J#(.A2-G=ZY=CU/KR.=#IDHI\HR!V)0X]N
M:[*V5D[=C,_+*:]Q4HJ%3<^\S.G6H77SA.E4F#&:9I?WH`RI%DKEL*2N@WD?
M20D6MBBVI;H0@/D$4R$1""'U&8?M2H[C#$IE66H6G<?B/0#/1:6LG:8D$1=!
M!LG7;K5X4$C!W3K)`]B3(K$K9&3,V3D#H,Z.I)".XJ$38<;EQM)8>0G4E)2W
MH0^]E:59!W,;/7:9?Y8QUFJ6FW5.;>JT#+*4C;,\S4!UII,ZP0FTZ5I4=HM`
M4K>];]W7I^&(Z8_BM^IC^#_^<CQ.]/77K_\`R-]"_#KU_#K_`/#2_!ZZRWQV
M7&R^.VU3RAL:*IKQ^[5R'E2X+))-S5TO@UC["FPR'DCM"G0*`?;^3;K+<%34
MK;R'=D=R-/MZ2IKVM^ZBO)A$N1T7S7`W>&1[;Y&\"Z1SYN`2:G53G_B];^6V
M:22>92D5,CW$QY*=+@Q(L%_6U/,*$NJD)W\*7&MZ^+::\$UX1^]\[\_2=RLI
M#G/E-XV5&AS"CS]3K%I\0;O=+&"#J0WI@>9ML#RNI\*PSFEZ5M4EH5`0O2M:
M]E/IZ[8V,+.HE4\H1G+KJ%Z-VGD-N["1V9^X'0*MP>QTJCU;4@/%C@=67FT_
MM]P*V_8LZAZ3)]BPB?FXSB6$^PI&WUL?!A0:N6?4TVA6D>97B8ES:=Z2I7@Q
MT)2=+]/TJMHUYJ)VI.E?A]/77K_XXOCM_DQLOOK54\H3M9I$/BG:N0\YMHYO
MTZ">OW!K'U`+:W/LR,S\=9KHCM_-95/3]K(=?^%\@6_R*TL^OQ(VZICR807E
M]!\YPMZ!DNO^2_CS?^=1OM#[PU*D>*5RYQ:"WNC9;(S[,N97R?Z%`#?)EG&'
MW?C$2_?9;6UKVU+TZAC;)AQ],H'G88O!XER7R;\=J)SR4[#56ZG=/$ZY]#LX
M=EL=$:G-E;D,\HJ#!-N22C;[[:FQ$/33+B&MZ7M&W5L;&$_Y=5/*$+2[P.[!
MVKD/0+\21+USRT4?@UCYO6ZFXL.N/"79ZB5[?T.;<DQSNTR7-,%1'NQ];8UM
M"M^_I@PH/7+/J:?!K6_,KQ,VY\.M;5KP9Z%I.U^GX5:1_P"M3>])^+_!Z_\`
MSRWQV+C9?G1JIY0%N=T<3RSM/(J1U$:D5KH=UN'!['?JA;%,`W(QE58H0WMU
M&)4W1&P[1+8T^<+_`"T9.XZMO*W[^ICX,*VY]SWSW%76N$>F^47C?<Z!$G[=
MM56J7B-=:+938WY:0A,,/;R/E5=8("7J6MISWW!,Y.T(4CV_56EI8V,-MUBB
M>;IR\DR7%O)'Q_YUSQZ*,0)J=]\6KAT^SP);,)ILL_-N0CR8YO!(L3R"5NLM
MI$1]QVE:;4MW>O<VQY@PF?&*IY05X=<6N]=IY%U`H0;@ZHLWG'![%R2'676X
MQ%!%=B@&NW=4<M:)<IV*MI++XO;*&'$;VYMU*FDUX,*$3RSZF>DZ^+S)\3=J
M]-?%O7@ST+6M[_P[UK_UI[]-;W_YY;X[&-E]6JI^44[CU5`4WM7(:]W."Z'W
M<NF'>#6.S<\L+4>-,0=0"Y3$[?7#-963EN,+CJ=M!'41#2T*T_MS2D3%^AA5
ME+YS]00=;ZS/OWE7XT6FD0S4"1;:W6_#R\5&P'0#3R5$A86TS?+.UPZ\2F,:
MVEJ8Z,GH85OXML.:U\./YV,);V&C^9Y^YK(<+\B.#<SH>Q(]A%7Z'XR6WJ]C
M2::5)V3(JMH;R/Y?"5`F(6SIJ+]E:6QMM6]O.?'K2$5Y,)'PZI>4U;FV-SR'
M[;Q_K$"7$'(JL7F/`[)QJ2#FLNS%%9!B6=[EUU%@CSF7&$LM-M0=QU-+WM;O
MN:TA->#'A1KO+OJ6J=>4SYB^*#;*GG5,-N>#W077&V%.*VRVX[KS/:TZXVUO
M6E*TE.E;UZ_#KU]-6^.QC9>A2I^4;_$1%<#]KY`/\@F'HBCG5IW!;&2YF28;
M+2'YK8_CS7<!QP6Y)"J:C-J7;9.FI"%/[2M*M,IF+]#%^BGJ_P`T^HM%/@I5
MF\MO%XS6HQD7(L0<3X7WP$5+`69S#A@8+.2/+\W'#$9XY+C3$MR%,1&=6EQ3
M#ND[;5;X[&-EE]LIGE[8K..F>/\`WSB/*ZBT#:C%`/2O'*T]@-S;"F=-<>+0
M[$#\@N3Q8`QP>Y':3#4/?<2ZTMSYC>G--MR*\D5Y<W$:=Y:URP&)7D'W?BO5
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MQV,;+B[A4/+"R&@<CQZ[IQGE`",+DLV(7TWQ[LW9"18NN7I<6>++@N\\C8#0
M6(7JVN,Y$F+<<W\>G4Z_28BO)%>6NXO2O,2O6R5.[YY`<-ZC2UA)4:'7>;^-
MEJY$>CV!<N"Y#*OV<WY#]5B21D>$W);<AZ&MK=<=0O3Z--[0XFO$&/"`6CFW
MU#YMFL4RG^67C$`J4LX5DU<"<\-+U9#06O/SGW`PDO8HOEU7HIXF/'J;:?F-
MCX+<EU"G$QV=*TVE_.QA;0*I^4D;BU@KMC[7R`OWV4\156>I"^"V,+S8,P[)
MBK%MEN12.XF#9UR%$0\V\INUPM2%N)7K36D;2MB_0PHG7+?J8:4G:O,?Q.VG
M2D[5K7@WT+6]IUO7Q:TK_P!:._AWM/Z&_3?I_P"&6^.QA?';JGY16/=5_P#3
MYVOD/*=0HY)-QUTS@UC[%]X)+WV=]DO`M@^X<E^[34'VI7O(=^T=R/>;^%37
MM;]V17DQY17D%&\TP-U8(]Q\B^"=*H"1A%F35N?>,-NY797BSJ6="Y[5O,>2
M73H+$*$I+FWH^Q*U2-*UZ.M?#OXDUX)KPC-WYU]0$E<++/Y[Y4^-54HTPQ+D
M5.LV;P_N]QL((&M6MPAIJUP?+&I0["0CI]=.2FA<!#N_PZ91^AC&QC9:%+JG
ME".Y-<0=^[5R&T]I(+-;HG1:WP>QU"A5E$@7#9`)L7,)O;K67MBA9=M^1)VS
M9!?SC#J&4Z84C;JV+]#%^BA%\L^IIM"M(\RO$Q*]IWI"E>#/0E)2OTW\*E(U
MYJ)VK6M_HZ]=>O\`XY;X[&-E^=?JGE">`TJ+P[M/(N:V,<V]J_E^A<'L?51=
MI<5`A-,+K80/V[F,BH(:(MR'E)?F%?C:=0WZIVWMQ<QY,(1RNA><02]!R79/
M)7Q[Z#SJ.V2T=J5%\5;CS2T$W7ALID4L=<RWDYT6`)1!*K9?>2L/*W(9;4TG
M;2EZ=0QX,,/I'/O/`O=["2Y5Y/>.='Y[*DQUUBJ7'Q+NG0+,&B(@1&I3!>XC
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M]%2?&/)#QZYWSMUD?H'4KUXJV_IEH&24#V&S+TZYB?)GG$`F@B4TZ^TE`B-M
MAIQ+2E.[3MQ2*\F$XX[5/*``&N<?NO:>1=-/$&XVJ$4YWP>Q\H'5=Q$.>W+7
M9!)GMW4'K<E^>[&=0EB4*]MME;>]JVYI;::\&/"A$\L^IGI*=+\RO$Q2])UI
M2D^#/0DIVKT_3;TG?FHK:=;W_@]=^F6^.W^2XV7U<:IY0D.1U`%1>U<AK/;8
M"PN[QTBQ<&L=KY_96XX^8T?17N6P^WU<Q55%";C#T;;UE)_*,M+:5I_:].(F
M+]$5;2N<_4#'6^LS[_Y5>-%JH\,S"D6VM5KP]O%/L)T"VYZD!86U3O+*V0Z\
M1E-?I6I;HR>AE7X=L.?H8_G9<;)5V"C^:)^Z.D>&^1/!>:4)0L>RS5^A^,5M
MZM9&S#7S'VF07;@WDAS"$Y!FZ4U[,;0I*V/@5ZO.?%KX45Y,)/Q"I^4=;=LZ
MO(3M?(.KLS8PU%1;YEP6Q\<<`2F53]E7S;IWN/6]6-F<EV-IEMI(_<?;*]J4
M[[FO;37@PZ^E.??4A$P21<AYH^)(\2,BS24V7*\'^@Z:@C8;3LJ0_)>_]:"=
M>W%BM[4M?IK7HG>_37Z&7^=C&S],].LM[X/1Z[7?(WAI?O)!9:1/Z!/\6>AW
M6C$(H*`TJ[;:X%&ZC$N%(W+I5X@1DN$+(XE3!1"DZD-36VMO/H:3Z.NO-JOT
M<R;JEK)>4?T]SE2;:3WDW"B_3^.\_LA?GM6,1@5HOXH[9?*"8[6G=1GEP8]B
M>'RD1U/)7I#[>O@5?W^QV;ZE-[3T`B!F>.GD;X\<JYL,#T!INE]>\4;MT(_%
MLAN\%ZG1S<"1ON/&-@!A@^):'AXR@^UIEPE.M2%)6C3<BO.ICRTW/Q1ZHV.Z
M5CR][MX?]5!A@7+ZBBE5/QF<Y%.J4WJ%NFU;FL.Q3;3V[K\":#N1AZ2.%CM0
MX:=S'5*TYO2]H4]K/95T5ORJM5\-\]I_FOX2KGK:-5>#4Y'@C?)KS58%KF/?
MB_<,J\N!@2P2Z\%<WN8/CI0I+.ER%1&65;]&-:G]KC9.ZY88PWA(_G%.[/XT
MQO(2%8R885=ZEXC6W7,H<RLW;[USW('``G256&./@06_A;*-VI,!9K7SS3JE
MZ^6QY\TD[YI2@`;V^]A@]K,^7G@3:N=U8O22LUDK]/2Z!'(H]LC/KH!855I\
MJ75@IDF.#(#1,],)YN,MA>FT+2VIO=^)OW7VA>W3K"=ZG:A4OQ?\DO%#F\1V
MD-#K77.I^,IGJMV+1NF=/GU6/\3T7M?&20"O6N^LK@2A<P=(W*+_`.5>7I3J
M-;D>J::L'C'WJWVJY[\C>Z>+'8"]6K!ZA3QU3\.+7QF\!IS(S[P$1S_1;KV3
MJ,0Y5VJ-N>]($Q8_MOQ9:)'O:9W\+R=,'C#2HC>5M[N%H$\J\R?#A==2;.=`
M%5]7@[>[4NL#?O80<%O6>WP/*\)7IER@S8VU.2U1Q\N=(8<F-QFT;_2L1K$E
MPYZT5K!_B!^KD^T^(EF[]VXLAU'3H_B>4%\S.R7[&*D4]_J7&B74"!PH[*V6
M;:&RS-K'H*SIS#T+>]K2VX\^:/\`A2\&W>0*4!'H_G+X0:@'HAZ'$<C?3IZM
M'C/@QM=`$K/$ER]>5FXP@8[1H`N4O<OVV'@Z(<C6G(FF%;N-I_:_"_>WDAUV
MN]>WX_=U\1.5VB,0E\KM$KKWC%,ZX9N1ZXRW*J%K5-L<+K?'D(%S90$F'E,,
M++Q9LM/RBG&G65,N2-,VD>K1<M`V3G%OY-8>]=Y\*[QSJ4`--<L"\R\-"G*S
MPO1><.818:Y>)7=^ICJ736R9U+9!Q0R+#?DD6D+E-..)TXUTM?\`E$[;#Z@<
MO<OI/-?+CP&KU:UJV&>9/'?"<Q=KO4Z-5&K"$+0'N@C?**JK*/U4?SPC!GR(
MP\:A*!#C>X[26?@TQ68D^)=X?%RMVRG<_,5.Z7KBU^-@+J9B.3N#<=>X?1@S
M4F"')_8#M,<Z)TYMVPQY$]R1,FMD4)>W*2A3#;C2U+DI.79'(A@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,#QA^H(6\C*+W,B?Y'W_R`J=;8\!/-[N3//Z>)YX:H
M&NO^/H;D$3D[.F2O*C]E<4>>Z*4DRAGVMIPK)AL>QIMMAYMS?&JSNU%5G=TC
M-^6/U(2]VM=4LW0`'C60DTIW[*LLY'XQ^-4%4CZ=]UZ>,Z'<;O,XC52<6(GK
MD&,5),)%S&A,]"6-)G,Z5$=M<:W_`/:UQ7A?N]>7/5?`_P`%B7BL9[G6>Q=C
M\C;CRHD=MUTYD7M!Z#4N;^4TH;;#77SW""5#/\6*WOG(4V..MTL>_9ZLB*RR
MQ'E$4ZR5%S>E%1<WHZR:\H_J05/H/DL,Z/UOI`2E,6NTU1R]U_G%4N`*N47G
M'ECXX<G\@NP<'J$?D:;+0IG!N.7H^::B6*=<F;$.*,EX\="04MAVUQQ17%)+
MIYA>6=?JHEWBG=^T=:Y3![SVBJR>T3>05^S629].H*'X"[TCS)BR8=-KH^V=
M&\=.MV@S5*=*B#78US#_`#\]8\FH;N5M4>?R=BH>H7C$<\I"WF+Y.<XZ+U*1
M;>%^.T>`0Y+*V!A#S/7&/)OVNG5QB^'6P,0=):\:PP&35@K@EW:BT,GJ65^.
M8RWO>9JHWE)JO5YG3O+SR<.>)L8)R;NOD-?OJ0^0%Z`U;J7(0O*J%-)^$I^J
M:OM]Z,*J'(;-4J8*"U0.,IVJDU,L9HCLY'EQ"L9^0^^EQ[51>:ZK47G16%P\
M^O/"\77J_9J.<ZWS+DAWQ7M4ZH5%^G5PU7J=Y`M?3<M7<&N2,4HIR9?0!72`
MG>J_/EQK-(L,H,_(KLBO."G7I\5W+UC2?S)45\NVU6\H/)EWPO\`/"Z\ZZYU
M7L]:Y6WR)?C%Y$6KFH(9T"UF;%5J-/[+5`S0SG%.KO3P'/K@0D1(1YJO)2I<
MR1`6[)=&+?S-1V@J+A</C;TGR.[)!^IMQ,9V^S6KNM*+71OCW>ZT1JQWA=0-
MW*=UV/R&B4>NSN7U=ZA=!XXU714"\UDP_:4K6B*102=04VE*8B*GPF,3X=![
M5]2OSEN-9Y_WSF-`\@&JO)NLOR7Z#R:O<<#DY=7\8?'01S'B_3>56QFTP`QR
MO1NU=D;ZJ?B$(2B-@^7J`S4*/\I)5MR]8C$ZM=8T\K'ZY]0'ODGFO4`W)>OV
M4AV.D>4'U(HLP,&H4><="\/J?CAYFWOQ4=>'RZ4Y%=K^K#1*K+#R])<>).L1
MFGG'_?<:=L<8\Z5"1$>=,+EYCY/>64WP^\];IQV_]*\BQW*JC0)_C'W>[\E%
MN7PT?.<R"E^]0*W7P-"H(;N<3AQV1)FAI#`'?VF06X%<5.<A+VK-1<65%PZ]
M&/+_`,M*O<0Q'QE[AUGRH\9>:=OL-LAWNV4.LF[;Y#<LIWB&?Z9WWB@ZT`.<
M4V#8I](M#:9]6+P($-]=J6FNN/2$Q7&$6H\XDJ/EJJ=Y]^7NN`7FVC>O2K-Y
M-<@IGA/WRK\0Z#0'A$+MW+>F>'_`QO;!AV*"HT4X/&-=@ZW/LNWQWPSQU@%)
MA*2U"V_'TF(^,E1?H[P^>EE\U.`T'Q*YOQ_M%ZLU_P"Z@37AD?[`W0ZP7>%>
M2'3VN>$N>>3QX'$JTP)685.A4BYNJ8<;0"924:9?;7M#"M2(B;2*F[="]><W
MU*+AR.Q]NYZ*/2-WKP]^H!=1M$NT/\7#G*[!XN4CQ3Y/!Z-6(Z>,7DK;[]^/
M2'T$R"K4],.&?C%=[3(3%CL:3>O&Z]5J-&S>\H/.ZT&_)X!S/O!YKM`7S>X'
MS7EU+L*Z\7%!>7$^CU'4B#8>3;X`#D4^@=`C>Z&FVM5S/NO0B#[S4<8Y&0[M
M7'XHJ,>R\[YYA^0ML^EE7O*I/1KAQFQDO*+MQ6RU*S?97)>X6GB];[=WN'6/
M&[G!PWRGH`BJ=C17:^%@!GI@!Y)Y0G<'<MA9/1!$J.U>A4=J4!UKSO\`)JNR
M^E6/I-\\AN?<KJ-I\D[9R&K5X93N27[LMPI/0^:,U7QN,='L7%>IB`-GIG)"
MTZ>'K28#,N]&Y3\9,]QL>M*+4?)$0B_8?-SZBU,B^18K=LZ5%A31'U1^N<)N
M@[FH5I`"F\;Z7!Y7SOEYB5]P2[";+R0P%^UPTMZ))=,!;.TXXU.^25ZHCC,Q
M\$1"VG/+3R-@]6YP)YMY+=.O]OD<[\(B7'N.!8-<[OSGR3>Z;Y1=VIGE5)M_
M3H?C)R<M(%T#DE;@R7K/%8I,>KI@,NO1I.G%)F*CR5#M?Y,^9?D90OJ%T>N4
MFN===\1N8-TGBO?38+EX@QS9[K/DJ"L$ZI6HY>I+BK<-D\;.KYPPVV*B21CT
M6[D]D'&UPF_@D1'7U2(BO5YJTCS<\[M4'F=0\DNW]BY:D/2/IP%NK][KO,ZH
M#DF:%Y,=`[!;[%TP8X0Y;9J^&M<;GB@U4M$;[->9&%J\\[J-'^;UM5KCXC=J
MN-X=\;UY+]_9\)_!R^]B[GUSA#71O+.W43JG?`'*@=+Z<?\`'D17/*65Q;I%
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ME3YCS\?8AD2N5QHE,A2H\Y=4D(1'?)*W.:8;G*(\;G*(\/?+,,&`P&!'[:`;
MM=5LU6=DKA-66OF0#DQIM+SD1LP.DCER6VEJ2AU;"9.UZ3O>M*WKTWO`ZMU#
MQ7*5SH=&Z@6Z(/LEKK4(@(-[732P422#.@>?5T3'KHX3T)G8.:,A4!*W'BKM
MA:DO3WU;91IN,EBWX6T;?\(1TMD4N1UZ^?:(>J!Z+"VQ&#)!(J8*B_=<</V`
MDL2VW'F[)I-@6I;ZV'9Z$H6RIO7IBRUBFO&F/=[:'Z+T.S1C-_"ZX_J&5K08
MY4P;&N1]4.]+C[9K+EV/L/*L:#.H$CYQ^9J/IKWV-(4OVTK+1:S^&X*W78S=
M#W0[:6U;[(\3O%6*L#9E4/5YFRTPZ#K$*"AN--"Z`P*`-@LR]27W-(W)=0AM
MR2K:5EOOCWBB7Y@2`+,]<(WP-7KC.Z0VP0J<(58S5_G4PC0G#5BL<8S+C3(/
MV$6D.JC1A\-QX@Y[SCZVM?+XF29:ZH^&(FB7BH7*MW)2T5^UGK@4%GA!PELH
M8M+Z-GI0PB/O(5\-[L*!#;BPWT$0T1Y$AY,#:I2](79,VS"OB*Y/%1JVQTJ1
M&K4FKUJNV:,]5(\PN5>I%@Z!:*A/$EOMR.P#;8+]`=^T&5Q9OSK$-I#3D3:G
M5K7Y+:45X-5BOD*W/K]Y-BU4^W\X-U[_`.S62$I%6IG23?3K!0C10H0F$[$)
MN1TTGUDRG52X.QH]:%NJB)^-9:P^E^*U4ZJ5.SK0;*.P35K)V[[*C*FCT1)Y
M#BT?C;;;<X26&3G6HL1G<_TVO2775[:4GX=:5I$T6QN;^,:N<GQA,?=]+'0*
MK<J[/C0:VL27MJ[99"=BB.70DBQ2@Y\=372KR0[6QC4R&I][TF;9?<84F;+Q
M2-"?#8150@VITRY.`ZJ4J/,:EU6+-`.6$_T!OEI59,2;@V@I85SJV<+,2GQ\
MMV0@NVV,]AF&B(J*T[I9>[\KWA@`J](W1!%W,-"M"+H/:<?'_/243;YQX)RL
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M1^_*/N7YMWDG_)1CZ^9TY']Y-^C]^4?<OS;O)/\`DHQ]?,Z<C^\F_1^_*/N7
MYMWDG_)1CZ^9TY']Y-^C]^4?<OS;O)/^2C'U\SIR/[R;]'[\H^Y?FW>2?\E&
M/KYG3D?WDWZ/WY1]R_-N\D_Y*,?7S.G(_O)OT?ORC[E^;=Y)_P`E&/KYG3D?
MWDWZ/WY1]R_-N\D_Y*,?7S.G(_O)OT?ORC[E^;=Y)_R48^OF=.1_>3?H_?E'
MW+\V[R3_`)*,?7S.G(_O)OT?ORC[E^;=Y)_R48^OF=.1_>3?H_?E'W+\V[R3
M_DHQ]?,Z<C^\F_1^_*/N7YMWDG_)1CZ^9TY']Y-^C]^4?<OS;O)/^2C'U\SI
MR/[R;]'[\H^Y?FW>2?\`)1CZ^9TY']Y-^C]^4?<OS;O)/^2C'U\SIR/[R;]'
M[\H^Y?FW>2?\E&/KYG3D?WDWZ/WY1]R_-N\D_P"2C'U\SIR/[R;]'[\H^Y?F
MW>2?\E&/KYG3D?WDWZ/WY1]R_-N\D_Y*,?7S.G(_O)OT?ORC[E^;=Y)_R48^
MOF=.1_>3?H_?E'W+\V[R3_DHQ]?,Z<C^\F_1^_*/N7YMWDG_`"48^OF=.1_>
M3?H_?E'W+\V[R3_DHQ]?,Z<C^\F_1^_*/N7YMWDG_)1CZ^9TY']Y-^C]^4?<
MOS;O)/\`DHQ]?,Z<C^\F_1^_*/N7YMWDG_)1CZ^9TY']Y-^C]^4?<OS;O)/^
M2C'U\SIR/[R;]'[\H^Y?FW>2?\E&/KYG3D?WDWZ/WY1]R_-N\D_Y*,?7S.G(
M_O)OT?ORC[E^;=Y)_P`E&/KYG3D?WDWZ/WY1]R_-N\D_Y*,?7S.G(_O)OT?O
MRC[E^;=Y)_R48^OF=.1_>3?H_?E'W+\V[R3_`)*,?7S.G(_O)OT?ORC[E^;=
MY)_R48^OF=.1_>3?H_?E'W+\V[R3_DHQ]?,Z<C^\F_1^_*/N7YMWDG_)1CZ^
M9TY']Y-^C]^4?<OS;O)/^2C'U\SIR/[R;]'[\H^Y?FW>2?\`)1CZ^9TY']Y-
M^C]^4?<OS;O)/^2C'U\SIR/[R;]'[\H^Y?FW>2?\E&/KYG3D?WDWZ/WY1]R_
M-N\D_P"2C'U\SIR/[R;]'[\H^Y?FW>2?\E&/KYG3D?WDWZ/WY1]R_-N\D_Y*
M,?7S.G(_O)OT?ORC[E^;=Y)_R48^OF=.1_>3?H_?E'W+\V[R3_DHQ]?,Z<C^
M\F_1^_*/N7YMWDG_`"48^OF=.1_>3?H_?E'W+\V[R3_DHQ]?,Z<C^\F_1^_*
M/N7YMWDG_)1CZ^9TY']Y-^C]^4?<OS;O)/\`DHQ]?,Z<C^\F_1^_*/N7YMWD
MG_)1CZ^9TY']Y-^C]^4?<OS;O)/^2C'U\SIR/[R;]'[\H^Y?FW>2?\E&/KYG
M3D?WDWZ/WY1]R_-N\D_Y*,?7S.G(_O)OT?ORC[E^;=Y)_P`E&/KYG3D?WDWZ
M/WY1]R_-N\D_Y*,?7S.G(_O)OT?ORC[E^;=Y)_R48^OF=.1_>3?H_?E'W+\V
M[R3_`)*,?7S.G(_O)OT?ORC[E^;=Y)_R48^OF=.1_>3?H_?E'W+\V[R3_DHQ
M]?,Z<C^\F_1^_*/N7YMWDG_)1CZ^9TY']Y-^C]^4?<OS;O)/^2C'U\SIR/[R
M;]'[\H^Y?FW>2?\`)1CZ^9TY']Y-^C]^4?<OS;O)/^2C'U\SIR<K'_<E?1V<
M?8:E>4!X1'==;:>*&_'WR+%"("'%:3N22)2^5HC08;6]^JW7%:0C7X=[UK'U
M\SIR>T?/NA4;K%(JO2^96ZO7SG]X"0+)4+E5"L0W7;&!*,)D0"@@K`=>B3(D
MEI6MZ4A6_3?KK?IO6]:QHQH\Y_K;7&S4'Z2GU!+13S$T!887C+T2%"+CGEQI
MT-DZ/2`(JB2&]I=CONBRCS:5IWI2-J]=;UO6LL:K"+6!L3X&_2OYN5\8:AQ;
MFP_F7)^%.;9M$.F@PT:L3DTYCHAT7$LELYE5[IUPA7Y<^2(A%[");L%B<99?
MFZ6_^GL?URRNLY=4^L^=ODY1W[78Q%SXTUSDEV?Q-H]*FWG@0SF!NK4CR,XB
M5[7/-76=U+R'I5.@6("W$8$[BE9X9MAYQ25[7+]J,NQQA8XQ\H61^J5Y:B^E
M&*`,X7SZ^S:?Y`^3^Y<.O\^M<5[H/CM4A_>:CXU@*<20>*0V^MWOLW`[#!)R
M6VYK"X`?:H\)*IC"M7K&OH=8U2"R_4:[+7"$)JK=M\3>VC/_`$0=M\G=V&A<
M_KH((<ZE3ZM>#8SD(H)8/(=R^244J57HWVC#%CS5C0PYO[3C"T[W(TZQZZI7
MNMWL?U+%0:GY4$>0]&\5B,GDK?CG<J)-D6*B$"EBXQ=*Y627;KC1!%AZC1JM
MU2V5\K,(#Z\/V;#0)AEMH:[*W*4EMV1QTLB-UV>9_FP<YCXO47M'C6CG-M.6
MI?50T]ZXTTI,B5^S4CQ/[OV&('M-2$&AYRKGPG1>=#(9P1)?^>A-[E05^W*^
M%QN1QS4Z$1<U+KSR+ZBO5>H=FA<TZ?)XAXE`J[U/H]%NEHZ?1B$V%8^B<5K'
MC#$NWC?2#9R\TVN(M5@N/3;64%FE.RWR-:BCG!XV3M$Z0BSQB(O4F(CU>Y@1
MZJ64*(L=>V"-@#XN`;!F1:8,T86#E8C4X:3'3(Z7&)<&?"?0ZRZA6T.-KTK6
M]ZWK,,MI]E"_]VP/]3C_`.;P'V4+_P!VP/\`4X_^;P'V4+_W;`_U./\`YO`?
M90O_`';`_P!3C_YO`?90O_=L#_4X_P#F\!]E"_\`=L#_`%./_F\!]E"_]VP/
M]3C_`.;P'V4+_P!VP/\`4X_^;P'V4+_W;`_U./\`YO`?90O_`';`_P!3C_YO
M`?90O_=L#_4X_P#F\!]E"_\`=L#_`%./_F\!]E"_]VP/]3C_`.;P'V4+_P!V
MP/\`4X_^;P'V4+_W;`_U./\`YO`?90O_`';`_P!3C_YO`?90O_=L#_4X_P#F
M\#I1YT>2\OQ'YWSJY5SF0J_SKWU\1S>5">@7*9H"$=HW0>@6&V("<TH/1KO8
M5!`?/9&]Q((MU7PKV\XMMEEQ6K$6L1:,>,WU`.(^577K1Q/G_*NL@[E1N;T+
MJ]W?NE1HL"O56F]<$,67C\@B:!7FQ,RB73JE(T4'1(293T:*AQ!#4*0VIC5G
MC,19,4ZG]6^JZOFG<;QP7_TZ!2%IJ-QL_*&YCMT;CL2.O6:X`'/&2HOP45!R
M2AKM7%'S-O?<0M2QK85R,VB4ESYANQQN+7KBT4K7UBQ)4I"<+^-]A%4/[@D9
M4OHC+%3G#9%R(C_#1R@VET'&N+QZM\J/&O+H?!EMNM33T12XCNF'$?/?)NG[
M.J4,?6+Y+O@Y*W$N*WH'V:K\:J=UZ#5BU:K#=%YU<>ET*F'.0:LIF'=)QN90
MNMW"_BAXE\1'*%(;$A3I>,,TTXI+IGT.N?1V7\/_`#B#>6_5;+4*_P`Q57J5
M7^%4/H\&W&H(R*[<K07ZOV?DEUW5($4P6EIH8:S\?EQ8;Y2.,*/O-.N*C?+J
MCNN28J$F*5E8/J:U+G?=O(GFG2>*'&Z9Q>WFZX%LU$!%3Q(U7N=\<HW:NS=(
ML$ZT@Z1S:+7>:5:]QU2A`.P'[6[I*5-BU[>;3CKBX7KC#G\@/JE<@X_XB`_+
M0'RTG/"7#KA+FE"J_29U6YK/O`FDS[01Z5=P4EB3;U)%CJ'SJQSP<>2S'F&I
M\.)#]N-\^P]B.,S-$<<TLSQA\Q7O(7R/[%R%NFT)ND4,38CM1N5?D2)\NTAX
M'0G*J!(NH>;W`U$,`MM3?C:_!\;FM)_2XF*BTF*BWH>^&'.LO-(B18RW&G&T
M2&(<+;\=2T;2EYG3\9]C;K6]_$GXT+1ZZ_"G>OP9E'17FU^ZW7[!0*/;`Y:\
M_>4Z8^T#ESI#<&SS13]_Z975N"R=0JE4I($9S>L4X,2FZ(0W'RK1]OV76U[9
M2]J8A6;T#MO7P5WN%(!\'43'"G38H9<!X.P*BRY44`WT.+-B3&@\J`N,YS[;
ML)#R-N(W:T)AZUO>_;Q4:E8035X\FY*+`VQ$KTUZ5:0E-@2H7+K(,:KAF)?;
M\@@7^4>DD-/5E%8K,&$41[CBY2YVI#$J*G;:7&%PRS?=NZ.S&Q,+C^M%1L\0
M[."@*798Q4I`"3*G+EV!LP6A$0;%+Z41E$`$:"E*R8]3*Y"I#R4O:95"83:O
M];O4'A'2NE%0D6VV:)T*6%I7V9S"RC@+XR8NL#!4EFKV*77K*Q4X!&=(^:F.
MS5:1[;SJ''$:2UDK)2!VOO?8;#6([53Y\S1K''$%9-NCS.;7$Q.%$3=3Z2Y1
M:Z+FNCH$.(?(%AH&0B1IJ>EE<Q#;T?6GDIRU'E:AL['W7OE=FRZTQR"JG+./
M9*#83C5$OC`NY2VG[NQN\"GXRB#(:IU'8(5]IP7G9$V?]JZW%>9WN,B0J$IL
M'>S=<J]^17SM,KQH9:;U6N<U>+JCV(7*&%SMUZP)>N<TRM^7%(TIP)SQ<OY=
M+:'Q\=Z)K;SZ'=/N*BC"0=CZQU'F][N`\#3ZW8JZT*I\^IQ%\YMI&4N;(K_0
MYTVON%Z[(D-$"U^L]<@"!K^F6F`[SVE2&Y*GH[3J(B8*3#LO3;]0K,/!U;E0
M\J')U>#9Y5RE5TT:#4\?!L#=<O,BP1ZZUMR?*K6K2#*1A\=YJ42&QRRFE)U%
MVZB1`I:N]Y[I*N58#SN75.4*N5Q`QF'I5/L54AA*F\'H[*G=%3$Q3CA&]/D3
MAH/I^-[T-@2L;)86\K<EFU!4)KU._=7YUU"X2!%<@6.FRA]*@U`2_2+00A:+
M1`5R,D:U"D5]YYEZV]*.:B#HA-UE$(5[+:9#<A2V6W)%21E(KCU;H5,\>(W2
MYW-1A#I1:;)2-IH2E&R4`>E^66F!A)^.Z5'EXS[P<<W#=G)5\+A60TEB*Y[K
M3"U1='E$HG=.LQ+'215AX]7V8?3+J-JE;7&K]DA2*TLO9^B>TBSN$$+:(?9/
M..3E"TR2RB&VF20'L::TVXE]^U!4)3T+I/5ZO?[4+J/)X5IJ]<2-G_!(`F7R
M%IU/7RT0T#J)*%%8$"Y2)5R(RWWY&IZ-)&.)VVA.W76)@PIFJ=T[HYLQ,WS>
M-?(I^U#*[7R8Z@7>L5\+./@V?LYZ.+-AU&6*I7"PJ<T8G/O/:^9<;VA;:%)1
MJU!4.)CR)ZR,L<TD:YTZH`.H))M^HZYW>7R(2WI&6Z93-V$W&K[\6PF>AD``
MS45L:VUJ)&,I9>:V_P"TXM4+7[7)QOJ5XZ?U\^+,\_GU6B5P=?(T%V?3)0%H
MQ.8+\\C"&S.I[I9#1X)M)=+?M26/F8TKXUQ65H]-28PE8=POLH7_`+M@?ZG'
M_P`WD0^RA?\`NV!_J<?_`#>`^RA?^[8'^IQ_\W@/LH7_`+M@?ZG'_P`W@/LH
M7_NV!_J<?_-X#[*%_P"[8'^IQ_\`-X#[*%_[M@?ZG'_S>`^RA?\`NV!_J<?_
M`#>`^RA?^[8'^IQ_\W@/LH7_`+M@?ZG'_P`W@/LH7_NV!_J<?_-X#[*%_P"[
M8'^IQ_\`-X#[*%_[M@?ZG'_S>`^RA?\`NV!_J<?_`#>!KRU4JYX9/"'*V`,A
MBL1^`4$E@XXB,)093:F9,*?`F1GHLR)(:7M+C;B%(6G>];UO6!XI?02$Q*/X
M_P#F;Q2N^]$YOX^?5"\W>.<AKBGG'8E,YJ%NP6QAJD*TXI6V!(HE:INV&]?@
M0ESTS?/6/9KGJMWZ\W]3K]0W^;A;/U2-S,,O0_@S+,C@G%6GVFGVE<DYKM3;
MS:7&U;14`BT;VA>E)WM*TZWK\'X-Z]<A.JU)VQ[,25));AMP6&7)4U^;[*(K
M,>,VIUV1*<?]&FVH[2-J4M6]:2G7KO>M8%-\W\D/'3L9C5?Y#V[D74S"1A8Y
MN#S>_52[N,C`,X(/,S75UDF3980+(6F`T_\`$I*FUSFM;UKW->MJ8U6I\K%M
M9^CT&NF;I=S54I=3KD289L-LM1$17:\"@[]5$"I@Z6>AC1D7?Q^KS[SJ$;]?
MTROPY$?E7,4:\UT-;:64J=PJ1Z`P0K]FJ\X/8*Z9&.N:>C30QD2[+&D8#CJ/
MC0XPXMO:M>NM^NL#A+S*'R^H6JTEU5JC4BM0[;T&XF'68`0")BZV3MMWMYMY
MMMB*SMY;DPB2F.?IW7%NO.J4I2E;"2M_9Y.-&E-IBS8DG4<A%>^!M]EW2FT.
M19C2MZ4E6]M[3M"]?A]/3TW@5`OR0\?8G-(O8Y_:.7@N1RS,JN0>E6*ZU^LT
M269A')U9<&PK.>G#0LIY9P8_&8]MY29"VM[:VM/IO=J=/*U.GE8U>N=2MSA-
MNK6,-8=A]B=$E!B$8BS%T>!CK,$6M^*XZPMHK7B\6;'6E2D.QI"'$[VE6MY$
M;N9/@CTL+GS8D%$F7%@1ES)+,9,B=.>3'A0F%/+1IV7,D+2VTVGU6XO>DIUO
M>_3`R\!@,!@,#ADR&(D=^7)=0Q&BLNR)#SF_A;9890IQUUQ6_P`"4-MIWO>_
M\&M8&HJ]GKUVK-=N=1,CK'5+<"$6>L6$1);FB3U>/CXY4*9%S&=J9ECB@V6T
M^PZC>TN-+2K7X-X&]P&!B3R$`7%<G$YL0="9VTEZ9/DLQ(K2GW6X[.G)$A;;
M2-O/NI0GUWKXEJUK7X=ZU@9>`P&`P&!T!^H_Y`/>.'!!-\JG-ZMUCMLOI%;K
MWCW2K73K7>(<CIA`98'BAB,&H(@Y?&70'*8EEDNRA$94EJ*EU*]ICN/;S7&+
MGT6(N?1U'\"O(?FMY\K;#2>`<CX/S?AMSY0<Z/5YG-N8`J1="`EKE?@AU>O"
MK44`.1H\MT-9?+*UHEQ51D:CO^RVE+:V7=O7E%1G7_VLQC.KUD)<.XL9LDNY
M&.1<R*V^?:*Q=YUI(T2KS;%,N=*KQ&I4VVRC4D6X2D66IU4O+&C9RW-RH,"2
M['96AIQ:-YN6;>2?F)VKQT\6/)?C_)`?C#P*57K]3`,7R+O,SB+A!//:@6*`
MN<>)D,@=KE9<I@,%)[#S84TIJRRH<=H768_V=\4B)&2UJ+F+RU$3,+'^G7'Y
M?YC\)B=@[+XZ^-DBZUJVR:N%D5[C-4'Q1(N;Q/E`J;'A-$6#,F)M^MR60ZM(
M>2C8B#$B?#[4=&LDW&A-Q-0])J+Q#C',#MHM'->2\UY_9;MN*JXGZ51ZU5S-
MJW!<DO0M6$D$&0IAA,21-?<;T^MS2'7W5Z]%.+VK-RS<O$.R^<?*F#';WO(O
MQJX)TBKUSZBLOAO/`@*K\I:L8SI(HK<^?5GO?39EKZA<RRE1AO/!K5@L\ZMU
M)5;"-.RD?:8N*X\SNMKT;J?\)+.^J;XY5EFE/#_$!\@)`\Z\B>HU5-23S@I+
MYY00>KZP=:FP84)(SGUWO<RE3F[=7ERV)U?:(1?M#YER0\RRZSN=9W6_X/\`
ME=S+I_D'$Y=RGQ8XUQ.N*XO?B;UTI%OYH2FDRW-^H`ZG-I]&<YT#0!OO/HD`
M]!F2"$`@IH>26N&\PAQGXUR8J,I,8>OQ!R2S`FNPFM/S&HDER(SO7KIZ2AE:
MF&MZ^)/KIQW6M?HZ_1_1S++H!(OGF>)C0XCE;^W#B00N>,7'Y]&0%LI\Q5ZN
M7MP:RRHMEVFF0.>22I!`E?N^X;E0]1%NN.(VI_6%PW+I7S!A$&!;FVCJ))>9
M%C6G5)BBVP$%L[:*\R3D!H%O;@G52Z_\D3]N3I3+;WP[0C7KZ)F#"$&NE>=,
M.2;BQ:8#1$'2`(AH@[4[),G/A]LCT?C#AQ*_7K&.E22AY,J,5#L/3)D*$MJ0
MQ$9;0N0Y<&&['W[N`4H,7<(MH<ABBGWIL4L$`L;X068#7^W?C.`./2X+LVT@
M9O*MRI-8B0%R-LLC8R7X[<UZ&Y)5'@7;U\EY`OV$4CDTA`BM[KP^7,=E4N&>
MF2BI)RPJDLNJ)&QBASHF,-A:TU[*O\I-WM>U:3\&IBC#KS8KIYJW:'T>!7Z3
M.J2((0F3K$$A"^R9QJTPH,^`.I+5OAKB:`ULN:B1"*B41!E]J!+4SN3M[3K,
M>X@P[I#Q%@O%0Y].-6*Z4\V.F!+%8H@R*+J\XO/@(<T1K%A'*W9FF*_*E+6E
MYB)-<VXA"-MRW$^CBH.B<-OR[J%.YU!;K>K9T&/0F;-"+6&NG.A?(7NS!+K#
MNLH[:K?;Y$ZGV"E0VQ.HPL?)ACS+A*5"BH3'VK<2X,.Q';)?D$/MG)%\V"'+
M/7*`Z/M/4)H\R%KOW[9(3X=1(UYH$]"DJL#L*GRSQO4&.]!TR99#[2ZI/Q(R
M10J*:*[\.\?:7#GJZ1][&NR5!=N5%FWDG95T-,*.V7V^[0#<2\/"5$$)]U,&
M4E7KZJ=TICWM*8LQ;-*]/\Q&?OAIJ@2678#O3G^:-1*7J7%N<,:T,WSEFXSF
M2YAZIRR(>1/G/)W'C^\1B,P_B94M+,JX,(Z*Z=Y86,M.#+<*QD5>R\[:M4ZL
M\FF):BUGYKB-J(NQ)5JCP")>VV.M6HU%,BM"H<B!';4]&88VVPN0P8=M[7`M
MW,>67214"5_Z-:Y1%4\2X6E0CQT8[8"8P:XL='9K\EM5>J45Y<[<-D=-DJ88
M=2RS(>4AM4'48U8?+DM2X-FLE-W`L<X$7]E=<YC`L-QY00^Z,:"A=.BJL2B!
M<E>[&0^2FKVMGY"![CB?;0TXYEP86W>[=Y14Z%S&+0*(BXQ7.=UPC<?GX[<P
MK$L0G4:M6"ORIKU@B;V8-$+J,+,/?Y9"(-8+I4I;C[&TS!A7]F.>9@.(/.0T
M2SYV,)/NRPXBEQ(]>-$I'XWV0HR7%V0L,X7%K(P0'G,R(VD/DY\IB/(VM#S,
M=JX,)KTISR2-<MY8X"-%Q5Q,AK;"N>J559:6GRTVJD7J60*,V"%7K15TCR45
MIV1I*!R%S5[CN:;:<0C)@Q?HE/++-Y(SNP&ZWT04+B<Z!!S,08;6`)0IUR^0
M-_9X2VLS1\&76A14JVT]N6,<(H7J-[+[$5*%*7B:,>';/(A@,!@,!@,!@,!@
M,!@,!@,#Q&^B!^Q3ZFG_`%CO._\`7BA9OGK'LUSU^%E?7F_J=?J&_P`W"V?J
MD;F89>B?`/WA^)_Q1\W_`&FALA.JV]ZUO6];UK>MZWK>MZ]=;UO\&];UO\&]
M;U@?SGD>8>(]L,<%N==\[^350UOK'D"_QNV5W1*M$YI_L?U`^<>3=@759#%F
M%P)K$2F3-\\V0FMR0TV;8V=HW_ETP7=YV_*:SLL[B_$>5V+Z<GE9XK@_.'G7
M1RPPL7C=&[,=M91\#S0K$U7AFS%NAR;*`+TN)8C7-R!"<[#)1VE&WR4B/-=E
MID2%)_\`J)HF?ZN81GE?T[+F8K[I;DWF32IL.L!.J\=(&6J'=Y#`BZQRO7^9
M]"X;]DV3I<P*9XX0Z'<)10G,,0R]K,VX.P7=)S7'M;3>V\+:OKM]+]ZVC+3X
MM$?,`38^ZN\AKQ$M`NH'LQFI@.$3^:]4\>ZK))01O3A(*&4"7^S:.5AJ009>
MGSZWZ.QI+,;3T-V\U@[>:=V.M\VJ'EGW[D8WE_E$-%E/%K[.$]0HVQ-Y:G!%
MUOMU;@'+%29D$_4ZU!NEL(\?-\^(*)LFXC@$S-2RU\*E-S<QB,^4B:C1MK%X
M63.2>#?CIQ:D7_F8*9X=6JF];<L%LYQ:[=S\^QSA-NF6*--Y[6+7%MS[)1!Z
M4XW&B3WI"I#6FD)7M7P8N^5[EYO=UW&_2$-"Z&Y2@_EN>8$`.3&:/SN=$@'Z
MXS3KI8^<>/%(B6-FJC+TW6AX+?XKK'%C`OEUM0`UP7%CK]^/N0_>V;H[>B3P
M/I1W%V``9/\`7*CT"35+EXP]#II^_#[[<+)12G`;",>*<PK99ZYPA#/+5PV2
M!`%[0R)/&G2"_F=2X;;3"'8MJZ]](KH+%3,@KQY%S+BK7/NNU>MB197L-+"Q
M[Y?*9Q6C0NV$9['43QI71[.US8V9LZM[D#Y)>T2-QXZ=?-.37:">4.T_;O`^
M\]NY'X]\[*=](U>S<4XKT2A3;W2`12F),=,MG&8O,ZOU8-4JM:Q(81]Q;`TZ
M9A"7E2XK*UI0RIEQIMY,CE4I$U+J^/\`I3]B&5V6&UWNN61F74.>"T!+W&Z<
M?"08]&ZN8Z$9XI&<"7RI.,^.?1XQA&R(R+'A$(TX;$;T[)&-MCVKVA>T,@1]
M(SH`NR5VZ3/*^V66]5V10'T7@WOH6S1%=%1XACXSLR&WTYP0IQRO<*O,!OW&
MGU:8Z++4\I]W4IR8[>AV09SZ,/0A='F5FI>5)T-))5RM!K*WM70)0V_-UT=X
MNNN!;1]O7VS>P!-W+C]T-OJ98<?3/O;SBM/>W)3+=XV7LG-D^DQTB<BQ3!GD
MB^;G6LBF7=0_1U=7LE;ZD,$V'G$^F5SINQ750!DF-J`RLEG&7(#\!V24(I?>
M^)M4II]V]$[.P'BOX&67QKY]WJC6_H,WJ]-Z;Q7DO-F:S66B`:XO3>:\27RB
MUE05PM5J7)K.KY$CQM"`3<]D/6Y#*WX\AO<Q_P!J3-S?DF;=5Z1]+SR;N/.N
M0$^O>39>O]9(\SGQNRG$O6XW=:9>SZN@[.:Y:5`=+A4.&W=:E;PM7N")$,I'
ME0*C$6,D-..?,)L\H\1@[1XT=RZMX<=NC>*'9^/6CR!AH[AT6]2>J43KE2!6
MV*`Y;?@6J(7YDY`K5@O)D\;K-6N//H<L@/6589+QGI,=>FD/KUDN+OP7FW4V
MY_2`N%M9O`4GW^#;JN<YS4`PR%T('?;+,L-KJ+7"2(X'TC2^E(#E>4C+[QLC
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MJ5O:?3>]X'./&#1+&XPH?!&QE+]W<<?$CPV-N?`VU[FVHS;;>U^VTE/KZ>OP
MIUK]#6L#.P(FFA45,TL232ZFDB?U)T=()K@?4TUJ9'=B2]%I6H?OD=2HCZVG
M/>4OXVUJ2KUUO>L"-W+BG).@5NSU*W<[J98%<AMT%6./H/%@2Y\7HH-^M7AU
MLN,1#,0"5H!2%1IDR,^S,=;]/5WU2G>K<P7*4`Z13:S%`PJ]5:\&C5>!,%UM
MH:'@1/L(<1<8>(PA2V6$N08Y)^,VY)2WM.I#B$J<^)6M;R#>S_F]09NX&D[G
M?*2?DM+^'X-R_97\MI7Q^B/AV]\/KZ_@]/T<#HVB-YH`A'V(S)G6PH2#`MPK
M5-<Y0U]@V#5=JA6WNG&6V0K#P]RSRBT$6U%A2=::81IW:&O;?7J>JX1*Y\^\
MOHQ"NS!5JO-N^P[#;"0@@V0XM#*"Y:@/5:[25DH\D&`%DJK-^U@+IQO;+\WX
M-*6PE"D.MJ87#,&5?S!*M$'^K'I\P!$,R91JGU4;38\$Y#9Z1SM<F"%G091.
MU&JK+YLV;4.BK^RIWS&U-3O?4MM*6/&J82RIC/))NL=!ERXY^->=UJFB-$9;
ME/9-VV2*Z)<G#5HKT+WYM!K]O*<IF1=1HCKTD="(*B1Y$AU$9U6F##@#\O[I
MNF]PL!8S>(G1;T/H**O)'V&B1+A!#4F7,=AAHDX=!17!5DG!7O@*I]U0M\M)
ME+BJ:9=]S%P7'PU(*D>6U1)<[`!++/31-V-LQ:I)&/0[&6#?:%E?F2:WN/J9
M7G5T1BM)=9<6T_+*,39+3S:WT(6VE@PEMY$>53)FPSZ^<M$^MEK#9-MB*R]R
M6,?!@1Z'V:`U2UVH=&&HV2)OL/G5%WY3JQ[3R6?;>]M"Y@PCNJ?YCN1/GC-L
M2=(D/E4EZIM/-T4J*Y)+]6^U%!?4#$L'R0X:,IBH&I,QQ[6Y$I3OQN+?TU<&
M&B,`_/B"Z,C5RV1)W_\`BI`GHD?'<Z)-N=$D46HRW`-B8&N5CY*D:MGVW%'/
MPVY;\5]33CZ9$9+.E/Y,-?\`=WR;;@3%VF-=+A)-094&RQ6(-0!2I//I=1M4
M*O"I\T6<,1VKE2K,Y*?4@+[BC+A"*Z\J'\"%(8,+/O(ORV=L8D?434J/`75J
MC`G'!_XO?NVPO80U'Z$1=C6*+*LRNA;L^QCX=267`J1^G=.)]WW$.,&'%T3F
MG=;8`YF)U9KHU.A3K2(MT\"<I(_4N&UT*I$*9<;1%>'LC2AF#2:P^ME<./\`
M"T2E?"Y$VVXM")<&&$"K/E>7_'``Z"7^<`3^366LT2(S&J#;1HU-K@H;7RTZ
MRB28\B*M_P!K)*J(I^00->:EQEM.,>QIK;'@PCI.K>9H<`0<JQ=3#VC<L8U6
MXF^<NQX5&<.A24PW7OF8T1^1T"8/=)-QUSB'ROQ*3[C:5_`[JX7#.Z76/+:.
M<`V+F4V9/NSG#JE7R1J9KGPGG1"^B7;E.M+UPJ9`B3/0)LM96,L-H.^]!:G+
MTB6\N(VK>UQ5>J1591J!3?,R%-W*@'3$:7;98YQVP.Q>9M2!DYK[FAXLSI`&
M:3L$5T+7J,V7;4D`YN20-,,OK:0EU.FV#"^.%/\`DXLR3D=V'Q(XN?#&30P\
M))ITID(1L4:81-!"4@6]'F2('/W03,"-);^8<(.&MK5I:&%.M2:\&':?(A@,
M!@,!@,!@,!@4)Y.>/H'RFXC=>%6>^=;YD$O"`B)MVX9?9W,>HA=`K$)LC&ZQ
M=QL>5-"JFR!"(\K:&U>_"==9WZ:<WO+$U-K$UEY&_P!WTX-^7G]6W\_:\_N>
MS7V3M"]O2#^[Z<&_+S^K;^?M>?W/8^R=H.WI"O.N_0<XO1^3]/NH?SO^K$Z6
MI_.[K:!;1#SPO<F`X1K]:)EH*)L=`-E;\14F(G3B-+1M2/77KKU]<L<YF:J%
M[>D.\WT2K-9;G])KP(MERLE@M]IL7CO3RYZS6HT2L5A,DIVYC\B85-F),TH1
MDK4OT]Q]UQ?PZUK>]^F8Y:LR]2LB/$;Z('[%/J:?]8[SO_7BA9OGK'LUSU^%
ME?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$ZK<P/'B#](RMUGG]-
MYK1.W&ZY6Y?"!7CEW[[4IOWR(]9YU!O#%]G3*/.L=RE.<2MY4G))Q]OQ/M85
M&BDO6..;D1(C[.NV;:[)%5OI0T2L<,\O.$;Z80L->\NJ7L/89EKJ$6TKJ-QT
M>Z6;;LHB)8["6W)JL9VZCW(U72]%%0)XR5-A[COEI6T7OF)V.V;5%>/HI4JY
M,G7F>RJJTZX6TQ=KT-J?-W:Q2KJ<.=*\A+OM5@`5CHH([(8J0+R`=#UI:#+<
MP$D"/?:?7IO;&G<[.Q/DY]-*G^0]^L'3F+?7:];#5#XU0W6;AR8'U*MFQ_)4
M]]B_%T,03L`"?T*(5B]S;F1(TF<PD6?JP<EI<A49+.I'*HHCE3KT>^BZ%(CR
MD2+Y%'2CLUB7#1KIG-1/211-HAOMT=XQ=A$NUA&[G<PS':WB08JXY&4+M`B&
M6TT[M*HV[W]#LYK)]%FK'++=S$?R6ZBP%MX[IH%BN%1$$XT-KMVY^<:JHZ41
M6:@OF)7/O(J]6CIS,M2&'9I<\N&O3<>.VYMW]#LJ7R?^C>?(<]O;O"+*$N'1
M>C%+Y]M`+M6ZX%H!@WTZP^7Q%/4.AHES"C]BLG*Q/E*Q#`SVFG2HG=6@RXB'
M5)3"2CENL<MWN!QKG3O*Z".ICTBMRW81`_/<EU:ILTT?*6;.$#*I$P6R1*:G
M'WU3OB)$EN)=+3]NS%MM+>VVG$Y8E:6`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!3'DA_\`
M@\=Z_B8ZC^T<[EC4=`OH3?U/?T[_`.;-0_\`]5*QRU'K)D'B-]$#]BGU-/\`
MK'>=_P"O%"S?/6/9KGK\+*^O-_4Z_4-_FX6S]4C<S#+T3X!^\/Q/^*/F_P"T
MT-D)U6Y@4YQVXG[&&,QKJ2$2+3!Z'U\-#;'#'`&IE6IO2SE;"3(X:42*2E-0
MPZ8++\GWEH?>5IW])[J4:LK*X\B/,LIY9]'IQ2YE)J(=PA!^O]6H'W8CS*7!
M@U<4&Z,'I-(,VDD+D3#=0$1QLM<R4X<^6?F[5IUG28JVUIU2TF<ORTODIX).
M8J%7$#7RME#6&B1[,HYV(2:KY2MP1P/Y&()DU1!&T,2IQ""A#DILB"0W+BOZ
MTI2VU05#>\]\M+7>S8:$SS@%L(LC4(U@L0BXE"\)I%^FU,>*&U_?W-B,$C],
MGVW4>R,R'8B83\!]"-J<WMMI,44R(GD)?;OV"N<[KH8/7Q`_K94/<9K99\H=
MCU.N0.Q0DA+&/>JCT2K6&W&>=PR\!O3^_F0$S2DOMJ4AQU6"HI6"?*?I8.=;
M93$H3U5`^Q]5AR:H(&-UE7.C%1N_0*_2*/:;/"@V9*V+F`K29>]+AI+1=PW)
M._<CR66=*A:2AOS!OA.?;*W#YU4JP="S>F!PI2XW9>@ARR\X>G"%4R,)$C';
M-JYV>?&;*BQ\EF$N>`=6\PIUUAQ.*2G.$\O;P<GB`8>@T.PF",>>]*=A]#GB
MA@-BM58I8B).S29E3F1:X-Z$V*5(I[CTA;$\6O<J2^PAI>MNI3MYRJ\L]+YU
M4+VPVVRFS!HY%UAE$M##$K>UL36(ZIC++LB,S,96EM].E,R$:TZRMQI:'%2<
M2BP,@8#`8#`8#`8#`8#`8#`Z"^>XINXQ/$_E!<O9Q]&['Y=5"A]*&5.X6>AD
M+93HO(>VWU-8E6:F%P%HB"95II`R1):B3&-RFXOL.[6PXZVO7'S/HL(_X;4X
M1Q_R+\T^$T8E;D<JHLKQYL].J-JO]VZ*BJ%^A<].R;C]B&.@V&T6(>/.S`$:
M2Y"U+^41)]QYIM"WW=K3F(DG,1+T:S*.IWGC;++1/"?RSN=./$JM:ZOX[=@-
MUVS!I2H!BOF!]$.2(!H5/1Z.0"0R0A+S#Z=Z6RZA*T[UM.MY>/\`]1[K&L.K
MM/X3S[Q8\U?&*L\4>Z%6Z_V+B'DTKI==L79.O=+$6R7SJ9P&=33$T9U"\W*/
M%/5R3:2*6I\5+$I39%]MUQ:'/AU;F>.5UAZIYEDP/Y]:7S8(WX^\=\U4V;JJ
M_).S^>E&`V#H;O;NP/P2M<N'U$&^&'Z=*Y^]>7.9?=&9RDBY7VQ20R8<:)IO
MV6VWVFW4])UZ^*_Z-3K7BO\`H_H*SFR8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8%,>2'_X/'>OXF.H_M'.Y8U'0+Z$W]3W]._^;-0__P!5
M*QRU'K)D'B-]$#]BGU-/^L=YW_KQ0LWSUCV:YZ_"ROKS?U.OU#?YN%L_5(W,
MPR]$^`?O#\3_`(H^;_M-#9"=5N8#`8'SM"-_'ZH3OW->B_5.M_'KT^'T7^#]
M-KX?P?A_P8#X$ZW\7PI^+?IZJ]->N_36]:_#Z>OX-;WK_P">!^ZUK7X-:UK7
MKO?IK7I^%6]J5O\`!_AWO?KO_P`\!K6M>N]:UK>]^N_37Z._36O7?_COTUK7
M_P`L#]P/GX$>N]_`GUVI*][^'7KM2=:TE6]^GX5)UK7IO]'7I@?OPI]/3X=>
MF]?#Z>FO3T]/3T]/_#TP&M:UK6M:UK6M>FM:_!K6M?H:UK_!K6!^X#`8#`8#
M`8#`8#`8#`8%7=AXIRCR`I$OG'9J(!Z%2YA`676#/QENMQC`26B>',C)D=V.
M1#F1<MO2V)<1YF2UZJTE>M*5K:)K0:7A_CGQ#QMKYBL<.YQ7^=A[$;58["V'
M3+D3[`=5"B#$E#IDK*(&C$N.,@,1F529#OL1V4--_"VG2=69F=5F9G5=>1&H
M/@`=K!&JO9PXRPUNR"2(&P`#4&,3#FPA>&\/*B"PV8V]$(#24&0XR^PZA3;K
M2U)5K>M[U@=<N'^%'BQXW62=<>)\7JM$M1`#NJNV&&X8*EX]97,BD'J\+G6`
MH7?"!)4V!&=?BP]L,/KBL;<2KV&O@LS,ZK<R[29$,#J(.\"?#L3UION8[Q^H
M47J#-RF]%CV%N+/W%B7\B])ES;M#K*YZJG#M<@C,>F;(-042M3W5RM+U(4IW
M=[35>%N7;O(C`*()N#"+861!B&5P)B!,HG$?GC8Q-4=Q,"00@Q9@^3,@LRMH
M4ZTW(8<<;UM*7$;WI6@Z&(IWU2](3ISR%\#5+TE/Q[1XC=]2G:_37Q;2G?F<
MK:4[W^AK>]^FO\.7^?7\^%P^ON=]4C\H3P/_`#2.^?\`O,Q_/K^?!@^YWU2/
MRA/`_P#-([Y_[S,?SZ_GP8/N=]4C\H3P/_-([Y_[S,?SZ_GP8/N=]4C\H3P/
M_-([Y_[S,?SZ_GP8/N=]4C\H3P/_`#2.^?\`O,Q_/K^?!@^YWU2/RA/`_P#-
M([Y_[S,?SZ_GP8/N=]4C\H3P/_-([Y_[S,?SZ_GP8/N=]4C\H3P/_-([Y_[S
M,?SZ_GP8/N=]4C\H3P/_`#2.^?\`O,Q_/K^?!@^YWU2/RA/`_P#-([Y_[S,?
MSZ_GP8/N=]4C\H3P/_-([Y_[S,?SZ_GP8/N=]4C\H3P/_-([Y_[S,?SZ_GP8
M/N=]4C\H3P/_`#2.^?\`O,Q_/K^?!@^YWU2/RA/`_P#-([Y_[S,?SZ_GP8/N
M=]4C\H3P/_-([Y_[S,?SZ_GP8/N=]4C\H3P/_-([Y_[S,?SZ_GP86?R&N^<@
MVZL2N\]<\6;CSO0TBW)"<FX!U;G=Q<,+2S]DRF+-;O([I89H=&5ISYAA0I;C
MVE)^!UOTW\3!AVQR(8#`8#`8#`8#`8#`8%3=\&$C?"NTA@\"65+E^3=&&"AD
M!AR5/(DI]/,Q8,"%&:2IV3+F2G4MMMIUM2UJUK6O7>6-1TE^C/SR^<F^ECX*
M\VZA3;+SWH-+\>Z8"MU)N0:?7;36C4-N2F4*.`RC$8@,(1]JU\;3S:%I]?PZ
MUB=1Z9Y!XC?1`_8I]33_`*QWG?\`KQ0LWSUCV:YZ_"ROKS?U.OU#?YN%L_5(
MW,PR]$^`?O#\3_BCYO\`M-#9"=5N8#`8'\^1??U9N;]PZ,6K\+I]YY`>Z)Y8
MW.N%)CE7ND[F5!/^3O&Z/6:O7N;3+,#1?R-9X#7RMSYS`D.Z1\18I!D:4MJ-
M#?W_`#,-_P`S"P@G3OK'$#=7-6+GM6#`MOT%-EH4'G%:D+FCFU>(\>UO;MK7
M6)$L&0L$+I_29<IEA,M(:33M1H[LE.M/2W\)_*'#^C?6.J/,X/V3RX;-5'H=
M-KJ*^3JT0K9Z+JO4[PXD6N[1K&1OEXL/2K<3+=`ZA&8'3(TYQQ=4;7_I;NM:
MGJX3*SU2EKM_U@D&;$L]R&I)A#;9P=F#6Z31YK\VW5<LBO:OCM'M]F><K-2?
M+_.$7RJK(J6H"J#J+M,/WFYNU<4KB]E>6SK&3YY49]O4879I0>.\:78*U`IQ
MI4Y6U^YLE5Q9FP#PDGTUKU8:FR4)_P#S]^N9G7#*?9`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&!XC?1`_8I]33_K'>=_Z\4+-\]8]FN>OPLKZ\W]3K]0W^;A;/U2-
MS,,O1/@'[P_$_P"*/F_[30V0G5;F`P&!3\OOG(H!$\*FW.+%F5NPUNJE4OC3
M;4?1ZV69BEAH(Z<H9J"<UNVR$C93L%R0P.FZ4U+6PM"])M2M+(!'A=D')*B)
M&Y$/<LF/7M;+T=Y@@&)2PQ:#(CR$-O,2AQ6`\PZA2=;2XWO61$(;[/S!5GM-
M/>MT$<=IC>G;$@S&)`A<1&DU[;_RMB,PH-=+J@*MHM$M,.5(5#=(QFW]-K>;
M2JU*U*6N7"I-2YD!VT5UN<.GC!1"$X;&(EP2AKX=!ALR.J3IZ+/+;5KY9E>D
MN/\`KKX-*R(BMD[%S2INUELW:X;2;>3EB`4H?%)'!SLP>1@AR&R!0'"(C@4&
M`7)QXC\J>[&BLRGVV5N:<6E.U24V,WI_/1[X&/(N->VY9I,V.'5'*0Y;4C0T
M>>)D);K\9UUF(-AQZU-2[*=4B.A]G;.UZ=VE&PW4"W50K&>FB[/7B4./Z^_+
M@&ALR,QZ,PI&_>?CR7&FO2.2CK_3;U^DD-J_06G>PCM<ZWRRWMMO5;HU(L+3
MKH1AI8>T!9^G7[*'U8*]';^7F.?'(-@_]+BHUZK?CZVM&MIUO>E2,HQTR@@&
MZ0\5M@>/&Z1:HE(HTQN3J9!LMJG"S9F$&'3H29$14F6.KDU;:EK0VM3&V]*V
MXI"%!"B?D;Q@4!;L\BZM2`+MQNE!T1$`[,>;;M'.I)^)>H<AL&%(OQ853>JQ
M#YZ>ZA`]A$5:U/Z1\*MVI*62?N%;K%3*7DR588J@<*_8IQF*W(*,:#1XNYJY
MT1H4S-E$D.1=?$TB,VZX]ZZTVE6U:UN"+5'LO,[S&L$FLVR!-^ZOS'WBAR&Y
M@LN%U"@Q)T_9,"5C0CD#8W4S3$E+T="HTQMV,YI+[+K:+0S>=]2HO5A,@U1#
M:RT*(]$9F-2Q!RO%(2R`V&9'*F@[*-#FX;!,018E17'8Z6Y,=U+C2EHWK>2J
M%@X#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8'B-]$#]BGU-/\`K'>=_P"O%"S?/6/9KGK\+*^O-_4Z
M_4-_FX6S]4C<S#+T3X!^\/Q/^*/F_P"TT-D)U6Y@,!@><-A1R`6<[!,-WCHT
MP/7#4HO[8SFY)Z#30;7:M=7ZX8A&X@MW=UK`?IE>>BEYR$JT"89^5]%N;2XY
MK*NYO((H^/4YST":J>Z1O/2"AE:HSD+<2QSK]8WCXA,1UUY;*`97;L)._BW[
MJ6-.^N_C]=Y1T@OE*\?'>F=2N<;IC]=Z'ONO/.<W.&5H/WN$S.E=`K/.0_+0
M4ZM$Q_R]D!0*_8GG&IK"TPH[TV0]+?\`B$:U'UEJ_P!*@7P;@XFWBD'^X41%
M0%O!P/+`>[8-/W#H#$PKU/=I9O,VKSJ::*H($;(0@BGI,[;8Z7"=;5\24NZD
M6YHN79&[4KQ6A\C$%+/;Q1;GWBQ0K.'L4>J:'&YU<>L`P8-E6,P`I;)!^/;!
M<@*[)90F*[Z$/=>]M3S.E(D7?NERK,/P_P`7:XNW<X,=8#P[%4FN9-7<J4@-
M#8AAN?4>K3ZP.T6N1`ZP?D'*G:Y)"?"A3GX[28K;^H\9M]2-LZKE)0?->1%3
M-6>KUGM',XEQ18)D>+:^<BJ</N]2KM^K'7#BA48]%#OP))J21'::EN1UR?LN
M)*TIA#C?N,KE,M7(\?O'0^JIMK\@>>D(0R>#H\0=`*UP?#.%8%?J]<BBM)K-
MP$;G6U`VI`EQ$KW(1'EHE*W%<;F:887*W+LT<\<$6?EU.YJ0M7W<;YL8E3^=
M&:."&AY%70(J-FI_.",>%+U/'?>&F_;48OIU#3<5TI"2GV$QMJ:W+2VBWXI_
M9(*MUVC]+,4^#6K1;K%!D(K8(T1:3?`MI`6=AA\C_HB9[T&R)<C2GF)&FI<?
M;KK3^G5HTO<M8Q?C+Q[G%KXP1/LM\Q,<XB<Z`Q(`UUFR!1^F"XF9\V8>(/LD
MFVZXH='C[TTT]IYA]U:U;=0EM>;&AB>,=)!F2YBG.-5'9=@X/=AB@@K3+0:Q
M53FM1)C=/>TW,D^L'G.I#;KSCBM39[SR].*TG6UR6WO&^,$.5,[<G7J9<BLP
M-70!>?+`C@K#XBEA(@"G0!<`>\XD8P*C(E/OJ<<E/2Y<YU6W$-(99;3-DS:]
M\B&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[SO\`UXH6;YZQ[-<]?A97UYOZG7ZA
MO\W"V?JD;F89>B?`/WA^)_Q1\W_::&R$ZK<P&`P.J%G\3P5C+$";71KZ)9F6
MO=FCA&(U%)`HD:;;Y_1;'5W(9NG$GBM;L_19;)F6U,=?=T_!CL-N(AI=C.VU
MMV`I%3;IH:2-U+V0E$;#:+03G;8^6U)*VRPDK%.]J/[K_L1HSQ+V64_&K>F6
MD^N]J]=[DHH^U>)O.;=<"UWFF+N/-&"Z+!)^QS<.#%:/0Y=*D`CD9K[)=<;,
M59BHR(PR1M:G(L<^3UZJ4\RJ/;E;:*M^&U!K%=.@X5KO#\RRDPI0T?F2:\^5
MF/"5VY+K:OBKWRZT%(EX(MOJ<0Z[[CNGDK2]\2U++3:'XT<^A5D_4VY!]P39
M0PP$30])&K<<@C.AW'I:-:]!265.2CUXFMO?&A>G(OP)]-+^-Q:\V6A@CPVY
MP`GI("K#=_>E"2]6L22I`.93::38)IMTS4BSDL'\PS#=$$XHN-*BKCD(8T3#
M9:?3I+^WUEHA:O"8*:'&?@O-H-66R%*A'*6D^NN"R46L`3-%41>0JHU`3]N6
M^;4:5]DKGS/\M,C3'$/N^VEM*+9:U=^+'-=.Z<:?/QTHK4BJ,L1Y`EIB,+DV
MV9<G/EFTA_\`(OZ*3EHUO6_A]C6D[3M7JK<N4=D\@8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8'B-]$#]BGU-/^L=YW_KQ0LWSUCV:YZ_"ROKS?U.OU#?YN%L_5(W,PR]$^
M`?O#\3_BCYO^TT-D)U6Y@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M>(WT0/V*?4T_ZQWG?^O%"S?/6/9KGK\+*^O-_4Z_4-_FX6S]4C<S#+T3X!^\
M/Q/^*/F_[30V0G5;F`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!XC?
M1`_8I]33_K'>=_Z\4+-\]8]FN>OPLKZ\W]3K]0W^;A;/U2-S,,O1/@'[P_$_
MXH^;_M-#9"=5N8'A]Y#=[\[.5^0O6(G.KFB_TBJ=AX1"IO-['RX97:Q-IW0^
M4]JZ)=097IM9IEKM<F$#E<]A0F)L>*N2W(DMM/+^)U*LW$1,-1$2F%2^HQV[
ML/,/.4U7?'<UR(]P3QKM?4>42+-,8LEG(W1KFARSU4=8><ZB03<J,<FQHI`4
MMICY<E!7MGU][6]8ZQ%>I54H'C'U6O(`/3:+&ZSR&;T>3*&=(-$KV%JUW&V&
M_5@+9.Y(&7#F%2IO/"-7Z'5>85KE8QRY%XCP9M_[R0UC(*E;::ENL+/&/#+M
M/U8O)0GQVT6ZM^-]8H^H-3;#/]&LMGZ%.``^AGRWE0&K9T2+KW'KDV;J!??C
M="9$N^Y)3+.WD%%7I41U4MU'&+.L6[#=!\[N]\['^/\`SX5R9BV]!Z=XQ<XO
MLRS69FW"BQWH]VIUR6<E5JH5:@$Z[($<4,4Y@S?HTPD(?@B#\/4%EUW:6ERH
M_P`I42H_IOEMYD\KYCX*+8O"BG6ND>(S_5;'4)W$IE\D^1WD0BP^.<43Q/:J
MO7Z?,YJ[9PW2+"OYF)&')#?*?.RDKA#Y2'+43,[65%SLR/Z4+R:J%=@RI7BU
M.N@Q'0ZUSQVU6BZ:J1B4;M+'3[8A!?6^:4ZB`PRQ5)B`!$_<G6I)DI&0\TI6
MM;ENL;K4-L7^J!Y!PC%?L7XG.8AZ(:#]T$%JD>(]:;O/,+]S[NO#>9CF.QFH
M?.Y`JKM<]YUTHE=[C`@02*TU\9)D#Y4AB-\P\ZPG6$RIGU,^ZV:;S<J;\71]
M-H%S[AP?B<\G,M-V)7O<GK-`$W*?=Z?SE[FX(M;:(U*/P&H<IEW4Z*+D.%"D
M*''ART-)XQN4W/4?J/\`>^>=L>YX/\1Y%OILCOEVX]6;$+N\H:>M<3GXGD$P
MH]"@V:L`*VS;K6OK;S]<&,$Y_P!K1JJ32E:7%:W'=8J[(B-U22OJZ=DBU\$7
M'>,`:ZD2_%"/3-5ZGVGISI%XVJH=8M[T&!LAQMA.ZKR,QSB'3;U*E:BE!]L.
M,M,#EITPW,=3K#*L/U2?*VLC[/&E^&M;)VBM3;O,TR)OW455LM6.9+\JQME5
M$*.\.V1;LEG,^+BE`X_RCD=<*V#''GM+UM#SK&YUC=DSOJJ^1D&TF*-OPTT]
M8P%;-LOS';T<&URPW`/W&U\7<.TU4ZC)M]AY8S.JZ'94V,&?G0_M)EQYE+"=
M./.L:V=8U5CT'ZJOE)%N=12'X37:HFB5WJICHW/#5BLL!739=.YUT-M%H$V^
MU<J%`:SQ-F_UU+0@@X3@FRYB!L:Y&:;D:=R]8I:AW)[7]0_H7*I_(A]:\:[1
MTZ1V;Q=.>2].ACMVBL'9</F-',73LM-)5<G3YYVN6<(@Y2H0J#+:V1FS;(\R
MJ,EZ!MM_,<;_`&E(7R?ZGETO'0N2<W/<,C1Y75+N`J5<N]5)W\K0;T`^^/<Z
MU=^I<X)F.:A7YU`K,/F@&1IXGH>IQVRMMZ4IK421-3QP3QII>K_4^[5S:9T^
M#KQ.FK3R;K]HX\9-FS5\@5^W6NN!>A]*KU<Y])#\OL$NP&^R\I@TQ%5>TSH:
MY:[8Z)??T\.^&78XD<;<W'?J+^1%A\A*+P+H7CZ`6];.T]_I9NW5\P9JL:FU
M2A]0N]9I0M8N[Q8ZK-?Q%$!"+"<9'ONM3`UA@SH2$MK6C2>,5<%12D>B>7GG
M%4/OZ<N-Z3QOF!;R)\S*ISCJ,CAL3J,:'`\?;+::SP?D35,KHB(=@/=SFC'M
MJ(%GIL\Y]C>P%>BOE8BD(CBM0LWQ-\M?//I'8/)0-U^A0:I"%\8NUUXGSZP4
M65$':Z=2$4N`8I,"W5G2S4X74;)9TPC3!9#A,EN=$DAU*89F)2F(K"3$5"E>
M=_5+\O`-%M/0K_PX#U@1:*]1[!4)U$1<*R%YV?\`Q+^#4_I<(_$.4B$ZQRFJ
MW#R&L1*40G%7RT.4!*0'?@C1-2([K&GE>L>'9ON'F1Y.U,EXI]9K]`'@^9V[
MQ;NO8.N\ZE$I)D;7[V>O/C3SD!/OW1:ISZ\+1R?C@WM1.SDGPFX\Z>*#S)7M
MN-Q-,J1$9CS:5&CK)"^I9Y9M=*EWTAS@G!Y65K##T6DV*MF1G-J+LX.\3@,7
MK%FZ=%YFOH*^.`9O1+%;-R5#T$'@4E.I$6-\NOY2]8KU6H70-^JMWDI9^?U#
M?A!>!I#H<3D#<,H^2MZ@@@EY#A0$CC<B?.=YHQMH%-+5GH>C;\AN,\!A5T6[
M,8;<,H9CSK&Z=8W12J?5+\CH5+JD^P^,ZI(TQ5N?#H_0;89O$.6)L4JL^&9B
M]W_M`>H\/BP*O116O*V1\3H.(^[N559R=PXC.W-PW6#K"R[)]5&YC*IX(64'
MPP$=(>8'%`_9B%-CW.V2+-`21O?`:7*I7-(XSF\]%O/0H';WS>WRWV#&T,K\
MG;FVMKVIAUU]#KJK(_\`5V[E2:?JT7GQ9JX*<OBM/ZT[6M7SINY@83?:'6>C
M!+P?*2^(Q!<7E`5RU,THM,94\::O49^(P.>CZ2ZIUC<ZPSY7U;.VMCRKL#Q:
MKQ"<.H]S-#42>@72LC+I$JL/HDZ+WZHGK=RL%7M>+MA<H4<;`(E9HP])-V`=
M$^2;0\W(==8W.L.$Q]4#L5YZ37:MS[G4ZD5>NV3F]DM%QN5.O]<&$ZT:XCUB
MT7&F](`V3GQ&Z<Y$C[<("SFR<6$L@L7O6V67M.H^8O6"L7+W7A/[E0HDE6VM
MJD18[ZML*<6QO;S2'-[96ZVRZIK>U?I=J0A6]?HZUO\`!G-EE8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'A%S?ZOEO"4NF'_`""XXC1+H<^UV8$F
MF*K](;<YDCJ3/'Z.]SNOG>I]&LW<CCEH^*;8%Q&Z_*!@=*(2A;+:64RMSQCP
MUU>F,#RE&0?#77F-T:G3^>@6>'2N[$Z,\=$V0X/K^ZP];@H%)4-K8HG9C0E4
M9IMB+MU.Y\E,=M3RM:4O-9I*S3S%Y?\`6JA-5CEP7O/+85:Z\X==J?D%!AE"
MG+!7.#4SI;-.`3J?SOL4(?UZ["W*>3'VDJPW!3-$@Y\:2M#J)3.:Z;:-3Q_3
MC@_6U$$E3CP;AMDL0Z'3[`8*5.!::K`;"(YD/\IKST>V#[R7?A.V@;+YSX\[
M>&#5!1TI<V0TRM>MNN[C.AU=H^#_`%'9?>O*`#P<5R<14`,G7DZ+L9:S=-&K
MO8>S<%*\3771T2HC@;U?.KOU)[!&/Z9%FB6X@MQ#BW=.1YK#4GC46G6HMI_-
M'ZB9?QK\C>:\4KU?%3ZL1H14WV:_$JQ>SD3F5AZ5&ME8\7V)!VN154BM1;?U
M*F281-FPS(3TF+*B_9_N.*7K$<;BR(N'483]<`ZYP,?9D<%!&^KQN)6*YRRB
MNNUICCMMZ%3N&<Z[F8J]7LU1@724Q+32+K)(%(TY$*.#=$S!_P`[+EL*UEZ9
M]%ZY6N?^LC6]]$(5&F\Z>MJZI=W:6Y#JMIKQL!TN6<*2Z+6G0%^+.5=BKMC>
MB!R#$MU0XE$D1&&WF7U-O:4AT3J]5/'+M,/R'XM1NPPJ[/J6K=$*IG5@E.A%
M)0$W73Y:JV$5]JCM_(E8T,\#DH8E-Z0F2QI#OP(^+X$YF*FDG$O+/Z('[%/J
M:?\`6.\[_P!>*%FN>L>R\]?A97UYOZG7ZAO\W"V?JD;F89>B?`/WA^)_Q1\W
M_::&R$ZK<P&`P&`P&`P&`P&`P&`P&`P(FJB4Q=Y;Z8NL!%]!9JKE'CW)P?'7
M8HU/?+(.R:U&*+1N5&#2S++<EYAM24//--J7I6VT?"$LP&`P&`P&`P&`P(E>
MJ'3NFU,S1.@5P5;:?8F&HINNFHR98PFPQ*8FLM2HZMZTXEJ7%;<3_ATM&MZ_
M#K`X!'.>?@)]8)@:550D^E4V3SJGRA`$8-<JU!F/UZ3)I=>^3C,I#U=Z14Q:
M]P8^FXWJ/C_I/\DCT#96NHU>]`9U6N=?#VFMDU0U$`1X?&*"IJA\Z*4@JE09
MC;L=Y4,C"9?;VI._@=:2K7IM.MX$BP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&!HW*S6W5"UNUX&ZL'\]L*MP3`6H1]IQW89+[+4J/O8_[0B/
MK:?]KX/=;6I*O5.]ZP,]P:.>@I&/0(3HU+;+*1[D5A<%+,;:-QVDQ%-[8TVQ
MMI.T)^'T3\.O3T]-8%0WWQUXWTZ]<^Z1>J8U8+7RX]NTTN0^:L<4/`LZ68<>
M'8R=5'EXE5LYP0V/8^0E%(4UX>MI"XRFEH2K5N8PMS5+%B4NG0([<6#4ZS"B
MLQU1&HT0$+CQVHJV),5<9MEF*AM$=<::\WM&M:3MMU:?3T4K6XCEA5*J#7(K
MHZLUX>[!GDRL)R$%&Q7(90TAQLR2BK8C-JCSRS;RTR7D;TX_I6]+VKUW@9TH
M(&FZFIFB!DM)+431%,J!%D:GZ@+]R#J;IUI>I6H3FOB:]SXO;5^%/IO`T[%$
MH\;X?EJ;5(_P0BXU'L5T0U\(ZP/ZDGH"?;AI^&$;DZ]R6UK_`"<E?Z9S2M_A
MP.2)2:9`]?D:C6(7Q/)D*^4`BH_K(1\'P/[]F(CU>1[2?17_`-6OAU^'\&L#
M?Q8D6$PB-"C1XD9O:]MQXK+<=A&W'%.N;0TTE#:=N.K4I7IK\*M[WO\`#O`\
M3OH@?L4^II_UCO._]>*%F^>L>S7/7X65]>;^IU^H;_-PMGZI&YF&7HGP#]X?
MB?\`%'S?]IH;(3JMS`8#`8#`^%.-HVVE:T(4ZO;;25*TG;CFD+<VAO6]ZVM>
MFVU*]-?A^%.]_H:W@??KK7IZ[]/7?IK_`,]_^&O_`#P&`]=>OIZ_AWZ[UK_#
MZ:]/7?I_Y>N`P&!\+<;;^'W'$(^-:6T?&I*?C<5Z_"VGXMZ^):O3\&M?AW@?
M>`P&]ZU^COT_#K7X?_'>_36O_CO>\!@,!@,!@,!K>M_H;]?P^GX/_'7Z.O\`
MXZP&`]=>OIZ_AUZ;WK_#Z;]?3?I_Y^F`P&]ZUK>][]-:_#O>_P`&M:U^CO>\
M!ZZ]?3U_#K]'7^'7K^A_^/TP&`P&`P&!\>XW[GL^XCW?@]SVOB3[GM_%\/N?
M!Z_%\'Q?@]?3T]<#[UO6_P`.M^O_`,/_`"_!O_\`+@,!@,!@?#;B'4(=:6AQ
MMQ"7&W&U:6AQ"]:4A:%IWM*D*3OUUO7X-ZP/KUUZ^GKKU]-;]/\`#Z;]?3?I
M_P"&_3`^5.-HVVE:T(4ZOVVM*4E.W'-(6Y\#>M[UM:_;;4KTUZ[^%.]_H:W@
M?>!^:WK?X=;UO7_CK\/Z'X,#]P&`]=>OIZ_AUZ;WK_#Z;]?3?I_Y^F`P&`P'
MKKU]/7\.OT=?X=>OZ'_X_3`8#`8#`8#`8#`Q43H3LEV&U,BN3&4_&]$1(:7)
M:1KX/53K"5[=;3_E$_AWK6OTVO\`QU@96`P,5Z=!COLQGYD5F3(WK3$=Z0RV
M^_M2O@3IEI:TN.;4O\&OAUOUW^#`RL!@8TJ9#@MZ>FRHT-K:]-Z=E/M1V]KW
MI2M(TMU2$[7M*=[]/7U]-;P,A*DK2E:%:4E6M*2I.]*2I*M>NE)WKUUO6];_
M``;P/W`\1OH@?L4^II_UCO._]>*%F^>L>S7/7X65]>;^IU^H;_-PMGZI&YF&
M7HGP#]X?B?\`%'S?]IH;(3JMS`ZR46L6R!WSL-Z(<[)UH,=;I]3!3QY^KR`U
MS&"&I\Z?T0]"CV-TNFQ-S2'V<S'?@,N11L1O;;CVY#C<>^%\.S>1'27NW&[\
M2ZS!ZOS,([HFW1]UDP6K!FM@;[*7N077!8!$+6VZ!A?+$%#5S7WT_&Z(:E1F
M]K4YIERQ/A8G=]]2K?EFY#7-HYQ$ZP2*IR\,E@:5!BZZ(M8J%>#%\MT,41T'
MDD6#5H;`0'6I<QUEL0MU;,)]QMUB1<$4IZR<S\@*&,D],CS;.<LG)1G1"=!&
MF[,/M,V^V@A8F%5X"85"%%2LZ%>A2=@X4ES;<P+!);UZ,:2O6F)PN%M=&XSV
MFR6>AR8=WNCWV)1*DR5L(BUA08[5[J@GHC1(XU6Y<"1'BFK83M`]*Y$>(MI4
M!EYE>VM(:TM$Q27#C!5ORVUSWM.[=9I\R_$2(N3SX=6XU-A"_@@V.?-=B`#4
MFWQGX`>PU14`61W*:%2A[D>3+A:DR'=..3!A513G/G(0>EV5ZQM,V1LO;!WR
MXG=4=^R*C8;C42#C'.)TRUB4E$R:^"AH]"VJ\XSL9)]$>Y.VM=PN$SE<[\JI
MCP8D^?/S;P,DW09/)E;#46N2%)$B]\T-4JWQN>0WI;\8-`I]9G,?*NLK*0"C
MSGMK?2[\\MA,)3SBH>4;5A!F+79[-&KHDQ541ZM8;%12Q&6(FPR$?I;]PF5P
M-N,9>V9])0+4:2U\K"<90I"'$.,-L$UX<59YEWTYU^KV3I)0E)J-'Z.?M$6(
M^?K3PJ=*G`.S5T:4K8@7!W.CU6'6[!6H[4(@IN>P2:DR-:WZ.2)<N*,4C%?Y
M7Y!A+D_]E"6`B7C98UT+HS1FJ_;_`%F3!NABQU*'%LTIRQ6D752H*8P-)BY(
MB)H(TRED4\ZSM2\LT-`GFOFE9*+9H]AN=C"&)P.QA@H4);JR'FQXAT+UN3MU
M1R$H]-9L@T_*JT<=.^U5[8CL;7ZMZW)3MA<+9Z[X^$NA='K%Z$#5A"#%3I(B
M?:V"HZ'=!,D3VCE]I(+C2OA(PE%8=&"F&D2F].^BW%--JW[NMY(FDM$*_2?,
M:38@,6RW(Q!#,D*\Y;RL`[1U0BU=%1Z?('BZW%0#?+#;"\0@F6[+)<99;G,3
M4?).?_HM0;@PUSW-O*\<Z`G2;=T&SKCU]H984!KS21A*7'*M<.-7)`R,0AA:
MVS9W;&.M;`:<MM*8(]2HZ'(R'X[C;"W"6#*!Y12N<]/'7BTNV.UW7C/0P<6#
M$-`8`D9?W130NCZJ[PX2$=!IFL2Y2ILI;OP;E?`Y_DDI0E,Q>-$PCEOY%UGM
M9&8`/5VU\RK)7MPOISUA)6"DG9X>J)\<]\Z="@8E?NA=P3=Q'08R9T.4AMV%
M`D+:(,J>?;4WJW$$326]-%^5DOJQ:?0VI+/.A[-80(%Q;#768MPD0"M)G._:
M\TF8C&JC$=9E6%@DY`A./^U$A+2DFF0Y#CR*,,OH%(\FY-JZ$;YS:F@49<IM
M^@C=R:RR"G/D*O$#E"%KB/5^81GRA\J*E4+;SJM-.(2K:7$:TWB)CR17EUXC
M4CS&I>S4R-.Z#%I9*W19P^M#"G-[%T6<*N?;7&;*/L-I652&%7%ZGE(DF(2C
MP9\*##CNM/SHJ_>E+N%PG`"@><)%XJQ;>BE!<;<3:AV@3U%:4_%C<Y)NU2-(
ML"G"#S=F'=#;CM6#V0L:"32_MUJ4N,VEA+^4PTR^<>;.^AOV2-89PI)2;7AE
MI,IFT0_%E,!;1U0L#?IM;<+5A8SGPP+8QK!*).D*)29.]J;C2/9<<D/YHPN2
MAT?R`K-E@G[O:[?9XH[F-T'>KME!SAK=M,5?BYI,PI6Q@\2T6DL7L3:F!CS,
M9U42(ZEG241W6]:8,*3BUSS2M7("E?FL6&9^,;GT>%'^]]EYS$LU7F3>?*;N
M#5IE0!K;/QV^XDWM"6XD5[8Z(E*93</V],:8M<-]%YKY512A"S)6;5%)*@#I
MD5VTT)WKJ^?#[C(?:K\:S*9U4XMZ179SW^FM26H[L?:65RM2D-R4,)A9'6Q7
ME.2Z3$=YZT2@<MB5D+!/,"K16(]JLT5PN%F'VP$@].3`KO06(:)L9A]3#<)R
M.K2_M%MU;>HR*K.I%(R0K/F"](CZ$%;%`)*L-GWLD0LU`?J3"WK8#^[96:*0
MQ++R*/'Y4B9!^099T218][D.)?2ILBV_DP^BU*\M+R'M4B>>LU'=GU[=?`UL
M?<*7"E,:*TBSA+&8F%Z\-G*BG$630Z:+?CSO]"4KW->BM.-Z8,..#5/,(K9S
MTE\N9I]2ALQ"%6#+M51+$)QH&R5@BHYLLYJQ/31!R`R-DEH[:1S6R*I+:-.M
M)^;E,&&YIM-\GJU7>AUZ,5L<Z7KF<N#1;#>;?7CDZ)>X9\\EG0>6U(,**1SX
MB2W,;GFXD5T<][$=QJ4PG;<1<&&($XWVN55?(`N<-7&)>;_RF/3><O[NH-FZ
M5^/7SG6IE2%R+&#9^RA-L:%V,5J<0CR'HK\M2E[=<6VY(7+@:*-R[ROK<^KP
M:?<2XRFDKV6M=IC3I-1LYROJ/=$Z*<:A18\DI6(4BK1:U.$I)QD39CSDIS;C
M#<A2'OCMP7"P++S[ID6V]?.!:B2)6VQF*].I_5Q=BJ;92!RUMVA1+=R:MLV8
MDW+IMH?%BS*QZT0]AG9TEJ:_,8DN.>U!7[M+\Q!M?(6TAT&QK/B1!6="K$4C
M3"`UQ@>GEC8"&0@0JDXX8L+=><N'V@J.O;,XQ[+C2=MI@H;O\F&G%U_S<+M4
MUB*0L==`RF-.$BMDM%")7F*&.@]-'H%@^08U7F;&+M,74X*_%&SMH'S?8>=B
M+BJ8D,>5Q\IL)K7D':6?(+EUEM!>>#A\@,5RG&MR(0\O.NO08!D8/&.V>,"'
MQU$:16JJ+);GL>XE<BX/)?U[D1*6V$QJV=%Y]Y'C>AUH<3LIL3RNM6![9B/'
M,TM8\_7@L.X1^=!ZH/A!EF@U=AAM`XUB8D?*RIQ1G;D=6XWON2%Q7J7'RAQK
MC_D\,,=1M?.;>?AVJ;+L<"G[MUN"G:X3$%K5VRRC5.CY$25,CCJS#N`*,(BN
MN1OD7VGD[0N.GXG&/)<)@;Y)VBP@^'&9QPL0NM!C6YXH\854H;S3]AM=4^R_
MM0)\_=*V:/UVB19T-B;J<_MQ_6W5N?')7K4N#"OW@/FLW2;!!:8L4F[/CX`R
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M$MR=N[W_`)5")+BXHPQP,+R4L)/L'-+:6LQXY+\<[R*D/M$@<2@LWL_7*,.Y
MQ"%380(5,"V[XG3SA*1J7\J^MSWVT^VAE+#"XU83/+/+BO2/AY$ICDU&G,VD
MM7.;OD*S:$TTVW6*V,CC+!(E6&0%$B;@4&D)D-H,V>AAB$[WW&%Z6Y\"X\F$
MH>HGE^6,6=J!=KG4ZF]!BIJ4$@1YW-LD:'&YXIP0P:M392TMJM<+I[#OVM[(
MU4,@/F-?#.6ACV$+A,(L?Y=YFBK/;25&LA:00G`10@;93EFI,P85K86;UB9+
M%EPZ8(<EOH<C5E$)"D&]QX+&FMIDNLI;<^:7'E<+H&<^[%(XKU(+U";8NFV>
MTZ$P*V%?%<KDN#`\:M5F-'6S6#YM-"D$X-DW.EST$S1!N<XQ\:7E(4TSJ7%X
M1NN14>[<L+"YEA#FS\FS\J\<N=FY(VSSK/&&W*BA^D1[M8IV[&5:W"!QXLD<
MAR6PWI\C(<2I33CVUJQ.25`=(XCUNY6/JY\/S"8!T<N\F&`#0KU7!H4PH?2[
M^"H7>WGX-F7)W;0]YL;)8@B1&ASXHR,,1$9F31FM*MP+$L/'KVBXC(;%(GG:
M^4\GT];?OD&X#W[!0:\-`\VFK^QHMFM`V=!CWBXAIL0C'@JDIB5[<V.S$W\V
MPA,O_@_[.\$%]^3"B2)4-T=)?C,/2![[L9]^"\XVE;L1YZ&](B.NQU[VA2FG
M%MJWKU2K>O3>1&5@,!@?S9</Y]XT`N$_3`[;1*_R4?Y7WSR0X>GH_3JTY7M=
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M:%3=$0`[G56\K^U5Z@A:M+1(E1U5$#41D.$)0PXJ*R.89;8]&4(UJ<M3EJ[X
M9E'B-]$#]BGU-/\`K'>=_P"O%"S?/6/9KGK\+*^O-_4Z_4-_FX6S]4C<S#+T
M3X!^\/Q/^*/F_P"TT-D)U6Y@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"DZ_P"-/CE4
M^A2^N57@'$ZUU:?++SYW3J_RJB!NA39U@TZD_-EW0<!C623+.)?7J8XN2I<G
M2U>YM7KO+<Z>%N=/"[,B&!25V\:/''I5Q@=$Z-X_\2O_`$`4D6@7>KMRFB6J
MXC4!)2IH5$"SG0,\W#2(FKV]%TV^G4=W>UM_"K?KEN5N5VY$,"K>H<.XIV^&
M)'=HX_RWKP\!*DS@4'J'/ZG?X86;,93'ERQ,:UB"S(Z5*CH2VXXRE"UHUI*M
M[UKTRQ,QH7*;UNM5RF@`]4J``)5:O7A\40`K=;%008`&)@M)8A#`X<8Q%'#!
M\-A&D-,LMH;;3K6DIUK60;O`\1OH@?L4^II_UCO._P#7BA9OGK'LUSU^%E?7
MF_J=?J&_S<+9^J1N9AEZ)\`_>'XG_%'S?]IH;(3JMO>])UM6]^FM:WO>]_X-
M:_#O?_RU@=+=?44\*7:37^AP?(.G&JI;`==LE6F5N+8[.1L@6TDNF"1,P#7:
M\#)V0O\`#,XU:]S&X\1QX:S7YKTQ+#+"W-7K.B]9:Z3]23PKCFY]=:[0DJ7@
M3*C`3'KG/>JVADO)OXJ4>H^JM.K=&*P+BS;Z_`D$1KHEV:U,'1GI32E1VG'$
MWKR.LNU4SI5(A%*T&6=:DD;<T:E`V1<,D:;=@5MV)&L!4A*$0YT0$&"S9\>-
M*FSEQHC,J0TPMS3SB$*RCEM/1Z+24P56JU!`GVE/BC8:9Q".TXY(E$8PI*U-
M_'MQJ(Q/F--OOJUIF/M>O=4C6_7%2-@?N=0JD)\C9[17J]!C!RMA?EF3`\:P
MT!!Q=331E3DR0RG[+$PU:=DO_P#Z)EO>E+WK6]8&O!='HEEBN30ML!3([5BG
M5):OM&,RO[QP"D\.Z(TR^XT\J9(FC'OEDZ3O<II.G6?C;4E6P_5=$HZ38.O;
MM`;92RC#)8`TF<PN.7A5^9"@&-CYR5[A2I$"3/;TXRAS;VM:6KX?A;7M*AM9
MMJK@^2S"E&1Z)C^M+1$1):>E)8^-#:YKT=E2W6![*W$Z<D+TEEK:M?$K7KKU
M44X?OI3O8;E?>RM?+/#]%V9/VZ+]AT5N8V.T3;>^:]MP?L@ZECWM;VW[RM(]
M?BWK6!E?>6N>PS*^WPGRT@M]@,2?M6#[#YWYE<+[%9>]_P!MPM\XTIKY9.]O
M>ZG:?A^+6]8'"];JI'@QB;]GKS`V:^_%AD'C0UN#+E15O-RHT:6N2EA]^,Y'
M<2XA"MJ1MM6MZU\._0.5BSUJ4ZZQ%L(.2\Q#C$7F6"T!YUD?-BKG0YSK;<A2
MVX<N$TIYIW>M(<:3M:=[3K>\#]>LU<C2I4*18`D>;!6/;FQ'BL!J5#<+/?+"
MD2HZWTNQUDY'^3CZ7K6WE_I4>N_P8&.S<:C(U&5'M5<?3-BSYT/;)P8[J7"%
M+>:*3(VT2E:?BC7([B9#B/5#*D*TO>MIWZ!@HZ#2G3PNLL6<-)-&0<^R#HD6
M<Q*U("#4"79!#YAA;D9ME<<W'>9^-:=R&-K<:TM#;BDALIUJJXQU3!*R`![Z
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M!^%YUM2G"4^&M,+>M;3-1\+C&W$*2K=J5J6^=LM<9*I!O6`(T;6MEM`=TK`;
M*K<DLR),=M(]3^I:ER(\1UQ&M(]5H:6K7KI.]ZB-//Z/SX5!CDR5YJ$$=+2.
M7%G2K('9B26RYN+6A;K$AR9IIUDA8IS,%E:=[2Y+=2UK>U[TG%24R=7BG:AO
MSGK."A1X;(I\ALB3AC71:3FM?8Z"\><]'D"GR*M_"RW(2VXM>MIUKXM;U@;"
M=9*Z,><CDCX4>^R,6:>8G%8,1YH,V^W%<+.-OOMK0,;DNI;4_O6FM+5I.U>N
M]:P..;:JP,7-:)6,"/<&QX<PBW-,#XBX$0@XXS`E34/R&U18\YYI265N?"EU
M2=Z3O>];P,B6>!0(4@E.-"80^(VT]*GRR,.-"C,OR'(C#LB4\\AAEMZ4TII*
ME*UI3B=IU^'6]8$:>Z;0V+&8JCUF&(-5X2P<L+.WO]$`#)/VG[,@X3^'[-$;
M4D1(5\$AUM>D(TK>OA4G>PDC]@`Q6&9,DV(CQI"V&F)#Y*&TP^Y*5'1&;9=<
M>2VXN0N8SI&D[WM>W4:UZ_$GU#6KO-);9C2'+C5FX\WYG<-]=@$I9EZA2OD)
MFXSJI>D/_*3O\B[\&]^V[^D5Z*_!@9#UMJD=Q33]FKS#J"$D2MMXT-;<04A1
MDS9@U2%R4J20B0UZ>=9WKW&VMZ4K6D_AP(<0[=R(7$K,^7T:GZAW(:+-UB0R
M>'RFC5?,D!8H?9(*HS[NG:T\0-1&MD/_`-C0J0CXG-?%K+4B:/VJL177V9-C
M`QWHK[,:4T^8'M.QI,F`LK'COMN2$J9?D"VU24(5K2EQT[<UK:->N01RQ=3Y
M_5X<.84M(?:2)"G#!T:#.BD)T^7?S,4#3]1(41UV0\P>(RTZ8=TGVEMI6O2O
M@0I6K4BP<@8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'B-]
M$#]BGU-/^L=YW_KQ0LWSUCV:YZ_"ROKS?U.OU#?YN%L_5(W,PR]$^`?O#\3_
M`(H^;_M-#9"=5LNH]UMQO>]ZTXA:-[U^CKXT[3ZZ_P#/7K@>,W-OHY53AMIK
MO1N&^171:#TBDU'DU<HQJ;4*-;:S6R%*YITKF/2SZ*25AM#93W;(O2GSA*/[
MS;4&S1]3F/B;DS8TC?>\3HUVO71-;/\`2:YU.J53I]4Z>?$BZ&2\5)=4B7.I
MUWH0Q$7Q1Y9>^45F&?&ONU])MRSB;X].FNH<B^P1C-+82AO6VMSM)VW=M[1X
MO,VZE4VE$+8*%,ULE?9D\]4.>5^H'Y42]D"\PB)KRPDJ,'K`\M%++B'6U0YS
M=@:VMR0E$E>GTRTMIA/B+&;L4ZQ6JZP[B[9+/7;E<8A*@`D,$#M4N9"X!(]<
MVY.F*K-<VZ0VS*@N?:&Y"VFY"76GMO*>667/PZ`7*%6Q4JW26Q@3EM7YE,3*
MK08J2G,TD!=`E=*0"4M6MA&I2[S*<,0VVW&2K;+#&U,MZ>]Y9;1'O!FF'RM>
M-2;(\W+&%3)0[`B"'PX&SOV2Z7F[&I,R!63X`@V39G793(Y]V9)3"9CZ2MN1
MIUS6UEI%=?#JJ7`!RRIM6#8*M\WYY^+5R*.JU?T1(A-&.?6#4X"3TTS]RS;I
M7G<;WG8C3C3S$E]&VO<]EUE9:($_!]BQO$I%FZA,F/6$?/AVM0BF"0[=FV]%
M:'!V"41\F6@_959'H=U":2UJ5[TN3MV4ZR[J.BV6^[!X)U(I:+5:1=J>%3+"
M[+(A?>$$'_Q=V!VT&[#!.4*()M5?`C9`AL\[IA$J!-3\ZVB2KXDJ>CO2RTG.
M>)"CG,(/+-]/,C:]%Z`6N2H(L*W$$-BB'ON0ZG`'I,;FQAP4@[\[&T_,E14R
ME+3N+N)J/$CKS9;<,^)U9EU.DU2S&F[)$HDFRK!,2ZT*=%#1Y^\5>X0P0<<7
M=.28`BN1:JR+AZ=E29&H3BDK=5Z)UI9:H3'@QO=B`E8-]*&(K%@J0YV,3:CC
M6:_RX80CSKC3(<>+J5`("K:`B2J\F-'C#EM0S3SSS[ZV&LMEI@8\-15XZ->[
MM>3D/8XY<K`?KHD"`%L$F6+'1*34I4T_894=R23+BI5/:EB%;:^(2^GXT.N_
MY)+"\%J^*>`#5C+6Q)SH$**%LX&G_,RZE1Q%5,M6BJ0K\#A)`?9LE.JA4OL<
M_!<)P(SSNSLK<S;BXJ'W$N.Q;<V;P7"ZJC`>H%FQIXC:HI`P<@,+%_*03K_*
MA=^G1'RTJV6":Y.I'/R8V-%E3Y"DMV*0UI]MM#:D.Q:T^A^+$2[G;.6B6H:(
MBV(P.L"1Q"@A+)]G$H_,IG()D-$B9-B(F5K=.F;D01[K6TCSFOG$N.-*7$5+
M+0HGX'<\DUUH*+L!(3/BO5^2Q8FQ0[1R?(K1SHUBA)LA88H.:.Q"A3H.U%4_
M-QW9Z(:?5UM;FW$WL6S>@^$U7OPP"`W:GZU7Q/+ZUS1V*"`L+-L1Z@NRRPDZ
MLW$P4*6JMQ79UF<20B;E3/M""VF,X[K2G'%2RV.YX057[-3#A65H5((,SH5E
MD0ZNS.;EQ#K8Q5AGUURRF[`<K=M=FBDOC2SA"?($;D2$,I4AW26UEM[2_#.B
MTEV^MCR/O0+SRQ'+_86+=:<`CY%&IE%-+&06S'W0T-+QJ'`FJB[#Z>3.V\K<
ME;3NVM)FRT?/>#--L'W8D3+%M,T,3+DCT>&"<"`+BNQF+L1-)-#JN?KY=:FH
MEYDQ1JU$7-P&VD>NGD[<;7>Q:;=#\1*#T8Q=#I2?+'E[L\3<F&A0P-'L(U!3
M\2K3NA)]419*+(CPN+L,LN_%M3:"#WI^!"-9++I6%=\!:E79[A=FT-RBKD6N
MRT.S0M@)C85MK-GB6",>'!3E_,#FAYAB&EDA`>3(VIY2Y$1^&I7P:O8MKK_X
M/1&^>_9'/)T`E;V1ME#19%I$5Q(,DJXUY^GRB]RA.!YZ+$BO!)KVXC:T*6PX
MK2V]*^#;+LO):TK5XAUNYVD(>/6#4H8-E<V,S@4BLAR#A,WS6$R)'PW34_;T
MC5&*#$K5*"*96RHCM,M+B5:6VXLMF73Q2$7_`*W*Z?:+B1*P]Q51!5.GB(,\
M.*C."`@_<1#<V1('/1(I`*HA&WJ$W*1+FO\`NOO-ZCHCKQ1>$.K_`(B38W,.
MI\\<NI"NMWV[,/#I,'222QW-@;46./I4K<-5>D_99XLLN<=8C2&5PY9UUCWG
MFFU)=67Y0AOP06)M%;D!KI&EAA,:,XV1-UD0Z18F5>V';W7&[5$CZ;7TY!BT
M7"8F=\W)'H:&16VFO22M<E5LM.J]X2``RJ_"(7B8?KE478B%>"$*I7_6'8;<
M`'"CI=V8K3R%-PR`QJ6'CLL1T"4I2RA3B6VU(EEMNOPHYHMR8M3D53;T$'!'
M1G*E5G(P1L)SFU\^UL4RJ!M$34[=J63>TC2=*G,(5OU]=[Q<EM'3O!2A524]
M,=L$\W,3/6]"+$X+A`[J#OI-,Z4TR0GFRQN*LDU.JCD+<J!&&I>B35>ZRMUM
M#FUERG[GBW7IL/C4`L3%DH?)*F"J"HSE+">Q9!M8L5)L@+XV7W930=#,VDL^
M^TWIUEW;RE(2TI*/19:G8WT]*"U".1)5N,$),\29&ASLR)*D6$,X;$S8;S^I
M<@\^.0B!.(R-Q?LZ(+D-CWW(2WW&U?'E[%I75?".I5FP@32;'IZ-73XZX#Q3
M-=:5O5J02H)4T])-GS%EL,ZNRI?/V'!X^1*><%.2W]HD.I3%1'EENZD)N4S"
MB,SI2)LUJ+';F36X^H;<N4AI"9$IN)IU_45$AW6UZ;TM?P:W\/Q;]/7(C*P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[S
MO_7BA9OGK'LUSU^%E?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$Z
MK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?\`6.\[
M_P!>*%F^>L>S7/7X65]>;^IU^H;_`#<+9^J1N9AEZ)\`_>'XG_%'S?\`::&R
M$ZK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[S
MO_7BA9OGK'LUSU^%E?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$Z
MK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?\`6.\[
M_P!>*%F^>L>S7/7X65]>;^IU^H;_`#<+9^J1N9AEZ)\`_>'XG_%'S?\`::&R
M$ZK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[S
MO_7BA9OGK'LUSU^%E?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$Z
MK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?\`6.\[
M_P!>*%F^>L>S7/7X65]>;^IU^H;_`#<+9^J1N9AEZ)\`_>'XG_%'S?\`::&R
M$ZK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[S
MO_7BA9OGK'LUSU^%E?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$Z
MK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?\`6.\[
M_P!>*%F^>L>S7/7X65]>;^IU^H;_`#<+9^J1N9AEZ)\`_>'XG_%'S?\`::&R
M$ZK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[S
MO_7BA9OGK'LUSU^%E?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$Z
MK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?\`6.\[
M_P!>*%F^>L>S7/7X65]>;^IU^H;_`#<+9^J1N9AEZ)\`_>'XG_%'S?\`::&R
M$ZK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[S
MO_7BA9OGK'LUSU^%E?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$Z
MK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?\`6.\[
M_P!>*%F^>L>S7/7X65]>;^IU^H;_`#<+9^J1N9AEZ)\`_>'XG_%'S?\`::&R
M$ZK<P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[S
MO_7BA9OGK'LUSU^%E?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$Z
MK6DN^Q'??UI.]LLNN^BE?"G?MH4OT4K6E?"G?I^'?IOTP//.M^<):#0J<;O'
M.2I*T6>I4X^L:#C"*5_]M]*&V8O1:\+!V.[V6;."S8U3EH?/KF-16];:=7':
MUN0W%UU6LTM+HWEL'HMX(\TC599RXLB&'(FFS\$57XUF3!`%RU<L5D-Q1P0*
MZ+`VB!-2XE^1M]$EI"D,+?8]V5Y\%*7"^?4A3`TR7Y\]/KB^8*ND]X"7!*->
MY61?22-_-;!+-29\`1%>YA.CBH>TOR".WX[J7=-[?^7O4K]KA">7T">>KP`Y
MSBSTN4<.5$,XY:W]C$Q(MJ*%*['M#;#@WYN34Y=NAQA`^2MMAZ3/(1DR68+;
M\=Q^=2F)*\M'8EMA2)%18A\HU]\XAJU2K&(06"?=?J=2Y/JQEA7O_&,&:LIR
M1[T)?QRVH3.Y#NVG4?*+44T0SSH`DH$DFWS6S-P8,S==F2WBPF"RW=9DN^L`
M0J6#.A11@,0C<_DR))29&AMP&9#2G&E)T^IF]2@5YT`RBR?IR^WL#ZU/8$76
MT:EP2%(IL]@T-''9IBW"62`J16!\`JU*8(1-R=R-(>]UF,RP[(3**2>W>8U<
MKEZM]#%4XM;)U06\_,(BBD&$+6+!UZ\'[N]\V:9'LN%*GN@38:XD54O3LU;;
M:W6=Z?\`944K]OS;G$+@X)#TN!(&2ETJ:&'2+$)T;=K%P-V.C"SUCE12+T2C
MN%.AS:Y#W%(M>_"BO3%[2^\A#6K12TJMY6PKE6(]F"4$JRR:Z(!YA4FC=EK(
MN.<LD^G(N1N1))-S)T,0$"Q&I$:/(5MYPM)91J(TM$F.MR44BD7S29,31HNM
M\H/&R)B)6#D!E%NIT:.BL7ZU4ZE4:>3E;GO:&G2%@NL71$2I*I8J*TXXY[BU
M1VGU%,-WSG`Q1<JV3>7V]BB0@+]@DV%DO5YI+Y6,/86\Q'K$0BZ2DRMFY;<-
M"4J]%(TX_O:4)2ER]5ZN>1YDE'1<J2.XT=ASXTD<)VS;K*-JT-P\_/&NSHZ-
MRX3IEL&BJRW240B_!83+^%IKVF_=VMM24MIKR'&/\J)]';KCR2@NYCJ%.HTL
MZ)&%P]E,]`$\^'#K(1*[@C`CC4\W'D2EZ4^PF.K:XSDM.VE.RLE*'KOG@#(%
MC$,A3#B8,=E1C1*/&D+&5<3(JD:0(C60L.9-PIJB=V&$AZ9D3U0I#XY3#,CY
MG]+>I38B/.^MEY]2$1^87Q9VXOA'!5=BQU3S[P&5&5H_96H$2$XE0H*99?@-
M:<<:=D/PI7OIA^SK2W4I*K)Y4S@MOTF)153^=B"'2PUF,-V`-NR1GN=7SG_/
MBQMBO(E*DLQ(A^TOH8@KTJ:3C>U);]E&T(>E8]2E?$//"'(H)2\B.:VH5!K@
MF@W0]NPQMIGR:)>KD(#AI].KW^A%[?+*"7)S;SK6F8(D@Q\+C[[7HM=ZE+"Z
M-Y,VRG6H`-%<]%'@$JI52\DID2\!GB$L0<H_=K6;A"M)T@6I`!KDK#S)!$B3
M'(ZD*90AO2DR$2BFOF>6WS5;MTRO@(^C5?)41P$Q9R$"MQ[D!M78XG,YY`>N
M01D#!HX6Z_N&Y-?GJ6P0_3O1&VE,ID*R4C4WZ@%'%B99\C0K0@3#?=$.[B&:
MI+)*LHR;2AM@@LC=EF%O`1TWH`Y3!=*]Q)D)$F8G2(S;3C]ZR4L&]>6X:H]`
M,<V%4TA<;$+'JEIV)-0(`SYH77$6VU"YY8U'@C8L\%7I<20EN.[,6]\XUI:6
M/BUO<HI'P_F6$FR>C6<H!6(Y=1J_13.BSY$2[8$C['U+H7,C5G/"VB2G*^'#
MSZ5[_P`L^C4A43XW=*4O3C#%HKPT$SS@62K)8_4N4G]N`ZT\1(1K4:KP=MFZ
MQ0MO=)<TG*BD9\P>5KEKHAD,6((8E184X6ZA"7_B3M,HI.QWE5+L0:XDZYS$
MPK=.Z-0.?/S+`4V!K)=^R]71R:V21%C?$NQIC]0+Q9<A#3:%IFQ-PW/<95)4
MVPK)2M17G>W!!UQFV<HM\FX.<\;Z#:852U#*CH8'=(J-L9-Q92'WH$*-.5;V
M-/,3)C.AK"'%N/NZ2W[UZK3LMR/L\KIA:T@2M((4DM5_=4XQ+.!3S$]N'=+U
MSXD['DAW5:91'L_/)Z6].I0MV*IEW>D*6MIN3%,KTR!@,#R`K?E1YB$J=0O)
M^>;\=M\&O?E2!X<GB,7EO0V.H"*5;?*A7BZ(.I[4YV"56B-N%R7XY^4UNG,0
M9"=.P6]M_P"3EYNHB:\TU4:/7_,,F`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[SO_7BA9OGK'LUSU^%E?7F_J=?J
M&_S<+9^J1N9AEZ)\`_>'XG_%'S?]IH;(3JM*;(3$ARY2V'Y*(T5^0N/&:]^3
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M3`"R[+<`42P@(X%/&ZL[3Q!*PG(U3LKJ)33JQKU:7/:U\+NWOARU)2^NC>0U
M!Y3+K,Y[DP0XUU.L"NB%+-3G1!$82'*E0Q1\RX50`CNVA(*UEZ="9?<2V[,^
M\$=Y*6]1%)5F(M*E3<;R*>K52!<^M?`13):V,6%.HO/BX6OPXE54=N-5VS!>
M<K0<7"O4>(Q.6T-0Y[,J"F0ZF5[BG(V[7DIO^6]"HTJK7X"SXY5ZK?B9Y4/.
MI(N3P5WF-D88()TH:&3,L%;&')[>B%LW,&SU,NQGYD64]M,=6V?>9&'=O)[0
MB&0FP./<_J%MMKX4MNPF3HI[9^ME+36Z*Q%4\[2HB[+TPF-/R?;!*<4UH<R[
MM,Y>T[:Q2U^F9'\E>=I"#G_Q0<XEENKV\91R]:<E#&[D=T3,@:\=/]&!0Z(Z
M-B,R++;1\V+!DRWWRH>5\\RGU]64J2D/F>9+9?F)P5/XKSIA<.G`),\D7M(=
MCC\.Z,\?@]0:U-27JK\IH#K<-N!6GUPWTSR$)$9Y4)7LJ6I:>AW/1M5G54,<
M'`ZNS+-LL'3;X<.)B)?M4O8Z8>ERTPF?3[82=%M[D;7O;R9,5'Q[^-I/PY92
M]%=K[;>F4`@Z&4I^#32!D)+>D>NE?!I&F-)TGXDZWZ>GIZZP-?'I%+B"=`(M
M0J\8$F,Y#T%C@!3(G41YE<9Z+H<W$3#U&=CN*;4CX/A4A6T[UZ;],".3>-\K
M(0"@I^@U9`PVFMMF!T4/"A0"D>I6B7<P,*?"B-,Q94")9B,F6MA:-M/N27O=
M2O3J]*MR-]*H%$FZBIF4JI2]08$L5"U*K8:1J&+GP(XJ<-BZ=AKU'@31<-J,
MZRCT;<CM(;5K:$IUJ#@;YOSQG;>V:%2VMLS1)-G;=6!HVT2`LKC`B#>TP=;1
M-"QUJ;B.Z]'(R-[2WM.M^F!MFZK6&2)(PS6P+18RJ.LP4;#CT$2RXFHJ8JR4
MU,?4F<J,F$SIO;JE[1IE'IZ?`GT#7Q>?T."]`DP:348<@5((S!;\6MAH[PV6
M8DLS2TJ`ZS"0N'(*3(S;LE;>TJ?=;2I>U*3K>ER-AJJU=+L1Y-;`I>@#%!8+
MN@X_3L(,MM;2Q,1S4?XHPQ33BD[81M+6TJWKX?3>\#$<HU)>280[3JLZBPQH
M\(^AROB5I.0XBW'(D0PE43>B<:*X\M3;;WQH0I>]ZUK>]X!FC4J/(^<CT^K,
M2_LN&$^:9KXEJ1]C#HST,>(]]$1+OV7!AR'&F8_K[33;BDI3I*MZV'.BH5-L
MC*,-U>NMEIK#$6:40%&I(RXT6*J#&CRIJ8VI,AB/"7MEM"U;2AK>T:UI/X,#
MY:IM084;4Q5:VRJR^S]XU-`QC:K!\NWMF/\`;>T1=;*^PSO:$>_[GPIWZ:]-
M8&9NO`-H>;V##[;DKDNR&]C(6T/N39!"7,<>3['PNKERBTMUW:O7;CDEU2O7
M;B][#6L42D18Q2'&IM5C0S>A^C45BO"&8Q?0EEF.*T48;AI:(:&1X[:(_NZ7
M[*$)2CTTG6M!S2Z;4)[L!^=5:W-?%J=4,>E@Q<AT<IX>V(>5`<>BK7#4Z*:1
M%5MO:?BCITWO])K2<#<L0(,5UU^-"B1WG]*T\\Q&99=>TN5)FKTZXVA*W-+F
MS7GM^N]^KKRU_P#U*5O89>`P&!YA`?`;K(=%5YD]Y30)OBW3?(*!WT+R;7!A
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MK]#6!CH'#VF8L9N!";CPEI<AL(BL(9B.(^+:'(K24:0PM&U;]-HUK>O7>`0-
M'-JCJ;@0D*B+?=BJ1%82J,Y*WO<ER/O3>MLKD;WO;FT^FU[W^'UP,G336M)3
MIMO24ZVE*=(3K2=;4E6])UZ>FM;4G6__`(ZU@<3T.)(]KYB+&?\`9>;D,^\P
MT[[4AKX]M/M?&E7MO-[<5\*M>BM?%OTW^'`_4Q(J7G)"8T=,AYEN.\^EEO3S
ML=G;FV6''=)^-QEK;JOA3O>TI^+?IK\.\`Y%BO;:V[&CN[8=2\QMQEM>V7DH
M<;2ZUM2=^VZEMY:=*UZ;UI6]?H;W@<7V:.]_YKY"%\S[C3OS'RK'O^ZPPY&8
M<][X/<]QF.\MM&_7U2A6TZ_!O>L#X^R16_CUL:/W[B&&E_Z'&_3MQ7U2HK:_
M\G^F1&E+4XWK?X$.;VK7IO?K@9R4)1KT0E*-;4I6])UI.MJ6K:UJ]-:UKXE*
M5O>]_P"'>\#ZP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?\`6.\[_P!>*%F^
M>L>S7/7X65]>;^IU^H;_`#<+9^J1N9AEZ)\`_>'XG_%'S?\`::&R$ZK<P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[SO_7BA9OG
MK'LUSU^%E?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$ZK<P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?\`6.\[_P!>*%F^
M>L>S7/7X65]>;^IU^H;_`#<+9^J1N9AEZ)\`_>'XG_%'S?\`::&R$ZK<P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J:?]8[SO_7BA9OG
MK'LUSU^%E?7F_J=?J&_S<+9^J1N9AEZ)\`_>'XG_`!1\W_::&R$ZK<P/-6D^
M<EU2W6)/1^4EGDW\8**4$90ZU8'+#8XDT<6/EID<&0FD9_V>%&@YD6&\I+:3
MLAA$AC4>,_KV]=5I84SSOH,5J?):J5HGCVK$_4@)F$CW@URLD_5(ETP75)7R
MVI)5VT@K[$*_%IA*6Q;,B5'^<:96K4ZR4D]X\O`%%C@)E@I5SK[!NA@^@Q(9
MX1'@'2,4BS,=,5F`(GE!>V#U36B*V74\[\(U<Z/MQI3+GO)1!3*IWEH'LQF8
M)(T"RUYD-/M=?L!;9>IGX,"V5%CHI">%@M@#,V<8COA^7$Y+<IIE*=*5'96A
M+RW4,J*0D=YYT6=&&:D42\`2U@I,J]UD?8HT<6W8123`0$)AB][4^8FEK(5M
M0Q@<PQ`>W.=<E?+[=;@2G$7J4_27F01-5BNV[F_-G2E9M;AMD,<L%E!0YRI-
M>9'*G0W*A%FK)HD3"4IR"PEZ3'5ZI3*VG<=2=K5N4FDKS$H":G3+D,!V,P-O
M-SW3P8^&B$H_/7%+U^HFRD`<B0['<A5SH=EC@)RY,B(TR0]4^YO:V=.RI*8Y
M?S(I0(!2"D^KV1PI?PLXD`!0GA&W_M$`;FUNZ@"4DG.$H$$>?'40XIW<I#*!
MSTY"5[]6WO@5FBG[KS!J[K,*%"I=EG6Z;T!?+TU-DG5&W]6^&9J]>+Z:*2#C
M4&57AA>S)3L@UM2'F8ZUMH4I3;:U%/J]>7]6Y_(NS9RHV!N/59AV((?3-$2)
M%U53'(B[UJOBATDB5:?KXV4J6VB4RPF1&C2'5+8:94YBBD;G^;H$6P_.G\NO
M,<9+G#!%5FM3:R3=LIBREW!-2AI%`RQ4P,:,[BOONNN,+^3:2C2DK<<]M*BF
M5`\LY1+4)_=+)@&CA)$P#!M$"2),/!Q5XK=&M=1D#7']R-=*%[G2RJH>]-::
M@NPO1#^ER'6E%,RP^:%+!76T4MBK'#KU1F$72Q@61!L"ON[7W3<*TE1ZS<T0
M\=*@#%8)07!@Y,Q]R5%4TE?N:<0VHIH!WGA1I1@6&GT2ZBG)M=CWHG.UL.;#
MUKG1(8'(B[G8C5;G%Q0N$T@TVHHTZ\AP3&9=?>]4>SI]UDI]0O,]5BCNSJUR
MVVKB`?O#JS-3$Q%DY92JP+4H[5*V&;DLGUE!\P(Q(<?EPF=[';?VS'=D-*93
M>I3=S/*><.<KA)%;A66IRC-^383M<(0UM1Z@#112]=MH-Z8299.1T@;Y&1+8
MC)>=E2FU[CZ0G7PXHI%F_/2NRA8\M!X]UF3$,,B7PBEAF8[QQ%HT[.J"`PY;
MBC151T*/G.K=CQ7(D:9"7$4^I:VU*=2F^9\V:S)FMQ8W.+NM#T*?9DN/RJM#
M?C4$*<-5HY8RHZ4<;GB3(XW7)C.@;S>B*])1ZI0OWD,NI21]Z\DIO%[,"#Z"
MA"`TZ)'VUDG-)OQ?8H])//3?(<\K33;C2U<\YF]%)PTZWI,B6][3JD(WI62(
MLB+5>*\W20D8[)OO*SSA$_8WA_.1]&2DX]9H**Y3K<[`>@MR9AB*:'`+G&VI
M:X[3,R7I3+24:TAQR]2EL0_*D7+JMRMJ^>W`>.J3M?FN:)/!4.?<X[=K;1G;
ML:1!GD'JT(KY"B%91)N0A4B%`CI><2G>W4,RBD&@>;(DB0%!0_.[)92!U<L8
M"E0R]*!1B]A%MT:87A+'E+7(GB140;T&"\W/7M^/(]I[2-^NX_S"BF:QYJ5M
MUIV9'I-H)"')$,>/,H=K0EAZP665<?N;6Y$29994B+N9"I<E4TF[MJ%$VIM:
MM)0IW3"BFS+^8]9$@Z`011[.9/7QJW-M4JNR@]AL8PC5Y=F$L,+6&E3@DX?8
M#E1FQ84EJ7_I*F_\BVZO2VT.I3[N_E]7J\]4!U3K[-^+W2FU:Y"D"K-#AA6(
MUHF0'8<8C89,!8^'\W7%S"$):M^Y,3#VG32$J]Q*BFEC^9K;<6&@KRD^@Y-L
M#%+8#AK73RB7+P:,'F*J`1+F$0ZOD2E?!+FR2BVD083ROE-J<>0OX5%.>?YI
M"(!(>#1R3IA>Q&I!.2!K];B"K*3,586;GU=^PL("SYC$)QRPCUH3$EKCK3#W
M\RXM&DK0E126%?+2DQ^75/J]?KEON0.^W*94*2/JXU!@Q9EC1UG,S2@^"-<G
M/[B.BZ825$0I.G)3S;2/1"7DN)5-U)2N'_/SG;<HC'CT'I,]`"7;X%E>@C!D
MQL$_4"\RL29<^7")RA4(%+M(V1&00ERHL1,334Y2_E'VW=WJ4G5F\JXM<6+&
M+HTQZRIM30*VAMV8%\-:%P9_+HUF.1)49<IVP[&QNJPEQ([+#:Y[C2V]*;VI
MO:Y5E)#R7R1@=:MTNGP*0>!RA%:&V4Z2(&*K.%#V;-"$FJ:.C2`YF>Z7(G:Z
M63+=U'0IF"II;3CFU;;4XK%E.RV1#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8'B-]$#]BGU-/^L=YW_KQ0LWSUCV:YZ_"ROKS?U.OU
M#?YN%L_5(W,PR]$^`?O#\3_BCYO^TT-D)U6VI6DIVI6_1*=;5O?_`(:UKUWO
M_P"6L#RMMWF51S@5O["Y)02@NIVFL;9W8"(9,>P5>'-KQNO:Y>#L=3%32AQX
M(?T\XTIF$NN;?1(U\PE:?BU35)@[UNL1RT>M3_%_FX^P&+(4IT0/"F50H#L"
M[#>+5S,^DP>>H(Z0'%3[-34R9.TPICDV#[:G6O=U[&GR,2=Y'5XEIM`SC]%%
MFRXZK5,85L9@4"^R0JI7-8-GJ@@T$IYF='%TH)?9A*)*FH'PU[:TEAI>]2$,
M**_374SR&JG-!-!H%$XY5Q)"6-J-YF-%+>])?KT/H'2*9$,/&C#%$CQI%LGT
MCLOVM'3!=>AM2YC@_>V6=)4M2:Y\+%XUUGEO6S<+GL?@_,0-7F!$VDA+U-IY
M6MMR2@ZLEZK7X8V/5(L0O>7V;W*06A>K6P\EE]"79>GT+7)BB<>[+KW7Z)8>
MQ1.;`N$4A)0E>BPMVR,S:RT0`0N<M='IS]BM(]BINSP=J9BT-UFO#=N/+F!I
MR7-28S;;[*+6"II35K[M7ZU7GZ#1N.<^((YM*ZGNOD;[8X%A+BBX`+W:?]IS
MQ\ZM2%A^EW7H/*G)2X4B7IR>.([E_,>_[C#2O*U/G1(W.X59_I`^DP?&V'+.
M4B#)X\V':L@N!S*NN='ZG#H%A9'Q'JA'ASJ<5<`-^^1:'JEK4C<+Y!.E/N:'
MA*+7TH=RKLEIA2.7\UT("N4/GW-)3#-<J\8/#2SS@@J3;K6Y4'9E,K8@WT)M
M4?494^*UJ&W[;#;[GJM$7">&GJGE!0.BU;DXJT<ZYK8+M>X0>8;19S%4@5(.
M=F"*Y8'K`<FO!K`X%A6GYU;@1>XSJR<M,9EI6_>2\VJO8J7%%\J:I;Y3'/P/
M"071YY"K09Y`=)D"1<64TU0[);K:!(#)].E0G3`^.*U"B18NYL*>_/TE<B,A
M#NTJ*3HAUGC'XK:1WNJ<VYY/1>;H$&5(D>L-?I$.(,6U]KT:PD[4\)(*K(TW
M6*B'*Q!NH^U?%(A_$W[GZ?%3=&=%!0_)'E)0W+M]@\>@LFP5A\]=QED*"X5<
MUNRVVZ2QU`AFQT.MGY$BQ_9B(8Y1[X9;T0XF0C:&&=O2$JE:3#E?=.+$CG+.
M35+QN!-ZFOJD0X_MUTG.J5=L`:E0&+:1GR*_L63L=CK]E9DEF6";\S0J*Y\T
M\Y-_^S\3$ZE3JS+3Y&<C!F[!137%*7&Y_P`]+GB5@BCI-9G?9E4JD[K-/N%C
MMM#:`0]5Q@6#I9,Q%C;7-T3!R/76VU..-H5*4DPON\RR\F[W*H_#X-%.<IKU
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M>>/76_$N/U20+J3E!*%:E8I0.<F+3KM"J9Z#<SKK=9)C6V8`EAN;\B.27);T
M(;:]E$U"(S<JI$<N?E!0CH"RUNK<^YZ1+(YS9[DXW;"U9^P(A.ER;@0&5M8Q
M0><DY?8M@A))PP;VHCRF9$F2IV/MI2G+$252PQ3U%:!],\@2U3J=<ZOSNF72
ML3AA$U`*U>MMTYV1[3@R3]G5MQ`*P%*O&7\P\PPXE3"VF=H]'=N3.AZ*?3Y*
M`[A&A4.)R`1&+VYR'5TP!)4()4B>?/V7E;K%QV[6B$SFA:,6^>EL0EL%WW@L
MA:O12UOQM6O)3>46[<[B\@*SIG#^9H`<X,<WYWS\/83H\L^.$=BKO.YQ.;?+
M&<J4K[H`?O/?IB9LMAF8S,AQE.:9VYO;&3R(L]Y?<G(L^[OQMAD#;5"FB(D*
M3'IZT/#859^_D:B1BKH=QK59(\CW*L4;>D_(K@-;1IOU<UO+2TDK'D;7FNCR
M:J)\8:^Y?0Y@?32YR,1K\`:/L%F[-(K,A4:SR*9&)D*6_9FG2CL]F-\TZ5W\
M"X.GO<?0KU*PW=][U5%\5"=+:YC4(QE=AN%;CORY`8HOE71ZQ"MC5<=C2=UK
M;ABPIMJDQ&7QC?V:U)(+=T2^45\T[*RD1FE;BNW\NYA7-\U,\`J[,("\!W<P
M<BSBK'J99Q`(U""68)$/UIA5N$`@7,F731IQ,)09:VU^V_I#SR;5KF64>\AJ
MG,O"A0'G?*2$21T6O46I6<JQ5FF6:A+Z=S[A=RBU69H;,1<RMJ&'U*8'QG8B
M&P[>DJ<>^!IEQ13<VKR3X]SVR]$#I\>*_&9H]F`4)DDD2$%R;-]T=13BH$*#
M&J,I4158'A6R8%I][4&2S";6F3#>U';6HJTAYUU($<Z+0D"N0<W#T&5JJE:M
M)JAD2H_1;E?/QY#D2#0<16A\-BR2PP:3&,C%/Z6$E2W=>]+=<<TV\)3T#S*&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P/$;Z('[%/J
M:?\`6.\[_P!>*%F^>L>S7/7X65]>;^IU^H;_`#<+9^J1N9AEZ)\`_>'XG_%'
MS?\`::&R$ZK:5O>DJWK6M[TG>]:WOX=;WK7KK6U>F_36]_X?3>!YE.>71<?"
M&EU\OJ$=B-/B,3Y$U^2U5&[%/O\`JE'JCSNPAJL38LMJ-((;F1B")+@TI'&/
MJUJ/K;WL:I:6W,\C[8(Y2F\6FFT2HV%Z_P#.:HV]831^)3!$#I-6J5SBF"I9
M=807V[7MVY4"3I$=MIZ?&4K;C"5J2U*R4K0-Y6]%N2#LZ'X[UBNN#QEE^TF>
MB6T2%)A18*L'3<NN6AE4)Q\*[8)X:!+A/%]!QKXZ:E>U[6SM2K4%,V/Y66RS
M.NJJW)*F:DD`Q>5[9=NU!RX"O4^MV.V0XM^$R*C)EAW^EQP6Y=5AZ<=3J+(V
MZ\I2T:2ZJ%I%#'DE<K?=([5$YG%6(H-U.F!\.568S*["0U*'1'$/NRQ92?2[
M@VATW%<?VF-*>020\ME"%)6M6$I>%K[I8+#X]"^F\6JS^NB]<(C6J)''575L
M)08YB(^=`V>W`G7@#WS,?E,5N;*BR'VE1'GT1/C5O2=+E9J2LU*!@.Q=)NU8
M[E;P(/Y&4S&Y)8N>A[-2XL!\2<LA&6-,C3[J:^].)$`C3"!\QY3<E^(F.K;?
MI^#UM:#`L_E%?HYE$6'RH?NT`3+`DE!`1IY2YD1U=/@YUE.BXI.L?#$YAT.6
MJ0#%S-N?.-F-:5\*UH7[*H*1L)Y==3,D[-6_Q;4GH^ITPGL,<B&5CZ07&3I*
M`D)NN:)`V;3<:_5"HY"3JHHPA(;V2;W\2&6-;<5"TN4IVZRN\P/V41RRD6*W
MP.BWFCV0%[\YZK/1>84>V]`B.Q+&*!'M6?<V#4XL"(\VUIJ&2FZ8=0U*B/0]
M2LI2*6SR<)`QER`&N;5N#>6-GQ9%,.Q%JW&,5T`/Z8.,700>?&5\DP+@HI+,
M.$M<V$XY,(,16I3+KC"EVBF/]^Q5?XT--3>:\X<$!_(.578``$%,!Y84-'CS
M@]`-/T@LPL_9.BO5I8M#\7Y=YYJ')^<^6<;B[9QY&AWY5W4J7(A6^-TLP;@T
MV?82`PW--+MPJN@H'1#Q$;:X<2B[@I(7U[G;,P*F,I,9:2[+KC6_;;U)4M+J
M[M:;7!)\E@<A8KL>/<+>X@^<^[:"#HMQ'0N9U`].'D8PT@@18-!#A2,J0XTO
MT^!6U;UIGUU(T2&J7TT#5NX>1,*O\O)68Y7.43KH;,:E')ANQ%Z8*$$X5"'0
MR\DTN**-0[WK[-V/AQH3K[<Q#+<MUM[3*L%(U'\G+?*M\2N5FD<QMY.UDJ2%
M?L59+V%P9,AF54/3O2ITAJM2W9O-8<:Y2@T%U;FWGC8=Z/M33:GMP[12#5[S
M9L!"`.-P>25">@W%#6=#E;+G)/WO('H%*?DT:JS7*A'V5Z;0&[/N2?2^A#;,
M$=M:=)WM_P"14M-D;\H^@.F9X!-!I,"<'BU`E?R;L,S*8T6G40\8>K@!^<.3
M,>.-V>*&C@B10:W&F?%M+49_U;WI13:C_)^XF9YT;"XI6I,1*2%CNJ)$@RJ?
M"'`S4JNSJ3:XC%/5%>ZY(@C6"#;*]_)H@S&-^JF]-.OJ1-KMW.Q!^JEN25KE
M%1,(F7*IAMZ)/$X[['VFYS:5)ZC:!\"LSH>Z@INUO0!KZ7%//F0BFE.H1MY4
M*5@I#^J^5/W!N'6ZS&YO43B:&54H9\K\U-*:MR*SS"QCS%W9=%C0U9@V]GHL
MN`,(*GJ5N4,4C2GG7]QF;13ZUY$=B,SF-ZYASB,,NH4W*K=8/.6]1S4>N7&\
M#Y)*SS$5Q3$MC0>KL.N0F(7^C32\?UD+0K2G%05#7#O+/HYIVY3P7#*N`C!]
M7`^2F7*Y#`<]A%,'NPXT6PQVF%*&6`PAJ#.@2##H>)($RD(:=5MOW5*@IK)?
ME!>056GV&R4>OD`%EG6$D$+%X!BKC?N$Y:NBUH)`ZE`GT>5-&0P\(="?0TTG
M<GY-6M/J4XI>GE%+T(^0\.+PQ'2V(5"CGXULI=*.1R9J4Q4`#EPNX6D#[:1G
MLB7#$6K$JL=CV`<E^,PY(#RXVUK9:=V^E62LTZ]@/,"[)*2YUHY#J!MRND+-
M%.'6Q4">#'G-S-A1@>)*37#5DK%>LPV(DS+TAK<6.98GS783$9U:E+4-I4_+
MNP6`SS.KL\,K\1^PF*E(CQ4F@L855(%K#@'7X23A%0X/$Z).58"LID(G2"?R
M`IW_`"+R)L>2I,5FTI,[_P"29T#>KA7D4>JJ<J!4S7W+(5D2IU'KE;*KHFXU
MBO%C"UXU,A*()G2FY0MA4:1"=W'3+9=9>CS,E%-I1.\6>YT,W:IO+`P"&.YC
M)Z-SQBON3",Z+(%.30;L/XC%.C0(TZ7M"71RH\9W>X;GHXU^'TVF**<D[H?2
M;KSN[%(5*J]-OJK!QY8,NW!GG5(K=RN(L/MZ8X4J[3ZK=5P;\_:74L/QHCKS
M:]>B4K]6@T%;\@;)=NG\^%T^OLURNSB<5'1&!X5!!IVU$PM5,'!90K(`Q7(!
MFJD"TJ#*4E:7??2O3OP.(4A-I:W=_LRR8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`\1OH@?L4^II_UCO._]>*%F^>L>S7/7X65]>;^
MIU^H;_-PMGZI&YF&7HGP#]X?B?\`%'S?]IH;(3JMI>]I2I24[6K2=[2C6TZV
MO>M;WI.MJWI.MJW^#\.]:P/,NW]SZI:!U5F/<@K=RL4,4Q;@U3(<_P"IQU`[
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MPW.D5:NFNGW^Y43=&.UGH!W8:KQZ=T8@/`'!]?>:-F['9YM*1#W*C(BP&VBB
M5I0YIK6WU9*RAW_J'\ACX^]#J+S0?S@72:\?*#B%KYI;R+XV/6V!0Y%,C5P-
M88T"<9'3-R7M/-R&M/C6VE-P$*5K%0M0D)_R-\C09$##8Y&#-1[$3E381-(R
MVA!;`=)X^)&5"9,GR9#B+B:$@U%6)J&5L;0I,;Y+>W&Y*E0E0PD]K\EY5F$Q
MGJP'W*J8&!:K>.`TF[KK!T><H8LV]5$$99-^>.OT.P_,L,1W$_!#C;8D.(F*
MD;885!4-US+R/ZS:-]1@/4>)-E<\HMP(1!:0=V9,1+?5ZO0C%<!6@S,BI'&Y
MO095J(:8CC(Z)$-(=Q*M.NN*0PF()AQ$O(?R!@V\%SR/S6#.L$LG+!&;+]Q+
MO%I<=N999@T)=1KNK!*(2@`\9!5]I0U?"G3SS"DD&].Z:TJ"H<M6\@/(Z5>^
M:4^S\IK\:%;'H$P]9VAEKKX:+"GC*?/EUP:X;G276;578QHA+7MQ#[<_4#Y5
M+497O2&94%0T8WR0[37[E*IQ*GM6@<6[98N;!3DNLW(#-K<RQ]8Z7!I4,X],
MCH'V4$/YU5&BBR(Y#;+<"1$TK:].HDOVHJRH?1WNQ_GO6^T.`.)3WAC#?RSE
MR^Y%Q4;L5H%5"]3`%;<=%/6-946>M0J$V,<99@-^T5VO4?:Y#;[JL'ACQ.T>
M3-?DVTX4##+<-BD7JH[!B\\O`QBM3HEP[JA=M;BQ2!&61!5BH50(Z4884^\7
MT^VN(]&6ZTA]4&&01\B^\1@!6URJB(%P6)!>NTR;N@]-FBK"39:J#("YV`0U
M*CE1-)O4JRI?B:4XAT%`8D.RGI:VEM)5!4(V7\DO)$O!EC%T*#3G'+ZW6X9L
M56;L>*RU"NA5@$Y66!$+1!P)-MU0G2+`/-3TZ@_9C;K;D5*6MS5*A:CRGEJZ
M#V=^\HY!SRL1*75:Q>J&(:E#Z7;WE@>?@K1S2,PN25A$0]>E@.@"#1%N,V.6
MVH7!"R6W]NJ4]\HQJF-4%!]\\A*)18(X]591^U#*33RSI"P4V\RI5\/'`=%=
MND@0ALC"AUJ)R_9R:7*P9<QYV;':5&B*C[9><85"U#MCPCH71;X.-2NF5\'5
M":9<#8$*"C'WVG0R:\`>(&'[`4T@>4;(6$A)3%1&;1IF,TE*E/+TM>I,4DK]
MR(P88P</=(OP8,6&\8G?:95V,PVRX1(ZA0AOSTQ2$ZW(E?9XYAGXU>JO;90G
MU]$ZP,[`8&`3%C3,-8\M!BDH+CL5]R)-8;D1UO093$Z&ZIIU*D;<BS(S;K>_
M3U2XA*M?AUK`X98(+.TM,P2.DZ<*C3CNGH;"_=-!W(+HDJ[O;?JX0&N"XVV'
ME>KC?R[?P[U\"?0-K@,#1V.M@[<&FUZR#F2H4BEM$X?(4ZEF2AIYM]+;NV'&
MG%-[<;U\2?B^%:?5*M;3O>MAM8L6-!C1X4*.Q#APV&8L2)%9;CQHL:.VEIB/
M'8:2AIAAAI&DH0G6DI3K6M:UK6!SX#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8'B-]$#]BGU-/^L=YW_KQ0LWSUCV:YZ_"ROKS?
MU.OU#?YN%L_5(W,PR]$^`?O#\3_BCYO^TT-D)U6Y@,#'BQ(D%I3,*+'B,KD2
MY:VHK+<=I4J?*>G3I*FVDH0J1-G27'GE[U\3CKBEJWM2M[V&1@,#'>B19+D1
MZ1&COO0)"I<%UYEMUR%*7%DP5R8BUI4J-(7!FO,[6C:5;:>6CU^%2M;#(P&`
MP,:-"AP]R51(D:+N9)7-F;C,-,;ES'4-MNRY.VD)V_)<;:0E3BO5>])UK>_P
M:P,G`8&OEB1<^6,GSAL"9."OOR@\R5$CR)0F5*B/CY,H:^ZVMV#(D0)+K"UM
M;2I3+BT;W\*E:V&PP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!XC?1`_8I]33_K'>=_Z\4+-\
M]8]FN>OPLKZ\W]3K]0W^;A;/U2-S,,O1/@'[P_$_XH^;_M-#9"=4ZM\^6+J5
MH)P'?8G#JZ;GPWMMMN^S+AC9,B.[[3R5M.>V\WK?PJ3M._3TWK>L",0:>;?A
M0WW.G]`VMZ+'=7OX*%KU6XTA:M^B:*E.OP[_`,&M:RJR?N49_A.Z!_B4/]PV
M1#[E&?X3N@?XE#_<-@/N49_A.Z!_B4/]PV`^Y1G^$[H'^)0_W#8#[E&?X3N@
M?XE#_<-@/N49_A.Z!_B4/]PV`^Y1G^$[H'^)0_W#8#[E&?X3N@?XE#_<-@/N
M49_A.Z!_B4/]PV`^Y1G^$[H'^)0_W#8#[E&?X3N@?XE#_<-@/N49_A.Z!_B4
M/]PV`^Y1G^$[H'^)0_W#8#[E&?X3N@?XE#_<-@/N49_A.Z!_B4/]PV`^Y1G^
M$[H'^)0_W#8$<BUZQO6XZ%7T^^_)#Z]5B4=.F:%IS4HN1M\:9M3FJ+\2D*:"
ML?"G?X$[UO>O_JWE$C^Y1G^$[H'^)0_W#9`^Y1G^$[H'^)0_W#8#[E&?X3N@
M?XE#_<-@1DQ'L=4M/,4-7NTF8-DNTZOF!AJ/47(DD>GGE\L#7P+&587.CR&2
M@",M*VWD^J4J2K6TJWK"KFPA@,!@,!@,!@,!@,"K'8IRPW2TP6[G9``\)!K>
MH<$&S5],*=(L$9$N2^X8K9B8X\XII"?P.Z;2E.O1.M_%O=\+X;/[E&?X3N@?
MXE#_`'#9$/N49_A.Z!_B4/\`<-@/N49_A.Z!_B4/]PV`^Y1G^$[H'^)0_P!P
MV`^Y1G^$[H'^)0_W#8#[E&?X3N@?XE#_`'#8#[E&?X3N@?XE#_<-@/N49_A.
MZ!_B4/\`<-@/N49_A.Z!_B4/]PV`^Y1G^$[H'^)0_P!PV`^Y1G^$[H'^)0_W
M#8#[E&?X3N@?XE#_`'#8#[E&?X3N@?XE#_<-@/N49_A.Z!_B4/\`<-@/N49_
MA.Z!_B4/]PV`^Y1G^$[H'^)0_P!PV!%KH!L@&N32D#I]\3*8D"FD;<9H+J/A
MF&($)[U0NBJ3O>V)"O3\'X-_ARB4_<HS_"=T#_$H?[AL@?<HS_"=T#_$H?[A
ML!]RC/\`"=T#_$H?[AL!]R3/\)W0/\2A_N&P,WGA`@5I@"<5F.D2#L1Q$J<^
MW%9?EKCRGXVI#[<&/$AI?=0SK:_::;;^+>_A2G7X-6=1,\@8#`8#`8#`8#`8
M'B-]$#]BGU-/^L=YW_KQ0LWSUCV:YZ_"ROKS?U.OU#?YN%L_5(W,PR]$^`?O
M#\3_`(H^;_M-#9"=4NO_`.P.[?\`\(V3]9IN"-6_%_\`[L'?_<(GZG;P3JS\
M!@,!@,!@,!@,!@,!@,!@,!@0H?\`OB6O_P#@ZA_KST3+X$UR!@,"K>A?LGXG
M_&E._P#^0]6P+2P&`P&`P&`P&`P&`P("!_9]T#_[I3?U"5R^%\)]D0P&`P&`
MP&`P&`P&`P&`P&`P(#T[]A1/_P"^5_\`;&)RQJ)]D#`8#`@/+OV!U[_^Q,_7
M*9EG4\I]D#`8#`8#`8#`8#`\1OH@?L4^II_UCO._]>*%F^>L>S7/7X65]>;^
MIU^H;_-PMGZI&YF&7HGP#]X?B?\`%'S?]IH;(3JEO05)30KNI2DI2FH652E*
MWI*4IT&F[VI2M[UI*=:_1WO\&L$:H\-ZWRE(X>G?3^=[VF%%3OX;M65I]=,-
MZW\*DD]I5K_PWK>];RK,3;-_&YRC^$[GG_.E;_XED2I/QN<H_A.YY_SI6_\`
MB6"I/QN<H_A.YY_SI6_^)8*D_&YRC^$[GG_.E;_XE@J3\;G*/X3N>?\`.E;_
M`.)8*D_&YRC^$[GG_.E;_P")8*D_&YRC^$[GG_.E;_XE@J3\;G*/X3N>?\Z5
MO_B6"I/QN<H_A.YY_P`Z5O\`XE@J3\;G*/X3N>?\Z5O_`(E@J3\;G*/X3N>?
M\Z5O_B6"I/QN<H_A.YY_SI6_^)8*D_&YRC^$[GG_`#I6_P#B6"I/QN<H_A.Y
MY_SI6_\`B6"I/QN<H_A.YY_SI6_^)8*D_&YRC^$[GG_.E;_XE@J4.@=8Y7KH
M%H=WTWGOMKJ-&0E7WUK7IM;9CH*EI_\`WGZ^J=.IW_\`/+4T5*8_C<Y1_"=S
MS_G2M_\`$LA4GXW.4?PG<\_YTK?_`!+!4GXW.4?PG<\_YTK?_$L%2@EHOU$L
METXF-KUVJ)XCOIA.1H>&LH8G.4PSR+JGO/)B0IK\A337QZ^)6D[TG6_PY57]
MD0P&`P&`P&`P&`P&!36KM3*OT6\Q;-;ZM794D=3I$>*<L`@3*?CZBEFOF&H\
M^9'><C[=0I.EZ3M&U)5K6_76]:OA?"1?C<Y1_"=SS_G2M_\`$LB5)^-SE'\)
MW//^=*W_`,2P5)^-SE'\)W//^=*W_P`2P5)^-SE'\)W//^=*W_Q+!4GXW.4?
MPG<\_P"=*W_Q+!4GXW.4?PG<\_YTK?\`Q+!4GXW.4?PG<\_YTK?_`!+!4GXW
M.4?PG<\_YTK?_$L%2?C<Y1_"=SS_`)TK?_$L%2?C<Y1_"=SS_G2M_P#$L%2?
MC<Y1_"=SS_G2M_\`$L%2?C<Y1_"=SS_G2M_\2P5)^-SE'\)W//\`G2M_\2P5
M)^-SE'\)W//^=*W_`,2P5)^-SE'\)W//^=*W_P`2P5)^-SE'\)W//^=*W_Q+
M!4H-TCJW+'Z<1::Z9SQ2U3`.]:^^U93KT3812E;VI11*=:TG6_T=Y8U*E.?Q
MN<H_A.YY_P`Z5O\`XEDJ2I/QN<H_A.YY_P`Z5O\`XE@J3\;G*/X3N>?\Z5O_
M`(E@J3\;G*/X3N>?\Z5O_B6"I?/)I,:9SNKRX<F--ARH;\B+,AR&9425'>GR
MW&9$65'6XQ(CO-JTI"T*4E2=ZWK>];RSJ3JL7(&`P&`P&`P&`P&!XC?1`_8I
M]33_`*QWG?\`KQ0LWSUCV:YZ_"ROKS?U.OU#?YN%L_5(W,PR]%.`?O$<3_BD
MYO\`M-#9"=5FDX4,D-(#B$!@K`GP9<*<+E-,/QB4.4PXQ)@2&)/^C/,3&7%-
MK0Y^D4E6]*_!ZX'AX(\;/I3PPJ7+A],CQ.'6J(*GE3W.JEXQ<U-V:D0P;-E)
MV*-:466@T=J/.J5?`(?F-1TO:DZD,.#=SX\F*\[N^6\MWRW22;XT_1Y@P8TI
M_P"G%XRLR21R`$""IGC#P0>5.)-[3&KAT8/F1VI;]>/%G&X2'](]V(\ZA<QJ
M-'6E[:^>Z7RW9*O%SZ0L.JU:R&OIM^-0J19(RGY(#7BMQ>>1KVH%>JEILKAB
M5"#N"?D:J"MS,F9(8D.HVTP][7N+2A"U\]R^6Z,6[QA^EI&YH#ZI1_IM>&I,
M#,3?W"<*U^-G-!$QK5,KLPBRW&?KM'M29#$R>J,XJ1":)^L3;B6FG)/HTE?*
MZN2^6[Z&>)GTZRPJE+3]*/P_#6"T]O9X[-#%_'>K25"FD\S<Z;(M7R@+AA6T
M-PI@MO6HK9$6,2RPZA\B[`]'6FU\MY6^6[6`?'CZ5%MG%$5SZ;_@I*!5_LL;
MG=CMJ.2<?+@0-+*H?8JO0SKM8YJ<?KR;L=&S1D"(03&C,2HZ=S9L9#S/QKY[
MR7RW2D+X:?3L)\/H799GTN/"P3$N)D/LTB=X[`H@;GE**CY!1=QM4LIP4997
M!D!#+45Z9%$.!VW93<M<Y`Q#\YIVY75RESNK^?X]?34;I]BO@WZ6/A'(#AF+
M2"#AB''N;PK#=.H`*%KH<6DAY,/C!6IA8!$,\TELB6)0U/+]]3$9YMA*GU\M
MY6^6\IF0\8/I8-T@A?0OTR/#XP)8OM@YL/C.\'X^,(3+A`YPY;@`";'=Y_(^
MR3!ZYH34W8SFUKA&'$Z5[GX4:7RWDOENB\/QC^G;:90YBC_2L\%)+,DKR@1+
MEVCEO-!#;<SHQ9NK&XL-`CB]@5)ET&Y-RQDQ+FV4/OP'OA4C>OAQ?+>2YWE&
MB/)?I;:'5F56?I->,EDGGZQS*P.!'O&[GM5(_,]!L!<-)#UU-IY(,:N+@B.'
M<=C2H*E0BCZD,-.M[5[F6^6Y?+=.;+XV_2T%A.5VH!],OPSLU5Z3<[^$V9A\
M!Y\_'@5.C](A<^U<FI`;D1L=&AE623)3:S#X89$CI4P]/2\IKW)?+>2^6[3G
M?'7Z:],K,*WW#Z57A5'#6$!SZY5=L#R?CA0B]4^JSBU?I:S[$_F(:,'.,V9L
M8DPVV]*'C!4^41U,>CBIN6^4^9+Y;NT_,OIJ?3?N(JPR#OTZ_"&`1`WJXU)Q
MH3XZ<ND0G&:Z9?@Q7TNS*<P^MU<9*=.*^!"5N:VI*4)5I"<]N6\IVY;K(_HI
M?IC_`-GSX9_FV\C_`')X[<MY.W+<_HI?IC_V?/AG^;;R/]R>.W+>3MRW/Z*7
MZ8_]GSX9_FV\C_<GCMRWD[<MW7_M/@5].3E<X8D5],CPBM(N/1>B],N#\SBW
M*:\0&5'F\RCQ32:W$US(S#/6&0S=-/QXLF2-9=^4VU[Z5.I4FQRY;R1RG=71
MCQ^^CJ',&X"OIQ>+DX97)AT.8L8_QR\=)(=%B'V#F5<KP6#*3Z1YJ[I/ZE"U
M#D>XW'B>R\F<N(I&]:7SWE;Y;NU%8^F-]+:W5JOVL/\`3Y\/OLFS!!1\9\_X
MP\L'3OL\Q!8(0]3!\RH-2X,KY>0GW&74I<;7ZI5K6];R=N6Z=N6[>_T4OTQ_
M[/GPS_-MY'^Y/';EO)VY;K%Y1X">#G";P,Z;Q3Q!\:^2]%"QB4,/>N<\5YY3
M;:+B&8+PPO&'V`!7X!2(P3'2'&'TH=2EUE:D*]4[WK)/+E.)E)Y3.KMQD0P&
M`P&`P&`P&`P&!YI^=7"O%RXVSG'2N_\`B_XS=I0P)-5`A;^N\;Y[U/H4"(Q(
M9ET>GUA%LFCB\.K$;*?F*ERH:"VALI]E;L%,5^7-B:XS/BVHOPZ;0>"_3((E
MB(R!]*OPRFI%C)EFFN)Y5PM@K!J0.=T2!8)9RO\`XOWY0"U(7SF0[!$..N(E
MM3&-KEL;T_IG5\MY6^6[-KWCY]+6PW78UCZ:G@S&H44O.!2[C)XYRN&]*>DV
M?B8FL'A0TSRX*ERNR@G8VID]3[C#L9<?2&O?:6AY<OEO)?+=G4;QP^F->KA0
MZT/^E'XH:']!>W(#FXW"^,DM(KS8ZIN2K`_'C4#4!#(\K:=(?87-0[J!'W*1
M\:G68ZU\MY+Y;M$=\;OIL5,V["*_36\%2;#HNV&$P]\(X]5Y(-JLVSKL;8LV
M5GU4A$:.3:ERY7R$-;#:R1AQQO3K,9M;K*^6\I?+=GL>,OTY"38]87Z6GA-N
M&2N0"KQ35LXQR"KM^DJ[<G#V59$/%YV;>#+#UOJ[#D;;CZ]R"$-QIU#"-H=4
MOEO)?+=R]$\3/IQ\ZO5HT1^G]]/^54J=?]4\YSYKQDY<UU)NGP^2L=3L79&B
MKD7Y)5:`0/F5K@_8_M.P8;BTS]2MZBZM\MY6^6[#@\)^ET1:>GQ?I1>*WV2"
M1+5=G7>%<1^U0<B+9Z4!^R@P>-2)2[,;>&]+KY5#&G8K>X9#:=.>^A+3J^6Y
M?+=]UKQS^FM:(`LFY]*?P]J%>(O\[A3K@=XKQUT<%WU$S;`]:,Q@[?,]&S@A
MIRM(;<6J/$U\]+0VOX(3<@BU+Y;R7.[MQS7Z9GTU+KSVE6XC].WPO@$+)6`I
MF=$9\:^3HC-2Y\!B1(^3T[5G'/D7'E[4QM2MJVSM.][]<D\N6\IVY;IO_12_
M3'_L^?#/\VWD?[D\=N6\G;EN?T4OTQ_[/GPS_-MY'^Y/';EO)VY;G]%+],?^
MSY\,_P`VWD?[D\=N6\G;EN?T4OTQ_P"SY\,_S;>1_N3QVY;R=N6Y_12_3'_L
M^?#/\VWD?[D\=N6\G;EN?T4OTQ_[/GPS_-MY'^Y/';EO)VY;G]%+],?^SY\,
M_P`VWD?[D\=N6\G;ENC-T^F!]-"M4ZV6.%]/3PM?F`*R>-Q6)/C;R?<=Z2*%
MRIS#4C356;=VPXZQI*_A4E7P[WZ;UO';EO)VY;NA`W@'TWQ(>'!+_3P^GQTJ
MU%Y@.(",43QQY[6*O.</T^G$=L/LJK'1(;+]4NET@C2WP%MK3&F,O,M+D:=B
M)M\MY6^6\NP'`O"[Z9_;"=C$.?3!\/07W6&`U3[!#X!R4M6IQZ7!BNF1@V6_
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MIN5':>2G3K:%)E1_LE1NQ!'F]YH`IZ"8O_MP?(*-/:'1!#4I7D#XXR7&AL(5
M&!L0FOFY#Z6V-AX3$9S6M:]YEAM+GQ:;1Z*C_9:C=S/^=GG:\/J`;^[U>5:`
M5(>+.!0/_J?X`^'4P:&S1DP<0AS)TE,\8AN9[C+"]_`PZRUMOX=-Z3BN.Z5&
M[&->;GFI8;!/M1?_`+<[R5EV$F:%V2:6UY+\$C2WCX8.JO#S/Q1"C"6B;0%>
MX2WD:2X]$_R3FUM_I<5QW*C=GD_.WS<,.`G"/_;E>0\C=98!0PK>O(/QQ8CP
MX-8=D/UP<J+'D-1I8P'(EN.Q(SZ'&&'5[6A&E?AQ7'<J-W`QYS>;L:GP^?L_
M]NGY,:I4`LT:B5A?DQP-T,U-9]4MM[A.DUM.#=-;VWN$O2H2F=^WMK:/TN*C
M<J-V'+\U?,B>3C%Y?_;==]>G1(#@QE2N_>-^H_RBXD\?I+T!$A,"2^R/*RH[
M3SK2WF8\AUIM:4+4G:HW*C=(T?4!\Z40B`Y'_;F^02(!6^Q>I$H2>\^,R8LW
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M^V[[U%=+29\J=O\`'SXU/(=43&F@\V.AJ0ZZU&'NB[*28U%:2B,AHE+2AM.I
M+_N*C_8J-TLI?U'OJ*4$7+#5WZ`?ELS`EFC!U;4KR@\?)BFI1J:Y->8CK>E;
M4S`B:6EF.SK]*RPVA&O7T]=JX[E1NEO]*K]3+^P(\K?SE?';_:,=>.Y4;G]*
MK]3+^P(\K?SE?';_`&C'7CN5&Y_2J_4R_L"/*W\Y7QV_VC'7CN5&Z#6SZA/G
MG>R=;,W'_MVO)&RDJA(DR:W*,>1'CE-V*>ER!DR0IAMV1ME:7)H2&_\`"XE:
M=2(C+NM:<:0I*N.Y4;HK_P"M'S(U&?B(_P"V_P#(5EB1)G3'-1_(CQXCNIDD
M-B%/.L2&)K<B+N.NOP%1=-*1J$N!&5'TTIAK:%1_L5&ZW(OU2_J60HT:'&^@
M+Y6MQHC#,:.WOR7\>7-H88;2TTC;CDI;B]I;1K7JK>U;_P`.][QUX[E1NY_Z
M57ZF7]@1Y6_G*^.W^T8Z\=RHW/Z57ZF7]@1Y6_G*^.W^T8Z\=RHW/Z57ZF7]
M@1Y6_G*^.W^T8Z\=RHW/Z57ZF7]@1Y6_G*^.W^T8Z\=RHW/Z57ZF7]@1Y6_G
M*^.W^T8Z\=RHW/Z57ZF7]@1Y6_G*^.W^T8Z\=RHW/Z57ZF7]@1Y6_G*^.W^T
M8Z\=RHW/Z57ZF7]@1Y6_G*^.W^T8Z\=RHW/Z57ZF7]@1Y6_G*^.W^T8Z\=RH
MW/Z57ZF7]@1Y6_G*^.W^T8Z\=RHW/Z57ZF7]@1Y6_G*^.W^T8Z\=RHW/Z57Z
MF7]@1Y6_G*^.W^T8Z\=RHW/Z57ZF7]@1Y6_G*^.W^T8Z\=RHW:^7]3_ZCT^3
M!F3_`/M]?)V;+&*D+&RI?D1XVR9(]<QA466J"^\XMV(J5%7MMS;>T[6WO:5>
MNM^F.O'<J-T9"?4/^H%7C]JM`W_M\?*S[?NCL1RQ%)_E%P<M(F-CTS4P(+'V
MH3F(&BH6B,CVHD9+,9OWE^B-?%O%<=RHW;A?U*OJ%N,.17/^WD\CG(KRY[CT
M9???&93#KA5:'"CCC*O5M:R3C:5/[WK>WMIUM?KO6L5QW*C=EK^IU]1EQZ!(
M7_V^/DRN0+==?&/K\AO&Q3PY]YCY5YZ`[M>UPW78W^34IO:=J1^EW^#\&*X[
ME1NP4?4F^H0WN>I'_;Q^1^E%23)DFK\?WC/O9`O&D[FQB<S>][W)GQIBMNMN
MK]5MN[VI.]*WZXKCN5&[9/\`U/\`ZCTEEV/)_P"WV\G9##^U[?8?\B?&YUE[
M;BFEN;=;<<4AS:UL(WOUUOUVA._\&L5QW*C=\._4\^HV]/65>_[?/R;=)N#E
MB'"3OD/XV.3UB7'=R'!:YBE[D*'+?W\>V-J]K:_P[3ZXKCN5&[(3]4;ZDJ-[
M4G_M_/*)*MKTYO:?(WQPUO;FMQU:<WO3VM_'I4-K>M_H^K2/_P`U/HKCN5&[
M4+^I-]0A<!`M7_;Q^1WV<V^J6U!3W[QG1%9EK5*6J6PPC:6V)?N3GE>ZC6G-
M*>7OU]5*WM7'<J-VZB_5+^I5"C1X</Z`/E/%B1&&HT6+'\D/'-F/&C,-I:88
M89;?2VTRRTC24I3K6DIUK6OP8Z\=RHW<_P#2J_4R_L"/*W\Y7QV_VC'7CN5&
MY_2J_4R_L"/*W\Y7QV_VC'7CN5&Y_2J_4R_L"/*W\Y7QV_VC'7CN5&Y_2J_4
MR_L"/*W\Y7QV_P!HQUX[E1N?TJOU,O[`CRM_.5\=O]HQUX[E1N?TJOU,O[`C
MRM_.5\=O]HQUX[E1N?TJOU,O[`CRM_.5\=O]HQUX[E1N_%?52^I@M*D+^@-Y
M5K0M.TJ2KR3\=5)4E6O125)W(WI25:WZ;UO]''7CN5&[3L?4Q^HC%;%LQ?\`
MMZO).,R#4\H*TQY`>-#+8=4CXOF%"T-[2D>I_P"+?Q[:TCXO7?KZXKCN5&[E
M@?4Y^HP*<=>%_P#;X>3`UY^/"B/NP/(7QKAN/11K.XXZ,ZN.MM3D>`QO:&4;
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MIU!^4AN1,!U(7#A#TR%)UJ0]'<<1ZMJ1O<Y3<XT29N<:/2[,H8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
;`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'__9
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g339540g32t36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g339540g32t36.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0I(4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````*````&@````&`&<`,P`R
M`'0`,P`V`````0`````````````````````````!``````````````!H````
M*``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!ZP````!````:````"@`
M``$X```PP```!Y``&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``H`&@#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#?^IF;F=8^M?UAZL^PNPJ;!@8K-Q+(J<[W,;]'W1ZO_7URWUD^O>9B
M?7NQ^9]IKP>D/<S&P:SZ8M>!L]6_?'Z*_=ZC'[+/T'I^FNE_Q0L%?U?S6.'Z
M=G4+FWSR7!E"P/K?E?\`/?ZU5_5[I+:QB81_7NHAH)AO\\[U?]!C_0K9N_37
MI*>O_P`7_P!:NI?6C`RLS-QF8[*KO3H=7,.$;W-]_P"=5N;[UU2X/-^O?U1^
MJ'3ZNC=&'[0NQF[*Z*""W=^]?E`;/4LL/Z3TO5?O_,7'T_7;Z]?6;ZQ8^)@6
M.Q3ZH(Q:):QK&N_2?:GN#GO:QO\`.^I_VTDI]L26=UOKW2N@X3LWJ=XIK&C&
M\O>[]RFOZ5CUY'U3ZZ_6CZZ=:IZ7T7?AX[K!Z%-;MKCM.[U\NYO[FWU-O\U7
M_P`(DI]M20:R:,5IRK6EU3!ZUQ]K9:/TEFOT&_G+C>K?XR&W99Z5]4L5W6<\
MR#:)%#/Y>_3U&M=^?NJH_P"'24]PDN._Q?=;^L75W=3?U>VG(HQK64T74-`9
MZ@#G95=;F@>HRK=3[_\`MM=BDI22!FYV'@8[LG-OKQJ&?2LM<&M^]RX7J?\`
MC8IMO.%]5L"WJV4=&V;'!G'TF4L'VBW;_*]!)3Z"DO/^EX7^-CJ.;3F=1S*.
MEXH>TV8H#'.-<@O#:ZV7_2;_`*7)224__]#K.A_5W/Z=F?6'"W&O!ZI8[*Q,
MNL@.8^\/9=7Z9^C9CNV^F[Z"XK#_`,3?UB9<^F[JE%.%:8N-)M<][1.W=0YE
M-;OI?G7+UY))3Y+]8J.@?4>EG2?J_7]J^L>9#?M=VU]E+7P&N9HVJFVV?T&Q
MG_"6?X-#Z?U[H?U#Z<_&PMG6/K1E?TFVOW55O/&/Z[?=:VMWYE/\];]/TOT:
MZ;ZW_P"*[#^L?4W=4JS7X63:&B\%@M8X,:*VN8W?2YC]C6_GJ[]7O\7W0OJU
M4[*QJ3G]18PEM]Y&[=$AE+/YJC<X?3_G?^$24^6?67&ZK8*\[ZRW67=<ZB`<
M+IS=#56XEK;+Z]OZ+=]'&Q*O>_\`G+O]&_M?J_1T+_%OT;[;UMX=US-9+L9D
M/M#9]F/4/S&_Z>U[_3]3^HQ<-B9OULZA]:\C.HPW9/6WN=M#JR[[.[^;;8UC
MOT5?V=GZ*K[1^CK_`.-7I/U6_P`7+<;(_;/UFM_:?6+';X>2^NL_V_YZUO\`
MVU7_`(.O_")*<RK`^MO^,*UM_52[H_U;D.9BUF++@./I#<_=_I;?T/\`HJ$_
MU@MQNG65?4+ZE4LHSL[VY^0W4UUD>_U;O<_U75>^U_\`@J?YK]);[.E^O?UN
MI^K/22:B'=2R0685/.O#KGM_T=/_`)\_1KG_`*K5=-^I72+.O_6?(V]8ZK-C
MF/\`=?M^EZ-=?T_4>YWJ9'YG\W_HTE/;="Z-A]"Z51TW$&VJAON<>7..MEK_
M`.4]RY;ZS_XT.G].L/3^AU_M7J;B6`,DU,=Q#BSWWO\`^"I_[=6%9U#ZY_XQ
MK'4=-:>D_5^2VRYTC>!V?8WWWN_X"G]#_I5V_P!5_J5T3ZLT_J=?JY;A%N9;
M!L=Y,_T-?\BO_KGJ)*>0POJ!]9/K3D-ZG]=,U]=1]U6!40'-!,[(_FL9O_;M
MW^D]Z]`Z5T3I/1\<8_3,6O%K[[![C_7L=NLL_MN5Y))2DDDDE/\`_]'U5)?*
MJ22GZJ27RJDDI^JE%Y+6.<T;B`2&^)\%\KI)*>GSNH?6GJOUK?GV8-M_4V/(
MQ\5]3K!2&EWHL91&W;CN]WZ3]'ZOZ2U=Q]7?\6>;U')/6/KM<_*R7P6XAL+C
MX_K%K#]#]S'H?L_\]KR!))3]34448U+*,>MM5-8#:ZV`-:T#\UK6HB^54DE/
MU4DOE5))3]5)+Y5224__V3A"24T$(0``````50````$!````#P!!`&0`;P!B
M`&4`(`!0`&@`;P!T`&\`<P!H`&\`<````!,`00!D`&\`8@!E`"``4`!H`&\`
M=`!O`',`:`!O`'``(``V`"X`,`````$`.$))300&```````'``@``0`!`0#_
M[@`.061O8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!`0$!
M`0$!`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P/_P``1"``H`&@#`1$``A$!`Q$!_]T`!``-_\0`:```
M`@$$`P````````````````H)!`8("P(%!P$!`````````````````````!``
M``8#``$$`P`"`P```````@,$!08'`0@)`!$2$PH4%18A(E%Q(Q$!````````
M`````````````/_:``P#`0`"$0,1`#\`EUXU71;^[?5KLCN&]35P>-?*XL!@
MTCH-@(D#FXP\#'3\E?S#7R+-9IIS2B)?4+<GD"@PGV"-5R@X?M_WSZ!`=T@[
MN6[3O=R6/5T!V>B>N_/^62*+TSJU!5Q5=(+FFK>R"8<3ZUAR03<G6U]:H'A0
M\-KH)M>3C8N8WEMY9859JWP&@/K_`'5'9'K+0E\7A?%(0NIV"%W:9!*M>H(I
M?LLLJ:<QY"_/+$<GD*A<K6ND#_9(BE#J2:!,X#7^P*=.8F-"()]/`/`/`/`/
M`/`/`/`/`/`__]"4;ZAC05'^?>T+`Z$G@L1@Z(WRQV<<O">6Z*I6V5U2))AR
MTA642L39`GR$O(!AQG"@!WK_`+9'CP(B>N]FB[W=4H9S5TY8Z]04IKH\FG[5
M[H)8K&UBTE#$E)9-EOI]@*A(%+A5U/D#/:V5N_.3)9#*AFB`8-'A$K"$KES]
MUN27%2@8/HYH^B'M7.:?CYT-B%3T>[M[G%RI2(X2E:[6S>:-M519?+9I+'!2
MJ=Q1](_NF70Q1@Y$FR(L/@+@Q'MCW/ZL=%*;I[729/E'K2K5;5::@J=2N<0A
M$-A\:DJ53+55]2%T0.<CDS)&&DL1#^<[EB0&#P(LAM+,-+3"#8C[M;Z:L\\Z
M9=KRVIM%GKZ*)`FIV!E]Y;C.K!?0@P(B*UU#4YN'B6R!3D8<B`0#X$A/N4*S
M4Z4LT\`:ZW:/M1U"[H[GUUJ=HF.;Z\5F]V0V&U76=>294Q2]83$7-.^%6OL)
M8[(>0$:.+?J/W1Z!*8%B:`D@*P%P5$@6GALUF)6KKZKF-9;<W8CW&&05I,LF
MQ7(:.*QM4XL+"G_K9BL$O5`0QYG5+$QZP6#CL%I21>@A^@<Y\!:+:W[(:&:V
MJIU%XV4$]]#MFE('%&ML%J3.2/7&O#"2E*7+^KD10FTV;,S&YX*$M<#%L?BN
M$X\"+?#1>XH(>J?7TW5Z)[I..\KQN?/::MBMJ@M"`U35-BTG'6EF@JBSVQ@>
MG:]89$'AL;VXZ:QJ$_M8\1AU-PI3*5)HS4*Q8F-P8$&2/`\LN6\:;UV@#U:E
M\6C`Z?KF/$B-=YI8LH:(G'TN<%&&EI0N#RK2$JG%4$H04Z4G)BE29Z`*+&/.
M`Y!4G9S[8,-ETV4T-R.U.MO?:Y%OS)6B7"A4Z;(`(PQ$9DIXCM<Q]F5W+.$#
M8X"`%66N1Q0K!99@P*LE^PP05&L%-?;!V6N2LKJV5V6H[2:G$$[BSG-*+1L=
M<2&2NE=IWIN7R-N9X;$X99Z(]8[,A9Z<DM^F:%P3F#Q@W)><9SX'_]%@[2'G
M;>^L5N]C:.$Z.,0UOW@LR6[)Z\;"5Z_1]++ZYFNQL<E<=LZ(HHDM+4K629T^
M\D(%;0N,(4-:M&6B,]WS"/2IP6"ISZ;G1%BELAA,TWOHJNM?)XL2)[(6U"\W
M=(YC-6%I"YB:R7VK'6'UK#'I2`;H>$LE=(U"='E288'YO3XS`N[H;!=!.`<2
MCNFW.&%F7CUAV&PUQW.P-LG1JP;4UXBLRPU-K4YQ@L30RP:MIU.5C@/^6*0-
MQ*Q&2,UP<51@"F["@+5U\WNT<^N]KM(*LHT<5Z"=C+R$,R[9S"C3994E6S!Y
M-3_KZ;76>U*1NDV:H>]YR-2VQPQ4ODC]E4<N6-@!H"$X0_\`2JM-I9.EB6P/
M4^S+&L?HMMTW-"W673%@#^(]TK53^_N;,U32U(<D8C6^OFU]4)/PH9`&,)+H
MY+AC7O"@DU(J;UP,\Z`0717ZO.G&;VWPDJ!SZ+;&1).XO5,PL;#-;?;8W^S-
M6L%.U\@3'D(HZRIOE)5RE]<%Z1H6NJ41)*E3A$A+-#H(O0O6G[)TG:)YMXOD
M_//DT:K0OL6HF$JOP;.O5K2'J#FU:<-Y;PO,B&[(UO\`Z2!]2I(XF"40-J8U
M9OSJ<!7;^RBN-:Y#!?KL\(:QAE;[';+$DL.UUO-&%;F\5E5[I'1'R8J>V8JR
M\R95.'F#?D.C\X*!'F,,>,_';",.+DEPB!K_`$:TXI_GUJK5>KM.MZ=LAE7Q
MS`'9\4`(3N,PEBW&7&:3^3*L8!@]WDSV8<J-$//L3DY+(+]I!)0`A`STX^T!
M0.M,C5:VZ!PX6]6X;HXJXJWML.3/CS3T)E)8U:+]>YN,7*%(K8DR1>2#.6*,
MY"2:5DS!KLD-+P4,(]Z8X#=(.MT_8]JNZNR\QAT/4G8D4&U/KM<W))5&FET7
M"7?S![>G1**_I)G"W_&0(A(4^R120+VKU*1<6(P0.#ZK:4:I:1P,BMM5:*@-
M+Q0L'M5%Q9K$-]>A?,8?\\GF#N>Y2^5*L'&BR$UR7*C`^OH'.,>F/`RC\#__
MTG^/`/`5CZ[?5XI_I]LT[;:Q79Z9ZZVS.D<0:K22K:];[>@\D20J*MD)971@
M8O["MWF,/X(VR(DY^1.BQ$?A-@6$Y1@S3!AE%SY^OUHMROC;Q;%65FZ[1;61
MZ(OZUBM*YE;4I?5;ZG;L."".UM&PIL02K<.SHWEIR'(I(I>R"U!A9KD<0(0,
MAKY*JN7J[LIU;MW8*!ZVRFX.B3^^RL+4D?ZSD#\'560X4(XHURUDC3T<1!H@
M73L6#A@8E<P*<&5H+-`J$48Y@2+"@=LY:_7+;*NL([>#JQ-P[K;W2I[_`*\*
M68/CE.ZMJUV'@@U$J,_H2@9LR<M8@B`4I5D@8&@O!1+:@P-*2O&&<G=;KC#>
M5&IKBLBB]I==LKC;W&(:R5Q^.2Y&EN^,)D3M9L@9BU!1Q<+KQ*M"<'U`,#@[
M"1H,!]AQQA(1`\NXKK=P=U*F71CK#;6&S?#>?"RP':+R8TJ4[`F1`Y7E^15Q
M"X>>(J3.4QD3N\`=I<KR),UHU2EO1+#B,(`G'!B`_P"P?9G[.TA?8'JVV.&A
M'+\MV71R66(\&.2118R1(<6-6WRB6M`T4AM=\++"$)T8C1S='4WY&"752<()
M2GP&CN8'%/27E;$"RZ5A6)M=;JWITTXV.LA(VO%HR$W!9V%:&/*`)0-]=1,T
MQ2,.&MF+3X4%!*_/.7'DA/\``ET\`\`\#__3?X\`\`\`\#C@(<9$+`0X$+.,
MBSC&,9%G&/3&19Q_G.<8QZ?]>!0NZM4@:G-<A;S79:B;UJM&U$F@(.<U29,:
M<G;RCC,"+)-6'`P6$0L9"'(O7/\`CP-/?>FP/4G;GJY(-B)/J[9UE[=L,S<$
M=24++J+F5AHZ(1Q5\?$E;,+!59S4!L.:Z>>"S5Q(G9(H9U3ZG4N#J2L&:M^4
M&F>>'UFKGV8LA5NMWHL*=7?:T@$B6L6O;M:*V1+"DQ1RI:F37#.8XY'`1L#<
M8LSENB,5<$;:B#_H>=DK)B#`.NP:"PNL8?&Z^KF)QR"02'M"-@BD.B+,WQZ,
CQQD;RL$HFIE96HA*WMJ!,5CT`446$./^/`NKP#P#P#P/_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g339540g49z29.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g339540g49z29.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@##`(P`P$1``(1`0,1`?_$`+(``0`"`P$!`0$!````
M```````'"`4&"00#`@$*`0$!`0$``````````````````0(#$```!@,```,#
M!`L/`@0$`PD"`P0%!@<``0@1$@D3%!46%U>8(=6VUI?7&'@961HB(R14U)56
MEC>W.%C8.7DQ05$R)7=Q0K5V89$T)J%2DC-#)PHH$0$!`0`!`P0"`@,!`0`"
M`P$``1$A,0(205%A<9$R@2+PH<&QX=%B0H*R$__:``P#`0`"$0,1`#\`_P!_
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P,<\&&$M+H<4,19I3<M,+,!ORB+,`F-$`81?\`801:\=;_
M`/'`_P`K',7J:=U**CY/AD<?*-FNG6(^F/7TKL.]&JS9K9TQG?>3+:2)=.GA
M[CUAQIM4)Z\=H(G</=!)MJ'XLTU)M4A%Y5FNE[9M_G_3=DW\MH/];CI4EHK5
MW4HN2&=T!0]%6?)ZU>";"*L'H><3GMFX.19S7G-J?4_)"U+=MU<)WYK+5)9&
MK1*UA:126H3&#6)WA/G_`"'C/ELDO]:CHN,,%P3!MC/-,J7(*Z[,F<>HM".:
M)[9YA=>4>@8A3,98^NE!4U7!`3=Z"2#/3&IVJ-C0.6BRD@'=+YU(7A/D\8D2
M=]Y]:\V="=APGH3H/F[3G%*EX834U7S!2SN2SI[)Z'L2:0-VE;"GF?1->*5D
M`3/"`2%[=I%)6QF1*3FD9JYL`0I3N+)9+/DR6(O9_6:ZTDT`BUILD+YI*BD'
MI&IK:NUM4HILXN\Z52SU"K4XCD3153TP68Y1B&-S@PU[J1MZM6;*"4JT>DFC
M'%,;I86\)_GT>,6>JSI?I.1<C^LP]6E>T(DUE<TV!V_%JV!6\?,K^;4XQ5]7
MLG=JY,<20RQ^7HDAR5,E<(ZK/))6"+*,/&J7><)A<LFS.G"9-F.<-4>HYUQ0
MLF/@-FV2JGUBT-Q'RY')!,[G7/Y=(OS?T]U95L9JWN:TRV94VJ7%%$*6LSV<
MU5)U:<[;M&W(DU6D)-]Y*UXR_E<EX37*?4GZGG,NK$#A:W/#?413=ZH]22]P
MA#)+6:O.OY-R[!H0[0N7TC/P6F"4Q,Z2()4I1-R-E>',]`]L;Z84L<RBT@T,
M\9GKO!D_EM#1ZM5UPRC+BE+.5SZW`YRHGC1JA]#2E?-9+>DS47S5/,DH>.I7
MJ2S.XV-8Y<VUD&Z5Y!XU/MU;F*-K#W23-P]G&E/&;AX\IMZ'ZRZ5LGT=[ENE
M2K15?>".W(-6$?F%&VA&HN3+&([KFL*W;Y''9C6]E7@@J5QG\0>C&]T2%21_
M41]8<J!LX_18=;22=^>A)/+/126NO4V[&YZKV'5&DVRV99H;8[N,E+/TS9$2
MDC[7RSG:^H?`H]Q@NZ%GEN\^M4LE:6'R\#\7/U!;^XJ6-P;%!3`M3"./)M[9
M>5R5857ZTEI1ZW[!;ILX<X1FOHTJ]1I-(*M11>PI;TMSZ@XD;"TL#DEP,#79
M"!OD:.YW`TM[*2ID+$5ME4$@1KSP;/<4\\)GX_VGC/E_*[]7#KV>CBT6CL'Y
M\ETK9;.[49;#<6A`Y+]3:$<CTKSO?*5OK%BK2\;=BJ*QI^VW,?&=!*EDE:TC
M@44OT,?LS6P:]LGN>,5RH?O*V+LZ/C]DS:T:8ML-H/OHKH@Q_GB?V_'*MJQ5
M?LTZVD<BC2]D0VJY#5V?$0[3M[RF7J!M<@3(T0G5H+$6%(1;,F?:V9,^TMQ;
MUE.NPU=#978[/R?&55\TOR1<,#L`IFLEMJ_G&-=$=7.O-<JE=^_&;*,4RZ(P
MEJ2)7O2M&X1E,2N4[0J3PI@^_P"3PGIJ>,62FW>/3EG>CMV!UG7,WIF(W93T
MAZEB\9LVL8J^RNLG6*<_7%*H"584+:)5)G4\)\KA<8$Y)5:U0O;T9JC1PB5"
M<'@*9)WR>AD\I/1!\#[<Z;I+HWHB7E2.I.DZ8L+M*%T\H8X5\O5C](9BL])V
M'='MCYSFXCL291"(5L_R6L=%)6#29\/<#I"I5:7:.`':F^,SYS_IDL^?_JZO
MIN>HC9O2U*W+=?2K;4$.@-<5Y7EP)9]7<BANFM!$Y;`'Z<SR.2^*,%XWB]QQ
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M*>8'NZ>R@3!&_EQU48+25,XE-2<D8F8E,!B%MMVS_/X3./\`/9,Q?JH=:\V1
M.YYI<<BI?H9G9^Y>W.44;!$X6_1>P:XM9B23!9Q%7+JT-4[?=D0FZ99$`L"$
MQ<B+</=WEM.VN5"&8I-GCVWXXADU?_NKMV]>5D?,<*,DO+E3S:T:KN>>V;=E
M^IYD7S\V32AJ^ATG<*CAR-KG$4=B9':[W(EAC.-:]'J$3$RKCBTKFJ+"5J22
M[>4DEU$GIV61<?2?>?1_0MGJR8^R./$G`C_"*47!L-.]4BGZ*A,HMA]AAZ-P
MG7R',>TL@9513ZX#C*=T<324`2C$)250F5.[)VR3WI>)D]W.;COH3U-:ZIN*
M]+DSOY>0?IJXZHY>KA!U?;[]=4??[EM#LJP:Q6W;&(_%A,\MIZO(-7'N3;N,
MA>1?%UB/0P)4N]>\FZL[=SV:OCN+8[]76_44TL1A?I#R#'?AB;OR,G1![;;(
M)G?,#OQ`V/(F"[.IT".>*5?S,7XZL)6TR-"@9UK<GD[&!`N>CC3=BGC,3QC"
M$>M-TD31-=WO(*(K^.N-U3OH[F2.\^K&V?&VQ1W;#&S1,SDB@[T5'.[<6)?=
M#B2]K'7W9L;O=VQP9A)3M^)QQ[PFY_F'BF3U7[ZO[GJZ?3[L*.VO*HM$Z@BO
M0W2754(KM8XMT.N.I*.7\S)KH;WB+''."EY:8E6=@2=^:"#QG')52,K?G$/Q
MWN=LEE.V2RJ!TSZDO4%-Q#JZPYQ=`'JQKWO>KK0H*$7HW`F5=516MO\`*TUZ
MR::>9`O]V\^1JM&UGK!`TAV)7(=J#UFE!*-O<%YI1.M7MEZ+XSA+;CZM7647
M>[@M54^TXOB<^YT]*ZRZ=I%QBQ8%5+(>TUJEMGUMN3\]VO6@)]!*\=%IR)W/
M<5["UJG)0QD#<V(LM8);/&=/FIXS_P!;#:_J3]>SVB;\32:OZ"CL>J_TYY[T
MQ:OR?G<RW(9R\CMWI:E(8GJ^P*#O1S05]'9,14+8_+#$4G='9@-,5M8%QZCR
MK$SQDO\`)DGY:5W)ZH-BS)O[IYQA<HC:6!M/.G6^H?+X>E65Q=%9V+RS(:=C
MDC(5.::]95.GML=U\Y<2279;$8.6H$A*.:S71*(T_5[>WI?59V\ZZO<>]F6I
M>W2G:O.UC'5:PR^B7K2ZL(]`6H,W82ZI>)?8$.K^;3*W(W;TG:WZ72(Z%#$]
MQ%8QPE^CBP@\@1*H@9*W>+))+&;,DKBI1/J!],\H\Q(7)YL'G$^;6`P>HOVM
M+;5Z'.MWX;?\EH?H]15J'ERIM.]SK!MEKRDI`,3?IM,5)V=C"U)4D;7G@6K#
M=WMEOX:LEOQP[E\8=,=)]5.W7#R^LE35K"JHM)VI&HHX?'9FY6,W35MKN"3]
M:\7-[68(F90F9#[&2M9[2U@0*#3FY0;M43HXLLG%DF>[-DF/\_E7^H9W`Q1V
MONK7"ZJ8N>;5IZ;EW6K><=?VB7M<4>"X#VK"XP[08^%0NPD;%#+X0,IZAO-?
ME2;8&E/LD@;0/1A@M[R=/G_C5DZ?+L=R7ZB%_=!]Q6Y0[_6E>L=1PR;=)P`"
M8I\A[/;T!6T--H]%XE)),QK+L?)[-F:WVMQ4.(MEP*.(6(E2U^R7.A*OW@6;
MVR=N^K-DS50F;U";<'ZK"J<J'V[@\32^[9CZ<\6(=(8ZD\I%V#"XH2M8;D9K
M)`(,>76I*>LX])JU.)`/S";0)-:%L0/+E\9X_P#[=5R>/R^=<>K1W!)H%5BM
M\BO)WR^Z-K?TY;4JH;;'K92PZ`L_;/5+YS1)(_/4JBQUSY,UT52M9#Z@6-Y[
M4#9YQJ$PDT)9:L;PF^O&GC/_`%]IOZU5SU#5LX=;-;^;6V?0_GWL]VC:Q6&7
MQF+V]T3R=W`?RBCCD'9'6=GO!C',HR26^*6$E8N>6\Y2'^&"3%[&)X33QE1C
MW/ZH-DSU+W7SU#95&$T$9:9Z55P>9PI(IJ^XZ[G/+=Y476\I;G-4AO67S9R:
MWU;/'(HIT7Q2"`4^X!.;-.:$T:@-[>W+*L[>E6N]5[I2W^9NON-[8BUJ3R+4
M71-1WMT9U!64:7*SHU9=)Q:W.7JEL-TD\53:%J1+*L@]UN4E;?L><A0V[V'?
M[K>9[9++K,DRZY[TWZC7=O/L+L<N9R(%CVO>_7PGM"X7^ZM3E7/.L=L/A:L.
MR(MS\R)I;<=`1J,(3E$]+9$!:B3I-(4R%P4D)'!2`M*+5[>V_7_W&LEO\+BM
M/JG=IVY;=H5+#JOIZJ%K)7TC:0-4@>(/-9M`IH7Q6V=),=M-`$7037([R@ZZ
M?N>V%$V1Z$&-JMI"!X`_G:*5H03QD3(B:DO45Z6/9:*=H[+*(MV[KTHWT@X:
M]VV\*[.<:T->>L[&ZCBLS=7.JXO;>H6WSROOD2'3D8R!9E+R^%J4ZSW=*2A2
MMMO;/GU+VS_U\9QZWG3<7@;*\J4O(\-F$3J<^42)BGB&QR]=-SIO[JLOC23,
MG-"%/8;4M928.VUEJ3NJ169)%B<;^B2G;(3%FN`YXSY_R'C'^C>E)PZ3QFG*
MYUF]33LV/W%;<(2+J@/<%#0P-D,G+Q'VV%3(3B\O1A=KPU(B"WR@LH9"<#R2
M?HI.0#6B@XK-3)D0P&`P&`P&`P&`P&`P&`P&`P&`P&`P/YO6MZWK>M;UO6];
MUO7CK>M_8WK>M_8WK>L#74\.B*0)`$D5CB4*432-,%.QMA(4XV#VNF(9&BTH
M=$B9='F>Z;#X;3><7L_+X[P(?0\N4D@O)TZ'*A;<;9#E`8'7))ZI.E4L;"QU
MQ)[&ET:6Q=B-3"0QR1@>;5>1*'!)HI2H+/"`8MZ!K+MS/1=K)VRLKZHX78]K
M+ZD'+P&MA3K8B:$1&(N$MDS+'TXS1N#T!Z7L!4C31QM)&;H"A48:62#82`#%
MX`VGL(DAU[<\WC*B8U,X*TQ*;2FMX6O88Y>+76J.83F#6,Z3!S:8ZQM6I#)%
MS\A&97(W12W@V,!>AIS1EZ-"/15RPRQ,&I/1!\4G\E8#:XEC%7R-[3SHJ&!B
MLE&T&Q(Q;+'..NJ1I&H`F=V]PV:K]Q4;+-`L,V9L(3!;%N<G*+H%TKR].6=F
MG+0ICS`Q7A2X+P>I5+F%KAJ)=!FQP8(*H16BYO@47N$EC[E)R6E2VNHMG(S0
M')A:#LL0,66'+:%-S<V.<LW`6E]K&9S9[K2'/&HTT.4&5*WNFIM+@PQD7D+7
M)P1,[S"#'5:;L*,M2;I0#?E3D'''D%',N?!E9)5,N5DC4A8ULJY^3,=<RU'#
M&QH5/==$M,$G9J1Q0((J@0&J0HXQ+#$.E9!2$L!"S96C@!!Y=&:QRG+:9.71
M<8D$7^69=3Q^4RAM-K2%_*8$0:G^0LZL2<DZ`1C;KHAQ=6Q4-22`34E]H4,1
M@`[*WL0=;G)RP37..9FN(R2/LLOHIN@=9A0[ES(UO\`21&OPG.8S6S<C;4BL
MMFBH37I*(1'O("/,J+WL'[X'?A>3E%DEN:@G>HDENJJN+LJ..=ZJ87%F9AB,
M&F#O+;3;K67TDSRV-B6NA,<4FNKTQ!.1O!B\D86OV9@C`>'L],O1<J"8%!.(
M7>Y'+M*27,[O,X6Q*;A0Q'H&VD:)CHIAG[RQP6S&YOJR3GM>H8:Z/L:21Q68
MYZ6Z3Z)^'H32TQVRC;MSQ7F3%Y69SHF.I60V/.%2L2(DYG:HV:S*X<V)2E$K
M8$"A@;60:$P@DLZ219`E,1DD;T)8WDE"+T,D`-ZSRRTF<2NC:3C29[;H*PNR
MAWLAGA3!%*QB\142"0VNXNSBI;V1&`2AD8D$F3.*E<K-/<5J$"0>SS##@#'O
MSWFKS49V/*.7[.B%FTR_VD@H&0Q2`ULJLKY/S*&U?9%.QJ9N@7^(L;K(`F.<
M=9B5[HVC3J4&S%K:HT?LDP!I2H'M;S.3EYJ"4\6<WUS+.<*_L^$$1JH4Q$LM
M8RP[&0R!S4+>@WEXFRF;V9,I:XB)?G2UW^1*EQZD\[9*@Q<`L``%#)*R7;R<
MWE-"BPN7(!LIC5SB@H2*/I&F3D,ZB35Y&]LB$IG;6EBD)3>8M1;;4A<?=4:9
M(KT``-(U))98_9F`UMS3EE$SOSK%%,TAR-SI:-K%S.LGUAQ5,M@S.I6,#N66
M2X329L91B8U0SN92H`3G%<5LDX)FM",WH6O%R<L2"Z.:I)+*TA26?5/*9/8C
M%8`JN0-KM&I%N0L,2VVM%AI(RK1&K4AJ9%[R2F6IB3->UT28`0!:3FZ+93EE
M7A^YT*?E#3('FEBI/54>)4*VUY<(,!]KB*+36<!!RA(M-TOB$?5':;]!$(*=
M.,7N_AX[]ECDY1U:5Q\IPJHW*PG]RIR5PE]B\H5,;2V.%<.P;5;XRN5O[['(
M8E7.!+3-%13^:8:8D),-"%P-V(>@FCWO:2Z26W&5E4KJMDN>`5(522^830]J
M(GZ!^CL%A*ICK5G*E"EF32IW>WMU9EC.,M^>%AI?PPE8MUYU!NB_$>_.]-.<
MULI%@<S.#0<_I9M1:YBU)@PU0]$2.`*6G4Q<7<J2`BASB6L&C^4J]^T!?I"(
M?O1JORGZ!LSP%C*<H,L2O^,^BK'J9:[6?`GA^A%Q-=EMU>P>T8>@;+4N&O4#
M6]09QLN-L*O;M93Y4YC8D>&=(H-%IO/)*/,+&6$&M.8<Q-MCV'4`[&A=&61'
M/CSI+(U*K09C))!AO->MJ2L5#.8M7.$G=T!L9;Y*C$\!4(TX#!K0%$&G;"4#
M0!C<YISFO-2%[5U=:V1+8E&I/&'KX#"I8+<RBA49>9G7$O*??FVL%K&!0K/<
MHE(0,SD!$%6(AP1C3FEJDB4>]!&LQ,8^GKMI:[`-K'6C*:Z-#0QMDZ4;^2:5
M''80XKG8P^/-#H9O7N+18+AO1KJ2@(T-:E1^16HT0%4C$I66=5S&973#E_:N
M?R)SE%#;7I5[1#;1?5[U7WO9#FC-.VPQ6>N:A3[8M<E/;S/=$+@/1A8R!>S!
MK8-^#DY:%+Z3YRZ1LJOI^HE**8+N:[64ST^%PF;M!D+#=S0T`9(Y*;>CL>$:
M<]3RM$I`Q,H',X&VT_>S-E"&63LIMAMB8D4_H^P$"IZ;YK54U;&QKEI"QV1R
M.(R-"WLB$IL(G12E<2L6$)&I(0M1@=M"$$D`#B-*/#0R_%R<H\G%C\\(XY+W
M?2.M;*(@#F-7,F2-JZU?W6-2&`Q.0R)I+<VIP=TQI4H:6Z)G)VY,`(W(@0?$
MLL!!)YA+DRU@I?<O,+-%CI,]D5HY+444K&)2B)"%7RB80^MKBET*C;0V3)H6
MKBS&"ODRZ7(5:\A2("#2<K9@0&"T7H3*96016[S&WJ#(RWG58@KLBG$<L^7B
M11`$M.ZKL,V<(4EC@9$2M`Q:;TTF$>`*7P]R`::(.M^U$(&,O\F5(DD5\_Q9
MH4V-+U%/1UAFVV_2R=R,V%M+3+=O#:00U^\R=S$G1OWQ-F2%@(\YYOMDI0=!
M\2PZ\'*,?`Y_ST8]76EKU^K%`]5W+R$M[FQX<=:#F:7N$;:I.6MG:U(%+HY>
M<Q.Y(A+%0Q_NPFDB,]J0<`MRO+.O/S(#*;FN0_-4,B*SUK;6EN>?DB(J-V@[
M$D/S*WMR-=X@9YZY)WTM:E*+"6XG`6!.+UO1NA"<IRSB.6UHWJM)6^309$LD
M,O=F'2=&],"94^3UN!LM]9=$DJ0&N<O0EH-A5IO`:TH)/@8'6@?8@PC6CI(]
M,XGLJ2JSD<@3S!S=CFLB)&)GM*A?24\_<'$Q('93DG1R4!8'@TW8PEKM!"IW
MHW6M8Y.6!:;`YJ4NJJR6*;4:H?'UY;*T6SYIDD"-=GF0&!2FLT`52E&L$L<7
MDP!Y`DK4,\9^]#+V65]D/C<O0Y9%HG-`2%E-2,,PIY\CS/(G(LY*TR"%N3,U
MRQB+5S1W`:0C5G(44A9BDI[LIUO05*<)9BH?ET$1FF5>64;UU-+3HHE:EE9*
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M4W?!Y[+:`4-,T:FZ;_"I>_5T<W2QC0MP5+1+O<7E6),^M2-I9]&)E_E-)+3I
M="`9H!7B%SZ+RDEHC]</:YCLIA9(2[N9\<3(HU/VAM8G!<=$5Q05:-(QRI$2
M:H,CBPDW1I1:<_:4P(M"#K>M^.3GHCT-=?P-D)(3LL)B+0G3*$ZM,0UQMF0$
MIU:1P7NR1404D1%`*4)75U5*2QAUH0%"DTS6]#,'O;:*S]!<.4QTP[P0VRW"
MQ00J$."-S44_$IJLB=23Q4WS)ML!'NP(DT)B1/A.Y<TIU2HLE0E`YZ+]BNTI
M3[V5NRV++8MRA;6YL`>6VH$3>6J6+'%26A2D)`*'!P/&J7KSPD%EA.6+E)@C
M#C1>(S3!;$+>][WO(CVX#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8&C6?%%4
M\K2PX,B5D-ZV9P:6Q1(O5%F&I42J1,#@SIU:DHK>C3"$QJS0QA#O0MA#O6OL
MXG%%2E?(#HL&I4F2*.%N2B(\.Q4MY):5&G9&3RG:SU84D-1KA^8\@,D1O1I3
M7K6_!*I&,9NMA%O6];_U=8>@..W^IZ6LJM7MS;5LOD],L-%-T_U/;`F)+]%H
M3%Y?'X:\.D5E:1*C@)I"B8K%1S6UGN!8!*!@TL-``D):W;IO.HP6<#V.SV)%
M)U#YW!5[+"8C5CNTUO*FMY3QY?<\1E<-=[!<#W)N*7C:X1826$HW0@($2I4U
M3`(W?V:K9QA&WEPNMD:^*;%2K$:E1(JZ3ADBEJD<VTS)GU#J*/S;V@;UC\!K
MLH3>9IPC7NC\O9BE"L:`\I4E3K?=]Z4&IT[8FM8?.'+4?X'2]?O*FMW!@H^(
M3VF@-\;L"SJN*MZKK#CC+''B6S1;%(VL<8M89B:-E[7("!O*!UV[.>]K$HCB
M]@;SJ[B;>G>:;9N-7`V""V"WQ^LH^T1U&XQEUD$Q:3$K[%K!A,L02E1N-`&L
MLH9K!%S6TIK>%Z5N2*C0KS`K3->R"ES[27$<J.&Y:T(*R61-YKD;Y5Z<IT)9
MW)J<FF,S23(.CFZ]4:>1J6U"X+$K:>6%;H*OW58H1/9Q;@$@_P`@RC7E[FMW
M+X^>G_F^(TA-W.&$*4W2*N])<G@94HBT6VSNG3<COU=$(D<V.#9)6DY,WOH6
MXI8`Y/LQ24([80`,V7IO.PWEY7#C11$9>HG=/--3H#X[:U6SZ!P20-#@TQE1
M':_H:24A\CG]]:&YX<FL;:.9+GYH6DHG#25S*+&,@8S33--]UWW00Y\'/<)9
M'&<R)_;)-MDHBP*H70ZO8"_.RH3;,C979@)!6T?0[6.Q,^@5OOB1IAY>O.2V
MPQ,:G$,)RDP95\O0U:)AHJ;[Y!CE53&&53:-ERMM(E-U,5C+G6/P1^L^=O*B
MP+2>$#G&6&7NK.I;;#>E2ID.3IS#D?NZ?V)Y0RBSP9WG4WE%`>3ND&$ML`RV
MVQR%6O@O/D=LV2KI1.(-.;$55$W68TO[.=.65IE$M8FEZ-FC6Y`=B5HWU7ME
M,0*C/*X'+RKL-C1B.![<8X]6;6SS2&KEM:1GF$X*Q%)K`KI=*I?1M3V-2\B:
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M0LWBFX[;MF32R;V/%WZ(GK92FCK8\K96Z)?D9(;&HR;M4/,KGW5'`HX3&FRI
ME"!4N*VYKY$>J)5*34X2Q)MV=TAO#'6SPK9<GW=)4,>J>5)KR;+:B3F7/V1^
M4IX!'["GC//D4@BC<UI3RG.2:<DRGXBF&8@(4K"F];I1YT8B#TONN^ZQMQ<E
M1^Z;@4V5)E:0D!%`R>HXFO2`7ERN$R:3/BA<=-F)44J(0Z/1H3@:*"8$0M'E
M!%K>M>.27$ER8BRNN/9LELRJ+.L4=/H%-5"JUC01.NV5V%&G%EJ2F>B:W9)B
M6!Z0H1-,S<':^="3I`E'DLC.UA2EK%8Q^U!;2TA?#JN'M%?(DKI!4Z^&0?A&
M(G+VV-&(C%&^3+.F4^EAB0TL`#R4LR)E8BD(=[\Q)VS1'^;0]^+R_P"KJR5K
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M-29<*`2!B9THT30<VFF>]JS#0&@;,X7?2)&YDY,F=!P&;QX,H1%V(;6#%44(
MMG<PG%@;5,D)*FAD%DCW7$U(31R)K6IYF![@H:F]4X)E*E0H#M5[(198%NI;
MJ&XQP1:AIXWF<6#&U;S*;.AR^S@*7Z>V(IEU+EUO`8G;5=J)3)P,2T:FRY+5
MS*N`$E"B:VM`5M$2FWH.C1WRB['S!PG>LE>)5(['MJ-R"1OK*S,9SVI<IG(/
MC"AD8>H674B*9'!.V,%=(%_S^(MD1QD3B0M@&]1KWM8,\)@9Y0V3H\,SX0OZ
M8O1CF[V97TC#&FOX5"4TR4SI]BBYG17)S9:49BSE6A!3=$X>R,#11!K.K4HA
M.3D^GK"7%2<6(L23=G=(;&5D'!]JOZQ1.MS*',<T56)JV3H?$Y!-HI%"I`;9
MKS*U,4;ITSM1,G;6L3$[>]?%RVKW@R4`$O$A]D9LC4V&Q,-I\LV,Z\\5?1=.
MR5K@+!&V!\C<TBBJ>V&%"[MS_!I`Q)B"+,;D>[(=&F*2EZ"NV@\6SX\E*TE/
M4)"=[!M+-VIO.UN55<S.49AMW5=8"B,2*#V[&(,R*G%E$XI7]7M#SQ`*)FZ)
MW;UJ#:,E*?N`:<&]26K/-'IQ,+-*+$1HP^:;ZJY,7I^V"H3N"BP+-B$C?I;6
M<J?)\YH(XZI`//82TIQCT*OU(6H7&C(1PJ`.86E.G%OWL);:AV$W6B?#=\O9
M=]@KT_[#2()>Z(++A*>>GPE@GD`>!Q-<<U1WM%SDL3G5O72Y)1*_>E43G<QJ
MN-F`0DC`M+2*'@DPT>EF/*?Y[&MMCW'TII6-W@BARR/RB(O-7O,#K6*`0.9$
MGBD;?H'+)':);:,O9R!YEUK=`N9#L8'>DZ?:4>]#$(\L'F;J:TBL^'9])$-6
M2NSE%=P%VCU95_`_DW6S.[)=L*&)<V753S=,$'Q9&AVQ642Y7DHT$@`#26EK
M:B$A:M2+Q,TU=?&1\"6A8D4+C\JD5-PTYMB5"0EM^04;>5[4K1\SI+$=H0]+
M6]X2-FD*>PY3-RFJ2,A>SRBX&!Q8@+E078U0G>4G0V/DDY'LRP%/1C\QOJ:M
M9&FMAL2\W/SY%'U$7`6AP$Y27I!>QI%@6EZ<8_8T_MR<I&I9HI*6J1D-QX0F
MIBB336FMO=>$I4I0OU;,SE5K#5:)VZ"E<#D!#(\*+)VMO&F9E43?`I4E$42T
M;A4"2SD8RE1*X]0O0L+,DVE3;1[/&\O7U-;-7O)]E1&VGZW7;<+>W]6:.R(>
MDW:5IDQ:"6TKH*,T<X1TJ$$1Q+'Y+"#$+$?LEY-TD<"42P)7PT1R4E1MO&)L
MZ/>OYEN!`I.31_=,O+9#^FI1U#`ULE,DR!SF[U.GB:.#O!;51H8X\)T88>18
M2K3!(T:AQ.)-8V;8VP.DPO%L_P!&QJ\-X.=612C=7UYKQ>YGV!0MBN25!%U)
M;0SJZPO:Z[S>HI$BEGMCT45:'&W]H(T`>PB2E(]FF!`(S8`O)=6XY]K64T_`
M6:N'E;''-FC;>?II<68#BF6&N#M+ID]N:50@5%:2)&AN:G%L)1>R,$,1@5&A
M!``)7FEYNLWE.V0,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,"E,Z]0GEJMYE)8#+9':B:3Q%U/97U.T<Q]02MK)<$
MX2QF@026)TX]QI[3Z";KP4(5BE.+_H$>]ZWX7*N5)<-ZLI2?5-,KOC+O-U%=
M0$QW*DZ]TIJZ(W(TXV)N1NSEIKKZ2U^T6')`EHEY6R]MC4LTH'L19.S#`#`%
MEW#+T00+U0..`A$,4JN;RA#L6_#D/L'>_#6O'?AK5#[WO?A_VU]G+XT\:GNY
MNJ*6H!NASK9[M-6Y%/2EQT9'%Z<N6RSU!;<G;E2O;FCK.`3!9&Q!(=2-@"Y%
MI!&BV((-"$69H$DMZ&:T^I>X^<;PG""NJY?K(7RMS1.3@C323GGHFO6D:5H3
M;6+A'2FQ*JBL52&@(#O991RTLT\7[DH(Q?8Q9898P4\]0;ENM)G)(!+Y':B6
M3Q)S,9WQ.S\R=/2QK)7E%%'#`ADL2IU\C+VGT6<'P/0K%!&]^.M#WO6]:>-,
MJ3(/U32UBU5-+IBCM-E-?5^)Y!*%SM3=S1:0IQ,#2D>W/X5`95`&6?R;1;<M
M+$5ML:UFE)F]E$^T.`,`67<,J!!>J#QN``C!2JYO*`.QBWKD+L$6_*'7FWX!
M#0^Q"WX:_P"FM>.\OC3*GNX>J*6H9EA<@LMVFK>UV"6I.BQD9IRY;'5*0)$2
M!P/VZME;0"6N<9$%*YD["%T)1B&+8@!UL99@0R2TRUIM3]S\WW;.6NN*[?K*
M72QX3.:M`FD?._1=?M(R&A"<XKQ*)58541:*(1@2$"V6`]:4,\?@`K0Q[T':
MRPRL//\`U!.7:RFDDK^82*TTLHB;B)I?$[-S-T[+FHE:$@E3L"&31"G7V,/1
M'LE`-^V1+%!.][V'S^8(M:>-,J28)U32MDU?-KDB+M-E4!KS;QJ5+7BG+FBD
M@3?`6=,_.7PJ"2R`,<\D_LVU6`17PML6>\F[V23[0X(B],NX8@47J@\;@`(P
M4JN;RA#L>]ZY"["%ORAUYM^`0T/L6]^&O^FM>.7QIE3W;W5-+44PPF2V2[39
M`T6$4<=%C8U3ES6*L4ED($3D9MU::Y@$L=XP+21P*WH+H0C$(>Q%ZULP`PAD
MEIFM,JCNCFZ[)RU5Q7C_`&4NECT0YJ6]-(N=NC(`T#):&]0Z+]J)58-41>*-
MXP(TP]E@4+2AGCUHLK0S!!#MEAE8RP^_^8*LFTBKR:2*T4DIBBX#<]IF3FGI
MJ8M1*HQ(F7!"AD\-I]_B[R5[LK!O9J)8H*T+>P;%YPB#IEIE2-7O5-+6E6\X
MMJ&.TV5P>N=.VY6L>J<N:'OB;3(R$R%Q^$PJ90!@FTIV6U'A$7\*;EOO!N]D
ME><_6R],LX,0(+U0>-P@V9N57-Y`@V/>]<A=A;WY=:\V]^75#;%O?A_V\/'+
MXT\:GFV>JZ4I&-0:76*[S=`QV,3M1$SHY35SV"O4E:;4;MO;LR5Y7\I?(L/W
M%>5ORNJ9$+VFQ%^'M`#`&26F5IE5=U\VW3.FBN*]?[+72Q]*<CFU-(N=>C8"
MT&%M+<I=5VU,JL"IXO%&X0$20>RPJ5I0CQZT67H9@@@VRSDRO!8O?O,-4S>1
M5W-9#:*251582A>DS)S5TS,VDE2>B2N!844HA=02"+/!>TJTO>S$2U06$>]@
MV+0PB"%XTRI$KGJFEK7KN<VI"7:;+(77`'0<L5O=.7-#'M,%F9`2)P^$PZ:0
M"/S.4[+:C-"+TU-ZW9YO[P5YS];+Q989B!-^J%QN$O9FY5<WD"#8][_)"["W
MORZUYM[\NJ&V/>_#_MX>.7QIXU/5K=4TK2D4@\VL)VFR&.V,66;$SX[3=S3]
MQ4@-:B'H&W:/U_`)1((L+;>I`+875*B$$S>RMZT:$0-22WH9K1ZN[PYJN2<L
ME<0!_LQ;+)#IPVU)I!SETC!&@SX6W*G99[W*IY4L9BC9Y$*(S8/>EI/MAZT6
M7YC!@`)99R97PLKOCF2I)Q(*ZG,AL]'*XP>E3/"9BYMZ6FS24<L;TCHGTCE,
M(J*115W`)&N+V(:-:>`L>]EBV$P`PA9;R96_5KU72MN0*=V9!G>;+(A6I3B?
M+E3[3=SPEX2EM3)N1+=M$2F]?QV72L0&K7F`%I0KA'&_O!>AG_O>,O0RH&WZ
MH/&^@;,W*KF\F@;'O>N0NPM[\NM>;Q\NJ&\V]^'_`&\/'+XTRIZM/JFE:8A\
M&GE@.TV11JQRTYL341ZF[FGKFI`J:"GTG;M'(#7\GDD5%MM."(075(B$`SQ)
M%K1VMEZF6F5HM8=Y<T7%.6.N(%(+-6RR1B7!:4S_`,X])05I-$VMJMV5^]RJ
M=U)&HHU:"A0F;!M6M(T:/6BR_,8,`!,L,K\69WMS-4,Y?ZYG<@LY'+(R:C)>
M$S#S?TI-VDHQ>W(W9-I'*8-4<CBKL$2)>5L0DBT\)8]B+'L)@!@"\;>3*WZL
M.J:6N*$SJQ($[39;%:W+6FRU2_TY<T%=DP&]E%(%6VB+SN`1J4RH06L&Q!"T
MHEHC3?WD&A';T7BRPLQ`GZ4+C?V?M/E5<WD\GG\?R0NPO'R^'F_\GS#>?Q\/
M^WAXY?&F5/=G=4TM3\&@MC3QVFR*)V06@-B2E@IRYIR[J0.3)J0I-N\5@L`D
MDKBHA-6_,/3LB1;*-_>3-!/_`'O)E,K0*U[WYEMR<,%<P:0V>LE<G.5IV=,^
M\W=*PEI--1-ZMT4:62F<5%'(JT`"B0F;")8M("8/6BP;$8,`!/&]3*_=G=Y\
MT4].7VN)Y(+-12R-C0@=DS!SATG.6DH3BVI'9)[I*8+4DDBKKH2%<7L>TBT_
M10][+'Y3`#`%XTRM[JWJFEKFALYGT`=ILMC-<%J398HD%-W-`W1,!(SF/I^V
MB-SVOXS)94+3:4(00M2-:(9O@2'6SMZ+VRPRH%UZH7&^R]&?*JYO)L'G\?R0
MNPO'R^'F\?+\PWF\?#_MX>.7QIXU/=E]44M44!@MF3IVFR.(606VFQ)4Q4Y<
MLV>%0'9C^4:';O$H/`)'+HJ(;3KS&!=D*(1!O[P9H!_[WDRTRH^K?OKF.VIQ
M'JZ@\AL]9*Y0I4I&9,^\V=+0II-/2-ZMS/TME,VJ&.Q5H`%&A,V$:Q:0`8]:
M+#O9@P!$\;U,KTVEW=S73,Z>JXG[_9B*6Q\+<)T31_G/I">-!>G5M2NR+W65
M0*II-%'/8T*TO8])5IVR1[V69Y#`C`%EIE;O4_55*W;%IQ,J[=ILN8*Y*$=*
MSY'3=S5^X)@`:U#R+;2PV%7\6?I2+W!(,7E:DRT6S-:*UKVH@@VRF5`H?5"X
MW$7HS4JN;R"!H>M[Y"["UOR[UYM;V'=#:'K?A_VWKQR^-/&IYL3JNE*JKN"6
MI-7>;I(59);6;$E;)35SS)[5`>&0<B0;=X;#*_D$SBFQM0-B,T[-Z'9!O[P;
MH!^]%Y,O0S4?5SWYS%:\WCU=PF0V@KE4I5GHF5,^<U],0QI-4)T*IQ-"ME$T
MJ"/19G+TD1&;T8L6IRQ#UH`1;&(`1,L,KVVIW9S92\Z>*XL%_LM#+6$MM-<T
MT>YTZ.GK06!V;DSJAVFE4`J>3Q1Q$-$K+V/29:<(D>]EF:`8$0-,MY,O5NU2
M]4TM>$;F\MKEVFR]CKLK1TJ.DE.7-7JY,7MM5NVMM+)8D`BKW*!>XHC-^5K3
MK1>?6B_#V@P`$LL,0('U0>-Q`"9J57-Y!`T/6]\A=A:WY=Z\VM[#NA]"UOP_
M[;UXY?&GC4]V!U32U7UI"+<F3M-DD%L731N*+&:G+FE[ZIT^,IT@;?BT)A\`
M?IQ%_:-:<0C/BK<B]W-\"3O(>()>YEO!FHXKWU`>7[1FL<KV&2*TE<IE:\3:
MR)GKFCIN'M1RL*50LV%=)YC3[!%V4GW=*/?M5JQ.3L6M!\WF$$.WC3*REK]S
M\WTG.72N+$?K*0RQF3MBI>FCG._1E@-`"7=`2Y(-IY57U42F*+QC2*`[,`0M
M-&0/>RS=`,"(.DEIEK<:AZKI6]&&;R6MW>;+VBNR25$K-DM-W/7:Q,4H0+W(
MK;2TV-7\4=I0/:1L.WL+40M$$>@EBUHPPL(F6&8@8/J@\;C`$P,JN;RB#H>M
M[Y"["#ORBUYM>(14/H6M^&_^F]>./&F5/<]ZII6M*PA-Q2]VFR6!6'\'^2JU
MGIRYI8_J?CK,I?VWXK!HE`'R=QCVC8D&(WXHVHO=C=:).]F<()>V7<,J-H!Z
M@?+MGS2-U]#I%::J42QQTU,B9YYFZ<B+4<MVG/5>1=)I?3S#&&4CV*8>_;+5
MB<GQUH/G\P@ZV\:968MGN;G"D9RY5S8C]9*&6-"5L6+DT<YXZ+L%I`G=T1;@
MA$1*:]JF4Q5:8-*:'9A9"TPP@7B`T(!ZV'3+>3+6Y4YU12U]-$T?:S=IJX-M
M?E)#I09)Z<N6MU*8M:C<%R?;6W65`(BY280DS6=L06PI8(L6@@'H(S"PC66&
M5`8?5`XW$$(]2JYO*(.A:\>0NP=;\-Z\=>(14/H6M^'_`&WKQR^-,J>YMU32
MU>U1#+KE+M-DU>3\3,",+FJF[FD\B4"?VM6\MGQ2`1>`/-@QK1C>A,$;MS:T
M>DQFM%'>S-&``IEW#+T1E!/4(Y;LJ91N`1&1VHJD\M="F9C3O',G3\4:SG`\
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M=>QF`.]AQP)B%O-V;MR:DFDP]!+.V68,`!3+N&(R@WJ%<LV/,8U`HG([54R:
M7.R=D8D[OS'U!%6LYQ5:'LDM=))73;)&F1-O1>_,H7*TR<'_`,P]>.L>-,K8
M;<[@YSHR;*Z[L=^L=!*D+>VN:E-&N>^A[$:@HW8D1Z$9<HKJJY7%E!PRP;]H
M26M&<3O[!@0;WK6)+3+6VTKU32W0::7*ZM=ILXD08EO423<JIRYJR&G*="G$
MY'MM)L^`0X^1#&6U'^<+<%6(G>@Z,T'9A>AK+.I9B!=>I_QP+6MZE5S>&]>.
MO_\`D/L'7_[MT/XZR^-/&KJ0*<QRRX9&Y_$#W)5&):TI7MC4/$>D43=#FY8#
MSIS%T:EK4QR9D4B#_P"9.N1IU!>_L"`'>91MV`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P,1('`UI87MU)"$9S8T.3@4`81#`(U&C.4EA&``@#&$0R]:WK0M;WK_
M`*;U@<PS.W[D!#0N.H"RGR1DY^?'&9Z:H78TD:VKH5L(K]W.,"VQT3D^!J-G
MA<S2OAP0Z.5J"GA`FTM)-T:/>L7'P<>ZYV4>NT<SI&1,?,340AG,D>&?#8''
MFZ>JE#F](GRSF!Q*GUC*H>2)C8W4AH5*$BXL20E8((Q:>)B5JWZDL2="1J1M
MC&UG&W=%8J_QI8R`5J8]`I6MGC(V,P')CG+D>W6:C61(E4ZI7A(D4("SM!&@
M`%4G&6PQX)YTY;+2JN)[2$1^O8)&`QB.0-;9\43M;JOM&31RMGN)0-4F5V<S
M+%3A+7&6."9>8I2-2%C1$)E7O9_\*T0PQKSAU[9A3K,?>@11C1P>S#6N2LZ=
M-&'ET!7[*YV+&/+%!K;09%<AL"=OD12KFMI5)6]P5LBL)S<C7&"\,88VI5TY
M/DTH=FE&]PAW2MG2L,J]K`G0QD\Z2PJ6J8TF=UB831:[F>I41,3\,.OAI*]\
M*,T2-S9T2;8SA,_\,="LRA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?GR`
M_P#X0_\`38?_`"Z_\N]:UO7_`$_Z;T'7_P"6!\!(D8MF"$D3"$<<G4'"$05O
M9IZ396TAYF]@\1G)=D@V6+?B('D#X;UX:P/V6G(*V9LH@DO9QVU!VRRP`V:?
ML(0;/,V$.O.=L`-:V+?B+PUK7C]C`_*A(D6%")5IDZHD>]"&4H)+/*&(.O`.
MQ%F!$`6]:_Z>.L#YB;T`A:&)"C$/2@E7H8DQ.Q:5)R@D)U.A;!X^\$$!T``_
M_,$&M:UO6L#^%MK<4(D92!$6-,:I4)Q%I2`"(/6>?WLXD02];*-5>T%[00?#
M8_-OS;WX[P/;@,!@,#_,A%H1TEZOO:O?:&4=M=.\F<G</=`#Y1K2H.1)LDJ:
M66%/(G'&YWL"R[*L8#6Z/#@0:Z.90&YO"4(@"<6M:]D(HP2KIL[9..;&_P!9
M..:LK^@H8_UIGK'_`%X''[QLGG?:?@\[[0_04,?ZTSUC_KP./WC8\[[3\'G?
M:'Z"AC_6F>L?]>!Q^\;'G?:?@\[[0_04,?ZTSUC_`*\#C]XV/.^T_!YWVA^@
MH8_UIGK'_7@<?O&QYWVGX/.^T/T%#'^M,]8_Z\#C]XV/.^T_!YWVA^@H8_UI
MGK'_`%X''[QL>=]I^#SOM#]!0Q_K3/6/^O`X_>-CSOM/P>=]H?H*&/\`6F>L
M?]>!Q^\;'G?:?@\[[0_04,?ZTSUC_KP./WC8\[[3\'G?:'Z"AC_6F>L?]>!Q
M^\;'G?:?@\[[0_04,?ZTSUC_`*\#C]XV/.^T_!YWVA^@H8_UIGK'_7@<?O&Q
MYWVGX/.^T/T%#'^M,]8_Z\#C]XV/.^T_!YWVA^@H8_UIGK'_`%X''[QL>=]I
M^#SOM#]!0Q_K3/6/^O`X_>-CSOM/P>=]H?H*&/\`6F>L?]>!Q^\;'G?:?@\[
M[0_04,?ZTSUC_KP./WC8\[[3\'G?:'Z"AC_6F>L?]>!Q^\;'G?:?@\[[0_04
M,?ZTSUC_`*\#C]XV/.^T_!YWVA^@H8_UIGK'_7@<?O&QYWVGX/.^T/T%#'^M
M,]8_Z\#C]XV/.^T_!YWVA^@H8_UIGK'_`%X''[QL>=]I^#SOM#]!0Q_K3/6/
M^O`X_>-CSOM/P>=]H?H*&/\`6F>L?]>!Q^\;'G?:?@\[[0_04,?ZTSUC_KP.
M/WC8\[[3\'G?:'Z"AC_6F>L?]>!Q^\;'G?:?@\[[0_04,?ZTSUC_`*\#C]XV
M/.^T_!YWVA^@H8_UIGK'_7@<?O&QYWVGX/.^T/T%#'^M,]8_Z\#C]XV/.^T_
M!YWVA^@H8_UIGK'_`%X''[QL>=]I^#SOM#]!0Q_K3/6/^O`X_>-CSOM/P>=]
MH?H*&/\`6F>L?]>!Q^\;'G?:?@\[[0_04,?ZTSUC_KP./WC8\[[3\'G?:'Z"
MAC_6F>L?]>!Q^\;'G?:?@\[[0_04,?ZTSUC_`*\#C]XV/.^T_!YWVA^@H8_U
MIGK'_7@<?O&QYWVGX/.^T/T%#'^M,]8_Z\#C]XV/.^T_!YWVA^@H8_UIGK'_
M`%X''[QL>=]I^#SOM#]!0Q_K3/6/^O`X_>-CSOM/P>=]H?H*&/\`6F>L?]>!
MQ^\;'G?:?@\[[0_04,?ZTSUC_KP./WC8\[[3\'G?:'Z"AC_6F>L?]>!Q^\;'
MG?:?@\[[0_04,?ZTSUC_`*\#C]XV/.^T_!YWVA^@H8_UIGK'_7@<?O&QYWVG
MX/.^T/T%#'^M,]8_Z\#C]XV/.^T_!YWVA^@H8_UIGK'_`%X''[QL>=]I^#SO
MM#]!0Q_K3/6/^O`X_>-CSOM/P>=]H?H*&/\`6F>L?]>!Q^\;'G?:?@\[[0_0
M4,?ZTSUC_KP./WC8\[[3\'G?:'Z"AC_6F>L?]>!Q^\;'G?:?@\[[0_04,?ZT
MSUC_`*\#C]XV/.^T_!YWVA^@H8_UIGK'_7@<?O&QYWVGX/.^T/T%#'^M,]8_
MZ\#C]XV/.^T_!YWVA^@H8_UIGK'_`%X''[QL>=]I^#SOM#]!0Q_K3/6/^O`X
M_>-CSOM/P>=]H?H*&/\`6F>L?]>!Q^\;'G?:?@\[[0_04,?ZTSUC_KP./WC8
M\[[3\'G?:'Z"AC_6F>L?]>!Q^\;'G?:?@\[[0_04,?ZTSUC_`*\#C]XV/.^T
M_!YWVA^@H8_UIGK'_7@<?O&QYWVGX/.^T/T%#'^M,]8_Z\#C]XV/.^T_!YWV
MA^@H8_UIGK'_`%X''[QL>=]I^#SOM#]!0Q_K3/6/^O`X_>-CSOM/P>=]H?H*
M&/\`6F>L?]>!Q^\;'G?:?@\[[0_04,?ZTSUC_KP./WC8\[[3\'G?:*]=6>E5
M?W)W/-O=/\B^JMZD8KOYZK^67-&XWT5T*5=E-3Q-6K(LF+O!IQ`GJ*($*]MD
MS6S')0F#$,)1Q@!"`(.MY9W2W.Z3#RVY9';SB/H<76W'W,W39K24P*[UI*N;
M-<V1/[3:5H>97&&YS>FU$(X9APT"-V..+($,6QB)"'8M^.]YCNF7&;,N+1Y$
M<#/10_MW];[_`)<+P^Y*$YONZ3Z;[^D^G?/,,&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&!4_O3_``,]G_FG]%?W03'+V_M/M9U5J]$S_:.].O\`--I_
M[ET>7O\`VJ]W[5U%S++@9Z*']N_K??\`+A>'W)0G-]W2?3??TGT[YYA@P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P*G]Z?X&>S_S3^BO[H)CE[?VGVLZ
MJU>B9_M'>G7^:;3_`-RZ/+W_`+5>[]JZBYEEP,]%#^W?UOO^7"\/N2A.;[ND
M^F^_I/IWSS#!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@5/[T_P,]G_F
MG]%?W03'+V_M/M9U5J]$S_:.].O\TVG_`+ET>7O_`&J]W[5U%S++@9Z*']N_
MK??\N%X?<E"<WW=)]-]_2?3OGF&#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`J?WI_@9[/\`S3^BO[H)CE[?VGVLZJU>B9_M'>G7^:;3_P!RZ/+W_M5[
MOVKJ+F67`ST4/[=_6^_Y<+P^Y*$YONZ3Z;[^D^G?/,,&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&!0[U".T#>'JD@EB$Q&*2$VP;GA5-@DEG6"HJ2
MDZO',D4@7%V'=MII8?/3H'7Z$U@"@]\^%*0F.C@C3BV4$[9H-=L\KBR;4'OO
M=O3K#TS%*('S/1CS%)%S4]]5FV;'>JWQV+W5\'-KQBGGP!B!SP4CD+V5+[!*
M*8P!<B4;NUD^^&*$@Q^[!>,S?5<F:IXE]=QP3\A4KUZOHJGIG&[9N^L:[?XA
M1O4_SI2&F8+**7EEZV5);7V?2T4*8+&J.#1%2I610L)^U)19@M+RO)H(]>'.
M+>WG$SRKUF4#->'7=.QKG1\G>Z%EW/\`4=%N[/8C0WF=/7C?%HG4>1"6PESC
MP&NO(U#+90KFYR?5"UR*`F:EJ@*?8B0D&3PXE3QXUN-E>H[?%(7SS7S-=-.<
MH5U:M]1^82T]PDO9;^PUZ2U1^SJVKUDBM<O[US8B>;&M:4%V%M2F8AMS46(;
M>86!6,)FC`SQEELW#QEFSHE)-ZC6E-(PRY-5$:7J7>H<HX.^3IDS!HQOT1UQ
M(N6_G.&X:C6]';%IA^-[:/8AWKVONOO>_+[?;QYSXT\><^&Q,G=;G)/43G7#
M".&5K&4=:P^*2IU?[#N)1$[?LU#,(,LEY,GY_I3=?+TMHUU#G,HEED+MJ1HC
M&YR$?K:;84VO;O'^NIG&MZ[$[(!R:ZTNVC@&YL"W!=":&I^4NH]J/!HCE^W>
MD!#$7MD>-N6I+JJ_A'V-D^Z>^^\_OOLO8&)-)-<[XAZZ44D-21*R7'G&7()(
M_<SF6@[U(AF[,MG+)T.MZ*J/FB(\S[]_9F=K$9-9K<S*O1250:E3?`ER=?M)
MLD[6]7PJ^-=A*)D%^R2'*7#HRL:WJB=:>3P(XU5]K/5P,`X\-`W*42M9)WVL
MZJ5)WLI<H4I5*8MO.3Z]V"<6H&$[R%YN>B7/1-61#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`J?WI_@9[/\`S3^BO[H)CE[?VGVLZJU>B9_M'>G7
M^:;3_P!RZ/+W_M5[OVKJ+F67`ST4/[=_6^_Y<+P^Y*$YONZ3Z;[^D^G?/,,&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!`/2=*OW057N5:,%RS6DP
M/:@U,_R2"QJJ9>N?8RM:G9C?H<ZL=QP"R8>H9W=,Z;&,?P\*LE0G*$`T(=&%
MF67%EQ!%<^G?1M5*Z@W"'>>H6JC^*I!PE#&5:^-[J1\TLA<:^=#GMY6JV<3F
MNG*8==H@EJ0FE(_(<=XI=^)?LWE;^3;_`+1-!?2KKYAIZC*&L6^+LO&K^='I
M&?5D<L%OI=K`U0Y+SE9_,1U<NJFO*FA2B2QE?`+36''*'`2EV$O2IQZ5Z+T:
M4;?+G?5?+G?5I$1]%3EZ)56AJY#/[Y.+;*>J"MF2P_ENR)[199I270EA]0PC
MH5LF26*`.^>TJWK)6+E*X\H]M5$%%IS$0B1'`->5T\JEH[T^9FX6C4=Y._<G
M23C=E51";5PIL'4.Y;3GSRL9W.X'/7&#R>,@Y_'%$"),Y5TB))7M*-N=O9&'
M[$JV,81`>7IG!Y>F<-!7^E"RGQ27U^V=<]+,,'<^E_RN*\C#<AY_/)I>ZQ]!
M.72(G^$.3I23@]O+<9/'105[C(U+VE]Q'[/0//K1FGE\<X>7Y;99WIW3&S);
M6UGR3L*XYO9?/T7E[GSRIG<)H,J.PCH&1T[+:@27?(=US4L`FLE+3HI<>X*8
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M]G7C]G7_`%U_X>/_`(X#`8#`8'\\=>.]>.O'6M;WKQ^SK6_'6M[U_P!?#>];
M_P#RP/[@/'7CX>/V=>&]Z_[^&_'PWX?_`(^&!_/'6O#QWK7COPU_^._#>_#7
M_COPU@?W`8#`8#`8#`8#`8#`8#`8#`8#`8%3^]/\#/9_YI_17]T$QR]O[3[6
M=5:O1,_VCO3K_--I_P"Y='E[_P!JO=^U=1<RRX&>BA_;OZWW_+A>'W)0G-]W
M2?3??TGT[YYA@P&`P&`P&`P&`P&`P&`P&`P&`P/\S?J7RCKU\[<;^@*.Y_O.
M?UAZ7S54\Q*=89(28RRRZ56/(FR7]8-2&OENR)#T&29R*60PM9#`G<1M\C<C
MP:U[R6(O73MD\<MYK?;F9?575N@_34.ZO;9$T1&])51O4GKB#FSN,3'.!-=.
MN5+SE2OC,_$D4)BCFJE[UI=ZVF4*QEA:B7:)I?$6O?1:U=F?.+QGSBJE;49V
MLU4/2_.)%>]$2]NG?IQ^IE<%2/;BU3@IPBEG]!41J,R+FF3K'$M*H9)>WW2S
M"?8D2O$2<)%+M)B!:VBWX7>W?G8<;_*]5H7I<MRG=+6!R'6_0\E<K:X9X=]/
MZNU+_6%H5.:AZ&L>U+R.N'20VS&",DQURI&H98-T?9*>`#2T.1:1.>KV;Y0Z
MDDG7WU)/=CJ6G5F\PJ.$:YZ)JKH*J(1P1W7TW7R@)[!9?1+DAYBM#C^XI=R\
MM?YG3<;FZ6TDL<26,WPM2YH0+"D[PR:`J]BH\=:<7<]8O%W/6+5>K$EM-1TK
MPGU?2\2MZ<).2Z8Z*ZNU':^8IGH^?LD;GO):>8U:L92$1):B:6)0,FF)+(SN
M).EQR\G>BB?:$F:#GMS++ZIVYEE<BGRA;LB=;N&[YB\E<3[&]4.END+M5W!2
M71%]U4A6WKZ:D\LN>I)'6-/KF>>2>NH+;T[(C("&A:G0MK\A3`.$$1)A>][-
MX]O^M<?Z=#J)IRJ9[ZI5^Q^U:YKU[K>Q*SYZB]4-LNY3ZC+4R.N5'!<`9WYN
MIVU5SNGJ>FJX+,)6HW2.R9,J?-J`G)!GEK!!UF;;X_Y[L\^*JZ#EZ1U5R1SB
MXUA1UCQ6=2AP];$5F@88G8FI$ZE,U"=S0?GP$M3;)/<@$[9#F9MBGMP@TJ":
MC`B]H883L5M_M^%ZW\-5W5_:4*;9S0IL*ZLED.HS@;DB)!G<((GY%D7'QK,.
MOJTM&W*[@;ZW#2.2KH>N*`7RJ#.")(:5(EB)C`:FU[PM*QL_V;'6CA%W?GRB
M?4J@?'5-UM3K+&E\D0\@SJN*:NFA6>R9;)Z(`LA[W)H[?P@.2R=0"6;;F1]<
MTY"5`J7H3#!E`%L00Y[NLM2]9KE&ZUX@4<]OJ/BVF>HX7837Z2W9D7]2`$MK
MWH".R.:=#.M-1)-5D=G"J>-A`+9ZL%>94A6HG2/"=%_PH:[>E6T*I$`>MYYS
M-F+Z\^[L19/)!,`](2QJ#FLXKWG4MV:V"3ODPYNHFZU,(0;63V%R(+3+*:;)
M[85NRAAG&T);+.2T#NG&L:%RXS7N1/GV#,O]MZLR_P!E):]YK@/2X?1XL"R.
M$8M5X5MQ])5K9D4AT$M..UHIINN*IZ?>*AENHO,$C)+X#4E@V`G;)A&6N5)D
MJY$K=$9!GG-\FC+;9LU=S<K1:N@,P)LVB$<8KF]VOU=FCU!K2D?45N2&&7*E
MA[IS`JGUO'NKE,+4<$(:<D_+D@HQ3&&^&,2%><!.Z:;RT2,I>E5C!?\`_&+Z
M?_KC1&^"HE?`D=C%-UO:\.]80NT.-#^JIS=E.WT[S)7<J?L^GE\VFUF3U2R`
MC5F4FGL-/I[3%,;PJ;`0HOQ2@)0%'`+;_;_]?_AZ\_JG6B(9T@IG'IP)*'8)
M74G0T.1>I`U]JR3K2N[5M=E7],.)G/PK-ELS>8=)JK:YHCM1_)-<J_?$#F6P
MF1OV2=M3`+3B1IESG>G&)QSO156L*]C;?1=-)?4)IKIV<,1OI8U5%N.FR-5K
MT'*7"*=3IY9=YMVLT<:X(UN3S6W54C<%4&/C[R\Z0+`-28`$RXLM,NQ>O]?=
M;UX]T]L4OO*#5!ZHE&=%)+Q6]>WEZ;'/B"-Z;ZVN"6(9Y=L1]-AW;K9#&[&B
M44=Z[22PJR$J@A1H+HE-6/.]!(",XPH.W&RSIO\`U../;5=+4KA2MH6_-<K5
M3>D0XT60WTN4T[C5C4WTR=6$@Z?8^N(FY7[+JYHIU3L=P/E>LE'EE$V1N,I6
M]`^;)T`DTQ66>IQ+SS^W+6^_5M-UT?+GJ\N?K>JFOBAT11]!>G.M?IK1U%]-
MU%+(*RG>H)=)=K/O(,&F#^K>X,X-J,:<V=L<H)?W!5!E)YI>@!$G,&EF9\_\
M3??_`#A=_B^T:^Y!["[1;I:VCLJO)=8Y2P_M(ZC;]A5T.5V7_P!9GP2!\:6>
M*<LJAHO!\CTAGX"XB]0[RMB*'M@!J4R9-[)2;+-D]_9+-D29ZMS78MVW3%*.
MHJ,6E+K$C?I]>I^Z2%'$HM.44:0+;HYT3UK2"(Z>A;4,%5RZ86*B.1-3<0XG
M.A!Y>SA%$E[":*=O'-]X=O'-]XH7T.VR'OD$Q-JMJZ?CU5OM(^CWR[*IV"L[
MFJN4P^U$_=CS*K?^3+9*X]'WQ3(Z9@<A1N,D<TR<UO;MA`4J4[`$>@ZG]>+U
MY_\`%G'WR@>T$/0-E.AK]UA5BM@7,WJA2R-76;:W.G1E[4`_&UCZ744IY1:B
M2K:*6L$VE=06G:L4TZQA4VK26Y(ZNB?9^Q#(/+W9GI[?]7CT]G=CU8:@46KZ
M<C>JK@VU=KZY>^;9Q`X731]@1$B5`26;6C8D;Y+`VD/RM?8E'F!R.<@L;CY@
M)#D91RPL8DN_#GVW^S';UY54L:>U)2OJ[2CI8IOVPU'2W//3,FZQGU?TC?L`
M=XFXL</JY2@<.C[+E*5?6W2C&^_`E":O6&()D[FA<?$TK2X&C-ZU)O;GKJ]>
MW$F>MP[U5-*VYXK-ZK"PU-F7%)#PUYT:UU7>$M2<70U`MA4GLN\#"JECC](6
MBXDC.@2-\-;-)BURM_/#HTPAO(<MBG9NWV3MWJKW0]:V/-/4HG:,3??T-L>6
M6;ZC2+IJWFU#9$+THY!L!@K=OX4/C%FN#>3"CU[(C"W'PU.UFGKX^O;7P>R$
MQNEVC+?U^.%WA566Q*%QOA'@/FF?U3>C#<BGH#HX$2ZA?ZWZ0G\CX]I.N>XI
MG+7NQ2WV(QZ4S1===BQ2/-+1$-*2]FNOQ':]8J"U%'Z4I>;[8N\WV?[&2QA,
M``P'CL!@`C#XA$#?E'K0@^(!Z",._#?_`$WK6]?]\YN;]X#`8#`8#`8#`8#`
M8#`8#`8#`8%3^]/\#/9_YI_17]T$QR]O[3[6=5:O1,_VCO3K_--I_P"Y='E[
M_P!JO=^U=1<RRX&>BA_;OZWW_+A>'W)0G-]W2?3??TGT[YYA@P&`P&`P&`P&
M`P&`P&`P.;=G=R7!7?8C-RJEY&<Y,S2"N9=<[3;Y%Y5ZU-Q]1UNY5TP6/*38
M0M0"D9+M'9'9:),G:O/M0XEEFG%""`.]:U.V6;K63-U6%1ZY_/BJHX5:4.B8
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M/6?K6+5_5%A._/\`<J=+=K/;M?5S&`Z85LQ<^Y*<LD=5/'"#FUM*ES0--L2J
M4)5NV!W$K,871$U+E`3@%I];,>'^?'N>-3$+U*VY!TD1QJ_4=+FSJ1PMV`15
MEK-/*&-P0/M#RZO%%C2'K!JE7NB1.?4%>$L+VQ.GBF"LU*FXEK"'VK@E&*>/
M&^AX\;Z-<ZL]5:'\P3NW*T5U.Y2645S-.1J\979[L2&UI6SW*.NR+;5QA1,[
M%E?BSU9$8FGJ%86M='`"C2E:N1I4Q1AQX0[3MTG;J8.M^Z?R1J$I.U9?5J9Q
MG%Y6'6-1,D'76Q"(?7\2L2QX\[R#W>>WV_AU!X]#6C4?5HRGG1!P'-P&D3I2
M!F+"PZDFW$DU#%P>IY)JR>;?2Q[D2Q;3C_)=3UQ;';,DB%CUT052"6?085G+
MHC7K<[*DBB_I?"*X(,?G(IL$W)!-IB;W90>J5%I=6=N^O5?'_;<I5ZFU?L-+
M]EW>TUY(I5%^0K,K:O3`-;XT$CM5):%>T%8T?ED7/4E!+:6O;/?J(.RE@?;"
M$B-WKPT8#6GCS)[IGHTB>>J$_P`=BO5MV0WE*:SCE?D<=[QV:7LHLR"Q-3-K
M#YY2.R2?L%:5JN+<)$_15#.V53&OCRDY"6-S3GC)3'I2MJ-O'I-YJ^/IZM/L
MKU6K,J:3]<-TRXGD2>)<?T$7TC.9B@OZLEXGVMI0WVHJJ@YCCA;>!S"[SY74
MJ\A0F-%K;)HTDQ0(81:\;X].>M/%E3?5&LE<DH%N@/'P;HL*^6CH^7-D+I/J
MNA+":T,+YL-JXB3*FBR$2])7\KF+XIM`@A*QE+DQI*A*,!YQ>A:%J>/SP>*>
M93ZCE6%\DT%U55,+G-M@ZLDM8U[SO5"(IIA\WF=H6NH6IF:#R57)EY$?@)L4
MVS.ATD6+%!B=I3,ZP8?>!%E@->-W/8\><]E9Y?ZR\1J%?%(C??/%@57923K2
M*<L7S%02Z*3%GHY'.*E4W7%[_,F#&$""<4>K@(`K%2\@A"N;2R%WO:4D2$P(
MGC[=#Q]D]SOU(8S">)+U[2%5CXN:*0N&U*;5P-1+HVS+']WK#IQPYC/?-2Y?
MKY.L#`[/B#XM[=5^Y1MXM^UWY@"WCQ_MB9SBKI?K6-+HS<_"8>>D)4FO.?=+
MUZ7J==.4=7U6)'+F*45M%9*[P"\79>K@%R1^9K[+3ACY[(9[1>:@6D^S":F-
M"&^"^*<RO5JHPVQ$M1`;D&[44^H*X\%BK35CP?=@D&-Y#F<*]387I9N2:KDT
M3=Y0A]VT;^^!W[3PR>-Z^F:>-_TQ9GJZ57['U$3TU6SDTC@F`3VS&I6I<F5&
M@Z8AU4JY[#[.>ZD6CV842W0:XZT>(BN.5>(`.!)1NO$HX./'I\GC4BW?ZB*6
MI>C.8.<FRKV5^?.DJZU9Y$CF=YUO3S3&F`N=5[!E+,S)YP(M59,\$IL,E0D8
MVCS+EQ24W10?'7CI.W9:F</9TAWO*:FMV<4Q2/+T^Z@E=*TLS]!7^**S>#P%
M'7E=R=QER&',L=',E(!6%;$Q(KY]5M[`1[D1M*WZV>O(&H(`-.W9MI)LUI-%
M>J5!^D>JVCGNJ((U+84\U'3US-EIR>Y:^B,HD$1O"ES;JAJB&4*ZCU9,Q*1,
MOLDSN<CT(IK.,$,[>@E#Q>W)M7QR:U*V/4^M*F[-ZZA4NXLD&XMQ]0#[TU-)
MVVWU6JWY15,:AN,ZM'!BBH6X+R6^6&XTLX)C$!HO:,VE!)J@0PB\-O&63GJ>
M/3GJQ%N>L]2$(3V4?6;#%[P35U&N,715(HI?%4-M?:D/95Q32G62+2>Q%#DN
MBT",K1PB(7%^6.9Q9)+>M+,\`AUL6T[;2=M3-T/WDU4SQM4/5,TIV&2Q98MD
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MN&7J996Z1:5.JQA4N95`6YBD#@F.;%;T,M&(8##BO/?#C=/'A97CSU`S.EYL
MBJFQ^?YWSC:4DY_A/4U>LDDE4+L*+631$X6HVDB5Q6:PA><04]19]<T:-\9W
M%(@6H3%Z4PO2@@[1NI>W.?1+,Y]$2L?J<,5BR2#G/_+LR!QK=O1SWR36/3C[
M)8"\,,TMUGETG@+2L?*9V:?+F"IIM9T'7L3'(%`CAJ%^DIBA"E3*B5&WCGVO
MC^6V\?>I<W=7\P6]U."J&J%Q&LX0YSU!%6>]*UM2<.C4TQ>12=4U31BA8A*:
MEE6R&'186QZT%5O9_FV'6BQZQ>W+A9EQ"C%ZRS<D@*216_RG:%0S.55!SOT-
M5,05SFO9DR6O1_0EU5/2!$LC,ZC"X]&W2&M)%<3.?(F)S1(EI"=60)/M0`[1
M@+X<\4\?9JYOKC0Y#^54<Y<Y2H:'FZN^N+(0*XY;=6RQ1*FSCVYPTE-6N>,;
M.O,D=!O,ZD!P%L5#)48"'MM`H-(-%[N,.WAT/%.39ZF$UER*F8=5O,+?;_1%
MW(;:F;!6=8].4Y-*OC%04T\QF,RNSYMT7'?B<);TRB6S)M9D;4@1N;D:Z'B*
M&6662<<7/'WO"9^&&D?JD3FJK2OV'7_R#(*J@/,-`I.F+FLM#>%;S\UGJR0I
M+4)@XX["&!(G>93+);*:D<&D#82<7M,<>F-,-]D;K>7QXXO5?'CAJUB^KS)*
M)B=@'=&<:3VF+09JB@%[5C7#Q;U8/399E<3:ZZXHEW"Y6,V&ZC5<32K9=:S(
M;*&YP`<E0H5H#TZU65HT93PWI3QWI7QCWK(MLWWS=&8;SFX#M#H:T^A:O;V"
M:WK4L)K<"OF:5Q**3]?6UVFJW>%WBIDJF9IU$40QX)BA]3(UX][2Z0G;QXGB
M[7YADP&`P&`P&`P&`P&`P&`P*G]Z?X&>S_S3^BO[H)CE[?VGVLZJU>B9_M'>
MG7^:;3_W+H\O?^U7N_:NHN99<#/10_MW];[_`)<+P^Y*$YONZ3Z;[^D^G?/,
M,&`P&`P&`P&`P&`P&`P&!5J><N,D[Z3BG22J6O+<\17F^Y^<2(NF0H#6E6T7
M-+:QECC*#EIO\.+=F(^LB24Y(?W@P"LS8_LA!EER8N\8Y\O'HF4DMINN:A9;
M"=8B&#<.O7$KM+XU7T$:W^?-3U,Z`F9EIRT2)&F"X3).KH0DH)1@C2-Z=U0]
M[\^M;WKSO^U\KN_*U4`X7.CW<TQ[FF]N[FDQ<*[F=102+L-4P&LRV"N)G,(O
M+O@UCS&+$BE5WN,/W#D2&/JGDTL#2D$JV`D2A6<?N;QB;QB*U_I,4.LH#I6E
M2%;>@D/4E\2B[+)N9-7$$U8SJFD72R3I!+7+ZY;;O;2V',"Q(%B2E.1IX0MN
M_'R:']C'E=E]E\KNL&D]*L-=N4=EG.'24OHB<UE;?2\SI!8@KB!RZ#5G4/63
MO&YE;/-7S;N9:!F>ZK2V7'`2*.Z*.;E3`M\A)`A)`"(->7O#R]VFR/T5:BE]
M?PNO)/>%PO*.L(/:[O64E-%'T4QB/9%U6H=<<W[Q`[M*%N2+KU13'80L*?W4
MIF8FX]:D3D;*7&ZU?._Y_P"'E5]FKEQ(5U#`.LI'-U<CLB'<K/G,3F4&,L;0
MVR4F26!!+%>9V+:7VJUF7GO4)V`MN(,$B**6F:UX["'>\[QGHF\9Z(0NW@5T
MLJ7]43F%74AA+SUA&.?X/.V:<T=7%Z0`J&48V6FV#83X)/\`>F=_+F?SF[4'
M#5^.DA[81Y`F%C.+'9W=/A9>GP]K]P2-#P?6?"%4W`*-PVO:^B%4+I5;E35]
MT4*=U[&HRHCBMEEL)GQ"6(JE+H,9"PHXLD!2$](4662)-H1`GE_;RJ;SJM!O
MHWM<9@SQ4%+]9W74].6SSO3G,W3\4TPP.;R6[8-3-=?,^VR5GGTD:1.E463+
MZH%N//3FVD*4YR`I,),D2J4Q2C5\_6SE?+W;!.O2>6R@OJB"QSJ"303GOJM_
M@\LDE*M530%P%$)'74#I&O(DHBUAKSMR<+4V,5$-.O<C]#*&(T[QW]GQQY=.
M.8>73W9:<^EP_/T3ZMI*&=8SN$<L=<'7U(YG1*JM(!+3X/8'1"9W6S]]K*R%
MX6^2,$65SQ[4R0+$J*7E`<5!P"E!*4W9&IY=+G,)W>OJE*[/3EB-U%=I%N-G
MRIA_+.Y0J[E.0B0,K(K^0K)5Y-OE(9@PA5Z\KH\NWSO'[/3*OX,#W(K0?_./
M$[LSXJ;T^$3O/IG6XX;H:1,';#S65H46R]$0QKL.J.9Z'A1:Z!]%ZJS<A;&N
M!EM3A!(Q*H\?5I!Z)[*0J#AGJQB.)'H`0[3NGMPN_A-<I].2J3.2J$Y4JJ83
MBHRN59)6%@\[6J@.:9=.(3:%3J5:IDG,B32A`IC\]/E(G=S)D:-<F"F=TSNM
M+UH@1@!E/+G:DO.HH9?2FAKO*45CWS<,EOVS)/<<XMJ^'^1PN(QN.7"AEG*$
MWX[:*K3PIA!IO@=:PNJ9J;M"G3'*UQSAHY0I5'&*1B"\O9?)^8[Z4T9C?IKR
M7TY";YL-\9W^2OTJU=LM8HU))[\5=[]#?I![\SK0:C\I-3O)0$*D2H/_`*@G
MT,P[7G,%CR_MY'E_;45I/1N-8%522V*]2.2>SJ[L/I*RGR12WGBDIK`Y"]],
MJJ@.E2&)TTN:T$#JAGC9=,-OPH#.5[P6I5KE1QQJA6<8.^?QP>2:5GI6U>-Z
M-F;;,SFVQ@]^/_?*"P10"&+).CDSRV/*)-5AKH8G+<EL!:U3L%0'SJ-'&^P"
M`7@'>\GE^,/+_P`5[3>@Y0$:KYLB5=7%=$1DKQRQT3RM=DY=90_6`9=<<Z6C
M9(IU+'"'S:2.T,KQ_)MTC4W)(C2-L0FNYIQ9Q1A9OB&^=_V>5_VMU5/`JUBN
MJK+\O^Z"NE)_4%+SBDX<;(J8KF&M#<R2F>5;.V.1(FMD+7$MDNAJFLM)DRY-
MLHTXIQ-V+8=@!XS?2);[/YTAP1);;MV:W/2O3]A<P2RYZ7:.?;_U$(9!9TCL
M:N(RXRU?$'9A+FJ%1NOK6AQ-@/J5ND"?WLH*5P\IZ$\:=.,M.[)EFDK:N8O3
MWI+E2S9S8D`3!7A?:XYTJB!-;^R,J]RJB$<Y5)\SS`U1B8FIAR-1\IXZ$!CF
M(PT'M3M;\=;T,7BO=:6ZQU[<`Q:]'_M%^<['D\>-[.Y!BO(<B3MK2SJBX*P1
M4=VC(FC`-7^[<GU7\]BGSIU7\&#[@5X?^<>)W9GQ3<SX0/='I$5C9*J>.,&G
MR>GETSC'%302CCU05H\Q%`_<4W--;HBTG>(0XMZ>/3(<_=YA[B](W`H:<:!&
M6`/CK>]:3NL7R39>G"CS?7*-5<[22[$S1+ZHLFHK4:[39*3KA.P.4GIN<$3:
M-I%E([!\W9485FHR4JEM`'W<9`-_8\1;Q.[+J2Y=5_B7I-/5-MT">>;^QK3I
MNX6>MK*J6R[1W7%5S%'9D)M"XI;?"E.W5HX,S;!ZO<:VL:=NYD)^!D$ML>;5
MPT`T2Q/H(=7RWK.%\O>-*E/H,\J2Z&RR&N<YN<M.DYMI_F:@71LG\GCRVA(O
M2Z=WD$<E6F^+/K#&;?F#I=;T;.EYLJ;UZ0Q[+)T4G)++UXO._P"SSK=%7H[5
MXIF=@V<"Y)4VV?;KYUH.V9JS0N(-+A84"Z\I&-U;+ZRD6D@`'KHQ"YE#&F91
M_1QQOP]V2C)`'1!YOF>1Y)VX]]/S?,\U1VK8E_S_`*.M*.T#">6J^?93&83`
M8Q6U$098D=DT2B<+@K6C2C=Y.^-J18]N[BJ7KEYB%*6`1!!`2MR]V\);O1'$
M0]+1#%9M`6@WHVQ'GDRH>D'WK*IN45<2A"9KB=QO$IE-@MR1PM=*A!.9)54)
MLF:N+^QQX[18DJ[:8!ZQ4E2$I]/+XY7?RGRA>$ZWY_XMUQK%7+1C8KIY^J61
MV<GBT<8IA+-/K`\Q\R7R(AG3$(G.0IDKR,01'",\=A\-B\-[R6VW4MVZIJP^
MC2TJH`ECMN]56K;\RB]0\\<]59,%\+KJ'L]44?SU=-47<EB$6@T6:TJ!>_63
M(Z=9R9$^N:M<O4)TA`2/=P$:+%KSYXB^7L_DF]%&IW:/W.TQRW)/"73H:M.T
MZMNB1,<(AGOUB,?6E]+^@HNY2@KV)('J1<YR=X7M\96JA'&FL[@I2G[T69K0
M7G?P>7*4M^F_9;:;4%CPGKE77/3%+M=J05BMF#\YT]'*]E%-6ZZQ612*JYWS
M^SE((:ZHV^60MO>$#HA5MCD0XE"&(PPHTTH<\OP;/;A+4[]/BO[@D723U<\U
MDLZ2=5<@5AR+:C4B0-,4T)GKQ9;KBJL*.+&LLXQCE;^XV\I4%E!`-*W'(4XB
M0BUYM;>69GI4U6V5>DBX7,UR@[I_K>Q.@)TMKFKJ6@TP>JSK2*H854E?7Q65
M^R1H70UA1;89I,[BDE3,Z24/2WR%J424!:5$D![0!M\LZ1?+.D?&U/1_:;$H
M)XY+:N@%T0YA?[VMFW!5F&DJLDSG`(U:4[;;*25U1,P?4QJFE-UK+CGP<9>F
MI()8T)7S9)!81(TAI:=V7?4\N=]794DH)!)1`-C$`DHLH(C3!FF""6'0`[,-
M,V(9@]ZU]D6][WO?V=YAE]<!@,!@,!@,!@,!@,!@,"I_>G^!GL_\T_HK^Z"8
MY>W]I]K.JM7HF?[1WIU_FFT_]RZ/+W_M5[OVKJ+F67`ST4/[=_6^_P"7"\/N
M2A.;[ND^F^_I/IWSS#!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@5/[T
M_P`#/9_YI_17]T$QR]O[3[6=5:O1,_VCO3K_`#3:?^Y='E[_`-JO=^U=1<RR
MX&>BA_;OZWW_`"X7A]R4)S?=TGTWW])].^>885*N'IJ15-8?R%#1<OE;>;6=
MAVLDFS=,*Y;&`V,561#]S;9[<[20B5$K&U?.VT@LL#><)1H9IA>A!*WXV38N
M<:R\<[%YT?:T:K2.M2'-<<7'LC8M,4.X3=M;\]Q<B9%-)N@$!/4EDQ@T3EM8
M65M&)K*,7>TTD`,T+*9=Q,[Y95?1K2D4@F<;:`HX@XS]4->[HTX"(0TG(T[G
M+#!C-T#3`A.<"`FJO'V0=F@\1?NM9$1Z9U#SR4JGB,RX(,6HK(AW/G`!/1`0
ML/R>D08>_IS#=_O2YP8I>84TK4J41ZE*Z*"$AH`*#R2QW*N5I]==B4E/PH]#
ME[!'E$@LV=5K!TJ]X*-.F"F$2T$)-=$F@D$[:BG.3'%MQ1*S1)@70T"#Q$K$
M$K:RPL98'6M!.[.Y.4,M&#RXY+%I7+$?N<@`G85+3$4KH>XN;A+?=5+&QQ_9
MS*L*"Y*#-)3!(E6BA&B2GA`RF6,@Z=7<W,;]*HR]W57K.^0A*[K92B<Y"C0A
M:4T>=&!BDA@EBH12%7\FGZ5-J!RT08:)O7KTZ91HH\T!>V4RL@DZ8H-<3!3T
MUJQ$8+*<US+"PC7B(/=W9K?28JXMQB4\HM2TJT,L5$M)H%H$P@.IY2+?@I-+
M*$RF5KD-ZKJ:PK7D]90N2L4B30VO54^DTP;WQ&-D:244N<H@I1'[,`6`Q$!6
MSJQA<BS1H3/=#P`'L1)GE9P8\H>R^;A2%@C^[,:R-R2MYW;3<^KTKBU18$#K
MES9&N3/JV1.J1$VHTI9KZ6:G$,>@*4Y8S2Q;![/9C*8VM)TU0J]NB;HAL^-+
M29P_N,6C"5*:K4/#C(&92D2/C89'R4HWUM.CZEQ3`<=JDQ`&_:HCWC96CBO.
MRF5#X.YZC2Q6CI9(5B"/H[;(:/E$0:^IG)35KD^TL\W:UL<B(;$JA2XO*J.,
M_P!A,06`\*<T*L0`D?9V\:8D6==6TG#D4K)13R*2F7QZMGZRFZ&LT@1&+9*V
MM$%7V,C;6MS*TI:MNKY#T&W-,GT8-2-J%[\$H237M<93&JN7:=)MDZA\`42J
M/%O#LTRI[G>SY"B3$U<W1"NR;$>3Y*<>4%*HVW(%B4E8`HW1B`:Q.)0$'MBP
MB93.$J1GH:DID]1"-Q>RHN]R.>-CZ\Q6/(E@AOSDUQ=6X-LD7&,XB@.+80P.
MK6H1+-JRB/=EQ>TQGE/WHO;*96D*^M*?8;?L"FIO*&.#R*$EQE2D-?WE.07(
MD<AACA-=J2`;)`6U^ZM[.N`4!0;HQ<)$HVGT/V)F@L,N:EEPMRKVIEE<C<9_
M$T;!!D+6XR]X.>T(6Z/(WQL2/3(:YJM';*3[>&IP3GI`;WYU):@K9>A>U+\T
M1IJ'IN@W%]88PGM*+ER*3-`'MG95RA0UN1Z$U&ZN2<"I(YIDAS6Y+&UA7*2$
M2K1*U0F1'FEE"+),$&Y5RL)&^P>7Y>N1ML9O*NWI8O2+G!&6B?B#`'MR%@42
MS;B%1O04^F]PBJ-0YH#]CT4YMZ8]2D$>20:,#*96(!V)1SJKA9L/G$6E\5D<
MCD;'(YHVR)"F8((BC]1RNXP25]4+`EECCCQ%XL(U(M",*10F.TI*.,)`+>,J
M8^#EVA00')E8(_.V-\?Y-!;!G["4I5J&!@VTUD]1QAEB61R5S0:11%T0N$E)
MUM,O`6?H)9FQ`#^X\[*N5NF^I.>-#G1?SPP;S5H!<.:_^LD["S":Y,9"71-H
M>M>1S7-DU+^"J4Z/:@\AX&6A,`%4:64)E,KPOW5U",%9LUPCL!M=Z\?;&CM3
MH)#'25CX3J>2*>IJU"P+4R$@Q6W+F*6G&)G0H\!9K>-*>`X`32]EXR]#+T:U
M7/7U662PN"QK?(TV2=BFIL1D<0>I8WMRQG*)NM;2?Q3XDI3E(G`9S^BT$"4C
MSF!7J"&\T1:DT'BLL+$JH;UJ%QKIQMM+/X_\VC6(P*N:J5!J%AWX')DZ<:-8
MN)3Z<BG0]<G`@&FT:!Q$H)TEV=LTOS,O0R]&(,Z3HM,,(7&RXZR!%!G"R=G2
M(:R-I"H4T-1[\\/:A8_)&Y(FTS,*4U<L3F#"J2(BAGFE`*`(>F5,::/KZE'"
M>5/74-ES+-9+:LF(8TJ!I<?8J65N5U;-K62/:LA4E#M0(]AB)(_<="`L`D=$
MRP0-)C"QF,JY6QVITA6]+3^!0NR7IMB;?/HC8<H0RIY<0)&Q&97SW630K;5!
M'L#3=%*2+'TL.6C$6C;TJ`TQ0,`!:$%FF6O8_=-<_P`75SA#(K=@[*IK<M(.
M;`<7I.E`Q"6NS/'R4YIQGE)6+02"1-S>:G3"./(7N"5.:`!RDD`V5,K0I]V;
M1L)(T:FF3#(S6^?5Y!Y8F0NH4Q\5!8,D3Q1*\J2CTHS'(+4^J0(5"5*$Q0!S
M%I"/1:O>B<95DU+$=O:FI<@;7*-69#7E&[K(TVMIB%\1&C5.4QTL^3+8%/LP
M*D#D[C;50"TX@!.T:D/+$$(R#0@94QCY#T51\2<I:TRNS8K&5T%2MZV4%R%=
MME*;4KH\,L=1'EJW(I,D<@&2&2-R`?NIA^REK@E(,\IJ@D`V4RL`7UIS6:9$
M"`W1`]*9V(H,82&/!9*Q;LV4JH+KWM&:`"IET5.41C(;M<!-HEY#I"9Y50@E
M;95RL@3TA3[PZ/$?B5@PB1R*-RN,160M&I0B;#$"B0SI)7@QI%"HL1#T>BE!
MYC;HI)LW1KR5\.V,M5OR:93&EJ^VN82FZ.NS9:[#)V^4V'`JQ9U<3TJD)*B2
MV9M;\BE&C&X@T`XV_!;%6T[J7L;>=M*>$LT8R3`A93*]]E=8U?`J!L/HIA^-
M6M"ZZUH"Q#7"0AQ>I&KVZ-+66BB&GA4RM;^-6:]$#2G$JMI5A8M;(-,\P?%)
MSAG./W(.KZL8;.JNM/;.CKNUJHFUT-\R:B$RB(1^!PYN:G9*Y2!6-64Y%FS)
MO6JS6@M,E4[/`U+-C]G[,'M&4QCIQVSS#7\+63E]MAA-;4D,F<]`U-0%KE*U
M<<K\]R0RY23%2$WQQ.:R/+2<W*`*24_N[B'28W8#=Z#CQM,K.J.JZ+9322I;
M9D#C(G5[5-L:+4RA*I5.S>B1PQ0K>7%$`@I3&4S:=/6LM=[\$LIOTO2"4&EZ
M5%:VRF,D[=#1!DZ1B?,KBUR`B6S6KGVSV&2[3H=P\\MA?`M)L/,6>_\`Q,J7
M+T!*US2D^Z[3FH&Q6/VVAE>03.-,XUH=9]K4;9+3\6T]J8@%PM>Q:JB2"4E$
M%NLW.KA_3,2^;QUN9U+NIW7[N%R0K$SFJ"F*+1N*42K2<9Y8-KVV&,9KK9P4
M5M+KG1TE-BJH;((=/X)*WJ0PIK6V0R[5("F=8@B*=Y=)9'&Z6(%WOS8<XI"C
M1H]:VI)2FC`3MG.&<YZI7DG3-`1%O:'20VW"$"20(DSA']!>2%JQ^3+!/@4F
MV1M0>].3N<JW&'/V92<HPT?PY5X!W[N;Y&5,KTMG1U#O<T9*\9;9@[O,Y(WM
M;HQL36^I'!0YHGV,ZFC"-,>D&<BV;((?YG5O*V;HU<W%&*"`F$E&#"RF/1)N
M@J5A;S*6"8V3%XHYPJ.FRR4`D:[X(C:(XFVTZ6NYSHY%IFLY*V_'D/O>RCC!
M)-+2-G:!HXOS,JY446?VYSW7%3N5J`L*,2`C4?G[M&(^G=]-KK*'*N`:)D3!
MHM8EVHCZM$]GI6T\UP)(*2KUR8DS>C#R0#9=PRMFLKIR'UM9K=3AK!*)19<D
MB35*81$XT2TJ'*9B=9.NC)C<U%KG5#M*5'M-YCB\N*OV#6TM8=GJ%`=["`23
M>3/5GG3IR@&13+T;Q;4*;E<#<&QGE:=2[EA,;7AX>RHPW-!'[G>G=T42L\MH
M]W1>\'!=S`H1!"J$$G;*97X3=/\`/:UTA#(DMZ#J7:QT+(YPQO(>"35+PADK
MNZ1V.J!%@UOX:!\DS(L:DFE?NXE#LF,0@T)6'9.,IE:VZ=C<Y-JR+("K+:'I
M3+[4:J;:`QTM6]@U.'Q`^N#.2J&A(-"2QN9<;6`3.>O.@4'$&`*-'LLWR,IE
M?6F>K*INNIS+1B[P0J,9J^8[`FL/9C3)'(XFF>8\I?PMNTK>E`<_'!&VK41)
MR(LPA6N0J""A"-),`!9EPLQJ,5[3K5<S4V[3]&IK#\H(^2*ZD*<GN-2Y"_Q2
M-PC=@*I6[22"ND@BT=1A8"S-'%GK1;(4E[!YA@\#<88WX?5_/.FAM?2;08%K
M2^1)_G$><$`7!6BDD:C2.0.+FNCRTI$)&]&";8JXJDI"<PP]<C1FJ$X#2`;,
MQE,K2(CW;S!,R%ZMOL8IO2ME:U3:BM0_-#NS@^3=T*G-#`4:0*I'HUSDSJO;
M/8:;4H3E8CU!)983!C\NF4RI)2].<^KGJ%QU#;\%6O-AM[$ZPY`C?$RHQZ;I
M0N>&J,JP#(V82C*D;U'US>@]Y$3M8XHSDA/G4EC*TRF5O5AV=`:H8BI)8DI:
MXJSJ7%.T(E+B88(YR=E12A20UM2!*4H<79Q$D1GG[(3%&FA3)S3A!T448,,1
MB8Q=M1360.$6A]C1&4/K3%62<.B)@>DCN!NB,E0(7:.2!<M0F'H$K;(&ER(5
MHC!FA][2&:.*\Q7B+3*(;EO;'/,5@[S:`;$C+_7D79ID\R=Y8'7XB])"X>WQ
MYU,*98H0E&[R0#BWR=&H*/3ZTFVD5)E(1C3J2S<OC>GJN5[X+V!2DPD-E1==
M,([$W>MG>3%+"'Y\3)`KXI%HE%9JY3'9ZLI$E;4:>.RPA8>E.,]Z3(M:4F!"
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M=$>E)ZPLA.0%<E$,P(52?9C*96,#USS,.2;B`+MK\<DU(_DG\)`]DC4;?PR!
M1$5"+0PAV1LM!,$HV96?H?NZ-X\J$\PM6,!(F7J95B\B*G]Z?X&>S_S3^BO[
MH)CE[?VGVLZJU>B9_M'>G7^:;3_W+H\O?^U7N_:NHN99<#/10_MW];[_`)<+
MP^Y*$YONZ3Z;[^D^G?/,,(`MNC`VG)$L@%)=LND]&WY3&T>FD+AHP-X&UB8*
M0[.$O2^&XW\W'AI+Y=Z5^^;\3"O9_N[JRJOV/P'\KWB/R5LGK?IRC;'"HNG8
MGMIFS=%G6/,58/M7R1"Z[K>RX#)-?&T3L2K("6NTG(]V&E-*4%J=F$WR)<2)
M>G)3S8S<U,M:SN.U@T#HB4\XOR%;!E<N3I*[D:B)JTRF&$:E[#\)?&744TD)
M]]&O3B3*]C$'VA`?:27W)7BEW&9[ZCBAS/8:=J?X%,KHL6*JUD3VO:12^S.L
M*\ZMC_QYM3R!O4.#%&WZO2FI<04H(/<TZD:@LY(<`&LOD:C9B]/YQ3V(BL>8
MSN)3M?(9@[R:S8^IBT_BT55EG7=(KSBP(:R1.W&QO`X1!^DQR4)TB*D!2X:=
M*M&44<4<6I>7&+K-R;A=\=X=6<!8;0:8@V0KG1UH&52IFA[P3+;)9EM?2^$H
MF64(29PFAJZ!M;U*02)(A5-ZMP;G1(9I$M3!7*A[;_ZFHS,Y3LB:V\5"A*79
MAI&MW.[),RO\G@$=2KETAMKHZH[_`--+:^([-D"^?-GQ"'NY!*H3/'=(D:@C
M2P*Y:`(M-DB[/Y2?(."&YZMT^RUDH:)&TR25OKC-X5)D$]2-2R.N%DI;.9D[
M/J%69%&\]^8'D*@'M'E([(%.S$YWNI0DH@*GEPFMXI+E.65=(-N,EL2)3=AC
M?/K+S;7\?W6FVK>H1&7MS<VAWL1P-ECGJ7O2UN6)T2].F(;4!ONQAY190E9A
M9<M-1>'A*<*8I&XVNN5J)+8FVQ&IL;R(A(WF.P5J>YS2]GUG&H$CE5A/+SN%
MUW-Z00Z,:G1<L*5M#DJ;T@VU,4C+(OD:D6(<OVE$+A5=!I[.@B^SYTM>D=M-
MRBNGPJ!K8DZHJF:$"&O&\F??'8M(6!FJ)&`2Y8M<BG8]8<8I(`$I&6G;,ST-
MXQBJ,X<)HQGIF(,UC">(523V]2R+MJ^*DA>PR6:U7,8!8`MR'XT<J-9WJ12T
MU\0@5!5K6WVI[?I4<B]T`D>1;K0TGI]/R."$U"7;[2*M-?#)4H,%7JCY<F66
MU<X(>>2%9+YJ9_#"(*8%M)?!-_N8E^AA&V^^[0CUH#R]5WU?"<>GI(IRA,AB
MNYFINK5J=K;F$2;TE=KM35--[=4))`O4O\R23YM/6QF.S4@]40C0$MJQ8W*]
M(S%A8TI2L3R]?4U+5=<T3*F9`V3F"BKQ3+9$GC44L1*)/.0L6F1;;+U.[)G#
M<ZR^:SB</$O>(RZ:1)B%KB81MS**4F"]W#M+J;J:^T_Y;DTDMN:3T<]9CZRG
M$MHRQ9?70:[`NFJIXYV,)>(XS1V:CE:5!MKF#RV(O?R5C8<(M,G-((&#:PPX
MI+^3>&F4URC*TG)R.O7R1.46LYSLR-7*UO$I;&Z1JXRLJZPXH_\`/\3FS&S/
M9+:_$PBL:PB<;>B$CF#:KW!080K`:,!X;;SIO+./_)MDS5VD1DJM*%IXW8\\
M@-QV2SQ^N70IV':-:P^*Q"/E0F2.<Y6&LD#7`@#"J6)%:9:NV)(L)*5%E.._
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M5%:_!C?'9FU`5PE0MZ$7[$<TU^V/DR6-E+*JXW8[*B>F:YH7<M5)&V,R5=5]
M6F5V\PI^C5;LL2DT]>I*JK4]VB)Z@UO"]I@MHG<XII]P3I$)1#>=-Y1Q9?"]
MC73+7^4V5=[2LV^QV<-R=O01*9JD$6.L/G22T*]1F*,KS:JN(-<$0N$E4R4`
M=-7QE>N4FD*5VRO*+=G=DQ9<;_+N9K2;[!=[%KJ<PQ:VM%KS+I6)5[*8@OTY
MO5S//.,IHMKB[[8R>3[`TUQ[\\$NAAB=G&Z%@\Z,)ON^@8U-2O;5`++@+VJ>
MI4C:'E7SA>]#N!S?'Q*T0%MZ$5IIRE+<4K=@*24C$IKWS%H!F"VJ`I#H9X-E
M>(Y+AN*_QS@9`Q2QV=SY2S.:$BUFZUH6[N#=/7.8QY0MZ,@?1LZBAA;O9KC7
MA+-(I'!RTA2EK86Q8`G20P_:@U&,:N^1K`E>GXYL[@Z.L9G\63/K)<(+:K&4
MR:,3^9/#6F<;X!?LJKZ4M;U;8XC\`?'].0B]\C[>Q+-`3$+!^T5$_OCR76;K
MCE:21;I*O):Z.#BYM$.BML6%9C^2RM3%";"O6TK/G\L@Y\49S)`^2-`DJQIN
MJQD_LE.S`@3/39L2I2H*&(#>$WAH]Q<3V^\RM_M!AM!)+Y>=/64R'$O[#(7I
M2SQF2=<\YW6;N0IY/:)L.W&J6C%1F-Z%KC[:PC<VTOVIHQN>]&&)9T65Y]\5
MW(X6?8:5PG<2(AERU\D^>F4)Z^UL+T^26[)U/)-%ZJ1F3HQW@QS%%ST3>2K<
M?BQ!XENW$01+"A%;NS#4HL_$<@)65RD?K5:UL7HTYG;:=1M4$-:WPN*)KTJJ
MZ71)8KL;+%R:52`\BH&IE(6I$S<4'Q4.!Q!R@_11,U-9PCCAV8V6LD\8L9O)
M>:P@'(D';#G2('F,[KKEN13ET/7+T#;)D"HDF:M<\4$%IRS_``;3R"S-C4@V
M,K;37N8.2G])3=D5*YV(V(6F8V;%IS#V*+QIY+@M3,45D,%D`(5!X_)YE(W-
M$Q/3G#CUHT@%Y+8W*74TM"D)3E!+&WG34>N/`[V24YJHG>CQ'7]*[V2&`/*6
M.*D*V"5W)F9`R0"IFIT8Y8U/R6,5RW!<4I2U$K0NAJ=W/$G.1J0%'@>1KTPG
M@HV+0FYXXHLI&8ZW'5-O5P:O;8HZA1Q0VV9G-9F<L0#D$VD4C>D#"?,-)_9+
M'':A>%+HTPXL1GD+>2ZV1RXP<I'JXG*06.W@D-T5K=\'>C6>'&DM3$XW@P4T
MTN[DSDKI*K7J&QE55-LTI(<?H:DM:$!AH=D><QJ:VV_>45US2QYG#%:"^MI8
M;`(?#XE(FJ.$.[K"W6-S21OCE)FTT]W0%J#Y%$)>Z,)I`@@"4G7&&Z&(7@#4
MEPEQKL-X_=:LL55-*YF,4+8Y$IET;E<'DT'7KFH%5R9ZC;LWQV(KVJ7-:MCD
M,:(95*0*LT*E(XD+"]GI@C1D[$TU&;CP+*WXJ+QY]M2$'QRL:9FM&5K*T=2&
M)+A.@4D;FQGC;%8DQ#./A,F009M;`""!(W-Q;DOUI6,M.;[31E\EUME'<P/"
M6Q9';DB.>(X%'U',['KF*2%M9CG5IJK==6_#D,/`)G=5:1F;W&U+ZFDL1&><
MU1IM=$R0TDD6A!*6_P#B6_\`C/USQ637[5"VT%@[<Q1"P*+G6U.HJ4B&X_,K
M1[/3)36((7I1M.%_+:??_:^8?NFC/8:`9K7M-S2W6DV!PE*++M283Z4W8<XM
M;O\`+-/&FYR8)(].;&QS)QKQS+BGD<K"'"F^-Q$<#$4B*:F1N.6:7B.6F&J0
M&&J;.[)A+CT6MPW*YFONQ=#+>8HL9T"R69"9SN1UH*8Z:838B.'@#\E2`S-B
M3DR=D5QE3KVZH)R164XAV8G"-$5LU*:EFW^5-V/<[7T!')X;`K5A=;)(16DE
M21XMU.C*H$R/E3^4]%B=F\,JK^?HMDMC]'S/8!5$)R5)"I,X)42M+)?3T-XQ
M%$0X(11N4'/*F4LRXEHN`NTX8[G-T]<Y8V-SK?*:_P"701=J1V:]PE(TN$G0
MIDY*IG9FH\0$28]2$X\L6S+IK=4/&29*EGR4V?&'ZG<BK9]/-!&RTYZ$NONN
MK:ZI]R`<%Y&8<)T,M0;*$WQ!M-M)[YH(Q&[(!--:+5O"SM5,>A3<PS6*FR&M
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M\^^E[2[5C2>P"F;P:\*+C6S6\=;/26VH6*5U?!J&:F-0JKI[4Q]=,J`*M2-,
M[FY-!D^]Z^3,RK^WG),M2`4Z6M[N4G7IE0PE^[":;&SQ#B\<<12@QPL0#J_3
MB6TE/I4X(XF6UHCI55_4]@]420+*W"?5HVI@E4CL12V($@SU`VA,2`T9JPT1
MFQ334B2>KK@L"/T//')_KZ'W]5+FX2M6F!'W^752:Z2Z#2.$RB.;;M26-R50
ME;F^3;$B<BEQ"C:A)K8B_=U!Q&W'\''\,#3?(#%5-66G5"F7N$B:;7CC7'7M
MW3M26/.Z8LFHX_5[TL1B3J5Z<DQP/:5"]&4$.B6T"@"4L(RR-#&MVZ:@]A]/
M4]N@;E'%$_8$,J6U;9]4JIBR1Z>KC9&WR^NXI7\1D,D3SRV)JY%KHH1'##A-
MZ!<E;QDJ]IR`D>3VP[Y+K;[&X7%:T)ED8D]D%M;C.+"LFS']QC474HTQ$@L6
MDC*HVE;BA2@#GMO8G/9;B`0U>E"E*7[GL96Q>\!>6&XDFB^7"ZFFJ>QECC'!
M299#Y='I2FC3?,S$+X]RF61E].E0WRQ9[8,R-7":HB@1'E*%YX#-$%B!LL!8
M2\EN\):BM;PY('5O7Q-=:S83"&!HO1KJTMN@ZDF6-7S_`-@-L\DQT\?#9<8C
MEOR;TB,0(`I4C9[V$[2I;LU22`67?R:FCH[G5VO8](!!,FV,-BRI[CI^3I7*
M-*)"8K8;74UR\:=FC93\SITKHRO59(PB+4EJ2%2-6>#P+'HL>27$0]:/"B:P
M[9>[0/E;2ZI9>^2U/+H-*4,^*C;E`)Q$:!C#XP"W`+-@RAS<R3*(*-!MRTM:
MU*=T,(/1"V04=N^7#6LDKX<3*&14S@L/97O$/GL3`K^21`C2@SGHY+T$H7>4
M+T#S"3&I0MIA>A:]XWX*=B"+7LL:FK\9E%3^]/\``SV?^:?T5_=!,<O;^T^U
MG56KT3/]H[TZ_P`TVG_N71Y>_P#:KW?M747,LN!GHH?V[^M]_P`N%X?<E"<W
MW=)]-]_2?3OGF&'.SH7L":T7:SW$%K=#ODG$&^)WU,GE<A>SEC3R.WD'Q*Z9
M26)&ZEDF32!6&)(K`+9>T^V55Y1$"-#HW>I-BR:JG:EZ7R[LSL>[RJ.U.)W;
M+F;+"AK6U/!:F5/SAZ?4(N2*Q]/(WF9G*HM)HHY2`Q*5IJ3?P@QMVIT3[71P
MAV2?Y]M9%F&GH>X:XYVZF>):XU_*ISS;2++9$9D`(](&&+.&W2D/G`1M<K:=
MR9\>EB!B>V\\L]80L)4JV\0-[+`H",9DR6_&I9-1H\=FVJVR&<PD-O\`.R9H
M@B.RI8U]"N487:K*R#(575-SU'3[6W);1VD3RLDZSUHG!6C=EJGX*U!$0DVJ
MVK,3,AC^G=]V^6O):54!B;(](C0UQ*6-U0R#;FPWST*E(E?%T3,`%W(#II<H
MH,A%+?/K1VW5U2[3B2`T,H3Q_P`_]/%YHSV'U#.W%2B9VFLHLBE%VMU1MKG(
M&]@>EU9K2;>E=>.K>YPN+78Z39^<U\2BYKF0>^(8H6E=RQI]D*$YH/8LAD3Q
M?G35@5O;CS%6-U@+4@A3103HWP"3-"Q9..@%%SV>_0!\:Z[7DR=I^%J8>F:"
MM)?8-[KLUU5A"MTG2Z`(Y)L21&T%E]KTYQ5)K&;99!Y%.5%[7(_S&8NS*V1T
MYQCI=\3-HD[FRL<MLMK89).D,79-Z:D2V0MR4TD@E,`6O8E%F+EJ]:B#HSN!
MRD-&6C'V>50=I>G)JZ'-0G>,ACDJ::[@-"([>@5@.K&6\`E$92NGQ9O4KS!E
M%B]P5Z+)T`T01Y9V\DG*8475UK%66U0M?8M3OU?ZNA73*:W(1%$#L?,Y9,HE
M43O729+!C;9]Z#&H[)[+6LCZZL2A^$G7-Z42M.WIA.!Z688AJM;\NUZ;N5-J
M[MA^G5[1\5GV_9/R6`,-C%VA&>EA/L'=V\RP#(Q$W%-)(6C0[/1!`M.=S1`-
M+$+1*0NV3G^2R-S=NQ['LIEJ$,.LZMH`N"U\)3FW5K4T%24#0Y7E<DJ@MB5P
M]^_2]&3$DFA1HM+HI2,3DE-]J2;^[,!L$S#(_,![*L;W6.C3*JL8$C5)Z?AR
M>CST4D<;(L]LMQX$4]V-!WUYFZER3L,#+5JCM%B1.91@(L]Z4J"`^RVB6%BQ
MG.MQW?9D4DJ.<OT#W+WCF:A[ZB[W#H,[MS7$WB]&"S-'1<QB=IF]*):V1!YK
MX!Z52-4@4+BE8B30%[`$P2R2_P`F16FC^PKA7QVE$\BLRJ9@ZA0<?1-YC!\=
M.1V3?)O0#1%-S6U(@>@FIR%I0UPH?5^CR4S>XIC#XB^[5&)0[+TA60Q)UG]E
MV1`;QNED4M3"VU-21*PB5"4)H8OE@8X*@$]KH[69&=1<C!/Y07J>.B:/%M2>
M,E,YB5,N4G/B<:8X*9)PF-2J'L&T+5E`:WDLUK&O?@+G:)"^6.C7'%[A;WR,
M>X4WIX)"P16VY)`V66-C5,P">C6]Z?AEGJ$.R"2_%26"V2+B6^)+2G14)K>O
MK?F,0>##.8N2Y_$WPE"NCCB8Y6S'YXR&P1>MD$H?5$U>DYM7>]D+]:2K%XU9
M_G3!]F'>3NZ\>Z7W:)<'8]FP"WKACS'(Z=<D%9SY'`&RH%#0\#LYX:G?E1%?
M`[*<'8N6D:*:8U)1G!.+3M.TAC&C5Z$H`L"6,#)BY&&;NM;N:'5K03>QZ&2O
M*.5U!!WJ$EPYZ9GZ0-5PUG'[)>;PC07*QS52*O:AU)U0#BS2E*=6U0I[-4KT
MR@P/P]D,B,3>]K?61>,SU;!HG')P^(GB).+)M.Y$KZF1.-T<SUXAE$B;I]85
M=Q94W2Z.6+J:-7Q@YFT4V/;*F-5AT!>-7?&&+24-TA;DFN*'UW=.X,P*)M5K
MG(H<Q0,R*R[;XXQ=Q+`_OLJ?(K9TRW!E;BRJT3DA;RR')D&E7>Q+>U*PD9.Y
M9,X+..%2[6Z/N&Z*J?(B7/:Q:MV@PFO+_%(]$W=PE-"HHYU%3]0+ZFM$L%B(
M53ROGT=G#BB7#.+9#/B#*Y%IBCDH]Z2622F2)I[TE=J1%<&)0ZS6:*15QY0N
M%R;82-B.;]O=BQ"Q:&;(\](9(W25"]I4[(W2DW9B%&2,8&_2G6S-[.`8GDSU
M(P\TZ^Z4B]CAIEC:Z^ETNCDMLA"9)5B.)P%ALS41'1KBSPDD$^NN+E0]T-8[
ME,"M5MADF6Z-1I5!3;LHTXC&3J9%G;BZ=5U?9[Y7YZZ$H#S#..B(,WOQYI#]
M*E%]]'2*H+#*:D?Q5*:]CCL>;TAZ;24K?N*H_P!HJ]H2,(-234D598NP>@C6
M:N02Z34S'3;MCM)S)%/!0M]01&D6:QY'8#*[I9"F=K`V&6Z5;B;8W-2M0L:B
MP/KSKVP#2=DI\N1<B&*'[-OI(Q(6".%0.=,<3CD]GCZ_JW1A)1V(TR6:=#2!
M5/X.MD]O(+#4Q.+*86E3-K:UQZ0`4IB%I!B\K8"3$]O;#(F]PZAN5F71&)6X
MZUA(G&>PJB9E%6F"L;@V-RYRDUIT^">`D(TMIJ9Y"%L+0S\L#*0M1[:7Q(60
M>:N,/&H;,F>QD:[&>V+ZEDCC,59IQ0JQ]LEJJ5U5L*6%219(>>G2Q+V+K&0P
M6;I2+#"&0R2)Q[VY18%1;0H%($"@1Y`48@$%WQAD>QL[CZ-630$:;X+#Y4?7
M\>6'R]I0?)B,*K9$TSF\H/(I+`R)+;9,V;3&\=0D'(VAICTKV<M4*T9RHOP(
M.`\89&R41;ME60JZZD22ZZXFTO2\M\]RF-2*L&)Q51.#2>3QJ_92!N%#ULS?
MTRMV:U9J<6O!<G4KD`4>E0`&A\PI9F?9?1XZAZ[M9<.H6YVLJIINH.=^8JV=
M(@G85">R;C37+5\*E\KO:*+&^8K$;:Q0YRDCA[5.G;G%`)/$GO9JLLW8-(5D
M3$@7+US:T"LFPJJ;4D`:5<(?X2[O<XDK2]&1Z'4O<LHJNNJWLF0)PR)K3GDL
MLRE$P-<=[5I$QZ6"J?.-&6:-24D]3$"3+LN^8DZN\V33JOYE'8)7'2<>;FAC
MBB5!#[CD5:VS1<61W.TNSG8J0*1L@+'8:W;^A*<--I(X^["]_3)S@'(61<FK
M1F=)6/'N:$4VL,YF8+`DUH&5=`7^-I*TE39)0K9$K31J0NR%'>`ZKB*YQ8FU
M2%<6JFXD2-:1O01&'&D-XF<Y$SE@N.[VM>^9>]225S^)IFR8\K<[63%JT:XV
ME]C%I1+':X&*6RQJ="IBZ*Y''G!VB9(A@UL9`0&)R"U8O9;/4K).GN68K/2E
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M7Z$-TZE560=>M*C+6QOBJ)6W(YY-F1PC4A2SFTH%$8F@3,5>.H1`?'I$H3KD
MPB@Z4J1D(S7B>+4F>Z9O:W&W;MQ[DC[")1,Z.KF:H'."2!S;E<`>)CQ_6+TO
M7URZ%N2X^/G-[NZ'+$!Z908(L_83?:FC\3!7.9/D_P#Y-7LKJ*[(^[5Q)43A
M)'MSY&U>M<W-#&M<Y-;3>-[QKEV_YTV)9*A+VA*=F1/$JV8)DE)\VRR@31&;
MH6CB`[`DG3W,GY;E^6CU,%_@\+;8S6T@7OP9/*(U+#'RDVMEMYA9'6J&L$6`
MI0=0/L5@KL2HGCF$TQJ=I<Z;)3MBKX8`"DXD;QAD?=@Z%O-G=$D=W.Z\G=AO
M%LVY7)4Y=XB^)BX4Q*/4%A]%(F)?"&.PP-BU9'J]D&UK?I2,A6(0$(#3?=_;
MB4RS_/X,G^?3TOG:]T,IQ:1SF5*QQTADNKJ#GM$AB#R2MZ$72/M&PN7IBY5^
MD#8:=;%SXU&H$G<O=4X'P*-V>2]+!A0EE"47Q,B>+8Z6L2,7F]P1DD%<1Y!%
MYASG"FNNI&R+7&QK=2WY*$<;?)[#5896RA(9JW*7'J"R$[<O`H,CSJ%:>F)V
M`]+).-21#\)CLR'Z>=0+5ENQ-JDSB](;#G#J^S20<_,MU_%Y"_OLG@C[9S-)
M7F809UF8E8CQO"%2I-.5)0A.3"1'*4^UO]E]6K13JFQ5,K+$P6K&8'6EKMW*
MB:N4%QQ\3LOH&&6!3-F3);)I6]*+#+5SUPETD@2:-HW!P7$(E+XZIS-*5>]:
M)4W)_)8P$WZSM.W:!Z(4*9/`XFO@=#OSFR0>)IU35-^AE"IGF(FJV:BD;_-V
M[<8K65J(X#<?$$MQV$9:KWM?LK19H4DW^3)K97KH:XE$U378P2F#HPQ7FZ22
MNQJ]51^6J4C>O8[_`$+*Y5(J1N$C8SXU/H:U^^-+P]*DFSQ.B<!I;>2E%M-M
MDS#A_7[J:RYTHA30O?(<Z$3"SH+(U\"@"5Q9Y_0YU9=RT'6Z.OK(<Q2ES&[K
M;#:9&L0*PJ4+.$;JWK"R"U"(1@4\S/\`/@Q$2;LNWP3Q@FB6>5S*'ZUZ7YF)
M=$<40-*9AYZ66E(^B),YQ^7LL_NB(0UPE38NA":+)%3H_1]8I<C]Z4)?:!3(
M3KX_A<6`<^L.E6F!36TIRHJ"OXW7$FJIBL"/,;>US*1L;*X\Y0Z[+*E$1=G"
MWF6*6:O*D,L*2H&5I5&JA1PM2>B&[.04R4^9$R)?Z2Z?G573]X:HL]UVSMT,
MK.M+':87,6AR53'HESL"PY/"UU=UJH)D;*8T/3$E8$918B4#NHV\2)NTH(*3
MZ\BM)*DC3X;$IT=R%</OERQ*.S60=,7F[N=CNJI[I]CD2.,=52*.;A$HF+1+
M'N3Q)'.8Q#P18MX:585[0V+$X$)(S$A03F\_POJ@0OKNPHJB62ROWM.BK]93
MO.,<AM4REP9[`70A_E/3UH4395NIK<FEN1U+;$/8_D\48A=5KFWM+JC6LZDU
M8E)-\%%Q<]^J1D73W6S^\QYDVJIB%J3W^B(`Z`/BYLZ-7++I>;3;S+!1NL/M
MIQB1`4,=A36YH6=(N=$P%BY4C4+S@%%G8R)D9:E[39KXGZ-^Z.LD^$/2*"4W
M(:B@#):<MJ"%296M,=T<TGS,SM$Q8S[`<%]EM9[2:VN*EX+9T*9&1LL/Q$PU
M;+..$OPAM^Z<O"XTJA0_-3?$(<W72O:F],R/<7:I=$'F*2JTX*5"),W1RTY;
M,'4A[8X_IQ4JGEEC'N[FF-)+3'%&$^PLDGVN1:+D'H-W='+566?+HT0I:*JI
M-YKQ,F$VJ@.<:DD>86!&ID4T%,'-TW9CQ+CAI5;&Z-;2J$?L`T&W`G9AX99Z
MPL]6H6'<EZ,72MO5]7$QCS8F7N3<J3G3YC?)NTQ9MAW-X[",0Q2-H)5%4Z(Z
M4R8)07`P1_EVF$:,`?;^0>F3-)T2OS9TV[7,Y265S6<UC`&1I!%&5+3AQ92:
M:)5$JB5:R!EFSQ*7B3IS36R7NL["0S)B&D!"A&K1:]X,5C,!BS$LQ>[,HJ?W
MI_@9[/\`S3^BO[H)CE[?VGVLZJU>B9_M'>G7^:;3_P!RZ/+W_M5[OVKJ+F67
M`ST4/[=_6^_Y<+P^Y*$YONZ3Z;[^D^G?/,,(/?KYH1GG<WKB56)`F>9P*NV.
M?3IJD3NT-PF"O)@].3`UN;RI<S24R=L<7=I$4,LP?V!')MC#K2DCVERKE8NR
MKKIB)P>#V:]K8E)J^F$^A;*SS9(X19PBB)=+%(X^US(V1+5H&@+<@+&(D:HH
MX9VBQ>S+\V]^7&7H9>CTRF4<]6Q'`54Y6)7KNAOZ#NR1C9V.=L2=ZL*&.+8L
M0+G"'&M;F%R>$8&X)_LU2'9FBPE#$$6O9B\KF<G+&,5GT(\6#,:".!`&25UK
M+$1K?!'@R')%;PM.@T9M<Z9Q"*[4;7B3MB69"$<MTF+-`J3*C-;\H!&;9>J<
MOT+I"AU3PRZ;IG!'Z*OD7LF=N5GM4GB+A7\>)IISK=K?/E)*"G0:)$O3#L9`
M808(>P$E$BV(8/$KSLJY2O+FHZ8Q>Q;C;%,+CT2CTWD$8DUE."V)(V-].@2L
MME+DQTO2K#$*QH",[V2,Y0HT87]DOP`+]SBR]#+T;$HM_GAS=JZ5J[,IUP?9
M3O1U4*%$OABIW??CIQ[+[:!FFKS%J[3PJ1&(O.AV+2@XO9'B(>O)C*F5[IE,
M:O02J-U+-T30(<OCDCFS:1(&YI'$=IXC,JXC!I:T]T%I$4^KY=:306W$^S$8
MI4F"\F]&:#H;Y'Q=[$H%DE:-$^3>HFJ;S%>&)(4SG(H<CE,F<F]Q4L0(X24I
M5ENKLJ1/!AJ$*76AB+5CV1H.C1>3;*/?$7&E)$\KV6"K*P>Y!4SBN:'%KBIL
M6<'>MW5Z&K^)MRE&T[-61-:ZGDJ`J"]A(&>:6:$>MB`/6IR<HE9;I@,JAMA.
M$`HNQ)L57MP.U;2"!ML!B,7D2R51S:"9G2M`R6/(H.VFL`SGPAR1KE)Z=2J-
M4!/)*$(P(Q7%Y2G!':LK*K!GL>'QIN<X7:,=;+(3)3(JE1+9(GD2--)4:QW9
M5R4@PU]5",+,&%5KVNE.M>87FUXXNR_*("WU361BL_9M'VE\\48F7S8H:GW#
M($HMDM2]UW\[B@YC7IIJHA0(RLK\D;@H,`_E_OI7N9A?Q`9*4QGX7/PD>*=*
M5?+)9&HE"FF8/*J7T`&_XH\M\+7-\;D%?(UL<0I&1H>G0+8G62TH4U0B^%`U
ML:$"K6E&R!C"$3#'HJ6Q*RGB>7NI->*:JD-)/SG$9<R3^/PYB?Z_4/$8C]DJ
MS`N\:>9'&2F601:7H70T]"YFDBTH%I3Y%!9Q8%E,?A)>7,,OL.O8VV3RJ9?8
M%GQ.?'U\:U.$<D3C(XK!UK6AGC<UNZ02S9B1O6O8`J$6C=;,$!1^]B]@?Y&4
MRM8?+6BC'8+53*CF>PUBUN9YE.*V,;XW32F*OQ=7IXX0M7PL`[(*61M;HZ6(
M$2!2ZHV4KWA2`H1Q7F#XL]=/E%[YUI2;DC:))*J/M?XS54OLM[$RJ8E"79ZK
M5!1;(EBMDVR<9'IZ[1U9%($EM<UIW\,6N3L):H6)T:`T],HT5<IB2(9+ZZ+Z
M+E,3*IF=L\VM5LE%D@LU^3UX]1*61N$,U4UDN<(\Y,D\D<J8(Z]M8&#29*L;
M6XE<8`TT1>CM&ZR>AZ-L8;4B,_L=P:8U3LQE+7&7635DZW<&.P9/`FEU8MJD
M\NB*)R?I2W3U[;&M];C6I>:U,ZUJ`[%#3#.V80H]B'Z6]#<P.+I#XX99U3R%
M=<DN?JHC:1`^QJ0DRR5M$6521]AZH:,]8G-4EQUM!L:=1O6C-')2]:$)0G"-
ME,K-Q>R.;C$+M,(9.J3^'1Z/.R=\D\<DD&`C9(G`MHMO1;H\MRP)3=&H?IT3
M"4>U,`D0A5$B%Y`F@V)RG+-.<YH^(R#;8\2VK8U*9M(6YF&A7O<4:7V52DMO
M:EK2VGISU)"]X?`MCN@,3%#T8?[)8F\FO`XKS.1\YS8E6,D*DEFO"I@EC56]
M;NMOFC9/@LG>BH-M@>W,,@CI`5`A&)),U,*TI$>686G<-DF`"8+01^5RO/1%
M3+T=0$OC[F_6<F:*?40RQ&B.N;%T!\@HPZ,=@N$+8)W'#D3A\HG^*KW9;!I,
MC7IU#<Y*324PQA,V4,DX!;+Z'*0;8M"JX!#Y5:3]\FY.MJYEFK@G1(%$;7RW
MWZ,Q0Z;2.,1P2Y468FD)L<:=*SDNC"AZ3%A.-\"@^?2>Q&:U-Z1DSN^5Q\K*
MN?GUM4(XG(X*)[BKFZ(U2Y,N<D$;=XT)2<J*/5)6Q2>4C-)T(8$YH]`WHL>]
M.3E@S+*YN,>-!.G=*#?8=$ETI`(V2P?;C&(.MT22Z2`LX:SV[/&%`%)05*D(
MBTH@G%^T%X&`\S*<M7%>W/!UI5Y"XN]US,[`M@9#42.'N\+>7U!&4%=R2V(\
M]2`"-<-Z%$EC-&PB;S`@-*]JM2F`UHLT)F,N:96FZ/HZA^C83%Y&Y3EZMSJ!
M%.00Z3RTTV0L+8@JY2SR53""W8)21OBQJY3,PFMFCBC%;J-'[`Q48)*C*TYL
M^(<V-YAU[\WV"AKF7%R>O&A^D$&369"V:9KHFQV$S1"7:+\SV!G7+1.S*F=3
M3=%G&E;T4<9XAV,>];QEAE2(5,Z:AR%_4IY56D8;FA\>V^3FIGN+LZ1MDS8V
MFRV1M[YLE2G*2OZ!G4C<UI)_E4EIC-J#`Z`+8]N4Y17(KQYO@S9"I''72LY*
M[/8(DU5VTP-S@ZN4.D6L"QV2!#=H>D2K25:F'H9$\[-<#$GB1K:8[6]".#Y-
MN5RK!H%<7EC8<YM:EADK,[$*VI0X(#F]X;'-*A5+F]<W'*DXE"5:G2+-J2#2
M1"$$LSVH!:T+S:R(K]7UR5G.V?<G0UF[1.EXE'7ATAETS-GKZ+5<Y1A-Y&A:
MX0HI5*=S)GC#NT&"-2+EC(V-KDU`V<2:8G,)$;<_*L6JOOGM&G50Q&G@SA53
M;`8M89LB;U]>AJD45D"VWU(36P"AU3-SL>R+J6<#E*9&2><`1@#0@V$A4-.R
M_P`G/\LK3G1-'6@P5/+4[_645FUKUPGF,,AIDV@CG-C8`Z:5OB4*/;0O&:M0
M[2-9BI44DV:F(4)%`?./:4TS2RF-K9;GYJ4*&!JCMI4F>JL!S/W&&YEF4',/
MF;L:^NI:@UD2H7$0Y`L/DZ%:#9A`31&.!9H?'9VA:QE.7JA]@TRZNR)B;G*N
M&6P++8@3=7!TK_`ULNDC8808$;TK3QIT<BY4F`F+'K:TDU60(L`MA,V`.]Z<
MG+'6;T9SQ5J*<.UD6C7;*;4S&GE$V0KWYF4R&(,RY8UIT;BN9"SSGE"6M7N"
M$!6_9:V,U0GUK[)A7F94ROE<5V0ZEX@FL-VA,JEM>F(12*4S6`M,8?&*&Q1$
MH2.8YI)-*Y$TN;BQI]NPEP-,Z9V7#+`<<6G%Y=[VDWCU636DVY>E"U<)Q;'&
M&_+\M<5,IQ9::O(O%)41$(]6B^,[G]@V82<Y-^M@AS@^-HU*<H*^0&#_`':9
M$?[N;LI):36QPKHBLYQ82VKVB.25&0O-G;;&)@YQ]K2UY9CA5#HWQ:R6B'.*
M=T5.#@HA+NKTC.]^0HB%GNR@2`:LE*>86S#$G1RR:GF$G?(K$IW7\GF,8-.6
MR*/QZ2QYYD3`>2>='5*IW;&Y8I<6T].I3&(31F@`(L8-DBWK>O+DY1')-E\F
ME.#?!4\[Y\+<V>:)T#5$2)'78%C782M<M2)DK>QEJ]&H9>H=25!``EE!6"5!
M,+U^^^8.7E>4[$,3(E/5J4S,U)U*]9\17*"&](2>M</X+_#E9I9(3%"S^`D?
MOH]['^\@^S^X#X1%.$4AYVZ.=*2?I%.!L#\^)4T\A="O$\CS(LDI[!*ES^U2
M!S@R)6-V?34,CC`UX?=CO=5FV_?O(%!:<807F+S$U:NGFYV<6!^^=*F7%U^4
MR^O8N][F$,5KOE<J"B*<H>PNFUXS_C:K2Q,6<B3F>U,$<4`0=[&#6V4Y:2X=
M!\_KZFA4QM'<=B<'L&SBJGB[)8:-E-2N,\!8+Q`V-L+0&;7-NSESZQ&*"!?_
M`-@C]],V7Y1^5ETRLP[W3S28G#\Y,SI2-/+W$Q'N,=F\UK!2[&0Y*K5JBREW
MLWQR1N,?]NG-4%A+-.3;$$8M?NP&>5E.?1NX)=1C[+HC'RY+5+S.G")CD,$9
MRW:).,I5P9U1[$)ZBB()YSH=%G1O3[WH](':5004+>A"``7@Y_@Y_AE9Q-ZI
MK1(0Z61+(!`T4B<`M*9PF;W'XTG?',\H)GP\I2]*49;DK$G2><1>MC%HHGS;
MUH(-[TY]$Y?EID=2JGZ?)6)\KQ1)HV:U+[1):7&.&O3$H(3J#F57/`I#1+6U
M0G2MIHTPW#R#+*($(&]!#XZG)RBQ%=/*$AD44K=GF5/29VOHN>.\>9&11%WY
M#8AD&4-@YT:>)![TWO#BVJ7(D2@!^QGF#`/?@+90]AN5<K<WN?<^)ESY%)+,
M:>3.%<$L\LD<??GV&ISX,0F^'(6*1N[:XJ0"C@$?OJ,E,K-`3['VY`0"#[0K
M0G)RRC?/J5G2-EE[9,:QEJ)MVW.4?DB5^BSV2V#DSTOA;4L:G4"I3I`<_P`C
M;5300,H8!*5R<U('S&EC+TY.7Y>9S2:Z1F4Q(9=6"V6/)"DXZJWA\BRE^<R`
MH_E&J$?"EJD:Y6';?XN`M#3"\Q`1'_9`$0].>J-9(MKF.0,S:\IK&HY\8%S@
M=4K0Y$2F#.;6L<G5.C.45RW*2UIZ8\]S0DISA-1>]^W3!*,V6(O0!8Y7E@83
MTORA(F&-K8C;E-IF9VDKQ!(BE^4T48MN,@@TJ6P-4RQ]K5*D1R@3?)$VTB0*
M<O8#-GD^Q\0GE>=93*VAVLCFYQ5/J)^G5*+%E/+TJR1IGF1P<XZL7,]P+:T:
MQW`O6"%#UICL8%*68;[N/WK>BM;]I^YQR<OLVV5SPH<(PZ-,YIXUUN<WVL17
MH)##A.5H',?F;O.QJ"%7O<O.9A"VFWLG:@28>_9?N1;\N.4:>DG/(,\D\>0-
M4XH&3R\<Y0/L=0L<M@R]\<;!CD?6%M:]*E:7(2MZD#''G0W:?S!.,3E#\X-!
MV`.PN?X7EM2J_P#G%*TK9:MN:F$[(C?UD4<)&IG\++;DTF0H=G+X^J=3'71!
M;RD:P[--3"'[8"77G$'1?V<93EK)=\<J*YM-6@ZP*@33:MW6%5S*C75RB[>Y
MM;C+FU#-81%"7%>,DU8%R3&%K$B8@P8-'$CV$.C"1^1E.5ELB*G]Z?X&>S_S
M3^BO[H)CE[?VGVLZJU>B9_M'>G7^:;3_`-RZ/+W_`+5>[]JZBYEEP,]%#^W?
MUOO^7"\/N2A.;[ND^F^_I/IWSS#"EEX\YS^P;3^<:(/<(3%HFBBG5M:I8F>C
M"U$WY_M.;SU@;7<+:6<4=%)6W6,M+,5!UM8R.K:@6DD+/*(D-E6,$Y<M6$*E
M(U%FV1UZ99#5TZDZC<"G9C>#JS^4!ETK[B<X2QI"CMO38W$G.`DB)W$68H*7
MATZ"2;,WM+EWG^#>4:UUP=(8G;;98\I>X]+FZ0R-GL>:QQNF%JPJ/PBR&"U[
M8N%H-KV(,3MN+S.+ML@M#1"4A_*(,(VA-5"V=[\8E)7NXQ=]$F6_QF=:RFV]
MZF"&,AM>U2IRK>&QF,^4;2R;Y,5\T&(25Y:M.-2[I5#@>XIS-C`4%.8)/X:V
M,0\DJ2HC0<%S'3.S.YCS"FFQ&813RYB4R>V+.BT^ED0F7+4K@"F1*+#=E+^R
M1=2BYN`TKVM'LT")"L3[(,4FI=B.ODNI6;>6;%+IU]C[A(J[+LI=U(KZI;DS
M4RO*>LA/NK:26B@A#XG,,V]."0>TWL%+R$H"@3IL+J%'HP.DFV\_PF\M-;>&
MY.8FLUU?9;"BY?:@(XZN0FB.KQM$4?4G4$NZ+>VR-J%9Y3D9'][D*=*48+2<
MY4ZIS7(TLL9^B"GDNI6O[GJQ[CGGRJ;'^"L2"%5\E:JW2N*5_<5;U--W71]U
M+13G:<20AIBQ2Z@6UN)VW^]+!E.JH\7E$G)*.DL3T10W<23A>1:#S+I=7XYG
M9C?(`".98VZ&-D:5/W1[O?!:%"M<5075<@;4JM(A$=Y4PU:U'I;[(GQ`25?)
M=2?RQRHJH!_ECH^*TLE7;2N\9B,TW.[,?'MPA#O/9+/=-C]#)4Y+89$ER)>]
ME^T$S><M:JT>H\$P3O=@2W4MU^YGS?*7*$W_`!%,TTY9C9?5SK)Z]1&WV^2_
M(TJ)KX#!XM\)<26'2Q8Z.R![A)*T.M!)(/)'LKSDCUH[3>AO*2Z?BMNU[`3J
MK6J&%Y(K&MH!!ZRL:0*%1ZVQ9(RP4I*^RF8QUN5F*6%B+D0$Y!:4"PU<862H
M&(T7F*-&O-TONK+"^8.BXPQPV8J9+3#AT+#K)E=B/4O7;GCG%K<=K*KX^"SI
MQF1/N[4[Q@UMT!NW'T3=[PC;&9C2-`-@(\#RKL_@MG\)>B'-,GJXBI#Z_E[`
MM>*8Y/GM"1M1+61QVW/DWD*ZIG=BF;ZB:70H]/'0.U:&#7MZ<_VXBEF@$GA]
MGYMS=->*LJ,O")<XV97"N;0V,7?-B9<ZANB)[?']8]61+6<D#C9DH)D+:V#(
M>#'L/D3(TA>T30U)DB-&$!"0@D#9OP;-^&FT3RC9=3V)'[#=9-$W@Q1,+P>)
M8SGR"R)6X-C);L8H]&D*99U.U[W)I@_,C]216E![GI&2J2NI@B@)O=BDX[;I
M:LFEK"1);8M.WS'EE<']\@D:KRJV]8WK=-\,86(IU?W/;N84J]NM52^?/>SG
M$2;1/M&YK;B]>)A.Q9-XP5@DW&D[1P*#1FMI_%B))NB+1H"VI/-F1Y<!25-=
M[HP2JQ+=8DK8YE"#/M3IN<'0I`K'[@M&\&`-/)]B#8KON:LU6U-"A%ASV=KW
M8AU^+1FMZTK]"!,(!D/JZN&,\Q*SJ51HA;6O3W.)$\N"Q06$H!J<2$D0=[2Z
M'N;QAJK\CY'MQ1(XJRQ>:5XTP"#WC-KR@$Y4()6&VH"IL.126<2J"E,J)87#
M)JQK9C)#M`5+E"8/P?8$AZ)2:5M4;=G\FM#BW"]QD)7!;,;/8W>32F<,;K+7
M4<DLB3/&V0?,EA\X3%^:Y;,53DX@F*T<\W(6Y&2D0,J$:<+>666#7OFWE%V/
MQ'?3M6[BL&9)0YQ0EP3O+##[L4@D-GV,@O#GUGA[`RN=?J$]BO:A1!M2A[A#
M&,QO2F*VY$V)#$GG4B&$X"]QKSN/"-\K(G$(BIO9I>4^GQ%)+"6'#GD82O,F
MB=G09YA,L4,$9?B29\XHJ:K=GBGN#ZK$THE*7;D`@\9HD^GE#8WZF^;)*[4!
MU=%7,:B-*[Z^=^LZF!*8\X-"^`4.6VRR&TO&7N.GJ=.13?'-R)R<2"![3J1(
MG$&AEDF[$`*WE-Y:3!N%;.K0@4CA)_/#0_KB+-C^ZE!#Y5\Q42C]K0FL8K)7
MZ,IQ*S7U;,ECM5Q#BY>T3HT3PF<UB'84HQC7FMU;=?I?P-9@(^IJYGLF%F5D
MB0398S/S\ROZ^Q7&23'D8WF$!;^60M(8B6QK6B$]F*"3#5"TL[23V9&R=J%#
MR]?4V;KWCX*FB5#9XF*;,[?/R9-.IGSS;[U)[2ER^"O4[O$-[*DKU5;N^@@;
M4D1O9)+<K/9S2S7=(`8Q`2;/.*&\C8PTW]/:?2YZ4,.[*8S*DCL1D4"K6/OJ
MB;O&F.!/E6Q2O4$'4P,+JCK=*F9E<?5+E;N!*J=WT2_8#S$X"O(:\DU(4BYI
MNV(V4ILNN]53,&^$VE=_0<!C[XB<VJ?RFP;9IF15TE@3[+3#@LL=B#._/0#1
MN16E"E0SITR/28H2(!JEL-3Y=7.QES2Z+R-;(R6'Y-578\3;%:!"8<\Q^P9'
M.*/L&`V-'5!B@!!"NOY/3I:LLDW0O>1F%@'OV7M0CDN&J85KZ;3RQM".)6A*
M6*PF1RK>+)7IY;9/:D5+BEL,W-J7G1VD$*JPE^7UXZ,2ML(.7MISGO3BU>_G
MD^*D02#R[>[V76S-?"]QQXI8_L]SQ\N>O$%;'R4N36S/40!).E)5-(ZX=`V8
M@?6I<XO$(;[3J^-%P]N/1%'N\<1*3%)!IIP"PZ>4Z>AL?%+Z=;HZ5E9\#EL^
M1%++5:(TPNDABZJ:!E+`RH^P[?Z<?D+)8,A?7:<J%XF>T2VM(Y*E1BH3HA^(
M'!WH>B`/+G8F^RZ]2,%HQA(36LW;(&K@\1KZ.LC)+X>WEQ0,J=0O4O:5"$%?
MMXQ-D-1-$%:V(X\M*(*0;DXJ2T8"TR<`<G'40<TTETS&J06<_1VPZ_;8]"XC
M%8=4MDM!TNC=BN$7A[[&RT$6FA*%$L0Q9<Z5LT*6%9)&16:M+5J=.B1$E-`%
M.&[-TWG4:5_PE,HPN:75XL!@5J4TK?)4K2@+F,A&7M\E?9TGVW!DLQ?G:2OI
MR(/4R,@;@X'&*5@VA0<9H&U0"R6_Y^#7U1<26$VHVN%)YC7A\(7K>=9E*Y*?
M'GDJR&R9<[5I"H$VLD+/+4C;2H=+%%>HE!AJ@T"IN3.3PG`4HVO":G;/Y-;T
MV<9'M4?CS,B?HLD.C].<154D4I(T-/I.'DNWW:SW$]#HM0$Q(UR8#@`E`G#O
M7N*@OVH]C^QK35UIU9<:V["[&H9VD%K-4C@=%N#,ZL#44OG3<!*F2T)-:B=(
MHTU^F=B:]!M=*IDHD0I(O+7O0RCQ-@`D$%%FB;"UX+,XPNJS;`M65OMMLKFB
M?H+?D.KPMZ7SM<0TH+9#7:F&L*F%%N9$$B++`#X'[JL6-:50[2$"C2L\\HTO
M9!B=TB;$\]!U9>5L&4^A9%%3'0B..:>7VU74M63,AKG,O83F1R@R$M\8VXU0
MO@D6D:=0YGMJI&3\76I&[2@6DA:M(JDLA,_EK5Z\YVS9[V_/<4E-;Q91-:WM
M7GZ5;<621..B*ELQ='EJ>8M!:5<D`?:,6$V+=!2G["UK]K@",-*TFT$Y+#8_
M=3\MRVOK)B2EPE,765'3SM>,@J%H;&QX(FYSE?4D.D3LDG*]8N4,XT$#*=G1
M`WC1@V8YD*R35&DYJ46E*TW\HTYZY_O!@>V^=/*>O(KJ!2[L`JOV$UJ?43\_
MMG0?49L^<G2P1(SMI"B28G&25*#:,9^W=6O(6*=)=I]DFVV+;'K7<)+E#0O;
MTTKBJ96JA]NQ@AQU%S`J"#K0ZK0]'C7>T+5!-T$H"$*=4$(M;4.(0JO'7EUK
M&IJZS"NM0<U7-DD8HD5!T\>4KT<H9W-<)Q<)"MFDB3M3`%D5A$8F)98"A;E#
MBK,%HM0Y+A`3!]D4/PSPCG^S\%3UN8#*S.GL+'`)9(*GFLVF*)E>D=N1Z05"
MB0(6QIK1PVH.;$#,]ACZ$05*DP)[1[X[!**4^_A$GUY>K6OW..1.E[`K&MZC
M<;)K2.0Z!0=-6QC3"UEEQ:.NY$;50$R*66MC,=5L8G-W+;(JN0ZB2]>LCJ#;
M@%3[9:(G1(FSKZF^OJL*OYVEJ6E877[%((VKE,&O5KN1"L>$SFCC[H2BO=?:
MQ[$I$BTN<4!XV-S,2`4@+.UI6`(]E[+WL.IO*;RB:`\++8@NAZYPE$3=SHQ8
M-%S4P_<6,"I5%4TP62U$I2CCU1XR51JR?>\(C-[WI&(!N]:\QOCE\C6CP+B&
M?4F\D35F&P7`X0Z),$LA,?<;#LV`)T-T5S1SA4,6;VV+(78^MU\7D:(!1>UK
MH46I:2W!=K0%(=D[);*NZLO?%(V58[C$)A$%]8ZEJ&IK8IR3,MA,[X]PH+-<
MZ>"F2"3,12`P*X]SC[A`R2P(%`"R7AM5GICE"47D.U)<25YJYYHE%247<=7U
M]8A3'-9V?*ET/LX3*6K=V)Z7P*/0F,2:1D'C$"02!I^3:<\\W>]!,\@0AUK0
M-:QNWDW;J-Z3Y-LZL+%CUD.LHBCLJ/L6U9-*V57)++F*UNCME5;2D-"2T3^>
MKGF3RV1M;]2I)QAK@!$E/2.A@2BTWNI11EM]"UJ]@<46Q:-K2:8SBTV1_C1Z
MR5)XVWO1\T>RRXC(K=H6RV>([@*IS(KB)HX<T4X:TC4H$BA;(#E92Y:<6(L:
M<;>,7>'T4\PR=-U!7JQ(><JABVQ[>N^V%*:,K44<=6#<G8YM1T)4R`U3I$IE
M\1N@HQ_+()`:(:?WPTS1/M2Q&MX-X82R.2+*O.VNF&1T41F!U#8-G5O+`3@A
MD7:MA:JB?-T<@Y`X<Y$GA:%3'M^6FI3SU)A)Z8A,XHP%&@7Z.3I<^S<GRRZ[
MD.\7=[16%N14]"K81J*=CT?E%<$S:/M==Q*IT<C;ULB9F/8!)IR\6(UR]:V.
M4;>/9L9;,G;TWO!YJ$M4)L_A-1R^\@7@XV9+X.@)K$%>3:I+Y@CE83LQOCBM
M98;=O3#K;`"8]Y=DZ+LB,L[T>':`P>FQ4J3(5_O1>T^THVS%V)%!PS-7%1#6
M.0RV`'PNHW]R60-02P.JV4S=IE/454]%O_SIZ7F@;=NZ$BL`(@C3"5%NSRKV
M[G^["!I)MY&O5KA5X*N@ZPEL@;)7$)/-U<EE$2.F5HP(EBTT='3KHF#.[*VP
MEX+89JZ('Z<;]\1/)):0:YN(5`-V$9Z<;RX3689.&5+1$XO&RY3&T9['6O$]
M>*75EC8FQ7LKE>P)O-)`L:S2CO.A#*@3(>FX&_-I"JT,TSVGGWK&FM;I7@MT
MKWYKE4C=8TXOU8-!\-.D(Y)9<\.FT7:*4EU00URTV6([.26N%R`B:N!IK4U#
M4(BDJLU,%0:#8/(O<MNO'^11;[!&DL?ALS@2.1-*:AW"$6Q[Y-&"85C.:SHY
MKHR3R=F9&LA<T3!I=6)C"9IE<U):!W2.2I"OT$L!9PFQ-]W4+_XYE%3^]/\`
M`SV?^:?T5_=!,<O;^T^UG56KT3/]H[TZ_P`TVG_N71Y>_P#:KW?M747,LN!G
MHH?V[^M]_P`N%X?<E"<WW=)]-]_2?3OGF&%%;/ZAF\,MN4QYI:X(*%5M,.<H
M3)H^\F._SH3M5T3*$T91OU?;2N"=J0M42&YEC+*4(G`3VH;G-,$U!M+HX=SA
M<X>QDZ+GI7)M:75.C(0SV1<Z2NCX''87$I3.64#S:_PE;$882TJ9?%7"5/)3
M>O,`>M,=&%OV86(X8DQ`!;W<YPSG%/!]KVO<D9J>0(%%>5PQ:MKDI@E[$5(W
MI#/YH\V%,!.#\.$KVF1*6<4%5D,PV[X<+3J)Q+)==:7ZTAUM1<Q<QM#7WC9K
M;5[?8B:+UZHC2)M%!4D!7/,P=[0%,6CD'?2!<R<Y&Y/*LYTB"A0D]T,3'HQN
M1K(8%Z,<AF#VCR>,W/4ST38Y==SQVN7=:0-NK%6SLKBO6RI_7N3N\*BXXQ4-
M7-RN+<UHF9>E2ZDCN=/R4J8P\_2=*B&6K&6?O8236)G#1XKUKT=)"ZQBYC/1
MB"=VNS4I.$#N!).UD2B$4MRB.B+:5,JQF^/IGF7R"-O-`&(BEI2UI3."1TT=
MM.F&F$6<R1<GX:5KO/H`QIKEE25K!GBQ[>C%76)$DT1:Y%)&-A8;*IBQK7(@
MSLB<YC$%DBDR177!R$#P2L;DYJ-0:NTV^*$:10R?P9'LL7L?I(B%VL\-C!6-
M<G@;[\A<(0N25XE<O@=B5/S?J\OC4O4DO::)2-,C<6YT9C&Y(2`K1I"5;I6>
M28<D"DAD6UIJY[$?[7D=4VB*(-SJ37S#-Z\%'(X\!26/&$[9#T,TL)ODHI@^
M-J-*V3N3?#U$<4HTCDUEF(S_`'E>0K"<"6>J6*'Q#I/IYG?%-A2J7UO,4\1K
M6TGF>,H&N4QUB<6.)]C2FLFQ!%X^DDZQ`QS(F(-IY(GI:)9H/NB8DU*;LT]0
M#5DS^5R5*K#VET7-5*04<J>+,$>GMR)*M@$OG#>Z(V:.');,G<&D+9($C5-U
MCS.I,F8H:)T!I,GCR8A8$]M/WH0`+#)D,CSUOVY?]H_-^%'643KYDO24(&JL
M;(G[8O#$(D(+);TI>X7)VEML/3U/IFD9:Q3D$'IS8PE-<G%00(D`F[85C)#(
MW[E*UYU==W36U)B[1INBJKG6@RHK$6=PE)S:S/<LGUSL\E=V=>ND@(M(6F=O
ML`+4M;B%E3."QH&V@T9K0#`G+,G\I>C)]1=7.U<6*W5;$C$CBG<2X[$I\,#"
MO0ND*=K9:)V7`GANL`^:-"`MU]M%Q*BVI$QO"HU.0:8<H0!V48))O))K2*;O
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M360MEI1CXA<6>%H_:($485&(VQU`J4.)1Y7N@WB8W\/5'6:J86-!(M3$1L)_
MK((H<_J65(HC$7'/5E(,%R-,E1R*5V2G,-C*QPE2..)&,U&0J<5&_?\`;LD(
M&80E9,TR=4T+>DGY\J_G1YKEY@JV1W_/#Z\+G,SBDIC,(BCPP1.Q9/*?BU?J
M)27)RG\#C6BQB3LICZ6,+J;]E8:`GRG3.41YRA9MA7I>4QLZ4N$>31G?-U+A
MC<0CRR6JVUI>7RR[W8Y?)69:KDFHN_L$W<JO`M;G+X*0O4,FVT/M@A+.]XMF
M3^5O$QK$$M9VC'-KIUN\V)(9];STVC;I/7\EG[@S5'5TQD%@LT-<8BZP%N#\
M-AS'0[RLTD>5XT@GO2%O6'*U!AQHAXLYR=$]<]&$GG:-^Q!19\;:V2CI+(**
MCUT2B:R4O<S00^P2*P;^<G]J8(<D3O3PMA;JX(+[,;G@]6K?0,KHS[V$E6!1
MLLAD7(_<[[-Z#B&ITS((]2CQ(J>;+F=YPN6`FS.RS'5:RBCV]B:XL@*>7=?#
M1/K+<N_?%BP]YTB5MNMEISRU7\'9$R/6_=J7%']6BV*F^EP/?/$:M";6,I<M
MREF0VVU5],2F5+%ZC;39`M6162+VC80*U"]0_%(G9P;$^DYQ:[1A3(N1.E%]
M"6=85DM[%,V:"M\3G*3IU?!TL>*D!4KCZ;FZ_6.G!`F*MT<538\+)DVR=*O&
M6C3(=-"I.:FV)8$8#P2R8ED_E6AXLJ]*OE$Y@@;%)/N5ZNRD)(FF\K?5MD5!
M(^>;(ZF9*P+:XG72!]CA=+S./-LO31]S2#*\B\"82Q(N7*?;G(+DZ^B\7Z9<
M[NZSR$\(6F,=2[(O8QS35NGVMD)9]*'H>@J_HH!E_G;=#`.I>C;#*./`A`Q[
M(?F\YD\P]F!<2F0Q(U+WE.ORLKXI&<OC":4QJ8M+SY2Y&O#)%Y$6&AZH,>(O
M14>7OD@*;4\5>%8WR4%*W,XQO)>48BRE/OIRM*LF:6<:D#J3H*?5+(H3&J]4
MU`@-D-4]`6NO=[8<7DA`<DHUNKYU#'F1.R.+4,9LB33([:E>,XP#4E3"5>[*
M]`$0.2:DGNK4_>H)8*Y^"AKF)1A>BF<92[@8YTP/L421R>MMT\XTM.8U(78J
M8N#U/$T-?KU4EKST+`QIDZ]GTD)4K-GB-)OC%\5JKPOV;4O(*IB)S-$W]XM]
MO!#8@O$)W9F]RNX,F@R(3%I'M2Z')HZ?!WI_DOL_>#E:=NBZSS&#\//DDU)-
M4>DW>$V>7;<D92TJM@KY.OO&"*4[8[U\VVK6<MY*[7G,';97&#IO,'U4QGN5
M+HG-,N6`9SEH32CPM242<LPS4[5Q,5L=PV8T6;)JIINNF.QI(R.\FVTZ;!!?
MR9$1#J5HVT%,+..#+XFACTFE#C=9)1+F-0K3M+4D$M-0+`BV$,G;QM).-KZ>
MH#-)?7+CRK;:V832-4Y%K;;/GD@D!G1D)F[AI]3IBX^_F[;3T_SC1F'J"%1#
MM&-+20.9*_1I!:]60E0GNW+QZD]GZ[(M:4,,NF7R?MIXKPFI>9)K=M=((X]-
M:%%9=RQF9EL1<2DR140JW,FII4IVUH4,.M^0XV4Z\X/>M(3"42+#5*\3'?3_
M`%+%W^<R"31YNCE`2F*QEW"R%M<`W+$-FHGAECA;0UMZ@2!:**ISSC5IJM2:
MIV/?M=%^0L$O0O2*>O??ULQYM2.Y\6K*2$6!++8@T$:H5I]>'ROW6M>MX9S`
MG>+)*62=L22-$[ESDEQ.1IC&`2-T2;:_>3?>0K4]\8N+0\]7?>=I6/((G8<%
MBU=ML$K>)O<E;5!#B*:OLIF,ZMB.,KF@0IY*[L\.BBR+UDG=PH5*AV<0&/6D
MAAP!H1FJ99,2R*J2;ICHETL9C1(3H%$;(K%-TPXS^M'M#,?D<CBC!"(E,:X$
MI5,4T4H[142AK!HUND*<QM3H2EJKVK66L2FHC+DQ<C*2GU"IN)Y4E5Q&(D^M
M4D@JQ;"#94U/,::VBQH_.*!@LLC3K*2I<X.4^:H\ZW0<6N5MT=:4J12W@(*5
M+!'"V4G;[GBGN@.DK>LNT)I'9A`VI!7$2>;9@B^P6YM^3K8VSNG9\U5R8$U2
M\3U^5O*&T5OQ)U;TA;>D,841"8E0I<!*@*-+))\I9Q\OOT9TY-ZEF,P;8P@K
ML;'4M30JXYBV3)8[DRVS&R9S^30LJ%55\/6(T;;)&X$/.UI4J(=2U3J[M2'2
M8KW@2C23236K5HS7K)^9NA!MUFQUNN24W[TB@89L%9*F9H0HXE?$HK]ICA2R
M4/-BF0KS16(:94"QL2C(9@&)U1:!2K)-VI7-GT>OPKR/L*RJ]2)GB(Z4.%?1
MBH'F/KJTLQ:JL2SV^]TG5K!SQ('1XMTN<J$D[A4%?9"8;LPD\`5S4FUK:E*:
M/Q3W)5Q*)O5G5(UA32?7=7PIT9E-%LKXBGR*3)W>0*+]Z9L;GN*RYK9(Y,GQ
M/#F5"R11%)QM2MQ=%QYAQS0)0G%H+D&9$R,A6UBO_2EG*H]:%F/E8$P*`$.+
M/$ZIF[A7#=8\PC]WW?5%CSW2XM7\L'>+L2FJFH)+&)>>D:M/.].6E@U*(T+I
M.#IT:X]=2W+8<@>&U)"'*)5BS=/0BMT4W;/,QKVQQKGMNI:;<XT_._RQ6*):
MFN!B4NZH29,SM9;6@`%*J$N"L";C/_%R?Z2%QM?DX?F^L8!:SBWH@//-]6SV
MMGAS)<WI_M9N*AM6))]-G2Q39.J;"WMHGT\+;5K"L:TCD'WM"M*5K2E@PD+/
M9+/5D+GNBWH=U&AK>NW.,FAG$3H".-3?.RG-=$HHY3)^ZK<I--PL[`K:'E\>
M#6BJD*4"/W]&2HT6'6SB?*(>).-)F<LMS9T[.[[=53@Y_-?!(M`XG##+#9E(
MWEQE;_)91$5,@6R6).*E\9VZ,5D@7@]V1J%R)T4.!J)P*$-*-+YAK,^RS&N]
MW69<4#*:FRO)BPQB+/\`0G73U)TYS<N)EZY\@=.*'^&JXC,$CND%%7!H=#=J
M-'`3*!ZV#S^&_)KP=LGJ1%UA]OVI3L(L9KDB.`2"V:G:W"<&M<8BDH<&"6UE
M%Z5A=JRQ2M<)!8T=*@AD;63)*UJG]:O7A/VH3J$[0<::-$2DE^B1-,<M6]U]
M,]M2A9,H$HEE8S>[FZGUB6&+BD4398I"D#_%$4L:Q2(T<D6HC%03!F:$E]OX
M^.P[!O0=,FSV.-5PC?5EZU8&Q+'G)\1M&'!?($A=V)B!)4DE62@[@F+W@O-K
MHE0]ND>BD9<)''!!^%[3K35)[NI5^\%"+"2HN3T7%CXETW<GY,5W7?/JV:FI
MUK>*+YK"56TXF"+6!'RZZ:)MI>6V$S&<.S6V-+HL5-XU9BW6G!,E`O**3@/]
M@3,FXF<XU*UNP[.:YK;<6JMNJ-P15`AO.1O+O)EL@=_B;525+<Q6H?&B$\<<
MD)3=()$XWTJ0&JS#3"FDA&2>)*J&(1`D[?=9$!V]V[:+#)XI::34-!"V=ZZD
M9(]4;8]/::>KEE7@8*_;GRTD@GHIE>HS\:?]2$\!*9#ME;#$(M*%`E>SRDDI
M)$UHNF>P'=5(8\W4[!T<KA=:J9LO97Y$M;I1.@N5L26`1AWB,/#91K5'TYT7
MCYSQMG<I(:K6.!&FH"M/I2!P)9$R-!=.[)8H;)J\U<Z5(),F@DVMXJP[446&
MRP*6-59\V\_6*IC#%$'"3E.=;O<F>;6&(U-I2HTSMK.M6'I%ZP9PLOCSRN/7
M(.^K=B46D]F/$$KQQAFA6O'HC&&0^1ZEY$DKF"QF7IW^3/2Y>6RFQI4>Y+R5
MR,A(0<A1I2U7O9GG-)(F0R-1O#K'I`VK+-CKPU0JE)%"J]U+GN0R90\PB1S]
M@D%N%U[%76IFYHGDD,@#J4E1G"5D.#B^';<U:!&$("EH%.K)"3U]'9?,,JG]
MZ?X&>S_S3^BO[H)CE[?VGVLZJU>B9_M'>G7^:;3_`-RZ/+W_`+5>[]JZBYEE
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MYZ2-L3^M*\J4.P(TBT\/@`LXS0IRB)YF^<D*V5D9)RHH5YCLDFD6JAD:7I+!
MW]D<)VTHUBF'04I":0O0`>V5`I.&@1C"$2,L[?L]`T9^ZO*\L0;>/.8WYD@X
MD<<63=XDL-:'B`I6J*NDDACQ<<6D6F5;-$*!8K1MI3_&X\L2*CR3E.S"/*4+
MSE&!\64Y9TEXY@I>)2*U8HBIN*,I#:>Q+WV`(X"SJ)"*"-:W:2"H5[0)N)>G
M=G1M!J=$U;/V(C96RP`!H._!S>#EZ6^0\X(5T(9Q(*UB\DZ-;W>4QJ+.+'&V
MB16-[TB1S*3J%C<6FV)[<=!5%*W#9HC1&*/W0A#'K6\<_@Y;3%V2B%6WJQH6
MT5(I$_OQ+G(YW%T$..V]RAG4*49#@]2AI*%MR?FM4O.*`:>>-008<,.MAV,6
MMN>ARQ+M!.:RE#S%7V&T<4JMF1[/D$;=H[`@*++ES/Y7L1SRSK$>C)E(VO;B
M%7L1Y:E21[?1O[GS^;;E.6`1.?+EL-<-<VA]JZ0-#?9"!EA9K,]M+>E76-1C
MZ](&>.-I3>K0_'UE=OZ14:B;M!4$)S"PJ"2_+[,S;F+S&*N^;4174KC$EL6N
MHR^V`[OM>UM`7YP:*UU)G=TL!\D"5OCD>D<P>&A8C3,0&I:Y+BAGIRO=Q[]U
MTI4CV1B:3?1,RG=6-1OS=K-P!M.FA"E'\A5.XZC-EB;X*%`L2_)@WV8WTCY.
MMNB#0>P-#[DGT`6O9`\-1&#C)M$Q)H;R(:94D988F\NL&:B8R.',K1&I"[N2
M,;W#V\MJVF1LSRYN^T^U3>7HL\Y3[/9A8A^7+RO+\I76A3GY#-T3C41LGF;R
M7'&R7)5D,&_2N0L"1R8B6%"_DF;<'UY94+BK1A2EFFGIBCSBM!"$8P[<IR\B
M9/SNRR1WEZ,FEVF7UY&4+`_2A,7!T$D@T.*":F;65W>RM%.D9C)8$@RR$QQI
M"76BA!`']SO6G/\`!RCE/9/-T;N$B,,T1BZ*:S]XA4D.G[#%(D0T2-WFD"NR
M4QB4N,T1&DJ754=%JMD"<*X7M3/%P))+&("LS865<J3W*!4&UGKI@\0NH&Y2
MT-6XHYRARCL,2'MC&6W*4FXTN>U2,LQ$U`:7<XKW,PT).DZH8?)Y#!:$Y.6,
MD+1S4_+=R^5M=&O+C)*_6@W)Y"B@+BM?JL+2F+'$.WIR*./=*_`A&(T[7M3&
M[16]B%^YWO>.4Y>]>EY^=XFBK)T34XZ0;Y'(I2VU\O)A2V)_-^T")4-TB11-
M0$UG^1S8,@L9*LM/[D3L`=A&'PUO'*\]6=9Y)4C:.,A8'^N4!DP:&9KAH6=U
MC*4<I86I,X'1YNC.D1Y8GMH;48E8D1*7VI))6S=E:T'SY.4Y:=7[9S;:FY';
ME;,%034^8"D\#EMB1R.15R<926RN1T8E46D4C3MXE[VA(7LVTQZ92::0:`D&
M_`1?DWN\]%YBOT=Z*YC91KJ]!2LAK&-1&9%4N[:E%+-==UU&7B=-;18"M@.6
MN86R/$,KRR+6YZ6Z3Z,(-*/)-,T(P.]`N7J95L1:J)R=$;<+5<+WJ=,[@]-Z
M`6HPJ=)C'U>FE4ZNR-+OSJY"SJM($)B@\`3B!^P($,6_(7O64?E]A%/O"UO<
MI-$:V='&-2=0_M2]]8(NM6Q^9&(DKRJ>F]4X)#3VJ3C;F\E68I+$6JV00`W8
MO*`(M-&/.G5+1^/&3Q/(ZX(8VA;(V1/(&QVBA:4#Z[.6G62QIN="E9*33^_/
MJ`)JI$$X)RI<6$1H1&!UO3DY:!"$_+4NB+BXLL-IUJ;K>B43M^>Q9TC,`:WA
M]99061(X_)K0CH"3-KE'OB[SZ5.&CPA6>?8#1#_=;O*\LT0@YV='"2I([$:E
MEZ^TU+,ALX,8:JZ=U$B;Y&S.K\QNMF`+-`ID+(\-Q)HTPE05@U(5&AE%C*$8
M,+DY8=\9N2Y-5KM&EYE'AJ500NBKB6SN\/8HPA"OCJF"+FA,ZL2UO(9%A\34
M',X@ISB#](!C2ZWHK>P8YE^3EF9]7-"6+/XNNL(F"2B0U5#92M;H7)Q1-Y;F
M6-RYRAZQ7,G&*O2988BTW+("E`@<]!(+3:V>'0M^?]RY.6`B;[SW+5-IV'!:
M^ALC=&&<LT4ETQCL8@2A=-WPYDK:;MKN@EA:HLF4-Z)+(V<X*D]7HP"IOWHL
M.S$Y7F<G*5G29U(K"O='J5URI#63DD='1Q='V,G!KYX<42]G0N*]8K5"U$W)
M>W.BI*4<8).::0H-*#O83!AW.41K"G/DQ,HF*&`[H=J/BT[+B<U*CJ&#LH6^
MQ'QCTJ+:7,21.C*/D;LR3T8->&S#3PN9Y/CL1AX,O*\LJZ5QR_'H4%N>H'0C
M'74=7-$R`A=(O7K9"F)R5@$V,,K"F5H2&)K7*BP[3I%V@@,&'6RRQ[U]C')R
MPKB]\FWB^1QW>G&E+'D516P*.PYS>S8J\NL+N-*WIUOPB*+'+SJ4LO\`<%!1
MP2D0MFF>0(PZV(G6P.8<QOKQ'J,52)H99`QU.IED<=#K,86EX;8>=(F%Z=WC
M1"BP6A`M)$Y-;HZ/ZG0!NQ(`&GK#/#9HC!?9<IRS#_,*WA(UD@>'F),[F\&?
M!=GF+V-"^2=R8$RU4FC*01ZA,J?'A"4H/]W1:$,TO9HO*$/G%XP03S[`N7GR
MJ7!_KB,P61QJT$+C(9^M?VB%/,D>"+"7K[/616UE"-*>%6:SBFX]?#7$9WN9
M`P@WYM?NQ6V[RMU,45=J2C;,69"'.JV"/(5C=`2AQ5;$FIF1N#<>8%IA18F@
MPA"G6(5+V/2=MUX#*,5[\A>MF[\SDY>"(LW/R%.[;@C53B-(9()8D?-Q%#"D
MZ<<J5("C)RF=MLQ0"Q2!2V-X!.P#OX2,@@.U&M@!KP<IRQK.RT"!\TZ:A%6Q
MF6S9V<X\WGKV2OT$GG^X6:C)`:UJ$0U"^2H4B)@1J4P/.,Y.E(3B&43LL(0.
M5Y?)PKWF^PDLEG1D?JE])6O#`ZS:>,P8X`]T<:FDK)+6@J93%D&2I<TD0D,1
M1'G)%ZHQ.7[D$L\O98=@QMZ&ULK@"CY^YUW(G4%535Y`I/=JF?7`,1D;F%8`
MK:]2YUVYJ=+%05(26?9YAS8/SZ"E\^]^!7B%RB*'R^>5G9R6TX[O5;R)F?9/
M8,-F[6O+BBR`-4RCQ;%*);&;`+=SBF@M]>5,R3G:)-)/$L6'&>?]]T/&7JN5
MNSU':!:DY43U`:N>5T'BHV!#7K7'Z_-=XS`9^N0L3HV-\;7;0EL<-D>P%@6$
M:T0D7%D>38#AA"7MR,ZTHJ+C$9<1L22IH]#H+MO0.PFDB'M,9APHNO%*VI$X
MB1@3M<>W'7-ZVY)RS?8^Z'J]J`:`,WSBG*<M4MA)SN16KK/;`@U;SR'U>URJ
MRF](;%(;,#4BI!'UMC/2Z'(7$@U)J4/+4G&X!$0,HU7Y]'"'Y1>TRS?1>61;
MC^;35YMCH-4F4]3]Z;659-"?D$!YETGC*A*XMC$ND9`MJG^11I:S$G$IA'G*
M$9R,`P!"(H.PN3E"ATIX<D+9&9\`%/)XE,9/4!$6L]G#%F!FF\UC-AEH*IAP
M'ID4('M_61.<0M(:F;UA0FY.),0+7B$H>BW)S_*PL]F])P1,AL"Q9!7L>(VZ
M11D;Y;(CV0HS3D\2(R)1%*E=E&A*`>:12XY(0,(]%IQKC][$`(SA8YO1.>C!
M/C+S+M4[/,E::)VMKUK%"GUU?$-?[50=EEP%&AQ)V7+RO:QIKDX'@W6T!PB"
MENE0_P!P/VF_,Y7EF9L]T<Z3.!5O89]=.\X?T4HE]<126I6-U=UB2.MI31*W
MZ,(W4A2(H:)EE.TZ@XGRF#1JC@>(BO;:TY.7Y61R@[/8BY8X,-06'&4:M0]%
M258UPR6L25<SMYC&J=BWDXAP;R%;6U)QHS#]&:&0G+V5L00!V'3F)R^J61T4
MR)#)BB?JE:$-KK"O:RE*Z0Y`DLIP;&S301[1\*/*)F*QO9F[W4'B:I&4F(]G
MKP`#RZ<G+#01YYR.J>,V/7IU1H*7,;&F5Q>5,::+,4$1-Y;86QM#PB5@(0-3
M.)$U#T@`+?L3$Q7\&WH'ALO3DY9F--]%0Q$BKJ'HJEBC?.2U[JW02-)H<Q(I
M@4Y-NCW1R11AK`E(D!;@SD:&H.+(.T:F!XCWL&LG)RB9]L'DNDERJLT[;5D=
M<&<V#LDB@D5C\-:_DDPWN]AAS.[R9H(+:T+1$)`HBP`N)@];#[HB)$<6('N^
MA7F\KS4E@C7/"Z1I'@N/TNLEUJ1M6G0NH&J#J)'8\0+8DZ)<0D7:(&YS"-@C
M(RBC0@$H2Z0[`$6O9>&L<IR\+LQ<RQ)B7UT^LU$QF,E1DX+I!79OK]E8BH:B
M=@O*@*^,+"4S>",I'QZTK'HPC24M6KT;OP,-\PG*\HKZ$@O,TFKY^ATZGD+K
M2$PN*J+`G3)'DU0$G)Z]:8L&,?'UR*30R5NT6:VF+%@1('ED`V.:(G19*-87
M^]ATEI-;U'K"Y3>FN3M##*J7<&6N$;*7+@#<(L8U1E%8\90ELYCTM7B]S+*F
ML8<B"?:FF"]^).]B,0][V#')R]CG#N4V)/'XR\Q;GMG2P%60;%H^YL=<-Z>%
M+YFNU[L9'VI4E)+CBN5N:?7L]IBR1KCR_L><8?L.3E83(BI_>G^!GL_\T_HK
M^Z"8Y>W]I]K.JM7HF?[1WIU_FFT_]RZ/+W_M5[OVKJ+F67`ST4/[=_6^_P"7
M"\/N2A.;[ND^F^_I/IWSS##GCT/R-8MDVD_V17$C@;&8EC,=LJ`H920]&@0=
M@U>8H9*NL-^`W(%19L(-KES5,;R$G8EPT^BM%ECT'PUJ7C&I9ZHJ6^G[+2T;
MA6S(?7*>&N#\VRPFXUQ[JHMQK"AYG+HA?7X6$,<"C6L<A>P'KU2WXZ26)J=E
MZ3:':@?O1CR-?.2\47U9J26N$R74[%W9]:$+.ECK,^R^5,2M&PT>BK8EMD;J
MNAL<4+F.9R!&<!R(+1AV3'EHR=>W4!%HQ+(FQ(J[DVRI%SMUA7BF.T3$)5T/
M;9-FL,(:%4C>*K:$*>-4RS&1Z:N!<2CK@[GOZFLU9CH<B:2B3??_`-R`6_/L
M3>8;RBQXX'L*66*7/I&FB#7&YK)I>MEE/U[9+C$&&M$;^^T^Z(W^#R@=.NJQ
M_D#D=5@G-["D118\]Y4E#(6:T6,\;>,74[W1R=*++Z126K\1TY0U=%:I;/<_
MEX?$'&"2:GY?/YJSO2!M35Q*EDK:9$Z2U)I4C3O<=WO2$PI0)6G4[`2ER)O&
M-!9.&G^%(Z=%&F>H%>ZN8>*4)\>TE4,34Y/W/*6W(_8,A1+"XDYZ2N#@Q6.C
M-:5(THE2K;5I,H&E!LLX#R-:HFX$LDAH:8JED%?1X.ZOH2+O%C1TQU32Y))*
MIK*W*T>%#8@!'$AC@3O4_0N;8K/<B3=&(QDF$E>4LX336I`]/RS$%>KTJ"*4
M_(9G(ZQMVHY)%[+L1ZE5:IU$^K&L*ZCEMQ733249"QN$?05MIO4,Q3.6K6LB
MX81.X3@^S%?)=6;OKE*7V?"*=C+$LA93U#*CM*GGR5._OI3C'R+,I<^N_EG#
MSB6=:N7J69]3D&F-XCVL2I&<9O2LHTL(3,RXDK*P7F!W=(OTFTV-'JZKAOZ!
MC<=AX*[J!8K=XA$2(S`CH;J;)'!?%80$Z8.JA04(O936GTC0,[65[0PTD0M-
MZ8:K\+A^Z%;:M%(U=,RF>7%%((7<%E&G2%$Z5/9S+<4OMB73ZC41\6<%3L2N
M!*TJ)G(4+&`]$HC#0<>8>6#V2>[%U\G/@>:ND^9'%P2Q0-?I)I<1:N-PRP55
M?G)([/.E1="QF?-HB*??S$\J2$JBFIS:T2AL-$<Q(#27?90M@37R-6@M/F9V
ML2\FFT!'0U0RM;[S6[E-[ZB/6NA/S+/?0KF_C2:&V*DA"MQ*MU!I",)@=Z&F
M4>T$7KV>QYWC$WC$'6WSO8=M=.VZ8T1*),L9?F'C%65=KSMW03N'J*<L^T;#
M>":Q$7%W)MD+F>28G1Z"%T:MM)S@(\_WLLP"?=ER?D]&M4IZ?;M#RZE-L%MB
M,E7UDXM"5^"ZS9;*V2>((;0MJU/%90S,A-5PM-`W]2[6<H//T=\9<"4@O*)S
M5#2IO,O=JZUY/PS>`HN]QM8BIAR;)16#W1<022J1O,D?>9X")_(>(O*81+DE
M7L)EFS9GT>89LY2CCSB:>QQ[2AT5FHU"\QL-B2WSC2TH^U-J^J':MF:7_$.C
MC9JO$G*:G:>,EX=8P2]M-PI.L@4N(;9)\B&!S0[=U34XB:W=;HU&5X"VI);[
MIJ-4'"4FB<!)*M.4,2N(L$6?2I:1#T\UG$F3,^XQV^WE!B*,F*EO4E?6`72K
M$-O]DC*4''M"@11)8])BQWRYX76Y/=-6Z9QW0S;)H+'9U?$IZ%Y^O>Z8TX-K
MDGBBF?O5S1NS;`3O6T;9(5K(P0L.MMZ588D6%-B=L2B-*-*)V`4XWX-Y^&$4
M>G_-U,5G*\L^N&:=2115S^Q-D=5GH6Z,)HCU[='3TFIIDE[A`'8QHKYP;+(;
MVA.M`QG%FK4&U)[3I.`I+C36,DO`MFJF-5&*W41RN&>2P%OW9&WFT'"P%4]F
M+-9!%G,<3`>II1G#"&%,XB7-*MU;"MMY[`O]T,CBD)";9#R-C?H]P@XH4SL\
MA01!JE+NBI)>A/?Y(KL%\BLG@_5\^Z*L`QIFI=?0OW-KD94L*$B);FMO))<M
M&`$7HH`#S'E^$U:WG.M9C3T;6P!PCM?-T7(G%T2=`ZQ%V6@6+R)M:CQ-HD)1
M&?D<S-S<?N/R4Y.X!"M/]V4H"@DB4%';&3+=Y*CF7<MNTPELI=G@^'.T?D'7
MU4=$@9GA.L6@^3E=4I75>#:UB0YN.1F2,,JA(EZ37B),$KV(Q&!-UL(6_P#A
M*@6K.#IA!KGALQDKFUR*(QY7&WMG+CL[713YO7&!NMI"C3$T1C=9N"J2Q)2R
MSHD&T13\Q)"#%"\HQ.H(V7HZWNV+K<KNY6N*RI-9[.Q'5DEK^PI_+[1^4+V^
M24$I2NDFXFD7*A,1'%T,34MONJ:1*4;P:Z_%!"$VC.3!1^V``T:61)8U:9\/
M2](_.+Y`8O0\C8CFQ0Q-M530#I'X"F,D'/\`&Z9=)L<F9X7(4P)$PGQ@LHDL
MM%YUT?7+$WO*8W9>A/+[743L7II3@MBED3ESM%I2%TB+"VLTD4S-T!'O!5"J
M;A$U@K]7'S9_$G>+[;:Y4DMRA5)%1`4A;?H3<6<4(93R/)+<_P"+;`DLIL]-
M&G*)513LADKI+VUK8G)VETG2RI\JNW:_DM@1I*E@T?<8F:K(GB`X,9`YNR':
MQ(><B-0",&!6V?R2HKH'F=VM>QWNRI#4E1PN",+]%$36Q(8#,V&.2L]BY=F-
M,JWUGCUE5S`WY28@7S4"/9JIE3$$-Y`T))ZP241IBW\EO&/RW>F_9FFN7,TA
MDS!(G)=#&0<8E*N=NX8^*0I:=JJL)#7$R@8*RT]2&N)*"`*DARHV1FEZ9U9.
M_A.U:?6]WRAY+.QCF&P!5'T%%79JJ:`O]V]`L5QMD:@:U[<H=%FEL34JG4MC
MBZ*(K&SW.2KS*R6*5*A.V)TQJI8'>M:_=CR;S$10]<&R=OB38GBK=71TG;(C
M-""U#2_K*^4#L]YZ!37+";%4ONZWG*1\%#!'+C34CLT."9<>L4$&%#(4F[$\
MEUMK#Q=+5EDII-/DU1+DB:Q':TULA8F@Y*O=YC+^4XS1;\[(X@='P-["N9)L
MS+W%`,3FL%MN<_#0RCP""-Y<)O#2H[R-T(VNU:S21,=#2A93L;H.%M%9*)?+
M38O82"FZWORNULI?9$XUFJ!&'X2VWDKRQ)M,[J4AVD.3FG>U-+6$-B[&XF\G
MVDT6#\KH*P53%7LOI!7:;1.T<E5A^%UO.D-5_.O"7^M3*L4LLP6O(($<B0J-
M.3>L2J24#DG6HQZ/3:;[^QL;#>W,%HSVU)U+:X#!(VQ2V+0I?)0R.3NKD.S+
M!K"70265R!4TEP%2MK`AM!#C6MP=&UW<"5R!00,UI/4)RC"$L)?=KD-Y?NUA
ML1_LR11ZE).X62?;*-V8SI1(][II-/K!,F#1)8`^KZ\5[D[XH:32$DB)$D9-
MKE3.W&IU`"B]E@;,PWAMT(Y?=*4J*T6-H11D1*_C.HZ:2,,#:E))[E.:D@UL
M,KZ[$MY;>AVX?*(,M;2$`]^9:<%+[,W0-`*UMNY]I;OY0#57"\WDK+4TCFS!
M551;8(#5C&&(0!.[+-L;M".9KSJ=NM1*D>(I&@M=H)I!=:;1"4XLPQJ;8^G!
MMP4*`@"3?*+:_+YP%:LWA1D85IJ,JDXB'T/"B@P(V1N[6XCY^;+-4`E1Y.XK
M$5",NYE4V(B4@;-B4'%UVH=T`EZLY<3[H\I#6R#X/G2^U&^92A0P2")/DD<G
MQ_B3#8KK"R(2H(Z-G'0+$H8%7S4R!TDR5>?*42%S3)5<8,,&RD:V<>0;L*:>
M1O&)4C_,%GE<O26D7'Y`I`H;)A,GJR`.;TLE\1;ZTKJ4UO+&JF+%G!$"B3O,
MF"1GPQP:SW!0R*5R=B<B$ZKXL:D--5MFZF\ZR=!\IOT%NQUO.:-%9M3@]-5F
M?!X;#MK7=%5JRQ)=$W=<T0UX<8Y'PF(WE#$_B#TK)2M^UCXXJMA3^RW[0:WC
M"UIKQQ*ZR*SI\_N['4BB).TUON:1W:M&8N<5[C=M+0FN2E;XQF14+<@=8ZZL
M+B6<HTJ7#5MZ_P`X=EF#,(R:NHOC_I]V0C?9$MD,C:'YS.61.11R;GSUU]W)
M5@+I)),(F]P8-9E.;JA)25@>6UKU,D4DA+);A;;R3BQ#(OE#8LTEY;^`<F+*
M+31F+/DC,?ULR$%AE"RMD2N<&VF9935,BI<5"I<I(DC(\`2N&C%C*X)UBQ($
MA248F&/6YO.IO.J[2_C?IB:PN05\_O\`23@.8"D<XE<_`=)6C:^Q)5P$]\AK
MV5!7C3$"6QMC)<X6%/@UI3D7L3.:-*2@(-`#>[LW_/==9=GX^N%OG##9;1&:
M2KJ7!L*O3#$,)DSJM@L1K>*QR!1*R2=1-VJ=.@GSM<L?B7N^B=EL2M@^%LAA
M#F,U.H%MLZ>AL>:/</V''V!@("R4RL4P%PI`$9CWOBY.S/B2G>F[$MM2\GK/
MD`:"*NTGA$V`6$LE&M]W="S"1GF$#TIQJ:\I?%]VC0H6MX;J/?VBKH_%F.NV
M]R?)(I%81D1ZLAO012V7A7U^M00,#W%(IIG&4G*?=IG$\TWSG)]A#E\HNQ@B
M>!;(:F6QSR--,DM#4FD3O4ECNMR*VI"B626U999S5,)%"M4&_-ISU#5<@`0I
M1.YLI2O!![@4`24I4(&YY&K)]*\QSR[4D(]R5U[N1IZ,NVG);*W!$L:C6Q=:
MD:A@29'&6Y*VO*Q1'SGV%F-[@T_$$!NVAY.V6K$,K99R61)7]8:'NAIK[IU5
M%PU94EC7<I:%4-AD5/'*JTA)S!7\9@IRY6O>*^:D*Y]F!+(;L]2*,'I$1&D0
M3$:_:8T*ALX-1;0G(MKU%/TLRD['5=D-4F<9ZA=V&33)Z>G>J&.9V("=#?88
M_N-8EM\N?'LA481($GP]@*6J6QN&2HT6`80+95MEX2`@YJL%IYMYEK8F.5*Y
MRCFZ4Q)X4P-<ZN)%6V>AA,8EL(3#5NA,',41]R7AD!$I1^U9'`M!($*<L8CO
M)[[J;RF\M!KSA*1Q787ES.J[Y4;F'-<I;E#.WN.R(.SU1T-8ESRRO(2X*F4I
MR01!HCEAGQV.A!I-HY&5L*@E(2;LH-M-2C;_`"P\63>#A-@LU:JHA(3^47A]
M5O@#MR0Q=S?<DPL!<SJFLJ,K$KVAD#3)T@D1YS@#2=:T@+,(V6(LTM+QAO"'
M(EPC+H[=<:F3RO:'V"H)$V2!`TQZ;JH4"NSH/?UX7%"DK,P!J]\/D;(L;;-;
MD:MN2O,=3%C1JDYGOB)0$(&\?*[PF*4<>(I;>ZVW'QHK9Z3K>@H%:INGIDTY
M/IT2AO,TCID,?/.5-!Y)JPJ8/FG%,3LW:0"?SF>8*CP#N;QB;QBK?Y`?03VG
MBT6F4TK-TC$+IE]JIC5DKG(*#30_<EK*-+8U,**KM&>\FMUF*1O9[RZ/JTU0
MU^[D$(THB`E`UL]%UMLOXMMI^7;?FJ/U;'SC)93-DN,:C,S"P@>W2'\^S"B9
M/7RR0K:/DS>)F853ZF?V9S/95(59A8DHT+>/0%NIL-C,*.%9)#X.ZHZJ;8.E
MLTNUH-,JUL!_F#DM<Z_;(=SE7M%-HIJL=ZVD?STHV]%%W%(H9UJ=N+<6Q=[4
MA6VK]A.3M]^B:ZE9E%3^]/\``SV?^:?T5_=!,<O;^T^UG56KT3/]H[TZ_P`T
MVG_N71Y>_P#:KW?M747,LN!GHH?V[^M]_P`N%X?<E"<WW=)]-]_2?3OGF&'.
MFUKVLBONA+`88JQ2&S5A;)`!U_6:"2E,*%5)?F4ZGG2]'LH;8N^)!DIU>I"A
M$><H7O!)!P-C&5HDW63&LX:`Y=Q6BSO#H[HVFO)W#'^&<XL<!(B3-;PGI#;]
MJVC>5>S$R61<<%46`D9XL?4JTA4RZ;/C:9Q;PHC"R3CU`T[/R8_CQUK=L]65
MJG15^EI]L;+ZY;KZUV^1REV9+**D%E/;0_/#(S11VBR#:Z#KXZK2I]:7"0.J
MTA<>,29,)$,HYDB9&_VMV]+:U'9TJ3UC'7VMX)-[.I]L*'-5K98#U9U;T7);
MLVM7-&XTM:&>#O?R8/:@C]X.7ITXRW;98THQ$@>/Y)-9V;]$W>W<]]=OB..5
MK';PYX:G`QKWI[D4CKA>-;5L5M-F7FG&Q]L?AJ6UIE6T9I`DOLE"U'HSSED'
M^0EDV>QG*&%/8ML48*^))9\6:IQ"F2U+G8(P4R2AY52A+(:^I6-V87'V]L^2
M9Q*6OE"U&Z(2C-"4.9`M@5;3F@-$24R7HN)[_*9M\JET\M5TTG:K+<+TA=',
M3/+S9S7L0D(9Q*HO'F^RT0)?"4-@(XH@3R49IB52T%JSU+:H()&(`B5(YDWX
M3.42Q'U#7U>WJK#FE+O,6HO3FI__`,GJ$TU:4+(TEKI]%FU"Y&RN%L+)(I.^
M3&,LY98&5:M0IRG[V1BC9R36UES\KGY8[\ORX#")PK3\V*!%155\A1B6N4Y:
M8\RV\V2RMX.[Q^4V&NK@,*$PN4HFZ\AN&U'N+CHMET:>E#[[Y$CQAD;)+>U[
M0A,C<:PD%8,::Y5]AMD+A\,0-]MR8M9%]0NS)D?;AGR0KV0NTH@LM2U8M):M
M,:9:<V*S_=G?:4Y*?K;QG7T,_"6)_P!*S>+L]'/KY6"^OXI;$&&[3)QF"A\3
MNE?V"\-+#N+TNL4,3"XHXS.7YX?#DB-S>O<FDQP0Z0@%M<K2DCF)BH4P[NL1
MAB]96Z")IT]00J2R1ID#,1/USG:M@O43XBL"Y%3.]MNX@6C6QM=*%:/V:E/[
M1=KX64Z"3B)4Z3DZS\__`%<6];NFIJGI&0S>>0@NO9ZCL9+6$+;'^*6\6TV6
M]._P`Y@<X9##X&DM]>E<P/)Z4*8;,69M:UJA[-"A![YK.<IG+#\[=>/]URF#
M-LE@[=6K18-5:F4,`Z*9(L<YS)&17IOL1NC#D./H(Z03`W,LPA4UKSD\@V1L
MM;[KI,(>RUF%F(L/[CMSW-<V)ZMK=#8T3AM_V3:5?R^=RF(NM<,U%(J:?!P)
M8)="%'RBE,O8K<)/1OZ'0HR-&64N(-4D':!J^/X,?UJ]0&:R=2O71>B7DR'R
M:;;JZL95)DL]B;"@GV[KB=%MJ:T).YP/<53(9)(9$L7IB8\K>EJ=.S&I3B]+
M%)0"WBN-4N^[[J;)T@9SS43:@KF?SA9;J&+67,V#Y4*8=Q*;<[6V5^H2QH)S
M1&`NB_1QR%S&I)4.*4L\X!Q0QI]62?Y]F<-C1]ZS]2JDA$?HUU=(NWOZ*J(O
M,GTV<M3"EM(V?5I53<98TZ60$N&@BTBED_/,*,9E;FZ%)&<9AR71BP)26>)G
MNQ/STW[\V"QT&^L.K)*]1A!3.D1<S.W!=1PV?MD6W&-/VV;3J&,F)3]GB;=I
M?B'MA;0>;9W@;C)O\&3_`$F"MNSG^8SZ(U,]UTR-=@R66O4>`6U3%0Y,2QEK
M6477!+GFS&I41Y$N6L,1E]*^P3!,**&;J3LX%&R#3Q!U,XU,08_]']4HK6=_
M=DM9NS?";(ZW:V^-%2*21V/.]<U/7]7RID%+#]1ES7K)F0K=SDR<28H24DQ>
M8<,0P$:*-UDQ<BP=$=@2>\[971QGIZ2(JL\TF:4T^&TS$(6211%LC*]0&3O"
MV*H:_.02A2^JDK:2UO"Y<5MN":>5H*ORI)9D3/RU97W!)E[16!<3K6-JI9:;
M)#US:WO4Z4HVMB5R_H-@HL!KJ>CC2MP4MK06\FN@O9D@-4C2"1@\@A^V`\3$
M<3'L*WYBP#1QV,Q:$?-Y97-T;N9]1S=T&[FN<S[364*^M]6I%$53DOT97I:U
M<]C^(F(53@F=](B0@5)S/:,G^?2XVBL^W[BM355:8:`+:DUVR.&*H)(Y@JL&
M&1DN!RFK[<MEQ1F*Y/736HEE@1J.U:F*-^#!/8%)TD2#+<-%)SQ#9$QX$O;$
MY5+8J@40-M;;?D`=01QKQVD\JCT<J^P91:=(1)LCEGMKO#27=4ZQYHM(AP"[
M-^A-[XDVG^%".3NR=44S\+GX92.]N6JZKU.G"JJY(9H#*HS%;6<&:RWI[./4
MR?KNW>3"#ZX)U!T1;D!O6U@&0G!<1I1[+5B;=:T>7M5CQ,>6MNY;<M<ROD$:
MH@IB,NUWCZBII9.Q6/$H)J-N4+M*Q7=HD#H\UVA5/\Z9HA611OA'P.#0>8^E
M;`KV6B/&>\9#(G3G^Y5)'#E9WM:,E1!6E42UV#,)-('4]T;]+`Q[;JM4KGAB
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M)O>L;)K12OC;0<AE:8Z(*DJU*Y`*V9LI&<`027#8"&0R)!C'3\_F%%2^P)U5
M,D@*MFF=0MC(H;C9K#6^6,=CR"O0%KXZXV#!([)#`QA3*CFYQ'\*VC<A(A"3
M'!+4^">9-7.6P49U!8MHO2MMD%8QMJW(JSE]HUBWQN;*79R<FV&6`NKT]@EB
MEXCS$UM+N_*MH%B8Y.,].G`K-(.WXIM'*+9B68CYC[J>A0R4NLE@K`DE\)JE
MXGDQC&GF11LZ)3-KG#1%%=4R)'+8P@=T+XSD/R4TY>$D:-<`XA2AT<C5ISAO
M'DQ\G2^>A;$6<_2ZM6>O&*.V/?\`8<0AS$]3&1E&O$6AU/\`26EAUN_#8LKT
MA4#D,!0N)+0VA./0K@@3J#]B3FCVR&1L%C=ES-FJ6E+-@%7QU[.M"AI[T&]L
MTJG"QD+CL<K>OXQ8#U&&Q>VQ9V$]/CT!_P#AR1284D3$&:TI-"(&MD"9R8T:
M<]ZS&NXU+S9%`H@IL&N'=R?)5!8LX6'+!.U4M=<U/:#I)F9W:("8EB^V!KN!
MO:UKD_A0M&G(K6RS!!4:+(>*XSS[V?:S(<O,U4L$6I)/+K*AE3)M6,\I5JI;
M5_7]=\G.3E8!XH.>E9D4@/LM*_IBF_2\U*2C-2&;,,,`:!XICQ-W<5E+9^PU
MDDHY1)Y5'WTUHMX,'3V!)FM.DU?4MHS3Y"'9N@RIH;T+<GA3A)EWRE5-("D1
M.D)1IYPMJ"WB8DUKZ;GRSFFM[C>(O"X]/[K/8SJNKQJ.L>R].*:21U9-&QD$
M7!X*HE#Y*4\,97!P7:2-X&]$0D.-,4:3D&';F<X9R^O/?5$GO-W0IW&$-5<I
MYO2,.N*I&E]62-<Y3MF?HA`'V1/R"0IX^FB*U@ADHGY+$YHTYXGMO.+3JE*4
MHAR1^*S"S%7JFZMZ3"?$)_8[97\A8'6CN3GRR&V/2"0MJ!K<+FZ&NBK0OU<,
M*F-F#5/AS;\+5N0%QJ<@TMJ+3)Q>)OMR]61<C;H[ZBTD%"2+8F]&O4:J9\:V
MN11J9*2YJP)CB)G#+(D=?PG0IG!X\EDTV=WJ#M;2<>S&JV<2^6MQ*90<((O:
MSQ])U,]/5+5U=27#6,C9HVRU+!GI<CKRH)A.RGJR'1GVA?;?M=-32*,1PY%"
MG<M<EC\C6>_J'!1HKVZ),(DM/HTX(RDFIG&M*7]QS!`IAK$3!HH]S,-CBJ:S
MXTR*[!6H8W(7F_I7S=!)6"9DP<^*1>(2Z=Q4Y4E(?%"=T4I2SR4Y1AA'M3'B
M8WA@[-6S:E9?;T.@;:<2W2VF*KBJ-ZE1R-`LM6U5E:QE_:)0X)F)28QL55SV
MSB6=Y/)*5*?>FAQ+"2$TH(!3.<,RXKW6W9EX-UB2JK'*MUEI2UNNJ9?+$,0%
M.)<U1N#J[=!4[*WPIY8H.N:&Q)&2FAR?EX)*H:0(TR?:`)IJ@8CR;DS5R,[5
MW;-\N#A7D)D]4-=AS%P5:?+!<:K:+)<F='!I7T;8E)QA;'U*:$K61I4P]HK]
MP>W@Z0+6I,H0H@EIAC//&(A9/3H9'N;NWK]=(]"I$FI*JP`E<$H6QSF\ZVI#
M[1`R]*VX?3U=LX%I5=#)4NL?7;+=WL_V82-I@C1I`FF["HTR;AD;`DZYL]TE
M31$H_7T7/LV0R)CJ=:0[V(]$5<T2)GL/LR&266-R1/##I">A$HYE-4$E[T6J
M6IW-,G,VG$C&<<R&/93_`'),[@L>#Q=CHY]'&5Z2"-ECO;6EFKT7"9--JV46
M&<[E2@F%)J_.@D=-]R:QC6N:%W7'..CRD8`$>S4+,GR8\L\[CGL*0OTL(JJ(
MOD1=9->U?U8@!8+@VS!QFM!RQVB#T.P$AD16-\8B\K7QMR&G4I!+SFP`$05!
M1AB_8$KQ,2V#IB0-=5V0\S-MAL?LR`6]\QZ5N:QSJ81:7S9S^2JV,%QAKCD5
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M<A$V-*-2W&$F*Q`5$J"IGJ8E)#TS9SA0Z>W2JZA);S,KUCU25S&1SAV&VZ8I
M-=[72+;,)D_%Q39J98!0>H>S&Y"D4>";1232C9VQG!F<XF<HL8.X;!/;5),R
M@\`BDCD;:\DU>G9GBP[#+D$KA]S.E*/[$J8(O`=RUQ52-P9SGIF);DIPR6[V
M@'`:4*8Y5EO:8T!J[%Z<L1!N901@IZ/1A^;N"E[#'Y6LF)[ZS*.@;Z?JLM%L
M=U26-EEJ!F?!32$`_9E#2$!`<,O2@0R0WQDZ_*Y&V1SO&V)T8A%#:""6U3^R
MF>!U?*9FHL"'14L*J:3.(NNI8].U>DHGJ0H&R(;>RTD;,=$HR3QHC%1)I`5"
MB>,/%U$S+*I_>G^!GL_\T_HK^Z"8Y>W]I]K.JM7HF?[1WIU_FFT_]RZ/+W_M
M5[OVKJ+F67`ST4/[=_6^_P"7"\/N2A.;[ND^F^_I/IWSS#"NEIK.<D[PX(+&
M:86[2EW/K5A>49C0B<Y46EM-]D%/U^O<]IRMNZ!E7KI(\-I2T0@%ITYZW]V$
MO9OC9JS7O4<]\W*FQ`QGU75XVHZ%%0QM;O@+*!.HA+<_E3=(W)"P%A]X1M,I
M\'A.>'S&I'$P:LLP!Q@S!-IM>2/U'S#,"J]MR/0*J)*3&(^P#K:?IF9C=0-#
M!'-*%477,#Z84=HH$?"I4"0J@C]JC"H/]D,&CC?.YZ'/1L;U3=#O$GD5AR"O
M*V<92ZL2R,RJ4NK$Q*5JYD>6(IC7H'Q8J)$`X+K%3RT!PSO$T]K$!,(0D_E+
MQMZ&WHW9?!(0YH)BU.,4CBUML1,:@G:!4T(#DLR2FL!$7.2R4@9.P/10XTC*
M0;"HT9KW,H)7_D#K6HC6R*BIPIKW%PU]`CVI"!<>>R*V!F7IPAD4740AU4N"
M1:G4>\"D$/T<UJC#]"VL0^<DS8R]B#EVKM?:,5E4\=C33!XO$HDEC$<=&R5,
M\?2I$:M$TO!;CMZ99`E(.VH$G7E.9'O"13X^<)A>A%BUY=>$V]48`BC:`]VE
M@2:SK4YMM9Y0O,N1#8&14RS9^;G8Z5HG%<V'$FM;DY%2`HQT]H$K9@U^AJA;
MV=YC,NU=K`FQ'G8^[']D-@4046U-88GFDI7;C"4T3^Q1J1Q5*A6OR[V`D*QZ
M0/+<SF%;.UM9[-"F'H6P)RO(YSX.<9.0\[\\NQ4Q6RBK:]6:G3VU/\Q='=G;
MQ*7=^:EBL;(XJ793K2M,M;G!V4B2[*-*V4>M/V#P&H-V-M-K97RJ:AE+C&%\
MBA4-?E]9$[31C;HWH%X8@4:B3Z+`E2'Z,3H!%(B2AD;&#S$Z"$9>P[\!8VG+
M6?F!YN.?3)F*I:C4OJ*,@83GPZ*1A28DBIT..AGN1@S4AA"=M65\<)H,%O6M
M'LF@I![$E`$L+:;6$E,!YOA$&A%/2"!11-74YG!;-%XN)D"KC@):B8I)9*=R
M--%HP#,-`WPA6I)7",+]@:26``P[$#6.>IRV1MJCG^IEXYXS0&NX,X1.#+FX
MEX:6%J:3(Y7[0`M6YI&A,A3EA:&,D!)>U`4A183-%EA'YO*7K3;4Y01#>:>4
M+=0U3::*H(ZACZN(323QZ`2B)QPC3J7:;A6#JJFLF9C@.2]0[_"ZZ;$9>C5`
MR@M:O:105L&BR2KMG"[>B>U=#T&[N<[6+:RKMQ<K41'I+"">Q-*G<T3H%B`"
MLU]1B+$0XJ4SBA2>V4"+V?I0G(V,?M"BMAFTVM*-3<LQ5T9ZU+CU=[7G2LZN
MC6<AF;'0;'(EU%R%],02U0:6H-:1.M'QE2F]NN'KWAN$4EV(0#0`VY.6\**$
MH92[RY2IJZO37>PHR&.S8HQ@:MCED8():FW25\;]E>Q<DQ:9H0)]G&%B'[-&
MF+V/RDE:"VFU\!T-SXF@AE4&U=69%?[>4\I-A1L=8RV7<G4NX5B26F-XR-!W
M*5$C!I26Z;_APW'6CM&[4:\^-O7U-KQ1NBJ\B-E,<[92F=H(K>J'"KJ]AC2R
MQQG9:ZB<M?V:1S52A,1(2G86YDX01GV9H\[W<K33L18/:&J!B:/ZH8>?V^<R
M0Y/%(4YV3*D+5(I4C96%`]2YV8YX)OK0,J<T*,A0N,87=`RE(UZ[8?8C0-VQ
M'BV4G\0N<^#ELK!5M.0R4/=@QJ&PF,2DYI1QV121H;VUI5;;&MO9TR)"[')=
M$$A$D9VIO)"(W6C=(TJ8O8O9%%!#.4>-DY]HR./CO*&"I*\:I"_O*:0N[VAB
MC,4YKGE)(`RU(X&+0I/;!-32L.W0O0!!"!R&-5K6CS!F"NTVOZZ<^48]/L>D
M[M4=>.$@B;F:]QMV5Q-F.6L[R9+5$_T[(S1)-[`YIITK.>2#]^)J9U/-5E"`
M>:88)M-KU1>C*<A)ZE3$JRA<>.52%;+![:F!O2`)D;DUO3(O=T)19.BFU8L:
M)(XIS-IPE:&4O4!WKP.,\S;1I+YR[4)M?/T#AD$K^%%O:-8C$XZKR)RDOV;F
M^1Y_=@.;5)6]:D?271;%D&S=*=B&':),,H99B5.(IM77OJ;FRJJD@#;`6N-,
MCRF3#*5N;JZ1R-)E;TY$6%(;72*3T+,T-C,@1,MB2MP<VI$E3DI&HX_^#`+\
M/'%MMTUZC.9>?#6J1,8Z=K_X/*Y*FF+^UACC>!"NE*10N5IWX*8!02D3F!2Z
M*Q[-3Z*$(2M1L7C[<WSMIM9&/4#4,8;YLQM$&8B8M/V./11^A9B%.="2X;%8
MF1"V.$L\0&5\GV6'HF,LP.FY,G+2[,4GCV'>S-XVIK[,-!4E%V9='H_5$`:F
M9U:7YC=D"6+-`27AIE1;27*$+QL241CL3)`,*+XA[R(W:W:0K9VQ[+#X-J[7
MM9:5J*.3QWM%AK6%-%C/P7(#M-F^.MB:2K`/9C<>^`$[%)PJR@/REH2'+]`$
M'2X],4:?[0PL(M-O0V]&OKN:N?W-:C<7&G*[7+6^7/<\1*%<6:E`TTNDKFB?
M)"^%:-3B"%4^/S8F<%8?#V9[@G*5##M06`S3:;4BO$%A,A>")`_Q",O;ZEC4
MCAB=X=V)L<7(F(3`YG42R+%K5B8Y0&/24^/H1KT?F]W5B1D[-`+V8?"(T-GY
MUHF/,S''F.I8&U,T;ENIZQH$4<;B"FZ9Z:CF'4E(&`G1NW;4?/$W>U$(0OAO
M@D__`$X0EZNTVLO%J5J6$Q-1`XG740884J=DSX=%&]D1%1_;JA4MRMO5EM6R
MA(R-MBAG2"2@``):7W4K100:+!K4VFUG6^NX$U>Q^%PV,MVTS"Y1=/M"RMZ0
M2>-O"_3J[,1`B""Q%-+DYATH.(#X%F':\XM;%]G&TVHR'RIS8:UQQE44=6*M
MKB2YV<X^B71%H7$H'!^4H%SRLW[XF/$L4.:]I1J#A'[-V-0B3&[_`'Q.2(%V
MKM;BR4M4L;E+I-F"NH@SRMYD!TL<7QO9$29:?*5;>]M:^2`$44$M,_.:"2N)
M:M64$"A7I<HV<,>SC-B;490VL*X/:&A@.@D1-8V",.L*8V@R/M8VUHA[XW)6
MAYB[:C$FVG1,#JU(24RA(6$)!Q!0`"#L(=:U-HU>6\]45/%1*V:5#74H5$JS
M5NCWR),KB,Y0<RL<<.]\]X2#TO)-8XNV)A%'^T*$6VI-;#XIB-@NU=K:#ZPK
MA5[C[S!(BH^&+G=T;O;1]K-]Q<G^9M-C/B])YTV_=UCO/V%"]*3`^`SG1(2J
M'O9Q8!Z;489PH^GW20QZ6KJUAITHBCX[R2//^F%`2[-3Y('4M^?7%.N(**4;
M/>'TDM<IT,0@G+2P'CULT`1Z;1ZY!3U5RJ'L=?2*O8B[0B,F-!L;BRMC0"98
M^8PIQ(V<3&A"2$EI^'H3!IB_8:+UI*:83OQ*,&`4VCXQ"EJD@#Z=)H17$-BC
M\;'6N(A<V%A;VQ0DBC*E;T37&FWW4DLMI84B5I2`TD2A)3B"D(\P=^Q*\K:N
MU_&2E*AC:%:V,-:0EJ;G%6B6K42*.MA*50H;)<Y3]J$(G2?V82VB;/*MU1EZ
MUHM(O4&'$A`,6]Y=J;4=R#E6HG1`4Q,48885&'.U85;<]CT;C3`4AL"05[*B
M+"BB=V"K0*2VQ,CL5N1/!PT0"#CSB#`><.E!PA-7:FAX@L+D"T]R?8G'7AQ4
MI61"H7.;.@6JST4:?@RF/)#5"@@PTQ.QR4.EZ0&]["G6:]L#6C/W61&CNO/U
M*N\A;YDIJROQS-E6*79BE!\195+FU/RB3KIP6_$C-2^!KNCFSFI=R5`_$XEP
M5'GEC`8>:(=VFUYH+0D"B%1*:;=6QOF\9?E<T>9T"2,;%I+.9-9,L?)Y8+\\
ML3<WHV(HR33&2+5HB"4X"B-FZ"7K6@!WC>=7>=?ALYIY_9#(><RT[7K0H@#N
MY/\`#E+7&6QO5L3T]."1X>W1*J2$$J!K7MZ0$+EHS!#VL7$%J3O.>`)FFTVO
M01SK125]9I.EJ>#))#'I*_S!C>4K"B3.#7(Y2[ER"1N:-2066848]2`H"]07
MK?LC5P=*-@]MK0\;4VMJ)JRM4R9$B3P&'D(VYJB+&WI2HZU%D(F6`O7RD@[4
ME*"ET`AOB$@_AS:2'6BT2K]]*T$?V<FTU^TU85PC=27Q)!(BF>4[H8]D.I$?
M:RG`EX.<9F[FNA:P"4)X'`QUL9_4B.T+S[/>EH_'S*3MC;3:PS;1]/LLK8IR
MS5K#&>71ED^3;%(&EA0-KBVL(0N(26D@Y$21K:%*%X6:(+%H6D^E9^B_)HXS
MS7:/,.@Z2,DTHF1M40`Z4S9-M)+'TZ+-!S@_IQJ6Q8H`Y'&)1;4;7*V1":I%
MO]TJ,0IA';'M.3L#:NUF9)4M8R]BD$9DT#BKRPRI]32F1MBUF1#3O$G1?#-H
MI(MT$H(S9`CVRI-DK?'2DK:8KRCUY`^$VH\C;356,#,%DBU=P6,H4VHZ-L3-
M$18DB%L5PQS5/L*5IFXA&2D"9$7Y88M;]:#K292,0R_*(6]XVC`06@H!$*?,
MIAU:FZ;Q9W4RYWFI4E8V(22;2>PI:\SZ>2%Y8D#>D823Y)-9$M<!$D)RRDYA
MNM%ZUH`=ZN\ZNO45SS1A+;%V<NIH%IKAB.2-\80;C38),THYDH3K9>G)+$0(
M)P)2X)"E3C[7VFUJPH"@[8S@A'IM-K(R"D:@E+LVO\@K6&.CZT2@R:-STI84
M'Q=+*3TK*A5/0'(LDM8)6M1QIM+4>8>PJ`-Z71FA^[D^1M1M!<&AA3,WQPJ*
M1XM@:7E'(FME`SH`M;>_-[\&4H'E$@"1I,F<T4E!I>4>`.C"UFM'!WH?[K(-
M1?J(I>3MFF9_JV"N;8#9VRDJB-MFM)QJ)/\`+508D,*3EG(SCI=O;F,90@"$
MM%L[>_/O>]W:NUCC^<J%4-^VD50U\4U;A[/7^FQ)&&M`WEPJ.R+Y71R-$(D2
M=.F3M4<E/BX-Q980^X+!"-3^S&(6]MIM99GI"GX\]O$C9*UAC6]/\F2S1V7H
MF!O(-52Y&8Z'$2;R`)T2G??>7M:<-44$!QIZP\T8A&&C$*:;4IX14_O3_`SV
M?^:?T5_=!,<O;^T^UG56KT3/]H[TZ_S3:?\`N71Y>_\`:KW?M747,LN!GHH?
MV[^M]_RX7A]R4)S?=TGTWW])].^>88<]+YY14VA?#I,2:UKQZCTT9.3DDIE;
MO\(3O(TO/O3"NU)9%GQ,)G.=W]JED/<TP4Q7MQHSS6CW96`)0B=[U+PLN1"[
MIR!>9E@5DU)(Y6Y-6UY<09E$CF8<&;3(M72OJ*S)]+H(ZF.M;O4[.9G.DY$S
MM#,P1US9&,D&EZ-PV<GT2`V^4SY78EZ*<HNXN4N;^?WNO8"QI*ELRL'";0],
M>VG0F1QFN)><XNKND1-30E0.),QTF+<OAZQ,7LT2C92S6Q^T\TV;:F\H-;.(
M[;KN)-+%"(E6AS2^1:$QRWX\AU#'1REFF&S[4E6G)H+M2#2ROUC^RMTF8R4Z
MYZ;5@DC0G5I$0"C2D0@ME76V\@4?8<&N*/0^8.*-XC]$T15#K*SD#D\N:,KK
M"75@PU'-"$+PM:69$^MS/4E9HUX!EDDC"?+SC3$Z?9Q8=K=FE1&S\BSZWCIF
MH^:B&0YD5W?TZ5-)6YR%8G?[_ADF[M:)JBC\K:M,A3R2QL4'@*T9`%IQZ,81
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M40QN\5D-93=U;6XN1.+A&&!ACUM`*D*1QBSY+HH>TK]#)<-%BV3(%BD@[WHD
MLH[.IJM[1Q#9;DMC[-)(57B!OCKZR@MF8AD@G-9UH0/K&G[L'*9XU`9"E8E,
M?A,#>?.E>3E8MN;\<VI=_"]FGGZ\EUX)3P+8;=%R6^NF:#Q\D;O-7>;QV,J8
MTW"LI@+[";+C@<%7AET'D\-<$;/405+<V)GIN6-#68$MJ`44W&#,*;#8G2;\
MR2#Y@^7(*RULAM9%2ULH;$E55V[,XP(]RC9L)MMI,BZ9U8XD@KIT4Q-YGZ(#
M6V[;D+$!$@+3AV4646+)O*;RKI">`;20OH$]D$DRM`968VN+GMLE@"R'05*9
M3$OK<5`2,F5U@KM63U6UK9*/20I`\IFE>$T*I6@)4)M:47RB[QPV@'$]FM!C
M/'8]7]9MJU$54CC'KH:I$!J>:SB=?T!'ZREE#QMA3QXEQ*C<TES2['>"0TIG
M,12U>K4$A7)P%JYIK-TUPW)JQO.L)$K;CDD,@\5JDV+.$!?:[:F^#NT,J-SA
M,ZA#XG>JY56@^1J<S)V<'P_X4_ID;NO>3U3B0%21[56MV?)O"17_`(Z22GI&
M2R^05+5SO74DOR#W9('9Q2L:DZ7HF;E.RJ0/CDGC8F79[\YLL[>4;H5[^8H0
MFIUPC0;TI(&`3>/E-X1]SMQQ:U=W+74PLY6Z/HH?%JY-9Y?&I5`!(6`44YW;
M:9>ZKD7QNM]V^_1(^2%.#VE3(I"4QJ5:\M:H2E+4PMJ%LQ=F/W9/!*^>S.RI
M@NB%;/#I,Y?TB_DNKTH-4N*I-/J2B<#J<MR,.:E&Q`C$L81JRD^]C):3@@6I
MM>];V/5V$N(P>^$;U>%]N.J]W=W";O+FGD#=*BI=5)48M.%K;`J&7OM+39,\
M4V]S=Q/*C$!4QY!N2JI!%R"0%#]UVG6*4I$\C8DB-\82N-R>(/D;@32@.61R
MG2W:42M[KX<\A6Z][5*Z*DL%,5U["(TQGQ1?#GH]$QM[(G3M+:4U$-PBPD!(
M.QY?Y_!J.7CD@^AX+6$CD4?J#<+AL.Y\!=$'?'I2WQ"Z+&A#A;:5W/FCF;%G
MA*\+$KI8S<\-SB[ICP+'!I(3J/8%Z*.*NZ;M7;X+89=$>9:IBLE@J>#I$,0^
M,-;<2O<A;;M2B9SAZ+BI3&^-;8^M+=&8V>U>ZC6`*4'%J_9&)DHTXP;SW9O"
M7JN7D0P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P*G]Z?X&>S_P`T_HK^Z"8Y>W]I]K.JM7HF?[1WIU_FFT_]RZ/+W_M5
M[OVKJ+F67`ST4/[=_6^_Y<+P^Y*$YONZ3Z;[^D^G?/,,&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&!4_O3_`SV?^:?T5_=!,<O;^T^UG56KT3/\`:.].
MO\TVG_N71Y>_]JO=^U=1<RRX&>BA_;OZWW_+A>'W)0G-]W2?3??TGT[YYAA6
M^S.P.7Z:2VNMM:]*YK])1>ZU^=]1*9"E:2J\U<2P3=5HI,)3L&D!<[7@&2VB
MWXA4FEC"'?B`6M62WHN5L1725#'6H&CR;7AAMMC?U,5!`"W<D<C%)$=<MMO*
MV0*(.M^9R35@\)'TPK6_.!M4E';UH(P^++F^AEZHF#ZA'%)DGJN%D=)5BLE5
MWA`.IV)`\&N#A.23)ZZU<!2R%(DJC1B3=AL:QGV:9LLK2Y,87L7B'>/&F5($
M"ZUYHM'Y#?-W=U=S/=F36QZX@08_(4CB.4SRH4CROLZ)-8"!"$:^PA!'EI[@
MG%H(R"4XA[UY?#>V5,K59!W9QS$[4GE(2CI&I8];E8QQXEL[KYZEB!LDT=CT
M>A)5E/K@I;U@R1J/@]>G!>U))&S3R&OQ4C!HG6QZ>-S?1<O7T8-F]1+AJ0T]
M)K^9.IJ9<Z@AL@:8E)YHEF+>8C9I9("T1T<BJMO\VGK4GDQ+DG&UMX4PECD`
M\`DQ9H1:WMX]VYG)EW/5XWSU(N#8S7]<6K(>L*49*YMIVDK#7\R<YFWHF)]>
MX4,LN:M(UI^P`9G"&&&Z"\$K_=1M8O'2K16];\'CW>QEZ,BY^H1Q0SS&SH`Y
M=*5>EEM+Q9_FUK-(GL0_D%%(O&VR8R!\D:\I.8V($+7%7I(X&;V=O?NBDLS6
MMA'K>WC3*V>M>U^3;C0PIQJWH"LIVFL6;2:MH7J-R-,X*WRP8;#5]ARF$DMY
M7_J":4LD$:SW<]">44I"WAT?H&RQ@$)EG4RME@W4O.UFBJ4%?7%!)B9>\>FL
MLJ$F/O1#D?/8W6ZM"W3][8R$^AG#;X:ZN:9&Y&&!+TC6G@3&^4\6B]LL,J,'
MCU#.)V"66]!WGI*M&^4T"V/[S=36>ZJ-;K!KBAC*7)UTR6!1B;V5/'OE"B&M
M$:;KW8I0$PSRE^(M/&F5E[2[NX]I7Y2?.ET-6L.^2$OB-?R3XB]>VVTSF>P9
M79L.B*C2`A9L4BD%=H3'M.D!YC]M?E4[#HHPL0F6F6OO(.Y.1HO-JOK=]OZO
M$,_N5BB\HKB&Z=3%4C?XS-A`+ATB.:4290L8&*4GC]DWJW(*-.K/"(HH8C`B
M#IXTRO[(^X^1HE!H)9<AZ`KIN@EGUZZVO7DF$\"4-\SK=C60]`\3./;1D*#W
M)A;5D_90''%@WHO;D1X_8'XXRF5%)'JJ^G:JCD6ER7KBHE<;G#Z]1J'.Z1X6
MJDTH>HXACCD_(V+V#>8:YA:4,N;#3S20B)`%<5XC_=9?'N]CQJ7HIVWR/.+N
M?^;(KT35+O?49>'^/.]3%2UN3S8M_BA(%,H8T+,L,3J'AWCB0S1R],C]X.2$
M?OAH0`UL63+F^AEZ^C;>@>GJ`Y4B*"?=%VK$ZAA;F[Z844FF2LU`SF.VT"UT
MTC,6%D'E)A:;VX\W8S=@+T$O?B+_`*8DMXA);T:4P]R<BR:#S2R6/H"NEL&K
MFMFRX9Y)/BXDJ")5>\NDQ96F<OWOA"<]NCSBZU\]D$GF`UH8VP_P^P#QQE,L
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MG#`#WJOECD6,HM_3:/9AB+'O2GP`/>GCW>QE2V/JGG,%G)J9'<D$U9ZR9)*Z
M2P_XT3MR/L!?6H[C0P<HS6MH1RY951>Y`4W:-][,:?!0$O9>];VRYOH97V0]
M0\].</A-@MUOP=;!K)M$%*P"6IG@HV/3&U#I4\P=-"8ZZ@UM&ZO*R7QY:W$:
M*&(L]6G$66,6]A\64RM-'W+R`"-2.8[Z*JL47B-MSJAY,^%2A&<@9+CK&*OT
MYL*N7`TG8_82B'0Z+N+FX)]Z\4Z)&::+>@`WO'C3*VD?5O-Y<-M*PS+G@0(1
M230P/]MRC;V1IGKYEE4#C]H1QRDROP\C<D>:]E;:\$"%]@:%:49_T%K&4RMV
MMBY:MHJM9#<5P3J/UY5\42MJV1S>2K-(6%H3/#HWLC4:K5^4?ETX.[LF3$ZU
MK8C#CP!UK>Q:R26\3JG56QU]2?@UFBU9S5?U147R7N1;+6RL79'(M.A4P<X$
MZ-+'.&QL(;"%BL#E#WA]1I7-.<64<A/4E@."`0M:R^/=[+E6;7VW6;78Q-1.
M4WCK?9BBOG>UR(6M<2DSX=6\?>VZ./LT*2G;!HQ@9GQW2IE1^M["G-4E:'Y=
M&!WMEZHK>Z>HWPHR.M5LKOU13;<XW7&X?,:R)62U(05)(E8:O2"OI.)8/6D3
M(P3U>+1#(L<3$B=V/_>T@CA_8QX]WLN5CW'U+>#&B=S^LG7J.K&V>U4CF[E9
M$77.RM(YPEMK="^.4X<9&`]"`IL;XZAC+@8<>8+10@HS?((>P;UE\>[KAE>-
MQ]3[T_6:&PZPGOK&GV*$6`]2^/PZ4/L@,96=]=(`GCZR;%IECHD2%E)(JDE;
M<:O5&^S2IBUA8AF:T+QQX]W3#*N"OL"#-D"6VFME\<)K5NB*F?K)[IX0'1$J
M#HV8<B4R[3^0>:V&QTMA+$L]\`8(C:;7M-"V'[.9^$5_F?='(-?5'6%\2[H2
MM6JH[K+;#:BFP7P+DVV22[M!S^C.A:9I*7.<A)"Q)S%AXTQ!@4B4L9I^RP!$
M+5DMZ+EO1LM]=;\T\NM,/?NA;I@E1,]@."QKACC-';36FD2YN:A/KB2W&;+,
M\X6YE+$K4#%Y2R$X1&#$$.M[TDMZ$EO1K$F[KX]B$IJ2%OO157%R:^F1ADU,
MM;;(R'\5E1J4/2:.QV1Q)4P!<T+LP/+VL*3)UH#?=C33`ZT/[/CC*97\CW=G
M'\L<YJT1OH2N'I77ED0RGY>:WNXSVUKL^PYJ?6\,A!3T%/\`!W5_?K`2FLI1
M*,]1L#F4-,9L!H1!TRF5XP=]\9G6/8%2I>C:S73^J6F:O-CL;<]"<2H8CK9H
M-?K!)?GM"G41]"[0AG3F*'5`)5[\@++%[8D&P[UIX]W7#+U21"^GN>K&U'!P
M2Y*_E94NII'T/&E#)(D*U*\T>O6`;TMHHE11FTQD.,7&:)VKV+0`&>(1>&];
M\)B8@63^I]Z?L-AU7V%).L:@;8-=;(LD532SX^8L8;`:&]W4L"Q3&'%`D5)G
M(Q.]HCDNR0"]O[<H8-`WL(O"SM[KTBY:S?Z1KAO3Q9["+INK@.M*Q-YG5L)Q
MO!X`5_%(\@9'1\>)0K&C"C;"6IODB`X\`S/;%@5%[V#[./&GC4TT9TC0G349
M<)CS_;D#MR.LSL8P/CA")"A>A1]^*()5&,<B0D&?$8^\:2*"SM)5I1!^R3`&
M:#L`PBVLLZEEG5"$,]2/@VPT#XYPKJZEY"@C,G@\.D*E#+T6BV5_LN7_`#?0
M!.Y>WT2)(AETZ_\`1T*T>M(3W/\`@VCO;?N,7M[IZ&5,KSTY0+!&[EF#K:L2
M)B_/,@W$[K?"%IB]OK>4!:8\^G1Z2'-Y*K29Z2M,K;3CTP/.<0%87HP(1"\,
M93*CVF.\^.>B%\::Z2Z(K:R5\R=Y*PQ)+&G@:DR2N\.CJ:6RI"Q^U3D!<S6"
M.+"EBK9.QA**'KQWX^.L7MLZEEG5CRO4)XH42BJ(6DZ3K%=*KR1(7.I6)O>#
M7!?.VURFCQ7*!Q9"T24\(T"J=1]:U`.,V65M8E,+\WB'>/&^QE37*[\IF"O,
M^CLPLF)QU\JVI1WO8C6Z.9299#J<`HDR0=COI0M>***A4PUU!M2+]SYD!VO_
M`)-XRIC1D_9'+"LZP$R:^JU/4U4XTLT6.F*DB0:F%N/1FH_NBDL@3ZW[9O':
MORJ;M,NQA\JT2L&@;\?'6F5<K`P?O'C6R9Q/*S@W2M12.PZQ+FYTYA2*7MP9
M,Q)ZT<5C18:H3.I,(6N".#NJ`Y,[')0'E(#@;`<(`MZUMXV&5'`/5+]/,=<H
M[=UUK4(:S<9<G@;;-C7M22PN4M5117.B&9N6'(0:7'#AJ$YTV85H9(4)0SA#
MT`.]ZOCW=,Y,O1+0^UN3OG%@-3)K^K9TL.T(,BLV!QMA?R9"?(:\=61VDC+-
M"%K&%P:TD<D#"PK5;:K4'DE.*=(:--LW18O"93+U:G*O4/XBA1=2CDG3%6(A
M7I$6"P*G3)WT3JOF4`E1J9/&YXA;FA.O7HX0]J5A929W5EIVXTW>P:.\X1:T
MRF5(C=UOS,[N+VT-=X5RO=8U?*;E^0-J61HSES-T(M2EKD50N24`MGHYLL2&
M:,*2##H1@/'8=[\-^#*94+(O5`]/UQ@LFLU#U?4JJOX?)XI"Y#+B7E2-C0RN
M<'OZ:(L!:W2'V;@Y2`^+.($Q:;VVQB2&?]/#+X]WL>-Z+9U?:M9W;!6"SJ?G
MT0LZNY2F,51V:P60-DGC+P20H-1JO<GAH4JD1IR):G,(4%^?VB=06,HP(3`"
M#K-EG5.BOUA]_<8U0N`V6'T;6D7<S+(E=/EMJYX,-<!V=!FR+O,QA(42),J4
M[?8TU39I4+"O+^\%.!(A;UH>LOC:N5,<IOREX19<5IJ769#XY:DXB$QGT/@3
MN\)T<EDT-KXM*=-I"RMIH@FN#?&"%I9BP1?F$46+8]Z\H1;U,1!\L]1+AJ"G
M503,.IJ:CHKOB45G]8&.DP0)DTE@4Y.3)H7.3%8M[2L,-EBM860W.CD-&A6J
M-[**-&8$0=7Q[O9?&INNV_J6YN@X[)O:S(C5L)TZMK"G?I:ZDMY+G('DP93/
M'6))^^.$@D3L,L?NS>A)4+#]`'L!8M`%O22WHDEO1'K;VKRB[0J66,AOBOC(
M3`V2LI'-9":[[2(XHRW*%,*K5\@`L)(4M0)O[X7I"$XL!A@AZ#L.M^.L95RO
MF?VYR.FOHOE]1T-5I5^FN1+$"L1R=%I_^4REGW(4L/&/Q^&E3=5']>_E,@C]
M.QB+]_"GV5O0\9<WT,N;Z->EOJ#<406,5S,93TM5C;'[=6R)#62H#_IQ538<
M0?CXO+5<?:6LE:\+6B*R%,-&YKM)_<D!_@$\TOS!\4[;3*W:J^ON9KOLN?T[
M4ES0NP++JQ0_)+"B,;6GKG")JXO(@1*1)'4W28*(M6RR4>D2DH)HAE*/$.]>
M.M^"RR;>AE:V[=W\>LCS7T=<>A:X`_VK.IC6M?,B5W&Y.TEFE>ST563EG2-[
M:G5JTX(G9`/@:]6>`I$F=-A3C.T8((=O&F5;3(BI_>G^!GL_\T_HK^Z"8Y>W
M]I]K.JM7HF?[1WIU_FFT_P#<NCR]_P"U7N_:NHN99<#/10_MW];[_EPO#[DH
M3F^[I/IOOZ3Z=\\PPX3^H1Z;UI]9=B0)>RM$<5<J7?3H81V&H7/B!"[(Y%SX
MWW5(^85[?&E'\*E(G">7BH"I-)T+:`IH(&/['DS?;W23Y:EDGRKM1GIE=GRI
M/Q--.BI%)ZDN`N]^J+IZTF]#6_'6V:PI5)>>(OSK3#=$Y;MO>BY*B?X;53`2
MXEI4YONY:@T(]@\HMY;W3G.BWNG.=&$Y-]/[M?FZ[^*92^0&VG.,5M0(J=LU
MTJ;I*HXN64[&=NW5<'O5V-,CWI?;\&/K:=H7-:D9-%*SEIJD@'@:+RA7N[;O
M^>A;+K8.+?3$ZOYKZ3X9G!\?B#?3C!*>L+@Z:C:68M*M=!K]ET7NZK8-/8JG
M(.V3(4EV59.8RG?2D?G&B<(P4H.\!'G;VO=++"]TLJ5KT]+"R;PL?U,;8E;G
M*G$Z=.\VG7%M.IYI!VZJ9+;<B].5FY10VK/`%L.IHW2A"ZN[VPITRY[3LQ*/
MR+1HACV`_4G=))/S^2=W2?YU0I7GIN=AT2^1JQ4D$3=(2>B^K.8>G60RR+9@
MY-C7[#&KB!^YAF5/JY"8WLT*99IR;,I&N<X`M7IVMI<FPXHHQ7I9[9;E\I?C
MC_I>Z,@L]++I;H:X&ZPK:2.O-4!Z%Z*[@MB]H535BUHZS>J*KO;ERE><F.N5
M3Z[1671-\EUV$U<M<I>NCB93\.4NV_='#VQ?O@WE)..N'EG1C)1Z=W6#*S^J
MQ1E;U59Y=9=+U]<$:YJT#I"K2><=MZWF2DJCKA'(JE=5`K):K2-=*T.;]OZH
MX2(I"$H9^OL['M.Z<6^ALXMZMQ8^)>TN=+;AEDQVIW_K9;5GJ"V+T2;/9!==
M5QRYKVJFT."%5"QM5.WN5*(M%RYG24P7EQ,!1:5M3KHVT(U)!6S1GF#;+\<&
MR_A>SB#B-30G6O<5_NM?"AC#=;_7RZBV13-4,K35W&9K$&BT>DHE$V1N5JFZ
M`H);U4^OKR[DI-`3O"\!2L'F)`1O6>Z[)$MV2*E0SFSM>H[*]4!:R\^R^U6K
MI.8]%RRD8Q->B*?WR#,_G78:VBT:+L*F51NK":'I1IL7F/RHSVA1[(G/2E%"
M4*2M9=[;)R;+BL*/TO>S>?:`IGFR`QV;6ZV<Q=U(^@8WT%3EV5Q2'05U5I8/
M+5G064.;A(+&7N22.695=BRE-%2MK=&IW&`IFXA,((TYH2]>4MV^L:\I;OPZ
M/4K5'5E"]17_`"P[G-3:-<=PBYKDDAM7YX:Q!:?.CA"J*A5)3>!7,@?G!F^<
MMAAAT:4/[:NAYSF%<M=G$`4A6S0G&YMEGTSLL^D&<*\A]CPB<<21R[*;C=80
M_P!/KC._>9B+%06M%9PEZ%E]E.],,L6E%?1M@_\`VAA\1)B=/"<ENY&4W.!*
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MF3N^%$>_?33Z/Z:F_J`3*"2FQHR"V.#:+IFGXO"+@CD)AUS6G"UO1*B3PZZ6
M5R:W`U7$VXN>-("#SST)!I3@L`$S>_-LN]O=))/E99)$?79PAV<S+;7L[GVM
M)BT=9*^W^G;?Y=OB!7G4T4B-8U]<4&YOCXD_0<)GOQ<BRZ7LISK,T3_'4+6O
M?TX6`@:72<X\H\-G=.EZ82SUZ8O7WKP=/^U;RY21/$NEL*I%CH_L>JNEY/5;
M_#H_*'Q@ON-4K'MUNWIII')>L!$[)0Q=W3."MM3E.C>027LE8F,,"9N=O=DO
MNDN2^[FTZ>C]TJYV7?`$(RV^LKN>/5#JR#-3Y8+,Y1;F2+]+TA$X)0725;L#
M84FDADED2*..$2F#<J6.;A\*=BU"<E*(H\9M\IGX7RG_`(GEUY\[KLI<P6:O
MXFJ&M9-SWZ=EN\7PZH'VWZZED%Z)GE[K:?CYQ#J=&M!1-')U4-%9G.NF]XTC
MD+H4X&)2&M.<'>S9LZ;ZFSW]6CM'I6]#5YZ9/4W`[0@)G%EUK83;<W$?5S9.
MVV"VI9%GJF^.2EEL&6OHW0]\KZV*HDR9PB87$\[W5=#B&Y,4/97O!0+Y3RG=
MZ'E+W2NF_7'(:UP]/X7.W)\1CS--J$9J6F7*L45N)#*RM]C\OS6$V94K$H?U
M>]%-I+R\P!.W+'`\6]^R6G&G"WYA[WF7^VUF7G:XT13TC^NX\?)XR9&X>9`I
M)PI;=M.I1<X8]J77U3KTYAE_,M@M)B80PA^3JEAFK@LU(Q[TD&:?X^;0M;\-
M>4_G?]->4_W_`*2E*>-NY$M&^HWS0R<UD2%+UWS]331`;6(NJJ6V--,YK3@N
MC:,<87((XY/9$L(-7V96RY&2X%IS$/L#2E`AA*\18V;+O3_\FS9?\ZK^=FUY
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M5IRR".J0UO2MZQV0I"O$:4[VI8!79S_"[.8E20\$=11?TCJ`].2N9%!%L^="
M*MJ6]K%,,6F5W7=0'RT^<W(1&HTL>(O)9M"R6)&*$-;.0J0+E3.X@%L:4)9@
MBIY3R\DV>7DJ=)N`NZ:ZY_/K6$P!?)^B.=.G>AK$]/SI+F:T*RH&'5'%>C(H
M"<JFB7U-<DCL$)U`LEHS%ZBSW$#]2)P.C3:C$W>(O9&$WR[=WT79OPZ.]?5I
MU@?97IW7K75,L71\TYQ<[D5W1$&.Q(A4S8Z.UH<XOE7B=6!QL,T*;4<%-'G9
MIA.BU"LE!]G1)H]:`+,SF7U29ECG9S]Z=G9',=Z\3RWY%RI]C4%IB:1FV">7
M;YKZL8#`93;';TOZ67U>\QVS4;;(+1YZJ^(S;;2G1-B9(L7$-V@DEE;-`4#5
M[NVRQ;98S,=X0[+0.\OK.NJTEU5\<QSKOCB]:JHNV+SJJRG&%RF!=O@NWHB<
M44_Q02EVA]'N=;IPN3?%)*YJWC3\:8!&G1E;V4)Y3KUN&S^<:A$N(_4M@58L
MO(\8BCNSU9`Z*[UJ*:3)@NRH-41U."XJ\OE?0]BN5<.30GNJ)7Z_6M8K,;*5
M:TX#.G,2*#@J518]"QY=MY]>#9U]6G%^EAWK71=ST_2C?!XU45I\/UIRI5DJ
M',6<:CGQ+?\`<,.E/9C"H8BW)L=GV,U>4=,GR+%MAA8E('U*VIC@>[:&4\I>
M:OE.JQM:^GQV76".+TBX--2RFI*J]4_GSLZLY/6A9%50MDI][9Y`]WS!XO4T
M@F\[?HBDKBSC%"Y"A$Z+/B@)`(278=%&$E+W2\_"6R\_"/K%X1[5>F?U@ZV9
MJRLQQ;.OG'HV644K4]%U(3SH]*ITWU27#RU%4'G%3N(6F]*(FM(.>5H_AJ=+
MK83-!V8'>F]O'P;.'2[C6D[Z#U/UIV+>%61GGL=^PCGFK(M2[+.V6QI6K04,
MGLDY7;%NRF)HT\,4SB4'6.%J1)V\]PVD9&5,$Y2(8]%$YMF21FYF1RMX`]*W
MHM@BEXUKUO4)`*YF?$;WS&<DG]S0ZU7YUEAMNS6P8V701T,3ZU25.-*9_`X&
M)'!48Z[DX$*PG1/N&S#-=W=+S/=ON[IO'N[7^G)SY).8^*^?ZIL-$:3<R>"-
MDLZ%=ETA*F+W+NB)T#<NN^92*9EC.^5SU(['=W`\Q?LPP)A>P`+WHD!80X[K
MM^&+=OPY>5EZ:72*NNO27@,S?9M3)W++9UX"\II2-L1R/SR(*;10+0P!OC3_
M`*0/Q,@;9(>:`IP`D3F^Q*W^[$#P\<WY3:ULY1/R'P'VOS5=7$\FD%>VROC-
M<\PPRD;0<*CZ3J.+MJ:1-/7M^6@X&W6Q2(6W*X(0&O[';W$U.Q^S4FJS51(-
M>U%Y0KW=ME+98MOZ@W-_74FNCH^8<\TDPW9'NN?3>>.'3UBJUXE6IM,6`*76
MZM:;!F:26:`HDE;GLESG'*-,05[T4>S[)`B&%2$TN=MF9?2ZDLSGW4YMWTH.
MKR+&G=EU"TQ)8^R[J7AB*STM;+FAI16WQS1%?<1.;W+1DG*`[:YO4%[\V.2]
M@0K-Z4GM+NZE%ZWM:4$5G=,SX7RXQO<7X4[1F#G7%=2NBX+6\-YLZ=]2WH]@
MNUSM>)R676\DZL5]5-M8U37T7C"=:OA46DS;T"@6R\V0+$00B9"R2TYXQ!,)
M;)^(;/\`41[7_IO=S3KESAFAW]SZ,YRF_.4J?DLFMU[Z2I>SI1`T:CT_;.H9
MI<Z/41=M>$[53X;6>&]M'&U:4QX^#+U(PG%__P!<IY=NV]39NI3K+B_KZN+`
MY`=J4Y^=>97+\F>AZ3[F+9+XK"3\J6!7=2TG/(876;75*M9([1,M>#2YR1DQ
M"5-IC>D"T*S-.BM3Y1DXV<[[FSU0)%."/4XYJIE1'*(A[P&X+8Y,X'A*.UZJ
MO*FX?)^?+AY2IH=32FJ+.*LYI=FZQN:WM:M,?R118T]R$XFK`>[!]L6H%?+M
MMYZ;3>V]?=*XO3#ZLCG5<1O.$1J(I(O8/JK3+H/I1C/F+,%0\4I"[)E,_P";
M[L9BM'!*,F\?:9>^1]S;/,)P/;'5&`1?@WAV&>4S/@\IF?#0J+XB[ZJCD;G6
MN'.A+9F%A\O]?<O7A\AIKU/14A@,IB%9/-K*)@V\\^P6H":N:$J5^;S!M\@/
M]JK$>6$H>]D&[QO;;_!LW?AU7X`IKHGGH%A!LNG(;&0=9=,])]3SQCKZR&AW
MBG+^Y<GKIOK^L"2CF5E4V9(YZ6RKG=^=6=*D;4K^<M'H)I9Y1P\]UEZ>D9MU
M3!!Z;71\D[/;+->WJ9U-6B;M7O.]#Y_3EJQR.3W<%NBG^4HO5J0P`T+VK.:9
ME(JJ>4SNV^[^W((3%#-$6$TO>[Y3/XC6S/X3)ZBW#%^]$])1'H&CT<=03FA.
M1+:#04Q>WY&WE)NF%%LU6_L%?/:+VH7(N`7%4[7*8L_K-!VF(;W<?G_?-%8[
M>Z29?=)9F7W4KA_!'<5+<\W=0C'S57USJ^V/3PY)Y@DDJ?[A@S*T<RV74G,!
MW-TV9+)2.Y2MVL*HXXJ<!RAF-B1;FL4N!B\C:4C9Y2S=\ILN]*NS=]JZ0=)\
MPWM&G#TW;9IZ*M_3;WP:MD#3,*KDTO98'(K1:IG0Q]+*+/A4FF`C(<DM:%+?
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M&I:+1Z-E=C1($$IYAU\X,"F;M%93I0[J7$0TPU)2@.O*(T`=.ZRR8G=99PI@
M7PEVQ6+O3LWH:N)/!NH6?I?JAP5WRPW?52>D4?+5Y>H)++W=:PZ+JF0_&)):
M,>D]4/0GAI+C2$+ZS2)0`O:U'Y#?-?*7KTS_`(NR_3_2SG-A4_O3_`SV?^:?
MT5_=!,<O;^T^UG56KT3/]H[TZ_S3:?\`N71Y>_\`:KW?M747,LN!GHH?V[^M
M]_RX7A]R4)S?=TGTWW])].^>88<J+_ZTO"I?4#I"F9<YLM)<GV(RU^TPRTGN
MC)E:#+?E^3243%E=.?G&XF&<,44YKE21J:F8^-B>VI>"3K'(XD@S9A(4XM22
M]N^K4FS?5R&KSUB?4%F7/<7LTZ,0E4UV+87)$/9[>C/&W0"M#&9E>=I6=#+1
MI&#U6Z68A<>J957L.B3.]HGN'NB9N/,=MHS`".\OEW>R;C7C)<=4ZLZ$[(Z$
MZ)=*(@-BU16['S73/+5DW],+*YKG:&R;HF'0R652H,3CE,.MR,"SG>/,\+AI
MQ*P;JOD3JF?E8DVBMA0'Z.S9)-]V<DFJ2TIZIO7EQV;1[";\DF&/2/EN4W[-
M$\,Y:L^VD3H^,W3O4-/I&:26"Q6DULG/<,%$J7:Q_'7I(Z)SW(U3H(0ZV$L%
MO;,WY6]LC;.9?4KZVOBU(PWO"B-,D1;^$N3.F9.U1'E&T9S&'V=7MRQ,;FE[
M=*.@4%IIX90#(BEK`06Q)7AM<U#H0(24LT1PM&Z7MDG\EDGY3[P)W!U78U@\
MIUYT^?2$U2]G<')NUZWE%.0N65N_5LO9S*@!-ZQL*)2.P+(2OK`85=#<-BDB
M54W;5'(59!Z+0O9F:G=VR;GI4LDZ>Z;O4.MKKJGY;R>5SI:=,0N/7]T3!.9I
M`VV;1DBM!R:'J>,=@R<BPVMW9;HK8D:1G10H"3;,8EWM0,_9WOI>@Z*W.W/5
M))>JG[)ZK-TF6ZQ46YP)>JDXO5C=>+'>R$]$V2WTBNI-G:WT9FVZT3'A9"4U
MT*UK6`WW+;@>,HO8P;1B\NQYKQG7XUKQG7X6:](OK#H+LF@S;JOEQ*&LDK;&
M'1B8FSENQZ%B3%\0,DGQ`J%V/.;$F[5T(P'E)$OE>6<AN2I1@WH81^\`]GGN
MDER)W22\.0\']9;U`)/0D0LYP88*"-V)8?,T4379'N+^BG9MALHMN<W,P6?2
M\,J<VQR7KJR2P&'5^S/B9\A;@2@'\6&D,*&=H&P[\.W<:\9JZE$]W=]=AM-/
MQ*JW;E>DK"'PC&>V+`F4MA$OM&%V5NS[0M*#4E$8=&V>VXRLKN(R*+U:8]RU
M8>[OSI'%+LG:RRQJ$R@T6;.V?EFR3\M0;O5WZ`FL\X%A49CM.1C?J?4WS_8U
M/+9(:K5?DV/:=ZVIZ7;+1*W)6LV?,T^AQ8DU0JB`-`GN4@-1'A.++R^$Y^%\
M9S\+BT'U?V+8?;4XXQG$#A3.7S.^SFQ+WN='&W5-%K*H"SO>]\4-M5HQRI<)
MDLJ6E[>`S,:KWQ(W*(&M`G!K3LEVFS9,WW2R9JK'6'JG]+<]75:%*,\;JMZ?
MJBZUA,LE@G&/R$(@^FLII*NK%L*>IRD\H*WJR([,),Z,Y;L+_P!,T)O\!H]B
MT+>]3MEF_P":L[99K29;ZM_3J`F7R>.-=0*X<]Q:46;4`U$2DAJI76_Z5JO.
M)*\<W=27,BBG0R54D]JW[1A`"2Q."Y*:#6B2Q$&/&?Y]'C/\^M=A(A?LY?>^
M[TYE6I6`-<5ORYSM<C`M3H%@).;+K5LGH.)R1.YN8W$Q`H9BFNK6X20D"4HT
MLX1XA&&:&$)>,_KOKK/IKG)>_J,]-UKZFP.:(TC@)M#M%E\35[(=R&G9T:C+
M;NI-SM')GR0=+(;`00"LIBTN,<1$1"/.+"L-E[FK"WD#`<8`P.IVSQWU629O
MJG?TGNL.B^RJAEEK76[ITYJ\TU/%F5MY5L>F(>P&)Y=8#!L^)6M-+)ES#T2V
M&(H^D$I5LR9K);U&MEF>;:@'DG=)+D.Z27%*';UB^@8O3"B1.,%K%YN#F7G7
MK:8=K0XAOD#8PM=[4[?S=RA2419UVGY>J@,0LRQ@.\M5G*_B1Y<1:A;(%YQZ
M-S7A-^*OC-^$MW%U1ZB%!N?1='R^U^7Y7;5:<+2?U`81:L=Y]F[?$Q,E5.KU
M';0H65UFKOM2X!*>WH3:9%Y:4]%&^Z:7!5-AQI`1"DG;>?E))<^W@A':G;ZG
MIKBV@9=/H*]([KY?K/IVQ9-5?$5KSQ.8"R;>31\F#NIS#?+BAH:(,D.4>['S
M9[,<T/OH=J1I"P:VFQDRW_JY,UF^5?4`ZWD]A<CN=X&4/+Z;[AO'LFCH2QU[
M"I=!;4I63<U2.\S8JY.J]UL.;,5KPN50VCU9;LK);V%0TNBU*(.CB#!!TO;/
M3K"R<_##=(>IO?\`0G37J&(--">0TGQ!13/9C)!VCG2Q'E-/7U]YR4V8G06+
MU>WSL-?4OHF:F)]$HED<5JG!K`9HG>A^!FD[99/>I.V9/>M+Z?\`4`[XXL8+
M`A-I2?G"V[-DG*T1Z7JR=5E2U@MC+7[T5TS0E#VE73_5^K9E3[:<>+;[V2+8
M>XI'-G<G54B4)3TVS!%;U9V]M^M627I[K)U+WGT!*O2RZT[*D2&NG"Q:.:.R
ME-4OA$'E5>,E@-W.0IFT123612,FF+].Z>DJ^31!4D?8FY.^G-`-*+S[3[."
M45/&>4B9/+%<;V]4'HNA>#*GLLZ5U4KZIO\`M5T8ZS*Z6H2<\40!%$8#5ZZZ
M+&3.,)M"V'9\=2U4;ARQBC[\!Y3)'9]D36$I,+01`.L[9;\+.V6YZ+21/M&\
M.T[S@]?<;3FHJDJDGC[G7LJ66-:-</=ORR>-72[W-T\`KF$1)GLFLFV/M+*S
MUNY[D3X>J7J"'%0F2$)0"+/'N9).>NIDDYZH6I?U6;9LRX^;*97UT\-CK9'J
M!=G\WS^:JZ1L=DJ!PJBA@=3C@!%:6TY..X6^V?Y:C8=/)9"A9L0@N>M)$^R_
MWE>W)OP7M_\`$B=/=C]A)+0[V)YQ=:`AD"]-FDX':\XCEP0N5RV0=%R*4UA)
M;N>(LCE3#/X>EIB%-T`8"V]&]?#G]0<_''C,)TF1B*-23C>M))QOJR?'7=%X
M]1=I79"%6E4<H.#--8N4.BJ?F"Q%XA([.Y>HJ]DP)]U47/\`YM8O.FAYM92F
MU&!Q_P!]6(TY9H#`ZWYMNZ23Y+))\H3Z+[)[XH6;^IRH+M/G63PGB'E./])P
M2-CYUF#6_P`H4V\W7X?`XE(I,"_UZ7V-='U(EVO5D-P!R#2HP("F[>M;Q)+G
MS5DESY:+>OJZWX%[NALIF"R>OF^'S#TT8/&2+BY*N-7;A2OKRT;KA=JOK71"
MB4P69VB4E9X*V#BZ1N&CVL6Z5$Z.4;\/9V=D]?DG;/\`U=7L;JCJV@N":<MV
MFF>*VCTU/[-YGKU#'[.J694H@FCI<%CQV-.<?6U.[S)RE]3RAZ0.HD25(X.J
MXQI<30;4:."`0-YDEN7HDDMST54@7JDWGUE:$:IGF!ZJ6&EWGTI/XE65R6!7
MLAEI-<T?4_%W/'1DS;'ZN$=@1+<QO@ZQ;D4,`D9CHUHVE.@6"/(.-1[T9?&3
MF^R^,DVM%%ZNG3L/MOEN&V0P4@5#6#H?K?GGNF:LK-*6]B^'T+?='\WQ.[ZE
M6.LM5?(:*'2SH!A<I$WNVWC;:`*U+I3OW;VXKX3+GQAXQI%:>L9UU,&&42]_
MB%0L30[7MT\36S4&*2?XJEY\C7II3KNGG-3)1G3+RJYN\[1,1ST>6`A.>@5&
MD$D$&;">%>V?Z_[AXQKJ_P!:KK/YAY"Y*HK4,8Z"J[C"$V-<4230B7S)(QWQ
M)^GN?ZT:'V,QE)-&MZD5:V11=UHY9&VL"C2U68XIR-+!#)-!MX3?C3Q_"W8>
MW.P!=-<?\]ZE+@%OM2DWVW[)DI_IP7NFG:U2AZ6:ZN1,DJJ(R[MOG+D.##7$
M6CY1(E+PB`<`M=LK1!X2-3)EO_4R9;_U97@_K2[+FO3I*H.G75EK.Y8`^2=V
MCW*9U%S&"/42IAOL^60VO+@BM[/DXD$4Z9@=D1EO;3U#LQMS82T/1YR,XHK?
MLR\EDDEG0LDG"B4:]3GL:0HK-*;Q08,IG/J!+^#:#'+>6[7B-+5P<=TQ9U4(
MK/>[Q/M4Q@Z/=6BO:X./5QEA)CQQ4B.(2G*BBS-^&O&?Z7QG^F$Z3]4+L/F=
MSFE$326U,MLBFNHXO6\VZ`@G+-KVPSRFE)[Q7:_5L:?$_,\(MH4R:K%CSI6X
MFR0%(Y$L0)F887?6B21#`4G;+S_G4G;+-7GM3K_J,C@SARYHZDIRL^ANL[+X
MGKF4&*&MPN.J8(?TX_QEHDCS&6]DG4742UO:DS][RW!"^^S&'RA$I.U^^BS)
M/*STFIDWX4>M3U:^NJM8K8ASW'J"76YSK^DKA=A2F,L4O45O8<MY+Y*K#IBE
MYA%&1PF9KQ#43TEM-&CE;`I<W4Y(N2J$Y"T(?9F9KQG\7%\9_P"-50>JWVH_
MU=`CVM7$U#M*N\7_`)836/&.(KSE%ENL4B_(;Q?<NVKX;U<B>W([.XG92#;-
MX*'HL#E&P!>RTA:4TL9E\>W_`$>,_P!.BU:W7VIT[>G0D%JBU:+INO\`DJ0U
MI3LJ53GGZ7SJQ;CMB6457]P3"6JXON[H$53$%9B;,;D[2U"$].*E6E6:4*PE
MA!K,9VR?:9).53:[[?\`4`>XW!XD[V3S6Z6CT-ZA-X\)5I,2Z!F<8A%2-/,3
MAT*MLJW))'C+X?5ME2>?Q.D=:CL;`X,B=$Z+/`]:K(+'K=SM^<D7)_I`?4'J
M]=E<[M[[7SHY4MJQZ'NSKNJK7M*-\YVO:L'LMMHKF6G^E:LD2.M(I;#:^4\A
MD;3;J5JG#BL?7-HB1Z90N&>%'H.@V=LOT3ME=C[BZ=N6N(SZ<:U3&X.R2[J;
MHFGJDNV/DJSIBS1='->?[:LN8M\!DC6YHTB\YHF$%3ID3H+WI,H0Z,'HH7M0
M#!F27?A))=^'/SH7U'^KH-)[J&W:A]:<]4;W18M%W+TVDY\L#H<B@:;BO,5!
M6[")%9%7PJPHR_?`I;/[*=TCY,BS/AD::D9(CT@=CVJ#9VS/G%DG\XR][]E=
MQU-9??RF/W'S9,JJY6X5#VK7#:3S]*T[M,$MCM71NJWAKK-2+_6-QK=$5M.(
M%BQU3MNOCJ988460@WY3=))9/>TDED]WV8>M_4`GRWBNLX!8=6L-E=)L_6$W
M?)-T'PS==,($B*BHC2CO$8<FJ-[OY+,TS$]/5@+@GRLMS4%K4?LAI46A%;]J
MSMYO_3)S4PJO4DLN7^FASCUI7M?P:.WCU!8-%T'&6.6N;M(*?@5L7#>3?0;G
M,WAT:361\D]7QM^VL=6\))R)4\I-)"-'$#4^U!/&>6>B9_;/153H/U).\^7Y
M9,N?3(]2O25UU-T=RDG526%P&4P$BY><KUJ;HBV)C#6ROAV',=P?HAC3\XO*
M-F&!V<6UR`K;C!)`".-#K4[>V\](L[9>?1T-Y'Z>M+N+G_HJ>5)856QQR;.E
M+@K7GZT`P!WG<)-JZ)O$=5P62R2&@GT372EU=HLYCTI]B[-0=*#0B]F#V8BA
M9LDO/LS9EY<_^?O4_P"IVR*^G58/0Z%IN%A[?@W2U@/D2Y=Y<M)]L""IJG9J
MS+B#(SQN.V'9SY(4.GF0N*EU=Q(R"0$&)R?8E;#LXVWMG.>C63G/0Y2]2WK;
MI.Y.*(DXFL48B]Q\@47T?:!,$Y(M6VRULAL>\KU@,@8'R<LMIMK/S5$P1>K4
M>DCO($CP6!P-4^8(]%;*U;VR2_9>V34D]U>HSTOSWW[7/-M3)Z[<8I)(UR$>
MBBLOJ*?/A<]E71G2\^IV3L;UT$QSM@@?/@F6#1`3E'3GUL<=2%Z)VVIBCSS0
M%9.WME[=)VRS4:MWJ1=F"JON7H0LAE?XAR1?%H(!0$?(EKQ6*.G/=!]<N-<6
MLZ1KI9?:JV&6?9*?GZ*N[D:@;&A+MH>B=>W+,++&2*^,V3W/&<3W+F]3WJ!T
MLN,(J,5QILIRU^QNAN?:FF,2Y<LKK:<OU?\`,M!,;O,IRS5Q6MH0ESF260="
MII$U@7)#24C:QM03QA-WL1F/&>O7"2>O5]F+U-.S7;OVXN7(?&JMLU+$)OTM
M!XA6Z^J9W5JYX1T;R?75O1F3,71;Y8JZN)G,I3==C-4>>(2B9Q.["PN8'8\X
MM.2(T;QGCIDS6@Z]43K`^E.:D:*?-JKI"R.H9)2O2T'1^GC>CM:_,3PV<L2B
M]AU(7RHCNPFP;%=$3U'`'HY2D>?A;K%EFEY)8PD&&B>,WX^SQF_#I-ZA'1_2
MW.5"4K/JO2;(9'27LR/J"^B.=9U=RR@:O)KJ2R%WMG7,,/G4=G;JT'39J;T+
MH6!T6#B[8N/5'EJ?=]BUGMDMY226\JBN_J#]36A=[)2'/5B<])F^<=@5U2$`
MNEWJ>4V'%7NKI#Z8*'MHV9%19HMV''+S9=-]#+1&ENI0$+&K``03SBMG&:\9
MFWV_Z9)U:)7?J?\`7-T73RS4R-##:\72AIZ29;Y453S-;?6+`ZV1S%V8S<LR
M)QA[M&;'A*JJ*.F23:MS+E#\6YDL8S2R%7MQ%#$9+VR2U?&2:_T;9AA4_O3_
M``,]G_FG]%?W03'+V_M/M9U5J]$S_:.].O\`--I_[ET>7O\`VJ]W[5U%S++@
M9Z*']N_K??\`+A>'W)0G-]W2?3??TGT[YYAA2^]*$Y!E-Z49:=_.R0%FDS.-
M-M%Q*;7G-H[!95:<(U()=#%D;HM3/6RL+`M.(EGN#@W*A,:]W2!*]N`6O=B1
ME66YD66YD1S)*!].R2T2P\A.3U`D53<RV?4D<:(/'N@)+$I535Q'NR-;2S`I
MF48L5HLJ*V"\.\L3;8TBER*7N!JXD)(#?.7K=WNW?4V]6I1"A_3/O>THR95E
MG1N=WQSA&6NN7)TJ'L6Q5EVI(1`I:8M1P2^'>"7'\O[-C#'--FZ,238QU*`M
M-/*'X".4`,;W2<]%VSKT2)!*;]/2@)>=#X<NJ6!3EYCJ3D,4466Z=\HEJ*8O
M%@]&-=+D,+_,U*[<LD*FTGZ2HTA96GD]O7[,)WM&63HM;W5-M:,S<D>FW5R'
M\I!A=&.!0FH:ZCU"2*<MW3]F1VFVN!<]L+W1++![3;R+72U=(QU@WJ%S":*1
MIE:U&NT8$\>E8/,%O=T7>[HB2!\8>E.DJ-BB]`V+#X>P]/)H/25?6C!^G72=
MS^SH-1DO3SG\G:EK/L"?6`^:@:4J$+4+I&HLH*)(;]*_*42>7H\I;W;R;W;R
MOQ/#N5;P0TG)IG,*UF+9$>AV]TI!Y3V&B);Q](P$N=Q),QQQ4ROZ1+)9U'=E
MR%&>QCVJ&6:E5!.3>=,+V<YB<Q6^,!]+F5IK&<XA:O.TD14;TB\]L6PN8>@&
MIW259?VPNR-ZMR>J$4\/(BJ4D1ZTHTA?LEC*-`8'V&AE"T&_V/[)&X6IGBJK
M:Z<W/AJ7MTNJ)[/3,A9T1Z.G=_5HR'1@UQ.^`0PN2638,5@GP\U^-VJ1,X4&
MA><O1Y>_9E:`[K;UZEMO5'D!UZ7KS3\8K"N;5YXD%0\"2R.6NB;([T`UOK9S
MU(:T5/ZIAELV?$T\6+VMNCRM<X^8;ZI,0"&$T!NA>QV$#^V_-6^6\]:B=TY/
M](2<\],%HHWVJ4'-M5HK0B"2Y:XZEE\$@+5";5LE1([0J.37!7]L,*9WJF06
M4^BT=%'1T/8TBL\*=.E(UY"\N]V_)O=ORV&30/T@'9,UM#].N64973,<Y^:Z
MT`CZ"8HX;+HIRW)P`YU;^>E3183:9'&.JIXG&-H+A8T9.GLP[8]&J33?-/[_
M`#P?V6E:YGQ?"NM9RRH;4IIF['N.(5U'IE`%-LLNK7E44K)++WBOD1=9K9,-
M>1\(;YN[JRA)&XI0J2J!G&;-**`($YSX3G/A!TBB'I:]&3SH3H!WF?-ME3-O
MYQEO)W2T^:[P95::(\]/;JZKI9!;+VQ3DIC@:43F!9HQT5%H71/[(PH*L`"M
M@#?[3@_M$6/-->CA+^8FZ:K)AST;RO"*;A_([=9C-TBK9J^C-:P.Q899,0K0
MNRV*RT`&Z4-%CQ!F<2E.W`,B,6$E^8\>C1!'=[]^5_MORE6+\F^GY%;6YTLR
M/S)U*MN4Q)N14`^JNR+Q=I%>,&@BZ1W&WI"4CM=2W\HN+Q8-AKW?0',I_3)F
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M/[2<]'CKZL/2+Y`M)AM=@G?/U>6?*I)<T.KE[L7I93)#FV3R&RSM7S#Z58K1
MLY^9(*Z+K4<!I9*WQ9(@-^)F^ZJP:%O16/[6?!O=4U/\M]..+3:V0S2UN9VZ
M7]GJS*ZM"/SNXH:,%WKJJ1*Z"=(-J(RF5F-;FKB^BCXPZ-J!(`?OVAI598E7
MB')G=GTG*$)?R!Z4/*47<(G<J^MJQ9[O0P>#MROHOIN9[?7N)T?,6.Q8)5]<
M3"Y;55R5@K^NY>2@<2H\PK4K84;LK9Y`M"UK=WNO1=[JG2713T_ZWJKJVOYS
M*Z>A%2W@GDUR=3LTFM\I@8%K9TXE50M\G;XJ<I@F,@K%<BAB5D)5#>:W(W)T
M`J,2>98,\8G]MV=4Y0W'*Z]*:@]<^3MSL^H3295'Y+'N8)!?74K[;R.2QRVU
M%<C?4].'7G:4T3/:&0CA,=)).:]&Z3%``2G&4!6<`]_:K_:M$0T5Z-S@SE+8
M1:-+Q(CCELF#*]RNG^QI'74BI2"2NT'.8RJO;+F5<W&PR)KJ<RSW!5LJ/2%6
M)B;U8AIDB<C0?9:N]_Y-[FZM=C^CY"4]-.2'HSDED20VX;;Z;I=8HZ@B@4NK
M6N!WM2/6M/X^:ML89,B+?GZQI2B.3CVJ;DBI2<4022-.6$J9W_)G<_O5]:>D
MS:*YJZ#ZEL.BVI#--G4HY3%UZ65U3`+M25G*7G:JH;101JRXE![S::^EOQ`"
MECD)#N2UF[5D'%%E#4%"2]W2$\ND6OB3MQ_2\QO5\C,^J*&3"=L4?Z=O71UF
MLX%&H0U09@K*.W&^-+I(SDT3K@B$URB;R7,@E&RB`W[%YMF>T&*<U.6%O.B.
M.'"']*VC?:&%-$`Z$IR)5ITC/9A/W*(P^24]#P2U/%&][D8Y,T,T7:D`;*=`
M@7HC4)YNU^O.</82?(EO2$M]$!.=?>EIVT]OYS38],W)*K.=*@9%CC4'3#B7
M*W21<G;E%F52GC+K4]F-SXS2:J2I^XO'G:C4ZT*=9HY4(PH!6P7>Z+MC>7.5
M^G0?$^<*"D]^TV_($\TK&P^;XW,^G?E/.II-JPL[SUK(XS(Y+8[E8%J.#3:L
M;$D+$>L=`K')(-(=HT0!E:9W<U.>J.)YR9Z5L6E(^?)1NI:EM>[[]?NNXI"V
M>_GVG[R=+\L%$HA4BMBFCV&QHS9L9=9@C;E3:I)BYJ1O7!TI($0/0S@;;W=?
M1=[KRQ49Y^](&WZLF%30IQYML*L:>I>[Z8LQBBM]$R,F#55=TH8YI>@K1>&J
MQ%;TWN\RFM=IG5TDSXI^-Z=$!JGW\!^U`Q+Y>I_;U9:.59Z35OL26P83)^>9
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MQ3U>N5RSU]00QB?Y\^&G-\8C^D*52O-`$M,/99(2YMLST3;>$?2^MO3;&V/G
M`$VD%&HW.TI\_709SP]7,G:;9<[)L2QW:ZU%BPIL-FR.U6*4J;'/5/K2N9#4
MI[>I*V-`(D!.M`N]W['/5K?-5)>F/*5Q3!S?):FN66TC;SS=\H<6#H!TO2QV
M^XYG7\MHUVF]QR=PL*8S&6/CM7J]UCI8).I6$%(R=IR"B])2PE+>[U6WN]6W
MR'G#@)^H(_C)T71)+3_'1%;3%SK]HOF71N4\X(H40HG]4R*0S%@L-LLVMD+`
MU-8W!G4KG-*`#<DT(H6TY.O*WNW?6IMW?6HKL'F+TE*KJFI839*>A:VJ^=ME
MU0FIQ2JZ%D5U:V^N(PD8;I.;Y<Z3Y)(+:EMN1M>GTK>5*YT=QA-*.*4@&(`]
MM[JN]S[V5SIZ6ECWLY4M+I=7S5TQ)9W$;J.K>'=33:K[P%84.I`VEX].&>/5
M]:\5G;0_#HC?PQ2)"60)S:2@GJ@G^ST<%O=GP2]TY]$O3'E/B>O+EJV]Y4M'
M5%O/#S5531:4;Z(LVLU-ZRF$H5*:HH+8C2ELEC:.DIB@0-YP&Y-)4S^Z+""C
M"Q>V*T(.-MF>B;<ST>&?<\>GXXU99U.S?YNF>#0^_@7=8(?G>=XE)ZCZ1N>9
MZL=EGI$];9JU3BGK&F$ML0"QF&B<6LXPMX`0C![LI"2.;W=3:KY!8IZ+84S?
M7D/M+E63*ZP37X8\-JCIILFTL-.Z0+:ZMZ#?[8<W:S'B3SB0608Z(F5T<Y*<
MO6Z4'ITY9I1FR@Y=[_E=[DZWM47I[N%#,%,WC-H=$J@XF<JK7(#U_2,MJ]_H
M![98$JBE3*I!:#)948L&-O:Z`RDQ.WB<W;2EU3K0C_?Q&!%M+W;LZU);O'6H
M"L&F?1\74O'U4^NRLV:B^@YF]RM/(EO<D[BD)Z2D.Z_@51S!OE4N*O!L27FT
MK(/7+*VO32YJW1$:)*,:HG:A0J&==[]^?I?[>B<+N+],6/CND=[V3SG!@W94
M<3Y&N%/,+P9(`B>ZO:XE*)E#JF-1&S5D1QLT$%MU>Z)-(`(W$UJ=2U`3!$:3
MC!)Y>A/+T5]>.>/1SFX8!1\@N:%RUYKN,SZRH/%73ONW'>QFRL[2K**R2>KP
MNIO0!M@.-.2:I(4VNAR)0J.CFF0C:L!02#3C#+O?_D-[NJY<.BO!/6?,JSGJ
MJU//EW<M,K%':Z,@E-S"+R*"1%LBX6Y?#V5L5UJ]B,A3M&3&E(M:3DBA&X(#
MTQ*I,86:6`S6?[2[ZIS+OJK'249](%"M/9ZFNGGZ>S*LK*,ZUE<D7=9#MNU4
M4ZJR&NM9CMFTY[*+4E$[>6:N81)E#3KX\M/9FA(>$&BB?`&]6^?JO]EG.)F3
MAB"4O*`<*2&G5E%*K(L2?R574%C(9]!VRPI>X;E,_.-=$TCD2*.#,4*@J1-I
M9J9*A3C!H@@HC8-9+OKU2[ZL-7%6<#ULU\D/-=NE5-#+4]5VP+D1V2VT8XMF
MJBF#%&I!;;Y"'!=,%J6>17<=;&Q:N=#AN)3>D]F<$XD!OF'=[N=-O*K$+@_H
MT1AKK#H^N;XI2*1#G1O@W/L0LN#=N2>-UTR((M*9;9L$J>=JF"ZT,*G/ED$F
M>'-*V28+D-:0I-_<&IOW.K_?HO\`;HE&QGOTGNBI8F=9Q=W,LZF72\;J:N(T
M>W=(LB1XM!KHZ\G><U(WUV3&K"0'+WJ$7VI5FHE;('3A\8!M,,T?L]$AD\I_
M!_:),C?,?#=&2SH@E&M0QEQM:!VA9_05>3#H*Q7:$_-U;4JD+_:MEN50S.R'
M&"0&-RR4%.PESZ@:6TGSZ5E:/"#VP,;:FVH/9^6_2>F3-0O&$!D];HG'E5@=
MI/152T]U?.(7<5<QNQXL)V>Y(W+*VMYDMUQ:9G$97[ZH6+52HI8C<0J!#$`X
M(Q-[NONNWJS#,P>DY-R;'LV,6QS\_:I6U9C?EKV1%^F_:JJMLB<TQKFZ;3B;
MS5ELL*N')9+4K7\$5>]JD[<<:EVIT'W\GW@#^TZG]F09_3J].V6HCZW8T3S)
MY7%YO'^C7F2L_55[N-^D2N=5N\U1"[(DUPM5P[N=4W/]5-JYC9!+'<3:8TIC
MB4@/(6/P>7<FUMUA;]/KKB!)Z+?.@XI.8O6L[CM-NK%6_7LOB\AU/)`QOL*:
M:AG\EK&UF*72U[F[.E<D)S$]+5ASP:0HV84:H)&,">4Y.9RBRX.8?29:8+))
M19KK4M50&O+JC'RAE;+TE*:-:Z]NR`T(R\Z1V'!E$'M&%'0J1M=`$HX_N.)U
M*7VS:9H1B49AHC1)>[T67N]&52<P>EHO::DG4(>*XA,:Y?BD'K.NI!2G2\QJ
MB,0J(7#)(59$#ATB555:479Y(VV_)G9B=TB9^VN^4JAP(.\%6U>MFM[OR;W=
M'4_,LJG]Z?X&>S_S3^BO[H)CE[?VGVLZJU>B9_M'>G7^:;3_`-RZ/+W_`+5>
M[]JZBYEEP,]%#^W?UOO^7"\/N2A.;[ND^F^_I/IWSS##_/-ZI7'W>'7/0:BP
MJ"BM8-;#QQ2T:F7,#K:3FO`^S/JM;9K!<[Q(Z@W&GHE)&7UF:*0CL+,6RDLA
M`8DE;H6#0B!GFZWVWMDY]6^VR3E7Z=<%=BO'04QZ<K^E'-BUTKZF7'LSZ%K1
M]EL'*<M<V5$=QO=$,N@`TLE4-"R5\^6?7,XC"M(4;[^X-;ZI,3%'%DIMCU.[
MMS/:&S,^$J<A<@=*$WAQCJ3<J+:(*X\Z+]0.TK*Z6DTDJ3;E;U?=$SKH0^OJ
M=K5KKZ82F<R2+RXNTV.0O9LD3,Z5M.CI`"BSE7L]ERV9>>LA;.?DZC]-Z^.C
MNOK/>M11VB,%DG<L'OBO+J;GJ->^5ZZ5MZ73A6E6W6VMH'P#Z(V`]6-#,E]T
M]W]Y4>Q%O96T8Q'9)W23YS_I+)&?0\I=CSWT/^AZ%L2F0Q#KJZ[*Z'GSI5,>
MDT)=$B%\M7LF1VV)3&Y"H=SX@>UB8G@3D@TL/U_!_9EJ"O:^<G+LG?OH;/+9
MT1[W!P)ZA-M6:VR*FET5L(C@^H8K*N7K%O\`^1[#9-O=+J[B;.B9C(*S;*0:
M:[K*%O6V&JXW68U3XR-B!2VN[CH>A@-5*QIW=N<^I+V^K.AX`ZML?I:_XD1%
M%U,<P.\5Z@Z_YQFCG*8\K<8+VEW1SBRTG*(.XQ^-NR]T;%5%S"16)*/B28G:
M4Q9+0;2'&#+\=/*?S_PV9\H&MGBOJJ^.>8K7<$X2=>9Y/S/Z6/37(4D2G2>C
M"D?0=I6G!JJAT+J^I5\+G+KJ2U(R2*OEDJ`^2C3($"P]*$"4*DY=LMY27=ZT
MV>M]71GF[BJ^85SOZI7.\B<%[9:W0\[N(ZM^JEI<-C6[=06OS5"H)6MAN4/J
MPAJC]?R6HSD!<8=$[6RM)2HR/A<R2S35HSARV;*ELV>SGS;/&G4E^T2AAL#X
M0=N8)#SWZ3W3_&SVSJ9/1I1%_P!KVM$*GC,$JRJED&G3PFD%/PY]KE=(DS])
M1,H=*UZ8):4!QB[9>I9+UWEK9+U]74+L7D2ZI%Z9<GYFKN7S&Z[><)?0#HV2
M>9,=*M$C*+C_`$M4D^?5ZEBB<5J^J7)+7L985:DM,8A`)Q(;]%'#5'&[V9F6
M>6WHS+/+7*SJGT=+RCLG<D='H97>L&14++I_;C:])Z/B"7K*TK&[WAO1UTT$
M4E);([JC4\OAZ9Q4QY7$=1TEL5)TY)K@/1BC1VIWSU]_^-3NGKU3V_\`(W2"
MM?:/-Q'*+FJE5G>JM&.ZXYWAI_JD,-B%1)^A8/>8'YT6*)<5<B*\Z]KJ-GUF
M@CZ9B,1J$82!`7!:S#M`FSKZ9F)LZ_"%(OZ/=X-/,X+DD,<<+(Z%8;@87</(
M+UNH8?#9'S57WJ-O/6,BI-5+&8H+98,EMMG0HW-`LF#NI0)3O8-PPHB358\M
M[YN>G_Q?+G)T_P#B3;<Y.MVWG3JSJT'+/45%NL[N_DRQ>5JSIG?++MT%#[LY
MQJ>X(:MZ@M&M9O93ESRMC\TU8I$37,RUV<G-4QM:98:60())B62R9.$E]&CW
M;R=ZL]X3>L>M)%4%$([SXMISD(5;PH$A&E>YO<T-/9+CZ\*YZ5,$I#7T08KK
M`Z"K%2&1F%)CDC./9`@)!%*C$O;./2F]LX]'4OT_6BYZHM3LJLK'YRM6&QRS
MNPNB^D(-=*]?5"RKY##K#<X<9&&4LMDLMTL5%+EA!9XQD*H^2E*"E,T)1H6R
M]#SW9<SV2YP@OE@'2*/J_JKJBW^$;B@$ND22M>=Z,@\5<.<4L$:>8HG="\)<
MF621FN+XG*K-D+O9#Q/I$%:V(B6N/MY34V"6+RQ!6VYDDO!<S)6G^IYP_<'4
MEZV*8RT^9951V%R?RS3$E+,>XNWHW\,<]2NI+>MB)'D.SXW.!8$=',[HYF&^
MS"4845LH@8U0@$B=O=)/G?\`A+GVF[TO.:^DJ+GG=S9TRP?$&M\M"HX'3]DN
M+PQ/Y]\TE3%%Q>J(/8TD1HERY6W2MUBK&C2OZ9P*),->4ZHT`1DF@'N=UES#
MNLN8JLW<`](*ZUY4B+$Q2>BI/#_5W['Z&F%C5L.FS)G7E'3]Y[<5US8+:3+&
MZ91!U3R%LM%B1%H3FQS5HTCSL(DA`R1B(UY3GZ79_I!];<6=BTA=/+DQ>X!U
M!+FN`S[U,T<YG=0E\92"?RE!?7>T!MZL7ZT6BXE#="$,.MNO8ZI>G@V)($+Z
MWF;"2F`A&+9&-F9QZ?\`ALST1%=WI>=HS[YR%S95*\]D0M'J`/KK67Q>I#&K
MI&,6=ZJ[?T5'J#4R1\7+I+7:BYJ&3J7)J?F=:QN+4O\`=RE:Y/O9R8=G=V_Y
M]+.Z?^?^.P_?=?VD[=&\075#>0I1UI`ZWKGL*'6%5;6NI=&-.NNJ%5$TPAME
M9%S3:+Q;<>=%497)'$\HQP]U*"(0B#@BT$>>VS+-QGMZ>SE["/3*OFL:C.B=
MTUG>$G7U]R=Z=J"M)'R,_P!-RF?5ST1S[TAUQ;K,T5PW7Q)H_#)S#^:FVT(Z
MUFD2%/\`#WEH#K28DP8/`B^4MX]ZUY;5L.:X%VQ3E^1;I+K_`(^6="V!?W(/
M,],2>1T<;1BETYFL:KYM:JJ=15XADNL.*,3%7]EH)XT25W6P]<Z(2'YL5)M$
M&D%-Q@I<LR7U3CI+ZN;RCTMNWX[1O0S,LJ216)*[@Y+Z"@U9(D+G2+,_4;)5
M7J1;O);5+:I2N#"USMNONN3F>7-#G*#WD]G<(^H;SE:0A6%'O?EV[_/_`!?*
M?Y].PZ^@;7M4/IA2=TJ:WW552'7]A3*Y7+I5BY=9+;9:Z4\_=.0YHD$K:^?5
M!%4K&91+YTSI4"9C*,5[*.(4*B-'`/.#C9S],\<_2H%,<M=)\P6C%KYGW%LH
MZABJR+>HO4!=01)XI!UE]:NEY>H#9W0$#G)#/9L]C,*.@/0-5O[<@?5B5>8Y
M-1:!(4M1B)&<`JVR\2YT7BS-YX4TG7I(=VP[GV=KJ_KU))NAH3Z9-'\F1V/-
MDYC08K9L,M%?URP=*\P-+\]/3>$2"DHY9\'=8ZXN1:1"J<8>A`G,\AINB[Y=
MN_&KY3?C7^IOGN>#M*'3:+/U7RV)-M23A91WM+"9DZ1!9@X#'(N2^SB)-RCV
MPUT".DZQ8V(59P`A7&-9IY.A)QDF#YWABN(M*^GGU"AK[TAHF2"><S2/G\[M
M)9>UC5:;1[A,:Y'8S3(DL#2'D35CLB(2$J;EJ2$AAB=K<CDQ(M>)B;>O/K?E
M.6K9RBGC'C3L'G.]>(I%.ZEZ/2Q^'<K,=-6([U1OD.3-0I@G[;ORS%2"]OG.
M=CG]JA1T$G#<]J5M>`(=P[5FE$#T:6$@#NLLOW_PMEB_73WIXR[K/U'2;!FS
MM(8AS(R\V\L:>5T=:*X7K[.M&@^M+*OAAKTN1R!([SZMTC"X`9'!<X,1*!0Y
M(U8T@5H-Z'H,G=G;\I+D^7(^#^E)VN@J2QH]**B+GLEL/F=H!&(_*Y%4\29X
M@;5_J2F=*67Q:^N,/&F3RB(=9UB2VJF]_D/QD;:H)6-ZYP3H3O=MZ\NW?Y_X
MUY3_`'_Q<&[.6ND>IGGL2<0?CJ1\Z,W7,$XLY>AL<L)XJEHF%?2^H[+L2=RS
MOZ:,M6V2^,[.[<W,<B;T\&*0.RN1/+NPH0")(0;*&"2R9ST_S$V17RRO3W[.
M=^8SZ;;^=UQLVJWT^.Z^4EDCC\J@9J>^K:EW6O,-CPV[695*9HH5#D?44:AC
MU-'/;YLGW*1B7I5^P?O&S[.Z;OIJ[-_E:.Y:7ZK5`Y*O'G2H.SC.S8*.:U<1
M+.A&#@LNMW6F)C=\!E-B0CK6+UE*6R)QF,.+%'P.D:?ZY;_E.3MJ`6IV8I-]
MB;F9S+F?RDSF7,3IZM?&O4W?TQJBB:N9:U9*1@M97)9DAL*X5SX9%3N@9?'%
ME24H.)L\$=29F385)MLB?9>WN"A/MJ3..V\7B:<#R!=MDYJ=MD^U+"^->\+>
MZ?JCL&Y*:>DAB&9^DQ,+QH@YSIDQ/+IO2[=;3%<%D,$S;7-5,&MQYELZ1-,P
M1(&]Y0M<I9?;)#DC@8())5WMDR?*[,S[7N]&NGKYYTIN9U7>M==#1)[CCG)7
M!N16$CY<-J?1#K:MJR0AOHI_IQR4VP_IG1I?4:M?N>&F'$G&E`2C+#[8&IWV
M6\)W9;L<ZHIPQZE#)(;TOB5T_6:V0>H=SUWG7_0<)ADH%NTH/(+@B<IGG)J"
MW7202OYOI("D0,R6LT!L;,.+1IW\1INS$X#%!=WMZ>S6S\)IMJM^M974?#ED
M45R'U35/<G,58I.>H:;--\AR:A'>,N+11B>TH[T(U.ET2T]'3,V,AH3D#_&`
MDR]N4,9NRBP;-()4R9S+9B<<[>'W?./.E#U$\Y@)Y87'R^9^JTT]TM'?1,BJ
MW<%8JF*Z,CE[:DZA<HEQ=U$7?%:Y:#:P1Q\IB&E.0:*'I<%J&9H-V==].ALZ
M_"5O5CXT[1[AMUC:*0C]7,,!YRH.23RI9S;+F]%B<.PYK+$#A!Y=5Z.'/1:]
MJG-%,E4IP)G)\(+:?";'E@T=Y#MESMLDYZG;9.J$K?HKMVV%G4L-4<@3%N<O
M43FOIH749.29S4@J[YX<*19>?R>BX9<II\^!+`/M?JJ>6":?@#<_)I#I:G`G
M/`(!NPW9[]-./PE7J_AF\Y^R>KZBKBI])73I.TN#W6AGM@/KUO=GQEK-EYY(
MM&0,0W=9I&TGP]VASFI$2[%%%K5"'S!)4A,#HR3NG&^FDO1&$LX/ZMKOI2P[
MT>8G97;,,KGO#EWH_;?.G&@6NRN@Z]B7$DUHIW>8LPLB&J*O53+G>RIFD<V1
MN=4C$)P^$"&2H,6:3'#OE+,Z<&S/X5_N?TS^T[X%,9I7M8+.:B+LM?U*;GC%
M:*S:.DPZK9;JY/IBHX!`+19UBF8PUB=.I9_7;LZ2,46.6+(X:_#/+<4Z\)Q^
M[.Z3KST7RG_B0IMS+U8AB=RUTQ<0VVBHCK"R.-V>U(K74NI*0VO6O+M2<"T?
M7MK51"W.>6_&DHY/+YS#3JT4O?Q7:I*S:<G-.(TT2(X<EG7>8FSWY2.MY?Z.
M/O'U'-Q/GKHROZVZGYN+CE&PMF0<<I:&;%:?T[HS3S)#;.7&25UN^%3:*3AA
MW&4*:++/DO[0LD9HS48C%.VS)_\`?<V8L;Z<G.%XLG2#7T)..9U/)40BGI^T
M9R1(8U(GVL%<^OZVH&_)7Y?:$C8J?E$SC:".ULVHU+,Q+'1Q$]+BGI3XD$)B
MB@BG=9F=>4MX_E'_`$CP5=UA:]4L^$TS&7@BV>E>$KCJR$N3E"XZR](UKSS#
M>:GRX*?4.0E`D\<;K"<:Q=V(9;V!(@5KA!$J\41IAVTLX^B6<:MQQ=65EO'6
M_7_6<CY]D7*]:7?7/-M8Q:HITHKL,_G$GI@JTS9=<L[CE6RN<Q"/'+6^?ML9
M:PB=%+BL;8^$T\))'N@,EZ2=2],ZN3RCTLNOY76G;=$'PMG;(-050V'S=Z<Z
M=_FK(%ANJE[EZ?3]4S^*/2A`K<%D`;G*N8;%*?-&X$)P_#T*@8@;2#%L6O*;
M+^5\IPLG.^9;QZ84^HA<L?XX?.:6>T?2[=^0*WHZ?*:52SBY;Y0-MPNT?E:A
MHK::R^`,3)7A,Q31B-NSBZ$*U`%ZD80)D))(A-DR;O)LF<^K9U'-U_5]W[R-
M:K-4U[IJK8>'N=*/G#C1+?RDX11'8D7N*5R681FZ$5R.`9>U01J:WPM<I<H&
M6!Z,V(S1!YA@0`R;+VV>NFS+]MI]0^G^F=WY?L\IOFV8]!L'4/IB33B-@40*
M5UBPCKVY5LYLIXCKC9Q=CS.&F-M8.[5:6S3WAMTZG(1M9H!I!".)\SMLSGW2
M9G\JOM_HY7;9+IUPJF=@.E;NS`PMK7R@!A;H$AC\BN%;Z559<7K+J=[*:VUS
MNA'"V-\5/S;J-Z4M:0TU"6X#3J!>RWN^<X_SU7RS_/E'MX<9],=*U*F8H7P$
MX<U&TIZ:%C<=2>#O$DHP"?H"=SN8\]',M7U^.!SQY;7^D:R15.].Z1[?S&81
MY[P66F1@,,6^5+)UYVFR=>>71;TV^4.@.:>G.VV:TH\(RCVF#<O4CR;91D@:
MW9;85%U2??S]%F1]2D+1R!NDE/1VU&Z'JCEQ!'Q$#.4L*$9[8>PY[K+)G5+9
M9/=S[@7)G9<!@!$0K+GJ[E_*G(?7G&W07-='W>LYF9>GE;#7=@V<Z=&UI`95
M7D]4Q.P8%$&&4MKC"UDU=T+\Y*-K40U1NO9';W;/7-L79Z]<2!#N9.IXA<]>
M=S3+CN5V)$M]K=UWH[\HER:G7.]Z[C'1M?4K75-78F8GJ>HZC?+0BK=4+F0O
M:$\F&N:FF8F^ZGFGDJ2A39GCOI#9F:\][<)];73)NT[<AC7=-61BX>E_3,M"
M$\N[4<Y)HO8T2J5+R8?9SA8BCW65R*//]0"@SL`Q*RRIN2J#V`&DP5Y9FA*$
M[I,GV2SB/],^<V%3^]/\#/9_YI_17]T$QR]O[3[6=5:O1,_VCO3K_--I_P"Y
M='E[_P!JO=^U=1<RRX&>BA_;OZWW_+A>'W)0G-]W2?3??TGT[YYAARHZ+ZVZ
MRWT)>=%\B0J@E@^5N<8/T';;QT`NG9?S@.EGK[.^0=25R7"%S8"(&*66H70]
MQE3G\52(3U:0H#8?H)XPZDF;?5J29M5RCWJ,]>V39]=.U=,'-"+GVU_3[6>H
MQ%V^71NUQ7"TUL@;H`F.JU]=6^=)(8?-S)'.=""ZD(@MX4:;8?=Q#&$W+XS/
MG<,G^T"R7UWY:XTH?8E5UY%7*1Q[TT(5V#.$<\K2_P"%L;1=<DM:C*\<X9&P
M2AGBKA8=7-J.SG)22N8#',Q68C3A*6#]KK1E\.<ONOCSGR^O0OK%=/T2Y<YL
M#0Q<[6;(+>JR06"G;U5/=7TTIMJ6ZZ=BU!0RFX`T6+K;]2$BD1,F\2WV?IBV
M-0XD@V6,*=42+:=DI.V5T'[D[YL+DGJ'A>K&R"PI[I_H%^F1/0$RD*]V1R.K
M(DBFU'U/%I9&S4BLEB$WI;'O=IT\C7@&64VZ,,`(&P;%F9V[+?5)-E4FB'K-
MW+,.>.P;63U;3+'-X_U'57/?"D;E4F?HY&;7;>C"XTX4-+;GD#FY$E1],XPV
M0[E#P:@&D3IF).8,&]"#YLM[.<^%O:DF*>H9V-?LOX(/YX*Y);ZX[FINQIXB
MU8\:M^02VL)O0,=AF[NA3RNB5@LK&_:33R0KFEO,()(VF^&#$=L_8]>#QDW=
MX3)-WT15+/4W[SK2J;IL&?M7(&Q5SW_#>!VQ5$JRZ3DQ)+ZND,62RRTW.'1V
M:R*<2II)9)27\/860@QU,5DB_=G!&$&KX]NYSTU?&?/1GWWU9>BHSV70/,`(
MY0LU!9+/Q*-R;DD`Z&K>;V"+IY99JFRY?7RJ<"/CE5(*4@U=G2+Y,3D"61.Z
M4E2D(%M87Y-3QGCIXS-73]/7M>SNJ)GT-$+K!5M7V54\M7MJCEM'$+2BE]5!
M&03F=1V+2&SGBPEQ4;M2.6-&H\@=&B1Q%N3Q\8E!R<!QXR_-J=TDZ=$[IG1`
ML!]6.:V+T)W#4$(J*'6&DJBL[[EG%C+"YN2HL3I*:\D.9=;=`P&3-FU*XJ-+
M5=T.S<@C`R$^MKVD9RGRG>S\<OCDE/&9$FT?Z@$UGOIM=%]A.,HHNQ;7HRMK
MKF+U"J_@]O5>T5[.:PJCY>#IFX(!;+RJM2,SB./18DSK[?3>)6A-(4IB"0FA
MWN7M_MGH6?VQ5"MO6/O&?S3TWJUW3=8H)Q?4WD=>]R(`.4I/(H:5(Y=/*ZAS
M17.O?PG'JI[)JM?W-#IX]ML3`D`;K0A&:%FKV2:OCU>R*>L9<5G./9!E4534
MDZ;Z%/!>M%1QAE+H]3;H#BVI[SEU$]/2$"-O=]!BUU,;E7ZY[BB$Y/M*YMCP
MR@,($)9L[4\/<\<ZK0./J#VV/TS>FO4:::WB#='6:&6I<_)42E*:5MRV:4)&
MFP`ZIG=O)#%B-S:G*V24)TB*0(0I1H6!R0$F;VK"H%D\9Y>*9SCF3:'KK]0U
M]$(L[%U]S>HVO4]3_)6Q%L.Z;3U?U:&BP<X%5X@H8D;8GE=8)[3EEY+8J*12
MPM=%6Y\9!&[7F)#0CWOPGROC%W+8]2?JF*MG5_0\1J2D2>6>%[;A]/WI"I<]
MS)1T+.G9+%:HEE[/=;R%E5IJZC)%7IK;)3,R)P;W04K/:5&]*&XM2F%O/C.)
MZU/&>OJJU/\`UN.E(BZ=V!8:II";L7,OY6I#*L9F2ZRSZH6<\]`PFH*X*Z'7
M&>TC$A/O^/RE6Z-"&,N"5V)-:#R]HS"][,*OA.%\9PS71/K%=/4,;SNTM++S
MK9<@MNK9O8:9"LIKK.FS;8EC9TG"*(@]+0)FL0.Y'2<DE?RPV$N0SU*"/G.!
M)6P#`F4DBVG;*3ME7#G7J17#`*MZ6Z$<:PASQ3/&W>\QHCH8A@32UQG37R?$
MXO"#Y)=\60)%RH#O.*W>9X2[O+<%,:G61MN6>ZA+5`+V//CSGK8F3IZXDR8=
MNWU6G`\0Z=GE)Q9OOF\9[6D)I.B5;\ZQ]FC[ETU<C)7/.K)<LL/+>U34[,4=
MFC2X38U$ET$A84L2(B?,$H0F3RST,EN>C59)T+ZAK;=-8\;,1?&KKTE*JFM7
MI*:6FX12[&FCHU3T(E%>UY%HDR5\78+C/9!8LIGTY,+5+Q/R=N;6I#M3[J<<
M>6DQG;F\X9.O.*FU]ZWDN>+DYD2V=4L#K7GRQ^:[#FM_S`4B>7J05+?M>SSJ
M&OSXS'WG7N$>D-82&1<GOZ-L6GHR%JH]>@_\FS=EZUX<<=3Q_*+J\]9GL&=Q
MGEY-*:VH6D[!N^V>O81,DKG5O35YH8@@Y_5T,;!V--$*95K9P1)G]KN4P#VY
MK`!96U4@_=[)`+6A/&<KXR+H>JUZD-T\*2VH8_5$5JV1ES&D^E+C?2[#B5RR
M<U[6T*?4`&>`,KE4I:Q+69,V^<=0!3+Y.3\F(][L6>X'$D;$+<[>V=R=O;*B
MQ^]5._T<W]1T+<PTF7&^)JKMR:1&!'5OT"]R";.4$Y:KB]F5P?NB&54'G-.S
M'2J>B;3VI.I+?%K<DTJ2@T`TLW;QG'ROCT^6?J/O_M'HIZINE*13\M++FG%)
MV7TK-[(LBH^IZNJJ/5W%)I#ZVB-?QRIYTXQRWWV:2.:211[Y(#%9+$E;$'O*
M4A<)045BR3F[B9)U5R1>N5=LOM7E:*PRI:?;]7?#.:#GNH)'NTG.PI/9EJ=2
MW)S7<\2K"X&%*74$?:ZF(IISDC8KE29%\IV\D1"7P5"T4"^$S:OC)U="_3Z[
M=N#KBS^E&:9CJMKBM1VE>5;1B+Q&H>A&*2)BZLOF:U0P2"17%.!F4G/-R1CA
M_OJIOC!IBQM4J=%J-%>S&#6>Z2,V2?:JDK]2+MVDT'7LNNEFY0?85R3U!S#S
M8_EU?!K[W)Y&._)#S$ZO,U:VQ1,92M5%Q:M[Y6DIVE(C5KU[XVE;*\Y1NDX[
MX]MS-VM9+F-=M;UG+&-7R'5),=?-,0%WD#E"*SJU:%ZMD#TGA:;B%%TZX2B0
M4'#&AAO99*CI[[PR$$IFDD@+4(M:,O9.A*-V=GO['C[^RW/J#^H';7%,4XLE
M;%!8)8K9<-E(D/0JM:DF4?,B].Q:MW"R+?GM<,JE66[(7>,QQF6N2=$]!.$4
MC3#+4:]J'>]3M[9=2275([#]:2^T$@[!!#*YIEMK^I>H>4*/H*P'MCMNR13*
MO;KNVZ^?+%M230NKUQDIF`6>P*+=S8\WQDK:AQ0A!ORG#,#E\)Q]+XQ8=D]0
MCIN4==UARVTN7/Z#<FYDH>Y5TI<N;NQ58IO+;E6W8D/1-2%(I(!S]&F(JLT)
MP2K$&B7G"6'$:%[8O82YXS-3)FM6K3U$^V4YK4MN6-<KN3,O]2.1^GP:16+#
M;C*YE+*\8[<<YE8P3Y7.7U+M.\GP)$%L0^SV),`X[VYAV_)Y7CV_/32SM]-Z
M((J[U[)\X4!![4M:BX<U6&U\G=(7]<]4QEZ>D:CY0PXGF*2<OAK]]>5*\A%6
MU^03I=N6'NC@4J&VJ$ZHK6Q"0J`COASQ[K>V;_+J[QCTA:]G6)>=*]`V#SF]
M7A32*O'*7UM0M>WS#MUJ&:`E`!)'J3W*I4-=J,BI<P#3M<@8`(T:LQ$KT8F)
M$$(`YLG6=&;/6=%"VKUF))(5/J5?!(=4I[5S?1'05]<;N2:5K7HVZ8GRU(YM
M3UR+K7;&US"NC!**ZXHE-;BT@4QJR+/*54'>Q;V9N^'3_;7CT:B?ZQE^R>)?
M#X75-11.Y&N"<41FP8K80YF[-E6].=`]O2+C^XH?(DT=?&MT=8+!R6E-(6`P
M@PA8Z-R],H$8(E07X/&?Q_\`-3QG\.G'('5D]M3\J*O>CHO`:]N+CFU@5Q:[
MS7<@='>HY0PO57PVYX=9,5625,D?XVA<X%.$^W)I<1*%#2N3'`VI4%;+-%+)
MZ=*EGMZN8M>^M':UJ<H]16Y'*\I9EMVOK)Y:>*(C:V1/<JB#_P`M]L7'"ZXY
M_LNS4\>?$T@;YTF;71X'(6E(>F]S<$!17E+T;K6]7LDL]O\`\->//PL,=ZCO
M0$';;=K6UJQJ,CH7G_M?AWFJ=N,&>)>Z4_-:R[0GU4ML>LZ'I7;:&81>4-D-
ML!8$]C<#EP4;LW`%[RK2*"][GC.OIB9/XQJ]=^I7TY(&WG'I&55O123C_KSH
MR7\Z5/'&)=/#.B8`<-7:;/4-DV(YK5@Z_D[?.7JJC-/+"V(4"N.)G<@>EJ\2
M54'3QG3UA>WT]4?6?ZOMX0?D?F[H1NJZJ5$GNOTR;Y[>?6=>.9&Q]EL*J2.;
MS&6)M($3L!V4PM?NZ5PE>AF&.`@HT^BC-;$/S/&;GROCSGRTA@]:B\D$>H&;
M2NK:CF-7ROKZ_:8M>V*^1VG%FP_G6AX%$GV>=#P>O+%VFL.$GU;+)`Z)),QR
M).H5>X15P5)?$DU.;CP_\/'\MEK[UH;(47KS,PVO7]21CGBTX)T4^6[:C.Y2
M<:^NWRONA.F:>IY6UF+'-2S*HG.$7/I1*TT\(C/B[P3H@82A!!B]G''4O;[(
M8A'K6=>3B$\]*'^LJ'I>;73?W4-;O);Q5_3%YI(?$Z?KVFK)K@@R!TJK66&I
MF,A9K:`0^*O9::FX]-L0M%`\?&^$Y]CQBQGZ76Y2+]M_GUUJNLV)_:.^ZMY?
MHN1KU4H-9[.J:06%%*GMV5')"74!^K$IZ82]J4+4A)Q:<;9(&XS1/ALTS)XS
M-^$\?7X6]X:OWM6^GWK1MNO?+:%+SW<,YYPC9E616VF\]\L^'Q:`2T,P?-RZ
M=O98((K1STLC;>GT!P":F$+2K81ZUJ629FEDBE2#U0.P*OCTNL#HY@YH7P*!
M^I!"N`I-\RM?7^Z2OV0G1M^<"SF:.@DLZ?WP8F9X)"SLR!O6+=*BQ[,]X"+0
M-7QEZ>QD]/9I\F]:"XI)((,VU0PU7%XQ8?7?8M#,$UL6A^L)X[EP7G"(5-(H
M<[.E*UPB:[C:9;+EE@*B7(2QM2HFTI.48:42$6]BOA/5?%[M^L7T05U#U[2:
M.M:0E3%SJQ]U.Q38VHK6C<UB;)R16+#*XC8LVDT@4&5O/HK9L\D:..JVJ-J"
M7IC,6$J5`=$[$+3QF2_1XS$EU#ZD765UP+D**P-!SFZ7_P!D2JQ%3#*9'4/3
MM5T[3];U!3,+M*P1OT%LQRC]F6[+Q.LU0M;0I8W!NCSB!6)2!9Y$1X#)XR==
MR)DF_#4TOJS=&.]M<[T0LBE'UY8+W:/6M*=!.VZYZ.O:+*;$Y3NFDZQ,U3B.
MHR2Y+'HG9T=MP+P0[2HC3?'30:2.)^QE[,.>,Z^AXSJ_T,YADP&`P&`P&`P&
M`P&!4_O3_`SV?^:?T5_=!,<O;^T^UG56KT3/]H[TZ_S3:?\`N71Y>_\`:KW?
MM747,LN!GHH?V[^M]_RX7A]R4)S?=TGTWW])].^>884@Z0]/KG[J":CL.<*+
M8A\N=ZZ.IJ?N]-7!/JA.MNF%#BX.QE3VIJ$/+4&7PP"]Y7B("9[-<C"XJRTZ
MDHM4>$RSNL66QOROCF@3Y2@EB2(&L:IHY>D''+(TQYU7LL;9*"D;C'G-9$6A
M@1&EMS><D-BR(M(K+!I0E(*]F6+0=[UC;_LU#4[],7DZQ8&Q5Q(H]-M1R-<G
ML'%K)MKL24M3JWT9&)37LS9&\AV1KBU@94BD-7LYX7GS>_[]W$'8_`P>MWRN
M[\FWJ\\F],7FB?QI\CEI+KIMI1(J0E_/CK+[-NF=R^>G5W+[0CUQ""7,'!RV
M\$2.+S^*-RQC<P#TK:-(RP)QA`'PQY4\JE3HSA_GWJU+I)>$??987\QMQ<\C
M$7*7EH--KR]-P`Z>[&8UJ$HM2<:^LF96@=`^56W*TWM2!`$,7C-LZ$MB,B?2
MYXK^/QYW=*G3RAGC,CALL;Z[F3BJE]6'O]=\XM?*<$<'>NI#\1B[T.(TVUA2
M(`JDYH$RXXU>'6E8_:ZOE3RK;ZI]/GF&DYI!)O6</=(LJJ^;]%SVN8ZW21U)
MA$'=.ISH\LN!IBT.*.`PLD2<W*-E*D#2G)`A:3SS]I"RM'"#B]UO4VUCIYZ=
MO.<_A$Z@JP%E1I'/^I4_9;G((-9\LB,S9^@49[(I13&*2IH7$NL:)0J(\E&4
MC3#`F`(&_`/[K?C/*FUYUGIR\X.Z@YWDOSGR^8GK^4WH^PY7:4M?;!.DW&,Q
MD\XHZ6FRM8N&XFR=O=YFYE.RL6]C>T"LQ,L]J3O8<OE3RK>:;XNJBEK3LR[V
MN17!/;;M".I8.XSZWK8EUFO\5KAND4@ES36T`-DJU4FB,):9-)UBTE*G+]H(
MXP.S3#-%%:!+;9GH:A^)^E1Q17B.GAUG6"BL)G2+9.&R*6]7+^XPZZWD%D02
M30":+;!M=D&EFEA.SVAE2AQ$J=E:H\E\*3N!0@*4Y0PWRIY5(<#X&H.!T?T'
M1&AV3-&3JPF:@Z%G5CV5*9I;5I*9Y7J"J'=Q?K"=E@W@A8AKII1-#=I'[L2W
MI$9.B"P"#L0IY7=]C;NM')]+KD%#-I?8[-#Y3'IQ.+.J>X7V2L,\DS:X[L"D
MZ:D]%UZ^-XBEVR6T35"YBY'FE$@`6J>50W`[0U6_/E\K3RKV0?TON)JO55*X
MU?2[)6CO3U2S>D&A]@._DF_S.N["AK'"I0UVV]LI:1SMA>K21M"O+7OIJU:2
M\$>_`-T>,T0WE;U/*U,;UR#23_R&'AUR9WPWGT-(L_/>F(N3.Y,A^;-BBR&&
MMS=\K2U&GSXF6Q-Q0!+?:^\#'K8]B\V][R;=WU-R[ZO%??%U`]+K1+;@C3I)
M-FT#>',ZA,5(WAM1*ZFZ'*@Y=EM:E,A4D@-=U@ZZ:C43C]A8W'I]F)Q@&+8L
M2V="6Q"<G]+7E28S<<SD!5N+4;\NJM]M:N`W182>I+_F5*-T::ZWGM\UNG>B
MHW94Q9DL-:/>E2LH('G;6E^)EK-$%Z#?*GE4I27A/GN5T!?'-#JT2K56]'V%
M9UI6:E0S1_0R!3-+<L$VT)DYL$E3J@.L;";,CMJ4I2099:,.M`*T$.O#)MW?
M4V[J-Y+Z8W-,^C#Y&K37W1;QTBHV?\\.LMM&Z9W,IV=6]AV/%K87$%R]R<MO
M!$@C<YA36L8G(!FE;/[H`"<80Z\,OE?0\J_:CTSN>%A_3A"N17THB?7K-9;9
M>=:&7C._FPD3C;D998C.)BV08#@!DCTX<F-@3EENB,LI0G%YQ%[#L8L>5X^#
M;^%F[EYTJ'H"DWOGJVHK\JZM?VAD:%C.-V>&IS3"C"UL=HN]LTE9%S=(F"41
MA\94;@W.:)40N1+TI1Y1@3`:%DVR[ZIT5:?/3.I>2LT%"^6YULNLBM5DWU"^
M@_RF[,2=",\5LA-'TLVK7=HH'-*[.%:OH8JW'":%0#B25R,M:3LM;KWC=\K\
M+K$37TCN$9Y78:E>*C5)JX*IVH:*311HF,J;D22OZ1MYTO&$E$JBW03H.1'6
M$^+E+L[&'F.+T4M4%+3C@GF^=Y7=7RO5FY7Z8W.$CE#3-V9[O6L)HRV=?ELH
M)94-X3VN'\$EZ87P9RM]`8X1UR3&&Q:0JZX:-EMF_P""I=)?`H(="WCRJ>5;
MUU5P+0G8SO#'JX55KI5<-@UFU=K5:V[/*M#*ZQN7Y(!M"O)N=!WAF626(S8B
M#-Q2Y(:;K1A10@ZWK0Q>,G=9T);.C15?IB<UJ'"_])72[F6$=-1"5PRW*;8;
MLG;32CTWR^G8[0[@Y-]9)'($;99$AK.)-J%"O3%@4)!(BC2Q:&'6\OE?POE4
MB7CPI25[&U>\.CG;5;SRGHD[UY![5I"VIK4EH(ZXDB9D3RFO7281%S1+7Z(2
M,<:;E"A*MT?LI<B)5IA$*0:-R2V)+6C*/3`XYU'BHJR5\\1&/M]=<U5A'6Z)
M3.3,VHDP<CVX^7G1;E&%9;B:O;9=&;,DBUQ4O&S3'%T$H,"L-.T89YKY5?*I
M1Y]XUK+F>8V++*SEUU;;K+DM@S%UK>66_,9;4S!*;1L)TM&</T(KMY7*(]$'
M%[F3VL4#&C++\H%1I8?``]ZR6V]4MUY93PUSY,=7)I[8I$;\_%^4OTK8FTTN
M?4@EUKT"*IAULZM@B%0=LS6W"I-@]Y0I_(F6>P-]J$7MS/%Y4VQHEJ>F_P`[
MVM)I!.5CE<L%GLAOM-TH;.ZIN2;UU,&FUD]!H^9A.D>?8ZXIE;*U*Z=1:;#T
M!.PIC=F&&B#[08M[L[K/P;4N6KR)2]WME5-5KMTCG)%0,4^CT;/?96]*5SLA
ML^F)50LY,F2SWD)\L72"O)HXE''J]C,]\/\`>M;T<$(M3;.A+BM&O21XX1UT
MQUE&F6S(.RQ>+\N16,/$'MJ:QJ81TKCN23Z84@_,\K0.07A'+&F4V8\+W!RT
M9M4ZJ5.AJ1#V`/A?*FU)C'Z?]41VXX3?+79_3A5E1.#5M7+X[F=#V*<EMR*U
M.]S200M%=[88Y[16F>A<+!=O:G.8#3#RE6P#WL.M:QY7,X-;!O@[G3:=*E^`
M2+V*/K:6=MD:^5[[XZOZ:H96WO[X(7O7B)@/331?HMIW_`BMC#L(-;`'PFW_
M`$:BQO\`2AX=1N,0<5=2FO\`\D>,E7`7N$BE$A=6N4\P*@MQ>H1-D1R\)<F<
MD9+=HM,[G_\`J:<!@]%G!_<^2^5_V>52-SUP?4/-CM84BADROJ6RFQ:^AM3*
MY9;EW3NTY1&:RKL^9JX'"H:^R]Q<'!D:HHNL!V4)C=C.6B/5;,./-$$.]+W6
MENH=-]'[@(J$0J"QZDD,&20NFK.H,V1P!Q50Z=SVL[CK0RK+%:+8F[)[K([0
M7R%C$!:-<]*%BPIZ)`X%F!4ZV/;R[E\JS=@^E7Q_8DLN>>K8W.HS-[[;N<$E
MARV!V5+H>_*'+D^3-4MI*5LB]H<"C(_,8T\,"`1SBE]F>M`A)"?L?E\=R=UB
M;4I17@WGB$\]7/S5&VN;HH5T2&?*+PEJRRYP^W#9S]9[(7&IS+I;;\@>W6>N
M4L>H\26A"MVMT8C1DE$)=$%$E``\KNFW=1#.?22X4F)3P0QT^13A,AK.+U2^
M%4"YJ*6*=X]!+5@]TP-U<B8&%H)736$V%7R!8V/9H1N:8`U!.CME*#`;OEW+
M.ZQDVGTN.4V<J#%DI[=7CBG0;/U/*EK_`'=9<D=[SO>+BCA\(G70CZ_R%Q>[
M<,K]?#VE2PH')0)L:36X@*=.`H'L]O*IY5F(+Z:/+5>6^SVXP-=BG$Q"?3FV
MJVIY[M:=/G/E3VQ9@)"&>V56E+N3P?"HK*Y#N8/(]#+3B2MYKPM,0$I1J3!;
MGE3:B]B]'/BEAC<]AFFFW7J&S&GY9S]'(I)[OL>1L%+4A.I4S326UA12!V?%
M(*TC+W((VVC,]UV-4!.VI4I9P$I!9.KY5?*ISUZ>O+F[1?[:/A3DL?I/9-L6
MP]L2Z2O"N#KIG>E*,%`VXL,AYR@;/I!/:]C:<+@DT#W8UQ$<M\FE!YHQ3RO1
M-JOQ?HL\!AHY-SJ=7,O652CIQFHA*QKK-FJI:17;!T`OZ9:D1;X:Z[=].R6U
M7(X_W_VWO8T`]HQC$GWL&[Y]V[ZKY7=2/,_3`YIEDC13-J=;PJ^9MMMW%=3;
M+Z=NR=5I(V^97Q'H5%K+(1.4;<4IJ>,O3'7[626V!\$B;1&]EA#L0L>53RK.
M/_IH\D2>40:;/D(?%\NKCKMP[@A\B',I$!U:[[>6UH:WQR]Y+6@VIB3X0P(1
MJV,W0VX\](2:(OVA8!:>5_T>5_TLQ4U&5[2:VW5\!0.*%3>%P2*\[`$O=USJ
M%=84I88M&GA>W@6FF!:6XUJAJ$($A'E(+&`0@AUL8O&6ZFZAL?"?.X]*0B89
M%X*^Q$7=AWA+GW6]]$(!MYB9^#O2K]S'=";"O%HU_`1:UO6P?9WCRO\`K%VH
MPFOIA<V3"3$SAO>;TK:=)[FNJ^$LVJ2\)[74J2SWH-DB$>M/:=XC[DG4E1Z0
M-,&;BPMVM^ZI_8[V6$.QB\;Y4VLG(/3+Y.DR]V=7:,2XUU?IMTM.WAR*GTF(
M6.+EUW5I%0WTU*C2UNM&QF915"C.^'[U[ND=$"5:3H"@@`]/*GE6'!Z8=`:J
MV`U@?/>FEQ]/RXF9TA:B_HRRE=UT@X%P@NMSF>KK-.=1/T=AKE!]&MRUC%L]
MI6DJ#=GIS!["(+RN[P>5;C"/3KYGK5+%"X&US^+.L.JCH2I6V7MEI3K4\6H^
MII3%IU>$^?9PI>E$H?+>F4XAR)WW*%"H;JD7A$8G-+UL(0O*FVKG1QD3QF/,
M4;2+'9P2Q]F:V1,O?G1:^/BY.U(2$!*QY>G$T]P>'926GT-0J/&,Y0<(1@Q;
M$+>\RC,X#`8#`8#`8#`8#`J?WI_@9[/_`#3^BO[H)CE[?VGVLZJU>B9_M'>G
M7^:;3_W+H\O?^U7N_:NHN99<#/10_MW];[_EPO#[DH3F^[I/IOOZ3Z=\\PP8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8%3^]/\#/9_YI_17]T$QR]O[3
M[6=5:O1,_P!H[TZ_S3:?^Y='E[_VJ]W[5U%S++@9Z*']N_K??\N%X?<E"<WW
M=)]-]_2?3OGF&#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`J?WI_@9[/
M_-/Z*_N@F.7M_:?:SJK5Z)G^T=Z=?YIM/_<NCR]_[5>[]JZBYEEP,]%#^W?U
MOO\`EPO#[DH3F^[I/IOOZ3Z=\\PP8#`8&GV&L5-\`G"]"H.2+4,/DRQ&K3CV
M6>E5)F5:<G4$&!_=%G$G`T((M?9T+6MX(@6MZ#@3S7<"=W-UMY8Y.L+BSDX*
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MF>E<PM-M6.#>.<R.1'MAJQ"VIRSM)QE`-T07Y];V`.]/0O197(A@,!@5/[T_
MP,]G_FG]%?W03'+V_M/M9U5J]$S_`&CO3K_--I_[ET>7O_:KW?M747,LN!GH
MH?V[^M]_RX7A]R4)S?=TGTWW])].^>88,!@,#1K._LUL/_[&EG_T!PP3JU>(
M2N,P2@(M-YH_-,6A\.I]CE,KD[\N3MC''8W'X8E=GQ\>7)6,I*WM;2V)#3U!
MQ@@EE%%B$+>M:WO'JOJ][A=E3MD,K^Q%,\CXX+:KQ7##7$L0*A.K%,G.WG!J
M:ZS*87%K+6)UJ>:+GQ(!"HUOW<S2@`MCT#?FQE1FX]8\(E<ML""1Z1(G2758
MNCS98#&0!2%7&%TKCJ*6QU,O$<060,;K'7$E47LH9FM%F:T+>A>(=!N^!#]P
M=`4G0#?'G.Z+/AU;)9<^`C44U*7E,WJY,_#(&K&UL#=L0W!X5)D10U!^DY1F
MDR8`CC=@+"(6K);T)+>C::ZLB#VU$D$\KF1(I7$7-=(&U`^MP5(4BI=%I$[1
M.0)R]*R$Q_F;)$QJTH][!H.S"1;#L0=Z%N9G4;O@,"$;7Z2H2C$[PJN"VH/7
M13"VQEV=-2E\2MAQ".:/#S'X?HI,:+WE8LE3W''!*W)B`&*5IR(\))8]E#\M
MDMZ+);T2PP/S/*6)ED\><$SNP2-I;7YC=48]F)'-G=T9+@V."4S>@[&F6HE`
M#`;\->(1:R(RV`P,2M?V)M<V9E<7II0/,C,7$QYI6N*-*YOQK6C&XN93,@/.
M+5.AC<WEB//"0`>R20[&/P#KQP,M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@08V?XEIM_P"QE7?=]<&7T7T3GD0P
M&`P*G]Z?X&>S_P`T_HK^Z"8Y>W]I]K.JM7HF?[1WIU_FFT_]RZ/+W_M5[OVK
MJ+F67`ST4/[=_6^_Y<+P^Y*$YONZ3Z;[^D^G?/,,&`P&!HUG?V:V'_\`8TL_
M^@.&"=52KUY_E_4?&D%HN+6`FK-NG#51H;#D^V)'(W0VLH^KB\HF498&AW(6
MQQ6Y31"R!:#0NJ96VB;UJD)R<[6]%BLN75ERZYJA]&^]"7JD6Y3T-`Y3%Z.>
M(0V5Q/)#%).W6U4=>U=T+9=Q14BJV^+.K16K9,)3$K%0QQ\.$W$H"T\*91)2
M-%A"4DUY1KRC&4[Z)]E1-M<$LLN*NHNL.C<Z2,ZVGVNRT6V.RW/DZO>;X7?6
MM/\`+0'NUE-4LARR;J-J3-EE/+GL1)FU96UYJ]Y>YZD/HX6TECL49@V##TZ=
M-370%83ID+L2?FM;@AML#N:TQJI5B.O67=`MI4E6$/*]WCR(!Z@K:IF6MSLA
M4:-*>4/)>(CD#H^%)^([#@]AT9*;RY=HR94%.4<TKMSAU33F-V8GJ@^52:`-
ME?&Z459*&!WJ%!I`%*@.0K6Q4J2&$I0F%#)FSGVJ;.5(9+Z,EM$UO84#KNXZ
MM92+?1^:U$;I$7X]OE4J'<W65E(I^0>L,?Q,,NC#=?,93I5B1,6O.*B0D)2M
M"2>G4)-><WF+Y/C:_I4VS%(A+[-03\=I3YQ='V16G%&>/2F5+NDF45T\F6##
MZIGK(]V5$B'Z`MC-2\J1."0+BG'M/*E(B`'>V6)ECR/*-#I?T@^B'RO(N^6]
M.#VQ[DG*3O5[K6)EM3&'/%8O$B9K$:3JR+F4,;;!7.==K0S9*Z+R0O*Q,C?4
M6Q"3/.@$J`KW3T]R]T]/=<Z/^GIT/%HU2M@E6O2DLZ>H&>U3(XHI>ZY=(W1D
MHA=<\PR[G84#6Q&('HU=>F`7VS+Y(U.#,G-):W)>7H*$1`S2=3RG\)L_A&DG
M]*6[K'M^?V'/KG@6FJR)JQ3.?$,9%DCD%I,#E<_-]H/U'6(J52%,WJZEJ!@I
MAYC\#TF*+/VAD6_>BDW_`*@%R>4AY<<(U4>B!+1UXJKI-<T63,:N$N)1Z`M-
M8@4!MN%4/U=4D1M`PL,JT<)SB;Q<T*7I!>?VB<F#)0%;`,A"(AY\ZOE^6Z+_
M`$?[.26/%'^,7LE;(#$Y-<[G#(4WNDLCY52);#E:J9-JZ#'>YR1:O/>U;DI;
M9.W!5LR=T;_*$:@TH1J4;RX/)@_T*SHT,\%0MDDK21AAHI*A)0.JNRXDXMJ"
MS>%J[YEMN0P>Q&1>^2R#S^5V_!#9E\23E&F&&NAQQ^QK@B-->?\`G\IY.B/)
M-%6/R)3QS9/FZ%6G*V^'5;&U#E14))B,EEHXBVJV+1+E''!XC4``FBZ%<2F1
MG-B1E"K2ISE1Z8*@[1();M2W4^?/F_?Y=N@?YEKC\9^90^?-^_R[=`_S+7'X
MS\!\^;]_EVZ!_F6N/QGX#Y\W[_+MT#_,M<?C/P'SYOW^7;H'^9:X_&?@/GS?
MO\NW0/\`,M<?C/P'SYOW^7;H'^9:X_&?@/GS?O\`+MT#_,M<?C/P'SYOW^7;
MH'^9:X_&?@/GS?O\NW0/\RUQ^,_`?/F_?Y=N@?YEKC\9^`^?-^_R[=`_S+7'
MXS\!\^;]_EVZ!_F6N/QGX#Y\W[_+MT#_`#+7'XS\!\^;]_EVZ!_F6N/QGX#Y
M\W[_`"[=`_S+7'XS\!\^;]_EVZ!_F6N/QGX#Y\W[_+MT#_,M<?C/P'SYOW^7
M;H'^9:X_&?@/GS?O\NW0/\RUQ^,_`?/F_?Y=N@?YEKC\9^`^?-^_R[=`_P`R
MUQ^,_`?/F_?Y=N@?YEKC\9^`^?-^_P`NW0/\RUQ^,_`?/F_?Y=N@?YEKC\9^
M`^?-^_R[=`_S+7'XS\!\^;]_EVZ!_F6N/QGX#Y\W[_+MT#_,M<?C/P'SYOW^
M7;H'^9:X_&?@/GS?O\NW0/\`,M<?C/P'SYOW^7;H'^9:X_&?@/GS?O\`+MT#
M_,M<?C/P'SYOW^7;H'^9:X_&?@/GS?O\NW0/\RUQ^,_`?/F_?Y=N@?YEKC\9
M^`^?-^_R[=`_S+7'XS\!\^;]_EVZ!_F6N/QGX#Y\W[_+MT#_`#+7'XS\!\^;
M]_EVZ!_F6N/QGX#Y\W[_`"[=`_S+7'XS\!\^;]_EVZ!_F6N/QGX$PQ=]/DC$
MA>E,=D$4/6Z/V-@E!+:G?4'L5)R<.EQ+2YO+>#9X2M&@]FI,\2QAWOP%XAT$
M6-G^):;?^QE7?=]<&7T7T3GD0P&`P*G]Z?X&>S_S3^BO[H)CE[?VGVLZJU>B
M9_M'>G7^:;3_`-RZ/+W_`+5>[]JZBYEEP,]%#^W?UOO^7"\/N2A.;[ND^F^_
MI/IWSS#!@,!@:-9W]FMA_P#V-+/_`*`X8)U>:I/[*:R_]O87]S;;@O5(6`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&!!C9_B6FW_`+&5=]WUP9?1?1.>1#`8#`J?WI_@9[/_
M`#3^BO[H)CE[?VGVLZJU>B9_M'>G7^:;3_W+H\O?^U7N_:NHN99<#/10_MW]
M;[_EPO#[DH3F^[I/IOOZ3Z=\\PP8#`8&C6=_9K8?_P!C2S_Z`X8)U86N'AI9
M*AK!8\NC<T)!0.$D!5.BU,@3B/'&D`@$A/5FE%;-&$L6]!\?'>@[_P##'J7J
MV/YPH!_3B'_UF9?Y;ERA\X4`_IQ#_P"LS+_+<90^<*`?TXA_]9F7^6XRA\X4
M`_IQ#_ZS,O\`+<90^<*`?TXA_P#69E_EN,H?.%`/Z<0_^LS+_+<90^<*`?TX
MA_\`69E_EN,H?.%`/Z<0_P#K,R_RW&4/G"@'].(?_69E_EN,H?.%`/Z<0_\`
MK,R_RW&4/G"@'].(?_69E_EN,H?.%`/Z<0_^LS+_`"W&4/G"@'].(?\`UF9?
MY;C*'SA0#^G$/_K,R_RW&4/G"@'].(?_`%F9?Y;C*'SA0#^G$/\`ZS,O\MQE
M#YPH!_3B'_UF9?Y;C*'SA0#^G$/_`*S,O\MQE#YPH!_3B'_UF9?Y;C*'SA0#
M^G$/_K,R_P`MQE#YPH!_3B'_`-9F7^6XRA\X4`_IQ#_ZS,O\MQE#YPH!_3B'
M_P!9F7^6XRA\X4`_IQ#_`.LS+_+<90^<*`?TXA_]9F7^6XRA\X4`_IQ#_P"L
MS+_+<90^<*`?TXA_]9F7^6XRA\X4`_IQ#_ZS,O\`+<90^<*`?TXA_P#69E_E
MN,H?.%`/Z<0_^LS+_+<90^<*`?TXA_\`69E_EN,H?.%`/Z<0_P#K,R_RW&4/
MG"@'].(?_69E_EN,H?.%`/Z<0_\`K,R_RW&4/G"@'].(?_69E_EN,H?.%`/Z
M<0_^LS+_`"W&4/G"@'].(?\`UF9?Y;C*'SA0#^G$/_K,R_RW&4/G"@'].(?_
M`%F9?Y;C*'SA0#^G$/\`ZS,O\MQE#YPH!_3B'_UF9?Y;C*'SA0#^G$/_`*S,
MO\MQE#YPH!_3B'_UF9?Y;C*'SA0#^G$/_K,R_P`MQE#YPH!_3B'_`-9F7^6X
MRA\X4`_IQ#_ZS,O\MQE#YPH!_3B'_P!9F7^6XRA\X4`_IQ#_`.LS+_+<90^<
M*`?TXA_]9F7^6XRA\X4`_IQ#_P"LS+_+<90^<*`?TXA_]9F7^6XRA\X4`_IQ
M#_ZS,O\`+<90^<*`?TXA_P#69E_EN,H?.%`/Z<0_^LS+_+<91L;>Y-SLD+7M
M2]$YH3MCT4L;U1"U(;LL8BS-%J$QAA(]EF`V$7AO?@+6];^SD$,MG^):;?\`
ML95WW?7!E]%]$YY$,!@,"I_>G^!GL_\`-/Z*_N@F.7M_:?:SJK5Z)G^T=Z=?
MYIM/_<NCR]_[5>[]JZBYEEP,]%#^W?UOO^7"\/N2A.;[ND^F^_I/IWSS#!@,
M!@:-9W]FMA__`&-+/_H#A@G5K,&BT8E]-U>URR.,,H;"X-!UA;=(FAO>D(%A
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M?:SJK5Z)G^T=Z=?YIM/_`'+H\O?^U7N_:NHN99<#/10_MW];[_EPO#[DH3F^
M[I/IOOZ3Z=\\PP8#`8&C6=_9K8?_`-C2S_Z`X8)U>:I/[*:R_P#;V%_<VVX+
MU2%@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@08V?XEIM_[&5=]WUP9?1?1.>1#`8#`J?WI_
M@9[/_-/Z*_N@F.7M_:?:SJK5Z)G^T=Z=?YIM/_<NCR]_[5>[]JZBYEEP,]%#
M^W?UOO\`EPO#[DH3F^[I/IOOZ3Z=\\PP8#`8&$DK,&1QQ_CPU`D@'YD=68:H
M!>C1I@NB$]")0`H0@!,$3H_S:#O>M;WKP\=8$&1F$='1B-Q^-);3I-4ECS(U
M,:92HHR=!4*"&E`0@)//"5T($H)QI:?0A:#K0="WOPUX9>!G/@G2WTF4;^`Z
M??ZAL<!\$Z6^DRC?P'3[_4-C@/@G2WTF4;^`Z??ZAL<!\$Z6^DRC?P'3[_4-
MC@/@G2WTF4;^`Z??ZAL<!\$Z6^DRC?P'3[_4-C@/@G2WTF4;^`Z??ZAL<!\$
MZ6^DRC?P'3[_`%#8X#X)TM])E&_@.GW^H;'`?!.EOI,HW\!T^_U#8X#X)TM]
M)E&_@.GW^H;'`?!.EOI,HW\!T^_U#8X#X)TM])E&_@.GW^H;'`?!.EOI,HW\
M!T^_U#8X#X)TM])E&_@.GW^H;'`?!.EOI,HW\!T^_P!0V.`^"=+?291OX#I]
M_J&QP'P3I;Z3*-_`=/O]0V.`^"=+?291OX#I]_J&QP'P3I;Z3*-_`=/O]0V.
M`^"=+?291OX#I]_J&QP'P3I;Z3*-_`=/O]0V.`^"=+?291OX#I]_J&QP'P3I
M;Z3*-_`=/O\`4-C@/@G2WTF4;^`Z??ZAL<!\$Z6^DRC?P'3[_4-C@/@G2WTF
M4;^`Z??ZAL<!\$Z6^DRC?P'3[_4-C@/@G2WTF4;^`Z??ZAL<!\$Z6^DRC?P'
M3[_4-C@/@G2WTF4;^`Z??ZAL<!\$Z6^DRC?P'3[_`%#8X#X)TM])E&_@.GW^
MH;'`?!.EOI,HW\!T^_U#8X#X)TM])E&_@.GW^H;'`?!.EOI,HW\!T^_U#8X#
MX)TM])E&_@.GW^H;'`?!.EOI,HW\!T^_U#8X#X)TM])E&_@.GW^H;'`?!.EO
MI,HW\!T^_P!0V.`^"=+?291OX#I]_J&QP'P3I;Z3*-_`=/O]0V.`^"=+?291
MOX#I]_J&QP'P3I;Z3*-_`=/O]0V.`^"=+?291OX#I]_J&QP'P3I;Z3*-_`=/
MO]0V.`^"=+?291OX#I]_J&QP'P3I;Z3*-_`=/O\`4-C@/@G2WTF4;^`Z??ZA
ML<!\$Z6^DRC?P'3[_4-C@/@G2WTF4;^`Z??ZAL<!\$Z6^DRC?P'3[_4-C@/@
MG2WTF4;^`Z??ZAL<!\$Z6^DRC?P'3[_4-C@/@G2WTF4;^`Z??ZAL<#U02`3Q
MKGLGL&P9C$I(YOD1BD-0((;!GB&-[<@C+S+GL:M7M[G\\4N2U>IE>P:\@TQ9
M0"-?N1['O82IHR(8#`8%3^]/\#/9_P":?T5_=!,<O;^T^UG56KT3/]H[TZ_S
M3:?^Y='E[_VJ]W[5U%S++@9Z*']N_K??\N%X?<E"<WW=)]-]_2?3OGF&#`8#
M`8#`8#`8#`8#`8#`J;TD3;ZQRC""L%TG;35#.Z;2K8S[/>B7O4IA(%1KP6LV
M%L/`FB1CB8E*4;\AF]'^&MC"#+,6-'ETRON"JZNJR#)`/?A3<:DLS>S&XB2S
M6.)(@\,4.GJK3*<\:&]RN1)YFG<V0D>CBE)T:="OX2,P!6..IPV&"V)TRZ(W
MYOE%>FMSZVUW/'UJ7G1XI&SND@*9:Z'5R`8@2107M\?%ZJ0&.K:49L*$TC1`
MCBPA(,4,A<1U,))VB2F?XPU)U^UP([)4L>F++`XV:-T&-BFBXV2J?>WE8TL<
MEC3HG8TK*VC),(=]J3?:@,_?#$=X.&)?I?V4_P"W5M41]R961586D309%(HJ
M'*`M2"PF`ID1NS@O.C[<UP^45B)0Z+7-(<L4-[F4<D-&7L92#;@X21.9IU8J
MM";L,"B9[1!&E$<>ROSJQM+R)R<&2$O[VC2LQ@U#2E$W3>3@0-YFS#UZA)K1
MFM^YC,!L$XSY.'BU,^BK2I^RFUC;`M\P768Y4Y')'$G5OC`4$=CKB-LG5L-$
MF6:E29`>8F2N!#2'W14),[D$`&6+0AB`XTZ5&JN9]GKGYC<G>*RR+?#XBJ:)
M<W1B)-$L:F8Q634!"Z5QD?RB0D6!*%TI2R0M&C&G"%"R_P`)V64+RZ67A>'J
M9I'W&RLD8;5:1`G!JNG!6<O>H8[R-T2O+,W.;2%C<=1@4N6+),,#4W.2=:I4
M:)6*G14#V*S2<!&/ZIPD_<DOZ55K*QO\8GS$K16/#3EZ>.$MK)-E54+?@#I+
M&"'"0F)51LJC20\]"XKD1YFW$TI4:RJ`F&)2$\XTXUKDF>.D861.W6M&:<2>
M+R$",J`,TD0F.4FA^TD&I%&V/KJJDRA_ECB2N>3Y$6Y(CDAZK9Z<1V]%&;.4
MCO'\G#4[!N#K&!0_<JDZ=NCY;H4L6DD(X>PNBUED^EED(XG7+<TJ)>6ID:&2
M@8V,U:J+--7$Z6#V3Y`F^*1D,C(IIKV@][0L3[&1-9DY>Y%#%0HI'UR,^J27
M`]I(4SIVECTA;FAYCL40B7?!OA9QJU8I&F,$-:7I1M*X.&:0OM_1J(Q\,<CU
MJ.%AG+U8+2-FZ)7+6UTL9*VEF,K)$@*Y`FBL:IJ3NYBDL]Y8P%EMB(I+[4LM
M0,X0'"\?PR"9S[.W[@4I4-WC(#V<A:I+@+&#Y%D*FFMWQX5I2Q2LS3J:C<WJ
M0-)/O&A@"6WEFC"89K8CIPG#!_*_N,#PU,0F2/@2F,+2<=*#H@89\0<WQ(E5
M2H`6IM7K6IH5U^M<"BFP"US2$N*<E1H?O9X="#?ZG#;XI(>FFRR&1)*RI!((
MT[2AG;71`1#6)M;VZ/%1UX:C9,EDB0*I$D3'/31IS=4"H\M7L:PD*`S0-:2*
M)P<8CA\GO9"JR7)R88'(T+(U.TQ9X2Q.+,W*V*1[62>OTZ!IG3LG5M)+&QA9
M&5S7(WY,0NVE`I&5I4>,6TYUXPX>LRQ^W0LBL37`2W0)S>-Q(>GN*HXX^MVV
M1%'`S%J'&4SV[[4.*MZF"L,:V40J"K210\1@5.U:<U2SM.$ES2V;6;ZA@JEM
M*="K)5S5@@LU4Q^L7IX-,<3H2XR5P4Q**2H<84+D8EY:5.>I&'92;>E0?)H9
M(M`F<G"'=3GN!A*E"4Z!"W_Z:\N#24D(42-66]RB>N"S:]"Z[;9"A&TP\:\2
M,IL&8<H&P%)S"$_CYSRK_5>&]P>PNO7>PH6T2>%(V6(GOKF.7/RV.KD[<H),
M1Q]9N--"-"E<W-H(CR%8L()<ERG2)R=DPA%+#DPBT^3A.'O=9-ULRGR)X&UF
M2!H//=4C7'66),B)Q8TKF[66B;'I.YB<I`K=M15LCL<5C)^'*SU@757H"<XP
M28A/>#AX*W>NN7"<U5);(8AH8V]MTC9Y^RM36C3EPT6VVK#(V?IL^41_Q<3_
M`"8M\$L<Q:,/:$@=$$I/9F'JBEST.'TD=@=8)G=6"/Q)>K4ERZ9)$S,?"40X
MR:G02UH;X<VCE/QE*:&+.]8GJWPYXT,9OQLK2(04X@A;SW!PQCA(NV&IQ84!
M9D?6HUZ5P]^D:^N%YR1`O;H17JGV:Q@AZJ0N9Q3J_.\D.3;]NC+"I;4B01IF
MO-I:X.&ILUS]9R%4\!3Q.4-;2T+4C/+=BK=E>Y+"Q%P2`O;2HCA1#VUM]AOT
MDESVX)7<C2=(!H;M`-]W3&$[]NX.&2FLD[840MR(4,:IM<)4QR+1Y<"BS4Z.
M\+?Q_.8T1V*L2@<J+,5M3P-K8CU+Z:;HQ!I9LT(R0&>9(X7AZI#8?4D)C+A)
M),%+%8FG4J$CJM^3[*[ND+86XNNQIY"U[D$QUN7/DB=G]Y2^ZJCM``G1A$47
M[0GP5.$F/O(YSU;[U"I;!8\\.RN5T%4[H]1\^)IA0TB7'(+-=K$6`-5R@A3'
M9:P#7LVT37L6@NXQE)!J!A`(]&X.&Z0N==7+#YT%UA!*MI05=+7&KG%[CZ*-
MNTML9N>'0J+-TO;2I*#Y/I7F)`95NP>Q1^9R7N:8S:0*`D`W!PR=723IAVF+
M,=+4)X*Z`\:9PFO,*;8Q)7Z/*F:S5XIE(41+VH/C+NWOS"Q-Y:$H@`#$R[:@
MPOS*`A23@X1.6N[*BZ"6O[<8^S9P.7_)T;5)(RRH-I$*)^FQCC.8XG9S#23U
M35'B&\IO2IF\XEU$(`S"E!QFM!O"\-_L:3]<-L=A;E$&]@6K=P:&BFH4,4=%
M!/RL?')0!^=4"-4G5RDM+'R424)C:%H&I]@XG&[\HTP0AG"3&FOT^[K+<A(&
MZ$1)&!$FGK4F=-,#@YMLG?XTB2C8W@I(B7+CFM@EY+B8<U`7*VK6EC?[%6>$
M)FBS+_4X;8U3'K`FW&.'JV9,XUZBFCLB>['<8HK;$$D9B0QK:9N;V9L;E3@Q
MB3,ASD9\24&@:UCT`'L5>TV]H0SC#C&CV;*NN%26SFN/1R3EH0JK`CK+,XU&
M`FNRA$>U2-5!`PV*N#\R'E!"\C;&I<ZJ0B$$7MUJ=8%(,LU)>#AO<4E71SG$
M7TFQ&(QBF)=HQ5)"D+`@??8H6YMGC$D=T3V^[1)6Q\BKE%5/MM*BS%>CDVUV
MS#M&%`+*G!PO!D0P&`P&`P&`P&`P&`P&`P*G]Z?X&>S_`,T_HK^Z"8Y>W]I]
MK.JM7HF?[1WIU_FFT_\`<NCR]_[5>[]JZBYEEP,]%#^W?UOO^7"\/N2A.;[N
MD^F^_I/IWSS#!@,!@,!@,!@,!@,!@,!@,#\Z`'0MCT$.AB"$`AZUKS""#8]@
M#L7AX["#9@MZU_TUL6__`!P/U@,!@,#\@``L.@`"$`=>/@$`=!#KQWO>_#6M
M:UKQWOQP/U@,!@,#YF$E'>3VI19OLC`G%^T`$?LS0>/D-!YM;\A@/'?@+7V=
M>.!],!@,!@,!@,!@,!@,!@,!@,!@?,THH\&RSBBSB][#O99H`F`WL`M#!O8!
MZV'>PC#K>O\`PWKQP/I@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@5/[T_P,
M]G_FG]%?W03'+V_M/M9U5J]$S_:.].O\TVG_`+ET>7O_`&J]W[5U%S++@9Z*
M']N_K??\N%X?<E"<WW=)]-]_2?3OGF&#`8#`8#`8#`8#`8#`8#`8#`8#`TFR
M;)@-.P"8VI:<N88#7-?1YTEDUF<H<"&I@C4=94IBUS=G1>I$$HA,E3E;W_W$
M,7@$.A"WK6P@3EWM*DNPD$G=J8)MGX/&$\><?C-F41<M+M4G8966Z'1V305;
M;4'AI,VCKH4SGB"J;=J`%!T#9OL]&E;';+.JV6=5L-[UK6][WK6M:WO>][\-
M:UK[.][WO[&M:UD1$4UO2M8/(W6!KGX+U:3=4LQN]'4,6)%(+2DE<P96A:GM
M[B\,1;VZ/.AO[JD;$H0:U[TXJBB"][&+>M7%QND%EA$\A,.G"=DD\93S.+1^
M5)XW-V-5%YFP$R%H2/!3)+8TO_AT>D[46K]@O0G?OJ14684/]T#>1&U8'\UO
M6_'6MZWL._`6M;\?#?AH7AO_`,-^&];_`/AO`@"$=*5U/^A;SYF82I&&QN>X
MI3TQGIZ]I*31D]GO!),ED*^3KP%<<8ZJ@%09=I:`1!.DXO9ZT(?GWY;G&F<:
MG_6];WO6MZWO7AXZUO7CKQ^SKQU_V\<@>.M^/AO7[G?@+[/_`$WX:WX;_P##
M?AO6_P#X8$`4_P!)UW=UA=&UG#"9(5).7;19ZBLL3XTE-S<=*GRMH7:B$V,*
MBURH;PS[B\\0^8\9:<6E/M`:!O0=#%<7$@UK:E<7'%`SJK)I'I]#3'R51LJ3
MQ=Q(=60Y]@\F=H9+FTAP3B$G/41^5,*Q`I\@A!`I3&`\?$.\G1.C1>G^BZ^Y
M(H&TND;5*D1U=U#&C)7+"HFU%/<C&UE+$B$06AI.6MQ2Y7[9:#P`(\O7E\=^
M/V,LFW(LFW$Y)U):E,2K!Y@%'DEGZT;KR#``P&A^!H=[WY!@UOP%K_MO6\B/
MO@1B]VBB8[3K^JAPZQW1984<G$D23ACA;FZ5?%R8,*.A4-4ZG2?_`-)BK_)?
ME&#;*D4?OCGI(J]E_P#IQY<XT2=K>M_]-^/V=Z^Q_P".M^&]?_'6]9!^?,'R
M[%Y@^4/F\PO'7EUY=[T+QW_TUY=ZWX_^&!%EZ7#$N>J6MJ^9Z6\'0>F*VFUJ
M3`F.H`.K^9&(!&W*5/X65L,4HRW!S^%-1VR21&E!,'K6MC#KQWJR;<)S<;3!
M)DSV)!H;83!I6!@G,3CTR9=.)`4B\#/)F=&]MNEZ8)IP$RL*):#VH-#'H`_'
M7FWX>.0;7L6M:V+>]:#K7FV+>]:UK6M>.][W_P!-:UK`_N!_-"#O[&MZWO\`
M=?8UO7_R[\HO_P"46_#?_AO`_N!_-;T+7B'>MZ\=Z\=;UO7B'>PBU]C_`+A%
MK>M_^&\#^:$'?V-"#O?ET+PUO6_W._'P%]C_`.7?A]C>!_=;UO\`Z;UO[.]?
M8^S]G6_#>O\`XZWK`C2RK/15F""C5P^Q9E\N[,B%8)P5Q#'*:&1=;,3U!!$P
MG`&S[,6KIA]W\[L\J/X,WEC`(S[`M8&F6)TE7=8WESMSW)"Y$9/>GC[83UL:
MUM12R/D&TS""+`E^I0Z"7$&,WM&!0'W+RDG[4'^(-^37[K+G&K);+?9/VMZW
M]G6];UX[U]C?C]G6]ZWK_P".MZ\-Y$?W`8#`8#`8#`8#`8#`8#`8#`8#`8%3
M^]/\#/9_YI_17]T$QR]O[3[6=5:O1,_VCO3K_--I_P"Y='E[_P!JO=^U=1<R
MRX&>BA_;OZWW_+A>'W)0G-]W2?3??TGT[YYA@P&`P&`P&`P&`P&`P&`P&`P&
M`P.=/JP<TV?UQP7=U(TRF8W>S70ZM9K$XC*7,MFB]B+ZGM:$6H.LY&ZGA$E;
MFFPTL-,:!G'^"8L2L(C]Z)T/>M=MRZO;<NN??8TXZ"[EJ6DMN/I_]GQ6GZ4Z
M3JR7]H<L2XNMXU+>AZE50JR&UQB=5*8?<9[;=<6JNSQ,#T\-)JQJ22-$22$@
M*G83$X;,[;UFM3)>LU4"M?3@O:V'SE*)W[SY:R;D]L?/5EE,-H2;6$M<E5#T
M?;`J@5<=4?<*MCGSB<Y+TJUG=7%G9/B+NGCPP)DPCPC1%Z!J]TFY>>%\I.G7
MAI,1X(Z$8U7&UO6MR5;5@WM)?1?M7F25V0C5ML@G-4=GL<%;66N7>WG%3.T*
MQK,4UFG<8ZB>B0N18UZK19W[Z,)X'EUSIIL_C6'G_IO=4R^J+JGKA1ER+>@:
MMX%]'5GY17)INN0N\9Z.IY)M/T*IAJ5%-4K2"QH:E2%)'=P5:V(Q(8<04<:6
MH/"8\IO7C:;-^-6BE-(]G(NGGRJ&_FZ\W6)JO78JSN_Y_F][B9E,)>8'6I8W
M&1E)E)T\3RYQ=8]+VY06\,!;3HA&07M0,6]&%:,FS/\`^J;,_A2"K?3W]1YO
MIKL5A0(.@X;UX^\G]`U]9;NDAT>@M>=7V!++CBDF1/Z3J3734R=[,M"10Q$[
MDQ!XU$8QN/-CTJ;5AB`(2"-V]W;_`!JVS^'6OTB.=G&I>J>[[)B/'5Q\:<XV
MQ7/&+?2E?7*K9Q/8W&O8M;#;99"%G;)[8)\62M\B>"A"0G+`[-&I]^T6`2P8
M`Y[[Q)NU.Z\3G:YGCY>[_E5N]86*5R1/J@F%Q<E^K+5UKME=QN+QBNYS9LY9
M@KN54K+81EY3:9W^[RDPC2Q!)71N843,Y+S4"$I(3[8@C6]O$].%V-DL?TY^
MH*VK^\8+1M%70KJBQ.3?2GF5^UHP62X%R+H^PZKO>2N?;\!;7Y_G8%0[JFU*
MDID3P;I6A+?4_LT?O`Q&:#I.Z;SUY)W>_7ETU](CF-RKM)ZC[9*N7;%YOHCH
M+IPB1TU3]O+FQ8_'TF[<Z53"5*100R2^8?`6LYR:W%,6T"<!F,I/@A#Y`IPA
M#GONYSMQGNO3W<FJEX(G].5+0E961Z>E]SGGFB^P.VE?95`5F-C4CZ3'/E\J
M'Q3?$%9=VVPH;NJZI80N2-!Z(]8W*&Q>I)5C1*#$`S@[MEYWG&K?GT=#9?RO
MV6Z__P"O%:O+LQA\TF74<BI6R&.#52LFJ&9V,P1I\MEV?Z:J1ZL):\JD$@EU
M<U0I:6=6XC7G@">WB\#SO9Z-'C9Y[Z)L\M<[IAP_UZ^17I=;SIRG?G/W)3S>
M7";W..2+*6L=FSFZ!U/'K.2]73MBJ\5_-;39$:?I(_0Y0Y-9TN:`V/N-GJ-C
M-&+11^MGK>>5V<;U=<*EYBG+7Z-=N\\RMY[$1J)K%+Z211GB5?Q6N^I:V@TZ
MF<A6QR`UA79MUV(U-39%FU?LF/,RZ8#5EQL1"`TQ,:#V1>;?[;PS;_;7,*.<
MH>H6LI2I$,$HI/RR_0KCOUC*T@$CBZ1JH&/,SO9B.E$W,MJVO!?G3GK11=LV
MX5&W9>H(*>G%)'E90U8CDGFV6'6]O^XUO;_N*I1*@Y):JSN;G_E;F"\**6E\
M?>DJW2*BRKB99--FB9)^US)9<LV0R"#VO,V6%NS_``*-N+P(X#ND=WA$A&]#
M3%F+P>UO3+;O7_Q?:U<*_P#T_.H8:@OFLJ>I*=G\51/U.F.WT=!-<<!=+/.*
M"DO&$48%T@AE-2&[*P-M"$1GJ%0I=G6+FR)O$:Z>=S*2JQ)/8FR=T]>N).Z?
MSB!^C/3]ZD<J=10N=<U=C=I-SIZ6L]I'CI>XN,3K^;\R])K;.MJ0F"N.(`Z"
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M^$'XY'X,SZ/"IVO&/V2?6]C$/[&VS_\`Z;Z)LG?OHJ[<_IO7=`_4"9$-70^\
M(U0D>?>0%'&EJU-7J6]5%"LE?2;Y1WQ$Y#9%A]25T]4VVSJ>+79UF:E:Q2KY
M;,3\<5L9ZE,4B"G=/'E?*>/RV</!7?X[`[`HNOVZ0P2K.5:N[YD7IIVJHGQC
M:WS.VO4&1)GV%L:!=MU/<F0?+36Z2^+MZY<``6PU_3*"1>5.$6GEV\;\;_">
M4X_C5=*O].[H.1T8U5ZFJGJ6#0F<]K^G.?;]**:[;>:6.&PV`.4V9NG;)@;G
M$^JKKDDAW(X6])44SDJ58T_'AI4RQ&!0HV><"WNF^G2KL_TDFWN$.L8[T7WU
M#N&*7LM"V6?R[;,)A5\78RLT#D5).\?K6J8/4E%\==!([D='664U93#&5J`E
ML<X^TGPY>7[^)S+,,%L269+?=)9DUTH]'#GV=4E!^D5#U%[RJF(SV0P)5&*2
MGM(1KGR.0&21^!&,4X>J?AK3T7T4<,,Q."W[=W(]>WIG)[0&+2"CM*#5!F>^
M[B=UURTY>XWZVA33!X1&.;K?05G!O5(X.MM%>5M0]BJWK"XH!&7JV'J]I3TX
MT,%RV"RV$UU(>_MY!,K*$WFR4I<9KW`T"8`]:MEY]<K5L_TC2EN"NU$%I46I
MC7+M\U1V+!(/ZKD>Z-[>F\[9U]:VI?EXUE8C7S';$6>RK'DCP[MZA6Z(`HG@
M+&WB8"3"VT03-$>0I>Z9_P#KQP6S^.'4'T/.8+AH1?;3Q8,1O"GT[Q55&Q"8
M5+85.1NL:]<[GB!<M#,[.B3^V=+7^XVO/78I:%+))?[NR)),4!N4^4Y0`X).
M>^R]$[K*_P!".88,!@,!@,!@,!@,!@,!@,!@,!@,"I_>G^!GL_\`-/Z*_N@F
M.7M_:?:SJK5Z)G^T=Z=?YIM/_<NCR]_[5>[]JZBYEEP,]%#^W?UOO^7"\/N2
MA.;[ND^F^_I/IWSS#!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,#'NS2U/S4YL3ZV-[TR/3>L:7AG=D:9Q:G9J<4QB-P;'-O6%G)%[>O2'
M#*.)-`,LTL>PBUL.]ZP(EI'F[GSFA@<XKSO2%44;&WMSV]/3'4\`B\`;'=V]
MEH@+DZ(XNV-A+@M*3ZT4`P[0Q%E:T`.]`UK6K;;U-MZIJR!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"I_>G^!GL_P#-/Z*_N@F.7M_:?:SJ
MK5Z)G^T=Z=?YIM/_`'+H\O?^U7N_:NHN99?Y<H5T!*/1G[A]1-JZ.YPZ7L/F
MGMKHC\KFA^@^=J<D=UL22236,MK78M5V$UQ()[M%GQA=F@'N/M"Q>\)P[-UK
MV9H!ZW<[NV6=8W>9*M)^T3<3_0AZAGU%KP^TV9\:SA^T3<3_`$(>H9]1:\/M
M-CQIA^T3<3_0AZAGU%KP^TV/&F'[1-Q/]"'J&?46O#[38\:8?M$W$_T(>H9]
M1:\/M-CQIA^T3<3_`$(>H9]1:\/M-CQIA^T3<3_0AZAGU%KP^TV/&F'[1-Q/
M]"'J&?46O#[38\:8?M$W$_T(>H9]1:\/M-CQIA^T3<3_`$(>H9]1:\/M-CQI
MA^T3<3_0AZAGU%KP^TV/&F'[1-Q/]"'J&?46O#[38\:8?M$W$_T(>H9]1:\/
MM-CQIA^T3<3_`$(>H9]1:\/M-CQIA^T3<3_0AZAGU%KP^TV/&F'[1-Q/]"'J
M&?46O#[38\:8?M$W$_T(>H9]1:\/M-CQIA^T3<3_`$(>H9]1:\/M-CQIA^T3
M<3_0AZAGU%KP^TV/&F'[1-Q/]"'J&?46O#[38\:8?M$W$_T(>H9]1:\/M-CQ
MIA^T3<3_`$(>H9]1:\/M-CQIA^T3<3_0AZAGU%KP^TV/&F'[1-Q/]"'J&?46
MO#[38\:8?M$W$_T(>H9]1:\/M-CQIA^T3<3_`$(>H9]1:\/M-CQIA^T3<3_0
MAZAGU%KP^TV/&F'[1-Q/]"'J&?46O#[38\:8?M$W$_T(>H9]1:\/M-CQIA^T
M3<3_`$(>H9]1:\/M-CQIA^T3<3_0AZAGU%KP^TV/&F'[1-Q/]"'J&?46O#[3
M8\:8?M$W$_T(>H9]1:\/M-CQIA^T3<3_`$(>H9]1:\/M-CQIA^T3<3_0AZAG
MU%KP^TV/&F'[1-Q/]"'J&?46O#[38\:8?M$W$_T(>H9]1:\/M-CQIA^T3<3_
M`$(>H9]1:\/M-CQIA^T3<3_0AZAGU%KP^TV/&F'[1-Q/]"'J&?46O#[38\:8
M?M$W$_T(>H9]1:\/M-CQIA^T3<3_`$(>H9]1:\/M-CQIA^T3<3_0AZAGU%KP
M^TV/&F'[1-Q/]"'J&?46O#[38\:8?M$W$_T(>H9]1:\/M-CQIA^T3<3_`$(>
MH9]1:\/M-CQIA^T3<3_0AZAGU%KP^TV/&F'[1-Q/]"'J&?46O#[38\:8?M$W
M$_T(>H9]1:\/M-CQIA^T3<3_`$(>H9]1:\/M-CQIA^T3<3_0AZAGU%KP^TV/
M&F'[1-Q/]"'J&?46O#[38\:8?M$W$_T(>H9]1:\/M-CQIA^T3<3_`$(>H9]1
M:\/M-CQIA^T3<3_0AZAGU%KP^TV/&F'[1-Q/]"'J&?46O#[38\:8?M$W$_T(
M>H9]1:\/M-CQIA^T3<3_`$(>H9]1:\/M-CQIA^T3<3_0AZAGU%KP^TV/&F'[
M1-Q/]"'J&?46O#[38\:8?M$W$_T(>H9]1:\/M-CQIA^T3<3_`$(>H9]1:\/M
M-CQIA^T3<3_0AZAGU%KP^TV/&F'[1-Q/]"'J&?46O#[38\:8?M$W$_T(>H9]
M1:\/M-CQIA^T3<3_`$(>H9]1:\/M-CQIBOG5GK7Q+J3G2Z>:.+>+^^+HZ(O^
ML9S3D#C\FY8L"K(.Q*[(C3C#E$RG<\FQ#<S1^+Q9*\C6GF#WL(O8Z`,1)8A'
M`UV]O.WB19)O-X=L^!>>GGDWB;E3FF2.25XDM(4/6E<R5R0"V8WJI'&XNWHG
M\;<:(!8CFX+N`X*<8@A$,D(1;UK>]ZUGNNVU+=NK<Y$,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
6@,!@,!@,!@,!@,!@,!@,!@,!@,#_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
